Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.6903543184598641,1.9978814844873147,0.0,0.07721326070226796,0.07,12/57,5.49%,JPH2;TAGLN;TWIST2;ACTA2;LMOD1;ADGRA2;SERPINH1;ITGA8;TPM2;COL5A2;MSRB3;IGFBP7
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.9009288759935027,1.932606193181004,0.0,0.09375895942418254,0.15,2/11,1.38%,JPH2;RYR2
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.5835032404449613,1.864476514597231,0.0,0.16545698721914562,0.33,16/80,8.72%,JPH2;LMOD1;CSPG4;HEYL;NOTCH3;NTN4;ITGA7;FKBP9;PLS3;COL5A2;ARHGEF17;TNS2;CAP2;ADCY6;CHST3;PTPN21
prerank,PanglaoDB_Augmented_2021__Myocytes,0.6345126262238151,1.8578137985784857,0.0,0.1433960555899262,0.37,11/41,4.70%,JPH2;LMOD1;LDB3;PRKG1;MEF2D;NOTCH3;ITGA7;TPM2;SYNPO2;ITGA3;RASL12
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.9142112152039856,1.8518719113376496,0.0,0.11692293763486292,0.37,4/12,3.37%,JPH2;RYR2;CACNA1C;MCU
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.6630220434758183,1.827022949259571,0.0,0.1433960555899262,0.46,11/44,9.68%,MYH11;ACTA2;LMOD1;MYOM1;DTNA;TPM2;MYLK;ITGB5;GJC1;MYL9;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.8373596236062316,1.8257736557827484,0.0,0.12448668562202385,0.46,1/9,1.38%,RYR2
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.5861663288814841,1.8227494941917577,0.0,0.11719869928022815,0.51,26/95,8.39%,JPH2;TAGLN;MYH11;NOX4;SLIT3;ACTA2;LMOD1;PRKG1;NOTCH3;COL14A1;ITGA8;TPM2;COL5A2;SYNPO2;SLC38A11;RASL12;OBSCN;MSRB3;IRAG1;TNS2;GJA4;MYLK;PRRX1;GJC1;RBPMS2;MYL9
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.9105320280929521,1.7676430091937025,0.0,0.2218349236049286,0.76,4/8,4.85%,CTNNA3;RYR2;CACNA1C;BIN1
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.5691078448323611,1.7582747258049887,0.0,0.22281540945511613,0.8,16/76,8.72%,TAGLN;MYH11;ACTA2;LMOD1;COL14A1;FKBP9;TPM2;COL5A2;SYNPO2;RASL12;TNS2;MYLK;SMOC2;PRRX1;MYL9;PTPN21
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.8144166151315166,1.7456756379290879,0.0,0.24066470868239365,0.84,1/12,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.812660966343201,1.7454610583997996,0.0,0.2224477272612958,0.84,3/12,5.02%,LMOD1;CSRP2;OBSCN
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.839468854606419,1.7437820525863459,0.0,0.20957885047758448,0.85,2/8,5.60%,CAV2;SKI
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.6502327276863986,1.7249856861718873,0.0,0.261579617889316,0.93,13/30,7.57%,CTNNA3;FILIP1;GALNT16;LDB3;RYR2;SLC35F1;ATP1B2;FGF13;CACNB2;DTNA;ANO5;HFM1;PREX2
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.6071618973538947,1.7187129926029467,0.0,0.27134945903939883,0.93,16/49,5.02%,JPH2;CTNNA3;RBM20;FILIP1;LMOD1;LDB3;SORBS2;RYR2;PRKG1;HEY2;MYOM1;ITGA7;NOTCH1;SYNPO2;RASL12;OBSCN
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.8619732041386425,1.704019823006607,0.0,0.31230006337613736,0.98,3/9,6.98%,SPRY3;DSTYK;SMOC2
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.6626823590099107,1.6981749989341564,0.0,0.3192346576934104,0.99,2/15,2.93%,RYR2;NOTCH1
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.9121491432154509,1.696392573544824,0.0,0.306401828183603,0.99,1/6,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.8367920718306853,1.6894041899727936,0.0,0.3152391019648985,0.99,5/9,3.32%,JPH2;ATP2B4;RYR2;GRIN2A;CACNA1C
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.9123686132177289,1.6719843591203052,0.0,0.3761388842781911,0.99,3/5,6.39%,NSUN3;TFB1M;MTERF4
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.9769897778549852,1.6702911594001626,0.0,0.36453063215900655,0.99,1/5,0.28%,CAV2
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.9288606952019293,1.6671447783699964,0.0,0.3599942934040805,0.99,1/6,0.64%,SNAP29
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.8970248027797477,1.65468067631001,0.0,0.39949469667695164,0.99,1/5,1.92%,ERBB4
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.8651055867500741,1.6535882276065388,0.05,0.3892835227072676,0.99,2/7,7.37%,PPIP5K2;IPPK
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.9102952940118044,1.6480220369004877,0.0,0.395331894795612,0.99,1/7,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.9215456204335672,1.640403038724006,0.03571428571428571,0.41321821936268677,0.99,1/6,0.09%,ATP10A
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.8356668555575143,1.628699597058041,0.09523809523809523,0.4555173845662898,0.99,3/9,12.73%,ATM;UBE2N;UBE2V2
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7862990535520852,1.625127234123489,0.0,0.4542188244373212,0.99,2/8,5.94%,MPP7;ACTB
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.8808591010675396,1.6195676895746796,0.041666666666666664,0.4674635340053563,0.99,1/6,1.01%,SPRY3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.86803792315144,1.6173370677796086,0.0,0.46438261079506876,0.99,1/5,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.6450542281065458,1.6108363831370558,0.0,0.4842730314091553,0.99,1/23,0.08%,HSPA1A
prerank,PanglaoDB_Augmented_2021__Pericytes,0.5456455147388063,1.608744210766369,0.0,0.47982526293552236,0.99,17/94,4.73%,TAGLN;MCAM;SLIT3;ACTA2;LMOD1;INPP4B;CSPG4;ADGRA2;HEYL;NOTCH3;COL14A1;COL5A2;KCNJ8;SYNPO2;SLC38A11;RASL12;GNB4
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.7819796984017298,1.6034834044896693,0.1111111111111111,0.4916913700997237,0.99,3/8,9.03%,CDC42;RHOA;OPHN1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.6427983565966848,1.6032532732978255,0.0,0.47787871014470884,0.99,11/55,6.98%,TAGLN;MYH11;SLIT3;ACTA2;LMOD1;COL14A1;SYNPO2;RASL12;TNS2;MYLK;SMOC2
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.9287779082563674,1.6022936919630915,0.0,0.46800690670558337,0.99,3/5,4.39%,MCAM;MYO1E;ITGA3
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.8607010859629416,-1.592664995835018,0.0,0.5175763483896213,0.38,8/19,6.78%,EPN1;ADAMTS9;KLF2;CEMIP2;VEGFA;RHOJ;ITGA5;GLUL
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.8365627626910553,1.5896286830787987,0.0,0.5129166603793515,0.99,3/5,8.93%,HMBOX1;ZNF618;PARP9
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.8653093421576314,1.579112172579722,0.05263157894736842,0.5574857046843286,1.0,5/8,9.68%,HCN2;CACNA1C;CACNB2;CACNA1D;SLC8A1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.9177050742100259,-1.5786430224299286,0.0,0.46874839099437404,0.53,3/11,2.71%,TBC1D20;SEC24A;SEC13
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.8014426562160466,1.572846136250385,0.047619047619047616,0.5796800060993575,1.0,1/9,1.38%,RYR2
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.6028539510121764,1.5714875062159956,0.0,0.571038730248641,1.0,2/24,1.07%,PPIP5K2;INPP4B
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.769541475227674,1.5681347767216436,0.1111111111111111,0.5733084607143396,1.0,1/15,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.9007336181831135,1.5637971164099111,0.08,0.5778887943849184,1.0,1/5,2.03%,JADE3
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.9417380566967236,-1.5630940102331403,0.013333333333333334,0.5240867427089876,0.73,1/8,0.31%,TEFM
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.8210831532698112,1.5626475122378105,0.0,0.5704326606983877,1.0,1/10,0.02%,JPH2
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.8454596124623501,1.562237915629099,0.07692307692307693,0.5594754870154366,1.0,3/7,2.93%,RYR2;HEY2;NOTCH1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.6032359329024911,1.5572731565401718,0.0,0.5733335299548274,1.0,2/23,1.07%,PPIP5K2;INPP4B
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.8457836150653868,1.5560383251321752,0.10344827586206896,0.5664756999458452,1.0,3/7,9.03%,CDC42;RHOA;OPHN1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.726278974334915,1.552680830493995,0.05,0.5680689894524,1.0,2/9,0.79%,MYH11;ACTA2
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.7610747719871082,1.551584327949894,0.125,0.5602068489249654,1.0,5/12,9.89%,MYO1E;MYO1D;SYNE2;ACTN4;MYO1B
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.6681574897610194,1.5513689225480018,0.0,0.5494550783902461,1.0,2/12,4.06%,HSPA1A;PTGES3
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.8532234919501909,1.5494845665252996,0.12,0.5443197212189036,1.0,2/5,9.44%,PPARD;SLC27A1
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.8480704494451203,1.5476039722651695,0.04,0.5418164808136289,1.0,2/6,1.85%,PRKG1;PDGFA
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.8345954660323827,-1.5426693179671664,0.0,0.6835914035334621,0.82,6/24,7.79%,SRGN;NELL1;ANKH;TWIST1;TGFB1;ADGRV1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.844015068113132,1.5393938857586695,0.07692307692307693,0.5729353714294336,1.0,1/5,0.88%,ST3GAL2
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.8627325463348862,1.5369824472461329,0.03571428571428571,0.5740084710448822,1.0,5/6,10.17%,BCL2L11;NCK1;RNF185;ATXN3;TMEM259
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.8403293270270621,1.5357975536735076,0.03571428571428571,0.5723354903806924,1.0,3/8,9.03%,CDC42;RHOA;OPHN1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.800385198732777,-1.5354416412327383,0.022222222222222223,0.6367165644340248,0.89,10/31,7.96%,CSE1L;SEC13;TSC2;IPO5;IPO9;NUP153;NUP133;BACH2;NUP88;STAT3
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.8646204669184439,1.5296460125132554,0.0,0.5907427247379866,1.0,2/8,2.93%,ATP2B4;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.8501120348381244,1.526550614020983,0.125,0.5946423843694143,1.0,3/6,7.82%,NOTCH1;SOX6;HDAC1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.7307404006693374,1.5263248190599406,0.0,0.5844177155704823,1.0,2/10,7.37%,PPIP5K2;IPPK
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.8494729287068593,1.5252677671198447,0.0,0.5809378662361113,1.0,4/8,8.36%,ADCY9;GUCY1B1;ADCY6;GUCY1A1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.5181591187498926,1.5228942212866463,0.0,0.5817619814981224,1.0,11/64,7.29%,TAGLN;ACTA2;LMOD1;ADGRA2;PRKG1;COL14A1;COL5A2;MSRB3;IGFBP7;MYLK;PRRX1
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.8068099337396412,1.5221614272143662,0.0,0.5735842223597049,1.0,2/7,10.02%,HEY2;MRTFB
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.8304771854717996,1.5203411587497582,0.07692307692307693,0.5735842223597049,1.0,3/6,13.48%,ADCY9;ADCY6;ADCY2
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.6074375923526285,1.518682609984263,0.1111111111111111,0.5694251942656717,1.0,3/19,2.93%,HEY2;HEYL;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.8735618161834027,1.51867651062635,0.045454545454545456,0.5604188276777513,1.0,3/7,10.17%,RNF185;ATXN3;TMEM259
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.5692720183508326,1.5178319413077237,0.0,0.5553751994276508,1.0,13/68,8.72%,JPH2;LMOD1;CSPG4;PRKG1;LMCD1;FKBP9;TPM2;COL5A2;TNS2;CAP2;PRRX1;CHST3;PTPN21
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.8979022299661239,1.5177844016553543,0.0,0.5466974619365937,1.0,1/5,0.56%,OAZ2
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.8903441120752947,1.5136304488110341,0.10714285714285714,0.5532202854711946,1.0,2/5,5.26%,ERBB4;VPS35
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.9569273588278361,-1.5134590867973972,0.0,0.968421155005738,0.98,3/6,3.47%,SLC2A3;SLC23A2;SLC2A1
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.7370470868272038,1.5111683041961446,0.04,0.5545315995890153,1.0,3/8,1.63%,MYH11;SORBS2;HEY2
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.6293820583014552,1.5082672705881535,0.0,0.559590347818782,1.0,8/41,4.39%,JPH2;MYH11;CAV2;ACTA2;NTN4;TINAGL1;FKBP9;ITGA3
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.8442841414041717,1.5069428864698746,0.12,0.5559030345098158,1.0,2/6,5.02%,CSRP2;OBSCN
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.7508050955765155,-1.5068818528475283,0.0,1.0,1.0,8/55,4.09%,STC1;COL4A6;MID1;GJA1;GPR161;TENM3;NXN;EFNB2
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.6595799402957861,1.5066997334491732,0.14285714285714285,0.5489655015560831,1.0,2/21,0.34%,HSPA1A;RBM20
prerank,PanglaoDB_Augmented_2021__Platelets,-0.7619238620997216,-1.5066464628755865,0.0,0.883786028853976,1.0,6/37,4.81%,SLC2A3;SRGN;FHL1;VEGFA;PDLIM1;WIPF1
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.7824185849731741,1.4984216652617524,0.14814814814814814,0.5709431249111364,1.0,2/7,4.54%,ZDHHC15;ZDHHC21
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.7824185849731741,1.4984216652617524,0.14814814814814814,0.5709431249111364,1.0,2/7,4.54%,ZDHHC15;ZDHHC21
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.9716123576701825,-1.4983565754432033,0.0,0.9657084907060022,1.0,1/5,0.88%,PRKACA
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.8206719592500497,1.4978870468932328,0.07407407407407407,0.5653113729987476,1.0,2/8,4.06%,HSPA1A;PTGES3
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.8175816609138491,-1.4936364587781932,0.0125,0.9804653844965658,1.0,4/16,4.75%,RHEB;GPR137C;SEC13;SLC38A9
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.9545422407721289,-1.4893636841294082,0.02857142857142857,0.9836613962533456,1.0,1/6,0.19%,COL4A6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.6786180414225704,1.4892371334368006,0.11764705882352941,0.5974583812461204,1.0,4/15,3.33%,CTNNA3;RYR2;CACNA1C;FGF13
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.7766049434201461,1.4877833900948827,0.0,0.5951979729423861,1.0,1/13,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.9231710848333176,-1.487721048539045,0.012195121951219513,0.9431933770181935,1.0,2/6,3.06%,CD55;CADM1
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.701304120269191,1.4858760359392975,0.09523809523809523,0.5969688098866774,1.0,2/9,2.45%,TIPRL;MFHAS1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.6664657798263821,1.4855717801421837,0.17647058823529413,0.5899847833735324,1.0,3/15,2.79%,ATP2B4;RYR2;GRIN2A
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6999362099895462,1.4854216547751553,0.05263157894736842,0.5828956545408689,1.0,1/13,0.08%,HSPA1A
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.46257127589557995,1.4852175532423886,0.0,0.5758468820139837,1.0,7/62,5.49%,TAGLN;ACTA2;LMOD1;ADGRA2;COL14A1;COL5A2;IGFBP7
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.48761760265756127,1.4844550841442994,0.0,0.5707916993686644,1.0,10/65,3.91%,TWIST2;LMOD1;CSPG4;SERPINH1;TRABD2B;NOTCH3;COL14A1;FKBP9;PLS3;COL5A2
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.6781449502097194,1.4844045497618636,0.13333333333333333,0.5636568031265561,1.0,3/11,2.81%,CTNNA3;CD58;ITGA7
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.9653418738511763,-1.4824796411077772,0.012658227848101266,0.9825687426612841,1.0,1/5,0.19%,COL4A6
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.8625701138242916,-1.4824688834320408,0.011363636363636364,0.912385261042621,1.0,3/15,3.23%,STC1;ADAMTS9;MCC
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.7708954320983485,-1.4804390844485658,0.022988505747126436,0.8958302583448037,1.0,4/20,12.38%,SOD1;NRG1;FGFR2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.813335140657201,1.4799460147441776,0.12,0.5735842223597049,1.0,2/5,5.32%,HSPA1A;SACS
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.6675387347184331,1.479581350314162,0.0,0.5682035073281879,1.0,2/14,4.06%,HSPA1A;PTGES3
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.678855060865091,1.4795126695883518,0.15,0.5616234762956702,1.0,2/15,1.95%,HEY2;HEYL
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.8097253006383816,1.478484362944485,0.11538461538461539,0.5550270857539498,1.0,3/9,6.41%,HSPA1A;BCL2L1;BCL2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.8097253006383816,1.478484362944485,0.11538461538461539,0.5550270857539498,1.0,3/9,6.41%,HSPA1A;BCL2L1;BCL2
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.8429683781522972,1.4743151998625919,0.0967741935483871,0.5626820177754975,1.0,4/6,14.81%,ABCA3;PGS1;SLC27A1;CDS2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.6923824394223415,1.4719589757457345,0.045454545454545456,0.566484152410071,1.0,3/10,12.48%,SNAPC3;GTF3C2;GTF3C3
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.9170778590211157,-1.4718803088187702,0.0,0.993038583525842,1.0,2/9,5.24%,SRSF12;SRSF10
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.7774100085629884,1.471806470105407,0.16,0.5602975249011978,1.0,3/6,17.06%,TRIM44;DHX9;IL7
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.8298034186074656,-1.4714341775680495,0.0,0.9415179078918862,1.0,9/22,9.63%,SLC2A3;BTD;SLC23A2;SLC2A1;MMUT;PANK2;ALDH1L1;MCCC2;MTHFD2L
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.8425027284010433,-1.469235528644808,0.0,0.9228483947701739,1.0,2/18,3.72%,MID1;TENM3
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.5916940902125647,1.4689159462273906,0.05263157894736842,0.5630495078176618,1.0,3/16,4.02%,NOX4;IL34;GPRC5B
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.7831853853003382,1.4674490569928984,0.1111111111111111,0.5630439994701889,1.0,2/7,5.60%,LEMD3;SKI
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.9147784167909847,-1.463785611088391,0.0,0.9816989328939193,1.0,2/8,6.05%,VEGFA;AKAP8
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.7212254181081778,-1.4617404239241343,0.0,0.9746060296091361,1.0,16/55,13.43%,CSF1;F3;SLC7A2;CD55;PDE4B;SELENOS;NFKBIA;ADM;ITGA5;PTPRE;EIF2AK2;SLC1A2;HIF1A;ADORA2B;CMKLR1;IL18
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.7419224393250398,-1.4616900161678175,0.011363636363636364,0.9291262750067057,1.0,9/39,7.96%,CSE1L;SEC13;TSC2;IPO5;IPO9;NUP153;NUP133;NUP88;STAT3
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.7131403473242093,1.4608486950987822,0.06896551724137931,0.5827964795235547,1.0,2/12,1.44%,CAV2;EDN3
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.7547702239888718,-1.458593035422937,0.0,0.9521451692073223,1.0,7/39,6.85%,GNPAT;SOD1;SLC23A2;CADM1;DHRS3;ESR2;SOD2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.6523679397695107,1.455413506373669,0.08695652173913043,0.5992420450154274,1.0,5/15,9.68%,SCN1A;HCN2;CACNA1C;CACNA1D;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.6449467460560577,1.4543919482684313,0.043478260869565216,0.5962381897854085,1.0,3/16,4.02%,NOX4;IL34;GPRC5B
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.9324746183336782,-1.4511277866832308,0.0,1.0,1.0,3/10,3.47%,SLC2A3;SLC23A2;SLC2A1
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.9260872367088726,-1.4508703414927313,0.029411764705882353,1.0,1.0,2/5,6.19%,VEGFA;NCAM1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.7545407994546486,1.449059411799951,0.2413793103448276,0.6101959812337285,1.0,4/6,16.38%,ATM;MAP2K2;DYRK1A;PIKFYVE
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.9610340006951026,-1.447316675282946,0.0136986301369863,1.0,1.0,2/5,3.04%,TAF7;TAF1B
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.7391474982894183,1.445747154017198,0.09523809523809523,0.6165449839534478,1.0,4/10,9.89%,MYO1E;MYO1D;ACTN4;MYO1B
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.9412999775604289,1.4451266011861785,0.0,0.61207595202527,1.0,3/5,2.93%,HEY2;HEYL;NOTCH1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.7346066253320344,1.4448415405548012,0.034482758620689655,0.6065619036611153,1.0,1/5,15.90%,MEF2C
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.9139886096884419,-1.4448247823656484,0.0,1.0,1.0,2/10,5.24%,SRSF12;SRSF10
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.894293421420197,-1.4437464770360335,0.0,1.0,1.0,3/7,1.75%,EPN1;ADAMTS9;KLF2
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.7371022778300654,-1.4435850369027206,0.011363636363636364,1.0,1.0,11/44,7.96%,CSE1L;SEC13;TSC2;IPO5;IPO9;NUP153;NUP133;NUP88;ALDH3A2;PEX3;STAT3
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.9143293741708848,-1.4399506320873081,0.0,1.0,1.0,2/7,6.42%,TWIST1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.5276672993583368,1.4379857369029738,0.0,0.6277235494701873,1.0,1/22,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.6223468423745342,1.4373557711782083,0.11764705882352941,0.6239455410284279,1.0,1/12,0.33%,ATP2B4
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.8895319066124758,-1.435747805022854,0.011764705882352941,1.0,1.0,1/9,1.40%,NRG1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.7855598552751807,-1.434631687581504,0.012048192771084338,1.0,1.0,4/19,3.64%,ZFP36L2;IFITM3;IFIT3;CD44
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.8096908206898654,-1.4323039361223158,0.011494252873563218,1.0,1.0,5/18,8.95%,ZFP36L2;ZFPM1;TGFB1;ZFPM2;ANKRD26
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.881641340346475,-1.4302280624511567,0.0,1.0,1.0,1/8,0.09%,STC1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.8905884792454553,-1.4292748624113982,0.024691358024691357,1.0,1.0,1/7,1.64%,NRCAM
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.8952382766294318,-1.4286228934918577,0.014705882352941176,1.0,1.0,3/7,7.09%,VEGFA;TSC2;LGALS3
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.8556512353303105,-1.4280544189660886,0.02631578947368421,1.0,1.0,3/11,5.24%,SRSF12;STRAP;SRSF10
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.7656509701978167,-1.4270440823081953,0.0,1.0,1.0,9/28,12.45%,RHEB;EPM2A;SEC13;TSC2;SLC38A9;DDIT4;UBR1;NPRL3;C9ORF72
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.7610204751472592,-1.4257696963220254,0.02197802197802198,1.0,1.0,10/26,12.50%,SOD1;HOMER2;NDUFB9;SPTBN4;COL11A1;ADGRV1;CEMIP;KCNQ1;DCDC2;GRM7
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.5072798318089892,1.4244560045266927,0.0,0.6648061746465272,1.0,1/22,0.08%,HSPA1A
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.7132709716858429,-1.4242450104191648,0.011494252873563218,1.0,1.0,8/32,13.18%,TBC1D20;SEC24A;CSNK1D;SEC13;CNIH3;ANKRD28;USO1;GOLGA2
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.7132709716858429,-1.4242450104191648,0.011494252873563218,1.0,1.0,8/32,13.18%,TBC1D20;SEC24A;CSNK1D;SEC13;CNIH3;ANKRD28;USO1;GOLGA2
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.7132709716858429,-1.4242450104191648,0.011494252873563218,1.0,1.0,8/32,13.18%,TBC1D20;SEC24A;CSNK1D;SEC13;CNIH3;ANKRD28;USO1;GOLGA2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.9246880537267905,-1.423992886764102,0.014084507042253521,1.0,1.0,1/5,3.80%,SELENOS
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.8899875949132122,-1.4237974983055797,0.0,0.9849620987125001,1.0,3/7,6.50%,TMSB4X;NFKBIA;SUFU
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.7214092790236663,1.4218975522766408,0.08695652173913043,0.6681622757800217,1.0,3/11,7.72%,PDGFA;CDK6;CDKN1A
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.7119720725584757,1.4207523081144577,0.045454545454545456,0.6663699053884806,1.0,5/9,9.68%,SCN1A;HCN2;CACNA1C;CACNA1D;SLC8A1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.8833403392607602,-1.4196315941520101,0.04819277108433735,1.0,1.0,3/8,7.72%,GJA1;KDM1A;EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.9020928611752054,-1.4188068825825044,0.0136986301369863,1.0,1.0,1/7,3.80%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.9020928611752054,-1.4188068825825044,0.0136986301369863,1.0,1.0,1/7,3.80%,SELENOS
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.7186809968209545,-1.4177921134802178,0.04938271604938271,1.0,1.0,7/25,11.29%,SLC22A6;SLC23A2;SLC7A2;SLC38A4;SLCO1A2;SLC7A14;SLC3A2
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7259098231269842,1.417137262261268,0.07142857142857142,0.6763924474279117,1.0,2/8,2.93%,ERBB4;NOTCH1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.8517225679205719,1.4168984621859013,0.11538461538461539,0.6705250469227171,1.0,1/5,4.65%,SNAPC3
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.9277349600392842,-1.4161146665148443,0.075,1.0,1.0,2/7,1.32%,TAF7;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.8398941044422646,1.4149303138996707,0.13333333333333333,0.6725432585250605,1.0,1/5,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.8612226184246307,-1.4145445439905397,0.05333333333333334,1.0,1.0,2/7,8.64%,CRY1;STMN1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.8668434836361981,1.4126046780627972,0.125,0.6754599396474682,1.0,2/7,2.76%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.8658520124130882,-1.4112179881785103,0.012658227848101266,1.0,1.0,3/10,8.10%,ADAMTS9;ROBO2;ROBO1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.755158183511779,-1.4108546263161197,0.02197802197802198,1.0,1.0,10/27,12.50%,SOD1;HOMER2;NDUFB9;SPTBN4;COL11A1;ADGRV1;CEMIP;KCNQ1;DCDC2;GRM7
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.897842282558331,-1.410316074431285,0.04054054054054054,1.0,1.0,4/7,9.35%,WWC1;SOD1;WWC2;LATS2
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.9027601872834577,-1.408809142437726,0.0136986301369863,1.0,1.0,1/5,2.05%,NR4A3
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.8809768225380423,1.407965584734909,0.08,0.680007790682143,1.0,2/5,1.44%,ACTA2;EDN3
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.8809768225380423,1.407965584734909,0.08,0.680007790682143,1.0,2/5,1.44%,ACTA2;EDN3
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.8821263401501427,-1.4078988794586589,0.02702702702702703,1.0,1.0,6/8,11.51%,TAF7;SELENOS;HDAC2;TGFB1;AP2A1;TMEFF2
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.8350799476286204,1.4071519498626306,0.06896551724137931,0.6760967165817198,1.0,2/5,3.75%,SOX5;SOX6
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.9178490996277353,-1.4066000455811662,0.0136986301369863,1.0,1.0,3/6,4.85%,CD55;TGFB2;CFH
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.8617449231819483,-1.4061526176781736,0.023809523809523808,1.0,1.0,2/8,7.09%,STC1;LGALS3
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.813809145137319,-1.4058301378245046,0.0,1.0,1.0,3/15,3.80%,OS9;SEC13;SELENOS
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.8405695966717852,-1.405464579939133,0.0684931506849315,0.9917126519241607,1.0,1/10,0.93%,SOD1
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.6987684334705686,-1.4035092616528488,0.07317073170731707,1.0,1.0,9/31,10.11%,CADM1;TGFB2;NECTIN2;TGFB1;CDH20;PRKCI;CDH18;CDH12;AFDN
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.7651686940679525,-1.399175367958872,0.043010752688172046,1.0,1.0,9/23,12.81%,STC1;NKAIN3;SYT1;SPTBN4;ANK3;NEDD4L;SNX6;TF;CA2
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.8131498143828592,-1.3977610459208991,0.08860759493670886,1.0,1.0,2/10,4.64%,WASF3;WASF1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.7842441226044377,1.3968022344745905,0.12903225806451613,0.7030679787239972,1.0,2/6,5.47%,MCU;DAPK2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.7842441226044377,1.3968022344745905,0.12903225806451613,0.7030679787239972,1.0,2/6,5.47%,MCU;DAPK2
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.9189502076006613,-1.3962540646368642,0.013888888888888888,1.0,1.0,3/5,6.85%,SOD1;KLF2;SOD2
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),-0.8928010590790263,-1.3962420912135056,0.0375,1.0,1.0,1/6,1.64%,NRCAM
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.5984188333538342,1.3942980633852882,0.13333333333333333,0.7049649491158597,1.0,1/16,0.28%,CAV2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.8111933228310542,1.3929722043701207,0.1111111111111111,0.7039975173005771,1.0,1/6,0.33%,ATP2B4
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.6914048762658891,-1.3928324345995238,0.02197802197802198,1.0,1.0,8/37,13.18%,TBC1D20;SEC24A;CSNK1D;SEC13;CNIH3;ANKRD28;USO1;GOLGA2
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.8813601127103753,-1.3920507983645103,0.012658227848101266,1.0,1.0,3/8,3.64%,TWIST1;KDM1A;CD44
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.8707349490648753,-1.3919866796596332,0.07317073170731707,1.0,1.0,2/7,4.64%,WASF3;WASF1
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.802011248132914,-1.3897454269412979,0.08974358974358974,1.0,1.0,4/9,13.86%,TTC8;ADGRV1;TRPA1;GNAL
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.7501096032046124,-1.389077854292988,0.03333333333333333,1.0,1.0,3/21,6.22%,PRKACA;SELENOS;PDK3
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.7574905770395812,1.3879967901654602,0.10344827586206896,0.7184316550305008,1.0,1/6,1.01%,SPRY3
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7496963588508574,1.3877863768265009,0.13793103448275862,0.7129517599999474,1.0,3/9,2.93%,HEY2;HEYL;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.8907648459984954,-1.3871512504096342,0.023529411764705882,1.0,1.0,3/7,6.42%,EFNB2;TGFB2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.6971221470049714,-1.3852668494265556,0.02247191011235955,1.0,1.0,13/39,21.05%,GJA1;KDM1A;LPIN1;VEGFA;CMKLR1;SCD;IL18;PPARGC1A;PRLR;ACADL;KDM3A;APPL2;TSHR
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.6473157351981377,-1.3850488100003175,0.0,1.0,1.0,15/85,13.18%,TBC1D20;SEC24A;COG2;SEC13;CD55;SPTBN4;ANK3;PROS1;COG7;CNIH3;ARF4;USO1;NRBP1;GOSR1;GOLGA2
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.7762623667232194,-1.384675235353827,0.04878048780487805,1.0,1.0,3/17,9.35%,WWC1;STK4;LATS2
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.9020242615314648,-1.384014703542308,0.0273972602739726,1.0,1.0,1/5,0.09%,STC1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.9083381375294628,-1.3822818416369722,0.0,1.0,1.0,2/6,6.73%,PLEKHH2;LIMA1
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.8437533552325508,-1.381554904305042,0.0958904109589041,1.0,1.0,1/8,4.62%,PLAA
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.8321976704540954,-1.3804305922577822,0.023809523809523808,1.0,1.0,3/11,8.96%,KDM1A;CTR9;DNMT1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.8365525004490566,-1.3802161515926255,0.013333333333333334,1.0,1.0,3/12,12.36%,SRSF12;SRSF10;PTBP2
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.6284252996310318,1.3796622752031797,0.0625,0.7415135553648837,1.0,1/16,0.09%,ATP10A
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.8523285127623436,-1.3790026424874127,0.04054054054054054,1.0,1.0,1/7,1.75%,KLF2
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.8666578122847879,-1.3776825972447444,0.02666666666666667,1.0,1.0,2/7,2.08%,GJA1;KDM1A
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.886817403643886,-1.3773213432703157,0.04411764705882353,1.0,1.0,1/5,2.40%,F3
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.7370024864710504,-1.377142096764238,0.011764705882352941,1.0,1.0,5/33,7.21%,GNPAT;SOD1;SLC23A2;SLCO1A2;FADS2
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.923092698467805,-1.376604210767264,0.0,1.0,1.0,1/5,2.08%,KDM1A
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.910613123612629,-1.3765852282739737,0.0,1.0,1.0,2/5,3.60%,SOD1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.8894107830277237,-1.3752829904358164,0.03896103896103896,1.0,1.0,1/6,0.93%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.7359854682766422,-1.3737082531235436,0.03529411764705882,1.0,1.0,8/27,10.69%,PRAG1;CRMP1;EFNB2;OMG;HDAC2;SPOCK1;CBFA2T2;MT3
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.4093406204716986,1.3732708663382742,0.0,0.7594051464673607,1.0,11/71,6.34%,ARHGEF10L;LMOD1;SORBS2;HEY2;CDH6;DACH1;RASL12;IGFBP7;TNS2;SMARCD3;GJA4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.7825557558202234,-1.3730889056379005,0.06593406593406594,1.0,1.0,3/15,3.16%,STC1;PRKACA;PDE4B
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.4808408605790622,1.37255003203698,0.0,0.7551195156815019,1.0,15/70,7.29%,MYH11;SLIT3;ACTA2;LMOD1;ADGRA2;PRKG1;COL14A1;ITGA8;COL5A2;KCNJ8;SYNPO2;MSRB3;DLC1;MYLK;PRRX1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.8006481562942154,-1.3713668842593012,0.011494252873563218,1.0,1.0,3/15,6.22%,SELENOS;PDK1;PDK3
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.7001995622999821,-1.3707523855401336,0.022222222222222223,1.0,1.0,10/35,16.16%,SRGN;CTSL;F3;CPD;SEC11A;SPG7;PITRM1;C1R;C1RL;APH1B
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.41894481451600923,1.370584155171409,0.0,0.756096719745978,1.0,15/76,8.72%,TAGLN;SLIT3;ACTA2;LMOD1;COL14A1;TPM2;COL5A2;KCNJ8;RASL12;IGFBP7;TNS2;MEG3;PRRX1;MYL9;PTPN21
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.6773735167937831,1.3693942044179652,0.045454545454545456,0.754300020622394,1.0,4/11,6.92%,HSPA1A;BCL2L1;BCL2L11;NCK1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.857180277503409,-1.3692341013790703,0.08333333333333333,1.0,1.0,2/6,3.60%,F3;VEGFA
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.6132193565846492,1.369178460718917,0.0625,0.7488865840249483,1.0,1/19,0.09%,ATP10A
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.8158588560905375,1.3678405034188221,0.14285714285714285,0.7475400930753531,1.0,3/5,16.90%,TRIM25;IRF3;ANXA11
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6727595378509986,-1.3670338897902587,0.02040816326530612,1.0,1.0,36/74,24.97%,PELI1;IFITM3;IFIT3;PDE4B;NFKBIA;CFH;HERC6;SOD2;EIF2AK2;STAT3;PTPN1;CD38;LATS2;MT2A;EPSTI1;HIF1A;PTPN2;C1R;PSMB2;CMKLR1;CMTR1;VAMP5;SP110;C1S;RNF213;NAMPT;DDX60;IFI44;STAT1;BTG1;IRF1;WARS1;MARCHF1;HLA-B;IFI44L;PSMA3
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.7762521601651999,-1.3668970262479698,0.08433734939759036,1.0,1.0,5/18,10.20%,PLEKHG4B;CRMP1;EPHA7;UNC5D;FGFR2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.8140208144365204,-1.3668660132637367,0.03488372093023256,1.0,1.0,3/11,3.64%,TWIST1;KDM1A;CD44
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.4350356950910269,1.365692944078984,0.0,0.7487264966355809,1.0,13/123,4.20%,TAGLN;NOX4;TWIST2;SLIT3;ACTA2;LMOD1;IL34;EDN3;SERPINH1;COL14A1;ADAMTS10;COL5A2;SYNPO2
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.9136803651377278,1.3654166849598055,0.09090909090909091,0.7438447995303741,1.0,1/5,0.28%,CAV2
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.7264211374838945,-1.3647382347473804,0.060240963855421686,1.0,1.0,5/23,8.10%,ROBO2;CADM1;TENM3;NECTIN2;ROBO1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.7601165426430128,-1.3643900425790774,0.06329113924050633,1.0,1.0,4/19,7.79%,NELL1;TGFB2;TGFB1;ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.8265022069359627,-1.363609282780244,0.10526315789473684,1.0,1.0,4/6,10.69%,ITGA5;PRKCB;HIF1A;MT3
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.7892403636887851,-1.363408510316974,0.06097560975609756,1.0,1.0,3/15,3.64%,TWIST1;KDM1A;CD44
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.9125430501124581,1.3610772957887756,0.08571428571428572,0.7544838617193039,1.0,1/5,0.33%,ATP2B4
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5367491378651882,1.3602676510362317,0.0,0.7514723694651566,1.0,3/19,2.93%,PGF;NUS1;NOTCH1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.8147484280172739,-1.3599997074787686,0.043478260869565216,1.0,1.0,1/8,2.33%,UBA5
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.7695895818676701,-1.3595503655866674,0.07954545454545454,1.0,1.0,2/16,6.22%,PRKACA;PDK3
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.8284978184756628,-1.3573533395803614,0.013333333333333334,1.0,1.0,3/12,10.19%,WWC1;MLPH;SHROOM3
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.6258873129410966,1.3571591065582755,0.11764705882352941,0.7560646056391929,1.0,1/13,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.7410920800230487,-1.3565311890679448,0.034482758620689655,1.0,1.0,4/16,10.20%,STC1;GJA1;SLC10A7;FGFR2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.8080243301606703,-1.3559715107138752,0.0375,1.0,1.0,4/11,4.75%,KLF2;VEGFA;IPO5;SLC38A9
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.7413667189912179,-1.3559550737075747,0.011904761904761904,1.0,1.0,5/22,7.38%,PDE4B;SELENOS;PLAA;PDCD4;CTR9
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.9233604210662907,-1.3558723576434442,0.014285714285714285,1.0,1.0,2/5,3.80%,TMCO1;SELENOS
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.648161536519487,-1.3548928644796112,0.010309278350515464,1.0,1.0,23/76,19.87%,STC1;SOD1;ENO1;COG2;GLRX;VEGFA;CD44;PGK1;PDK3;RARS1;HDLBP;STMN1;DDIT4;ADORA2B;HSPA5;GLCE;LDHA;GPC4;PYGB;PAM;NT5E;DLD;EXT1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.7950310645828217,-1.354802306106185,0.06172839506172839,1.0,1.0,3/12,3.49%,FHL1;DPP6;ANK3
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.8196372103967934,-1.3542792656625933,0.1125,1.0,1.0,2/9,6.61%,VEGFA;ITGA5
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.7800953713461181,1.3527642320731543,0.14814814814814814,0.7659279700019617,1.0,1/5,1.44%,EDN3
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.7991162088201708,1.3524982476934957,0.17391304347826086,0.7605035887995252,1.0,2/5,8.00%,BCL2L11;RHOT1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.8110556793220287,-1.3517459883098504,0.03529411764705882,1.0,1.0,6/14,15.74%,TGFB2;TGFB1;STAT3;HIF1A;JUN;TEAD1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.747268507697487,-1.351511182657236,0.0898876404494382,1.0,1.0,5/22,12.84%,KDM1A;HABP4;NFKBIA;TGFB1;JUN
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.8164565075463781,-1.3514999696906818,0.06172839506172839,1.0,1.0,1/11,0.43%,NELL1
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.8799726801666081,-1.3508043207229856,0.06666666666666667,1.0,1.0,2/6,10.20%,TWIST1;FGFR2
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.7653793289749424,1.3506341483778974,0.1,0.7543659788785372,1.0,1/5,4.14%,MYO1E
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.7653793289749424,1.3506341483778974,0.1,0.7543659788785372,1.0,1/5,4.14%,MYO1E
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.8924363198185701,-1.3505794143774388,0.028985507246376812,1.0,1.0,2/5,4.25%,SELENOS;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.676338489914078,-1.3497557918586354,0.011235955056179775,1.0,1.0,13/43,21.05%,GJA1;KDM1A;LPIN1;VEGFA;CMKLR1;SCD;IL18;PPARGC1A;PRLR;ACADL;KDM3A;APPL2;TSHR
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.6072152072459212,1.3496140061101716,0.0,0.7524114711723168,1.0,4/11,6.20%,MYH11;NTN4;LTBP3;TNXB
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.7735339253940496,1.34949525792332,0.14285714285714285,0.7473347928981058,1.0,1/5,7.44%,CHMP4B
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.7569712963847771,-1.3490539169388274,0.0449438202247191,1.0,1.0,7/21,15.76%,NRCAM;DIP2B;OLFM1;MT3;SIN3A;GOLGA4;ZFYVE27
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.788753188602666,-1.348714284045352,0.06493506493506493,1.0,1.0,4/15,11.96%,CSNK1D;TTC8;IFT122;IFT57
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.905477976275243,-1.3478052351480123,0.06944444444444445,1.0,1.0,1/5,0.43%,NELL1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.8615392391996892,-1.3456470375291054,0.0821917808219178,1.0,1.0,2/6,3.60%,KDM1A;VEGFA
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.7493406545385917,1.3451405482067476,0.12903225806451613,0.7568216619367288,1.0,1/8,1.36%,LEMD3
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.573922006323554,1.343874818682726,0.07692307692307693,0.7556277618778561,1.0,7/23,14.42%,MYO1E;MYO1D;NDE1;ACTN4;MYO1B;DYNC1I1;TRAK1
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.7992106026662352,-1.3438482762739994,0.06329113924050633,1.0,1.0,3/9,10.61%,NECTIN2;LGALS3;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.5572404108263755,1.3437583864216305,0.11764705882352941,0.750314994492312,1.0,3/25,2.57%,HSPA1A;RBM20;WDR75
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.7037486478845757,1.3432854820163878,0.1935483870967742,0.7466900727349667,1.0,4/7,10.92%,LRCH1;DOCK8;RHOA;CXCL12
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.8925710609845356,-1.3430126437874297,0.0875,1.0,1.0,2/6,6.05%,TWIST1;AKAP8
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.8217454253347425,-1.342974814659194,0.047058823529411764,1.0,1.0,3/13,4.30%,ENO1;CRY1;PGK1
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.8963186165323594,-1.342786357025633,0.08974358974358974,1.0,1.0,3/5,5.04%,ANK3;NOS1AP;KCNE4
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.6696615787670555,-1.3412859328882552,0.04395604395604396,1.0,1.0,7/35,8.98%,PELI1;PDE4B;SELENOS;PLAA;PDCD4;CTR9;SMAD6
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.7953333043633299,1.341044654262116,0.1724137931034483,0.7489526426296592,1.0,3/5,11.38%,ITGA8;ITGA3;ITGB1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.8365625192747447,-1.3407566335000383,0.10256410256410256,1.0,1.0,4/8,12.22%,ADAMTS9;TGFB1;FGFR2;MYL3
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.7611164327421637,-1.339909467137415,0.07058823529411765,1.0,1.0,5/18,13.91%,SOD1;NRCAM;OLFM1;LATS2;SIN3A
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.7365104835923019,-1.3391409523547564,0.09876543209876543,1.0,1.0,11/19,22.32%,SLC23A2;SLC16A12;SLC16A6;SLC16A7;SLC3A2;SLC36A4;SLC6A17;SLC1A1;SLC13A3;SLC16A4;SLC6A20
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.9009254319179686,-1.3390980041760958,0.0547945205479452,1.0,1.0,4/6,8.93%,VEGFA;NKD1;STAT3;AGTPBP1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.7630075919041751,-1.3388639763059629,0.08536585365853659,1.0,1.0,4/15,14.28%,SSH1;PLEKHH2;LIMA1;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.817583724530407,-1.33864705905461,0.10526315789473684,1.0,1.0,2/9,6.50%,NUP153;SUFU
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.7261578176710727,-1.337863639542946,0.056179775280898875,1.0,1.0,4/20,4.30%,ENO1;NR4A3;PDHX;PGK1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.8735115901579276,-1.3376657003279646,0.08,1.0,1.0,2/6,7.38%,TET3;CTR9
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.8999081475394488,-1.337558846796796,0.06666666666666667,1.0,1.0,1/6,1.58%,RPS21
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.8741413024202902,-1.3368833553456885,0.07894736842105263,1.0,1.0,1/5,1.30%,CTSL
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.8741413024202902,-1.3368833553456885,0.07894736842105263,1.0,1.0,1/5,1.30%,CTSL
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.7233655818125572,-1.3346824850814878,0.043478260869565216,1.0,1.0,7/26,14.81%,TGFB2;PDCD4;TGFB1;SMAD6;USP15;HIVEP1;USP9Y
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.4845478486852112,1.334649572341674,0.0,0.7676093224799978,1.0,12/67,7.29%,TAGLN;SLIT3;ACTA2;LMOD1;PRKG1;COL14A1;TPM2;COL5A2;RASL12;TNS2;MYLK;PRRX1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.8013806273838417,1.3345123452462784,0.1875,0.7625203439556626,1.0,1/5,2.95%,RBL1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.8613958647139448,-1.3334905065443527,0.056338028169014086,1.0,1.0,1/5,10.61%,PTPN2
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.725006607707619,1.332812614949311,0.23809523809523808,0.7577619297289979,1.0,3/6,19.80%,ADCY6;ADCY2;ADCY3
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.725006607707619,1.332812614949311,0.23809523809523808,0.7577619297289979,1.0,3/6,19.80%,ADCY6;ADCY2;ADCY3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.8798926545646473,-1.3316936764287264,0.08695652173913043,1.0,1.0,2/5,3.64%,KDM1A;CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.8798926545646473,-1.3316936764287264,0.08695652173913043,1.0,1.0,2/5,3.64%,KDM1A;CD44
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.6546500501266275,-1.331465327823634,0.04395604395604396,1.0,1.0,13/53,10.45%,ROBO2;CADM1;TENM3;TGFB2;NECTIN2;CDH20;CDH18;PTPRD;UNC5D;ROBO1;CDH12;ALCAM;LRFN5
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.6614505118990036,-1.3305573216856024,0.03260869565217391,1.0,1.0,11/52,9.17%,CSE1L;SEC13;TSC2;IPO5;IPO9;TOR1AIP2;NUP153;NUP133;NUP88;STAT3;TBRG1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.849814345174875,-1.329663445816097,0.0958904109589041,1.0,1.0,2/8,9.71%,TUT7;RPS27A
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.8032295994337622,-1.3289102183550072,0.08139534883720931,1.0,1.0,4/10,14.93%,CRY1;SELENOS;PTPN2;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.7730630613562587,-1.3256813385030488,0.07462686567164178,1.0,1.0,2/9,6.02%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.8492419945815242,-1.3253726150742786,0.0958904109589041,1.0,1.0,1/5,3.47%,SLC2A1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.8027089590325125,-1.3253551655801163,0.06666666666666667,1.0,1.0,3/9,8.70%,PIGL;DPM1;PIGG
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.8315576141956174,-1.3246997086085575,0.06756756756756757,1.0,1.0,1/7,1.16%,ZFP36L2
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.8956903627933009,-1.3231022807322401,0.05405405405405406,1.0,1.0,3/5,10.20%,TGFB2;TGFB1;FGFR2
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.8722665434258225,-1.3230379490090531,0.06756756756756757,1.0,1.0,2/8,2.67%,BASP1;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.7725274196905528,-1.3229205904763515,0.09523809523809523,1.0,1.0,4/14,3.64%,TWIST1;TPT1;KDM1A;CD44
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.7912435622674628,-1.3223725150310688,0.058823529411764705,1.0,1.0,3/14,4.30%,ENO1;CRY1;PGK1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.7901974689366503,-1.321734965146215,0.0975609756097561,1.0,1.0,7/11,17.73%,SYT1;RIMS2;RIMS1;LRRK2;RAB27A;DTNBP1;PREPL
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.8217724334857488,-1.3209033907217753,0.1,1.0,1.0,3/10,6.58%,SSH1;TMSB4X;TMSB10
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.7003354815299576,-1.318354405098039,0.047058823529411764,1.0,1.0,8/21,21.43%,VEGFA;CD44;DDX3X;MT3;NAIP;RNF34;BEX3;RAF1
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.8352071041757398,-1.3183202436088652,0.09523809523809523,1.0,1.0,2/7,7.09%,CD55;LGALS3
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.8675802221129878,-1.3178898932136667,0.06493506493506493,1.0,1.0,3/7,11.09%,CTSL;ADAMTS9;MANBA
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.8632919596044009,-1.3178298222116538,0.06172839506172839,1.0,1.0,4/7,8.51%,CEMIP2;CD44;TGFB1;CEMIP
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.707859857148076,1.3177588935967681,0.25,0.8042983709715764,1.0,5/13,9.68%,CACNA1C;MCU;CACNB2;CACNA1D;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.8099878398297624,-1.3172379028861652,0.11842105263157894,1.0,1.0,3/7,15.23%,NR4A3;CA2;AZIN1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.7327302205718309,-1.3171396525454633,0.03409090909090909,1.0,1.0,5/24,6.42%,CSF1;SSH1;NFKBIA;RBM4B;TGFB1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.5178208379650407,1.3169487731534453,0.06666666666666667,0.8010875797860301,1.0,4/35,6.13%,CAV2;BCL2L1;CDC42;TTL
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.8743535501898285,-1.316807383712322,0.05555555555555555,1.0,1.0,1/5,0.31%,TEFM
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.719082158849284,-1.3162362328931245,0.04395604395604396,1.0,1.0,7/27,14.81%,TGFB2;PDCD4;TGFB1;SMAD6;USP15;HIVEP1;USP9Y
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.8442905491218419,-1.3161453827444223,0.047619047619047616,1.0,1.0,2/11,4.30%,ENO1;PGK1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.8442905491218419,-1.3161453827444223,0.047619047619047616,1.0,1.0,2/11,4.30%,ENO1;PGK1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.8067139100394118,-1.3154082761960018,0.1125,1.0,1.0,2/9,4.64%,WASF3;WASF1
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.8587932052028846,-1.3153409090110704,0.02666666666666667,1.0,1.0,2/7,5.24%,SRSF12;SRSF10
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7611834841513331,1.3149278548702334,0.2857142857142857,0.8035504165498093,1.0,3/5,7.71%,ZDHHC21;TRAF6;RHOA
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.7889121344383618,-1.3148672391874443,0.11842105263157894,1.0,1.0,3/10,8.70%,PIGL;DPM1;PIGG
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.8434906421497812,-1.314029357807014,0.06944444444444445,1.0,1.0,4/6,14.66%,OS9;ANKRD13C;TAPT1;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.8038588805252679,-1.3137227507668119,0.07142857142857142,1.0,1.0,3/10,7.72%,MID1;TGFB2;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.788082302842256,-1.3135368562900445,0.06578947368421052,1.0,1.0,6/10,16.49%,CD55;CFH;PROS1;C1R;CLU;C1S
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.788082302842256,-1.3135368562900445,0.06578947368421052,1.0,1.0,6/10,16.49%,CD55;CFH;PROS1;C1R;CLU;C1S
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.788082302842256,-1.3135368562900445,0.06578947368421052,1.0,1.0,6/10,16.49%,CD55;CFH;PROS1;C1R;CLU;C1S
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.737130113555741,-1.3135068443129503,0.1125,1.0,1.0,3/17,7.79%,NELL1;TGFB1;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.7043933895496024,1.3134561669475986,0.18181818181818182,0.8032596749378796,1.0,2/8,2.76%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8946023203504853,-1.3133530787854923,0.05063291139240506,1.0,1.0,3/7,9.71%,ENO1;PGK1;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.8986679960110957,-1.3133382973006003,0.0547945205479452,1.0,1.0,2/5,9.32%,TAF7;KLF15
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.7813681657517186,-1.3131412958553492,0.09859154929577464,1.0,1.0,1/8,2.08%,KDM1A
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.7277751372326092,-1.312667971016896,0.037037037037037035,1.0,1.0,4/19,8.98%,ANKH;TWIST1;TGFB2;SMAD6
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.8150472019622028,-1.3118921535732877,0.09302325581395349,1.0,1.0,1/12,0.09%,STC1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.8330131181386069,-1.3117753123903448,0.05555555555555555,1.0,1.0,2/7,6.42%,VEGFA;TGFB1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.4831937236616243,1.3113174282577638,0.0,0.8067247481147549,1.0,3/38,1.44%,ZBTB7C;RALGPS1;EDN3
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.7047337016159991,-1.3111856941979647,0.09523809523809523,1.0,1.0,2/21,2.61%,STC1;HOMER2
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.7069368807270207,1.3111356973935995,0.19230769230769232,0.8020937371407412,1.0,1/5,0.95%,ZDHHC15
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.8050862355737074,-1.3110800637556577,0.12345679012345678,1.0,1.0,3/9,14.33%,NAA11;AGTPBP1;PARP1
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.6972206088685213,-1.3109271906556959,0.11494252873563218,1.0,1.0,7/29,11.79%,NR4A3;MCC;VEGFA;TGFB2;TGFB1;FGFR2;PRKDC
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.8102759984155669,-1.3106480580670816,0.08860759493670886,1.0,1.0,4/9,7.34%,NRG1;EFNB2;TGFB1;NIBAN2
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.7377484770809539,-1.310458521788106,0.06097560975609756,1.0,1.0,3/17,9.31%,SEC24A;SEC13;ERAP1
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.8449597931267503,-1.3104058778603376,0.09333333333333334,1.0,1.0,2/6,3.60%,GJA1;VEGFA
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.8972850011279545,-1.3103838702321284,0.0958904109589041,1.0,1.0,1/5,1.05%,TBC1D20
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.8033418127661269,-1.310219470992409,0.075,1.0,1.0,2/9,6.02%,HS3ST5;NECTIN2
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.7217647053472535,-1.310074267716774,0.09411764705882353,1.0,1.0,6/18,19.99%,SMOC1;TGFB2;SMCHD1;CPAMD8;ATF6;RAB18
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.7634635450349022,-1.3097522470183758,0.12345679012345678,1.0,1.0,7/12,20.44%,RIMS2;RAP1B;RIMS1;LRRK2;DTNBP1;PREPL;NLGN1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.7946750480725493,-1.3097277918021755,0.075,1.0,1.0,4/13,12.38%,ROBO2;VEGFA;ROBO1;TGFBR1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.7604368735114799,-1.309559443526641,0.07792207792207792,1.0,1.0,3/12,11.66%,SPTLC3;SPTLC1;AGK
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.7089371781301659,1.3080573977128207,0.16666666666666666,0.8076669935395431,1.0,1/6,3.86%,BCL2L11
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.78496735947285,-1.307336475456691,0.1111111111111111,1.0,1.0,1/8,0.87%,SRSF12
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.8306381827600795,-1.3073034243218389,0.03614457831325301,1.0,1.0,2/12,4.30%,ENO1;PGK1
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.793390344434105,-1.3066293790175307,0.08860759493670886,1.0,1.0,3/11,10.20%,TGFB2;RARB;FGFR2
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.6374897763184382,-1.30552514900005,0.031578947368421054,1.0,1.0,11/83,9.54%,SLC2A3;CSF1;IFITM3;EMP1;CD44;DHRS3;PTRH2;RHOB;MAP3K8;PHTF2;ALCAM
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.7634583240685815,-1.3052328450078363,0.05813953488372093,1.0,1.0,6/17,10.20%,ROBO2;TGFB2;ROBO1;ZFPM2;SMAD6;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.7474327695050482,-1.3045861397287652,0.08860759493670886,1.0,1.0,3/16,7.79%,NELL1;TGFB1;ADGRV1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.6536110783020939,-1.3045455390066272,0.12643678160919541,1.0,1.0,3/36,2.71%,SEC24A;CTSL;SEC13
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.6443527993859764,1.304418407612371,0.21739130434782608,0.8139013042406684,1.0,3/10,9.68%,RYR2;SLC9A1;SLC8A1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.7346814353669417,-1.3043438618442327,0.12162162162162163,1.0,1.0,7/14,16.52%,EMP1;HDAC2;ALDH3A2;CCN2;FGFR2;SVEP1;COL7A1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.534222599821164,1.3041988808983462,0.125,0.8041354716558564,1.0,5/12,17.15%,NOTCH1;TBX2;MEF2C;SETDB2;MICAL2
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.534222599821164,1.3041988808983462,0.125,0.8041354716558564,1.0,5/12,17.15%,NOTCH1;TBX2;MEF2C;SETDB2;MICAL2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.6362989869380997,-1.303080860588681,0.11235955056179775,1.0,1.0,3/39,2.71%,SEC24A;CTSL;SEC13
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5938273552673198,1.3025197928906327,0.14285714285714285,0.8055123826577403,1.0,2/10,3.61%,JPH2;CACNB2
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7821066690355497,-1.302366229051619,0.0958904109589041,1.0,1.0,3/10,8.13%,CD44;NCAM1;MAP3K8
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.8335291653068575,-1.3022244076931917,0.04411764705882353,1.0,1.0,2/6,9.66%,NECTIN2;PRKCB
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.8686141848790956,-1.3019735641213461,0.10526315789473684,1.0,1.0,1/6,4.71%,CSNK1A1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.601039150593152,1.3019187538891273,0.08333333333333333,0.8022156956079789,1.0,5/24,3.37%,RCAN2;RYR2;EDN3;GUCY1B1;MCU
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.8137902454636312,-1.301916688960377,0.07894736842105263,1.0,1.0,3/9,8.10%,VEGFA;EFNB2;ROBO1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.6145485554881752,1.301204818453224,0.1111111111111111,0.7996020251158366,1.0,1/14,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.6804675238652415,-1.3002735048356215,0.10227272727272728,1.0,1.0,8/25,23.68%,RARS1;FARSB;DARS1;YARS1;PPA1;LARS1;WARS1;EPRS1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.8216668866539845,-1.2996452193039556,0.13157894736842105,1.0,1.0,2/6,9.65%,PDE4B;KCNQ1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.8416238736960857,-1.2991365571391011,0.10294117647058823,1.0,1.0,3/6,13.99%,SLC23A2;SLC1A2;SLC1A1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.7270556273738003,-1.298148795677467,0.1518987341772152,1.0,1.0,5/14,19.99%,SMOC1;TGFB2;CPAMD8;ATF6;RAB18
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.7208333234056932,-1.29813137963909,0.09302325581395349,1.0,1.0,3/15,7.09%,STC1;GRIN1;LGALS3
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.6621908776076847,-1.2981174176189212,0.09473684210526316,1.0,1.0,6/44,6.78%,STC1;ADAMTS9;VEGFA;RHOJ;RHOB;GLUL
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6956659016384253,1.2974643204544558,0.24,0.807274539778199,1.0,3/11,6.41%,HSPA1A;BCL2L1;BCL2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.8011535757822646,-1.29738433258874,0.0875,1.0,1.0,2/10,6.02%,HS3ST5;NECTIN2
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.694045534545898,-1.2973196027395322,0.09195402298850575,1.0,1.0,6/25,7.38%,PDE4B;SELENOS;PLAA;PDCD4;TGFB1;CTR9
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),-0.8324555265893767,-1.2971572407931775,0.08571428571428572,1.0,1.0,1/6,1.05%,TBC1D20
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.6728524697230959,-1.2968142427749465,0.06451612903225806,1.0,1.0,7/30,13.18%,NELL1;RUBCN;MTMR9;CST3;STAT3;MT3;GOLGA2
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.6936291211410367,-1.2963252685785402,0.0963855421686747,1.0,1.0,7/25,10.11%,CADM1;NECTIN2;CDH20;CDH18;JAM3;CDH12;AFDN
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.8027937678474286,-1.2962733179272194,0.1038961038961039,1.0,1.0,2/9,12.22%,ENO1;MYL3
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7568950057645182,1.2953141118608476,0.3,0.8095799845971189,1.0,2/6,6.33%,BCL2L1;DLC1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.7248137139566714,-1.2950638454562389,0.09195402298850575,1.0,1.0,3/16,6.50%,IPO5;TGFB1;SUFU
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.4560763746765499,1.294907492563568,0.09090909090909091,0.8065504528872529,1.0,5/27,6.51%,SPRY3;HEY2;CDK6;NOTCH1;KLF7
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5736820055058924,1.2946960980063997,0.07142857142857142,0.8026571665096498,1.0,2/13,2.76%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.6986772875250765,-1.2939213172154467,0.11363636363636363,1.0,1.0,8/22,23.68%,RARS1;FARSB;DARS1;YARS1;PPA1;LARS1;WARS1;EPRS1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.8463607949929344,-1.2929411869601835,0.11267605633802817,1.0,1.0,1/5,1.05%,TBC1D20
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.7356507463235059,-1.2927754232441362,0.10666666666666667,1.0,1.0,4/14,9.54%,CADM1;TENM3;PTPRD;ALCAM
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),-0.7732182418573279,-1.2927539919533755,0.14473684210526316,1.0,1.0,5/10,16.76%,SLC22A6;GJA1;SLC1A2;SLC1A1;SLC13A3
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.6599333500194214,-1.2911462192904892,0.02040816326530612,1.0,1.0,13/62,12.38%,STC1;GJA1;ANKH;ADAMTS4;CD44;TGFB2;CREB3L2;SUFU;SLC10A7;FBN1;FGFR2;CMKLR1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.8860710178861122,-1.291000981244741,0.06329113924050633,1.0,1.0,2/5,10.59%,TGFB2;HIF1A
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.7436354538363561,1.2908915938950487,0.3225806451612903,0.8043333457361365,1.0,1/5,0.88%,ST3GAL2
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.7436354538363561,1.2908915938950487,0.3225806451612903,0.8043333457361365,1.0,1/5,0.88%,ST3GAL2
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.8416387021409181,-1.2908245771214473,0.12857142857142856,1.0,1.0,2/5,9.99%,CTCF;RAD21
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.7757783457587766,-1.290487430035108,0.08974358974358974,1.0,1.0,2/13,6.22%,PRKACA;PDK3
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.7877492585736747,-1.2901352828039574,0.1232876712328767,1.0,1.0,1/7,7.26%,TRAF3IP1
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7127126299706474,1.2901296343340722,0.2857142857142857,0.8013429146428498,1.0,3/5,11.99%,PLS3;CARMIL1;ACTN1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.783564466295852,-1.2901288923195104,0.13414634146341464,1.0,1.0,2/10,5.92%,TGFB2;EPHA7
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.7799165423513644,1.2900595964367507,0.16666666666666666,0.7965620435814165,1.0,2/5,6.27%,ACTA2;WNT5B
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.702251572269306,-1.2900389793222613,0.07692307692307693,1.0,1.0,14/31,23.12%,TWIST1;VEGFA;KCND2;PGK1;HIF1A;MT3;FMN2;RGCC;MDM4;P4HB;CPEB4;MDM2;CPEB2;AK4
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.6062457520922128,1.2899790133594127,0.1,0.7918394758256103,1.0,2/15,5.09%,GLB1;LARGE1
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.8585215346139494,-1.2895839072029374,0.11688311688311688,1.0,1.0,1/6,0.53%,TAF7
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.8479848732044,-1.2890519489949857,0.08955223880597014,1.0,1.0,2/5,6.02%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.8479848732044,-1.2890519489949857,0.08955223880597014,1.0,1.0,2/5,6.02%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),0.7667688847268213,1.2890043156210815,0.2692307692307692,0.7899819062499571,1.0,3/5,14.55%,ITGB5;KIFC3;PLEKHA7
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.7643666723671063,1.2888448730533772,0.2647058823529412,0.7859539135855641,1.0,1/5,4.65%,SNAPC3
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.6902461477089827,1.2876355601475862,0.09523809523809523,0.7854748471098123,1.0,3/7,13.48%,ADCY9;ADCY6;ADCY2
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.8145466322599584,-1.2876042918432793,0.07228915662650602,1.0,1.0,3/8,13.91%,NRCAM;OLFM1;SIN3A
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.769506093648619,1.2868283523794877,0.25,0.7832287303719001,1.0,1/5,1.43%,LRCH1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.8357555209990444,-1.2864952316893212,0.07246376811594203,1.0,1.0,1/5,2.40%,F3
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.8627996346053797,-1.2863909944267626,0.08,1.0,1.0,2/7,8.96%,KDM1A;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.6155950811156344,-1.286376123940173,0.06,1.0,1.0,31/121,21.08%,SOD1;ENO1;GJA1;TWIST1;KDM1A;LPIN1;CADM1;VEGFA;TGFB2;TGFB1;OLFM1;NIBAN2;EIF2AK2;SDCBP;CMKLR1;TGFBR1;SCD;IL18;CFL1;TAPT1;PPARGC1A;PRLR;ACADL;RGCC;PPIB;AGO2;KDM3A;APPL2;NLGN1;TSHR;SMURF2
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.7973986588485253,-1.2861149605976154,0.09302325581395349,1.0,1.0,2/8,12.38%,TGFB1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.8478596917850945,-1.2860877244258349,0.08955223880597014,1.0,1.0,2/6,6.02%,CADM1;NECTIN2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.6271579062010545,-1.285503325514995,0.10869565217391304,1.0,1.0,13/55,18.19%,SRGN;ZFPM1;HOMER2;TMSB4X;SELENOS;PDCD4;TRAF3IP1;CMKLR1;TBK1;NAV3;RGCC;LGR4;NPLOC4
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.718305740817458,-1.2852003291026546,0.0963855421686747,1.0,1.0,10/22,17.20%,SOD1;GLRX;SELENOS;MGST1;PDLIM1;OXSR1;SOD2;GPX4;TXNRD1;GSR
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.8746888342569767,-1.284943937445602,0.09090909090909091,1.0,1.0,1/5,1.32%,TWIST1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6131235800630122,1.2838819348212736,0.2222222222222222,0.7887762092873273,1.0,1/11,0.02%,JPH2
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.8177624193063142,-1.2834554881036584,0.16,1.0,1.0,2/7,4.39%,KLF2;DHRS3
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.7561921950755554,-1.2834457559539265,0.07317073170731707,1.0,1.0,2/13,6.08%,CSNK1D;NUDCD3
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.813908542279284,-1.2834347216089648,0.13924050632911392,1.0,1.0,3/8,7.34%,TWIST1;TGFB1;NIBAN2
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.622532016208034,-1.2832055438078078,0.04040404040404041,1.0,1.0,29/91,15.80%,SLC2A3;STC1;ENO1;SLC2A1;GLRX;PDK1;PGK1;RPA1;FADS2;EIF2S2;SEC11A;GMPS;PSMD14;DDIT4;MTHFD2L;ACTR3;SSR1;PSMA4;USO1;PPA1;GBE1;SCD;ATP6V1D;UCHL5;ETF1;HSPA5;TXNRD1;TBK1;LDHA
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.8421421077832829,-1.2826744484182455,0.07894736842105263,1.0,1.0,3/7,9.65%,NOS1AP;KCNE4;KCNQ1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.6602982331720595,-1.282641453491942,0.07692307692307693,1.0,1.0,3/40,3.32%,ARHGAP15;SOD1;VAV3
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.7901897561624939,-1.2822352350763386,0.09090909090909091,1.0,1.0,2/8,4.90%,SPTBN4;SZT2
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.511551484471131,1.281386173925203,0.0,0.7910141690935704,1.0,19/62,12.78%,FAT1;LMOD1;MCU;PLS3;DSTN;TPM2;CDC42;MYO1E;MYO1D;RHOA;EVL;FLNA;CARMIL1;MYO1B;ACTN1;MPRIP;CORO1C;HIP1;PPP1R9A
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.8196141529423911,-1.2810834932101378,0.10526315789473684,1.0,1.0,2/6,8.70%,PIGL;PIGG
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.7896203346041155,-1.2807167489771245,0.07792207792207792,1.0,1.0,4/12,4.99%,GLRB;IPO5;SLC38A9;GRIN1
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.8639536103570413,-1.2805100763134885,0.08333333333333333,1.0,1.0,3/5,13.29%,NRG1;KCNQ1;SGK1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6247514682117337,-1.2797364679011283,0.10526315789473684,1.0,1.0,38/67,31.75%,RPS21;RPS4X;RPL28;RPL34;RPL21;RPLP2;RPS27A;RPL19;SSR1;SRP14;RPS14;RPLP1;RPL13A;RPL18;TRAM1;RPL27;RPL35A;RPL5;RPL31;RPL41;RPL24;RPL27A;RPS12;RPS18;RPL37;RPL36;RPL32;RPL9;RPS20;SEC62;RPS8;RPL37A;RPS2;RPS24;SRP54;RPL11;RPL3;RPL14
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.4995761636332078,1.2789515336938704,0.0,0.7934839765234738,1.0,8/40,8.59%,ATP2B4;SPRY3;LEMD3;EPN2;NOTCH1;SKI;RBPMS2;SLIT2
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.6678450476220816,1.2784350997509504,0.2727272727272727,0.790666354815832,1.0,2/10,2.93%,IL34;NOTCH1
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.8090020577346883,-1.2784136887602675,0.08641975308641975,1.0,1.0,2/6,3.60%,GJA1;VEGFA
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.8133542996932028,-1.2782604418767887,0.14457831325301204,1.0,1.0,4/7,13.43%,CD55;BACH2;STAT3;IL18
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.4369222653133217,1.2779508294753879,0.0,0.7870524278355042,1.0,6/59,3.91%,TAGLN;ACTA2;LMOD1;CSPG4;COL14A1;COL5A2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.7816926199747554,1.2775661846793007,0.17857142857142858,0.7832898598006757,1.0,2/5,14.87%,CDC27;TPR
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.6482843764890105,-1.2772766985486679,0.12359550561797752,1.0,1.0,11/37,17.37%,SOD1;TGFB2;EPHA7;SOD2;PRKCI;SNX6;MT3;NAIP;PPARGC1A;NAE1;UNC5B
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.7319408554869004,-1.2770897132852692,0.16883116883116883,1.0,1.0,6/12,14.66%,KLF2;VEGFA;HIF1A;MT3;ATF6;HSPA5
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.7922559811210532,-1.2767261544512623,0.1095890410958904,1.0,1.0,1/6,3.60%,VEGFA
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.7569067412692141,-1.2766912443844691,0.08045977011494253,1.0,1.0,4/16,15.04%,PRKACA;RAP1B;ROCK2;RUNX1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.6834218285527416,-1.276439971998125,0.17777777777777778,1.0,1.0,10/26,24.53%,MID1;CD44;NCAM1;MT2A;GBP2;CAMK2D;TRIM5;STAT1;IRF1;HLA-B
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.5970845396626752,-1.2757849052102377,0.01020408163265306,1.0,1.0,37/126,21.29%,TBC1D20;SEC24A;CSNK1D;SEC13;ELOB;SLC2A1;WASF3;WASF1;CSNK1A1;WIPF1;CNIH3;NAPG;DARS1;SPG7;AFDN;RBX1;ANKRD28;USO1;CDC123;GOLGA2;PPARGC1A;FANCC;WDR19;TEAD1;RIMS1;COL7A1;LRRK2;TSPAN4;TLE4;MDM4;FARP2;LIN7A;NSF;ST13;SKP1;MCFD2;MDM2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.6182159364213127,1.2754412517606573,0.14814814814814814,0.7849279473676268,1.0,1/9,0.33%,ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.7174603262824346,-1.2744892068423683,0.14457831325301204,1.0,1.0,3/13,10.20%,PLAA;ARF4;FGFR2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.8088005736919043,-1.2743963275008303,0.08860759493670886,1.0,1.0,3/7,9.66%,NR4A3;SLC2A1;PRKCB
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.6713366811329002,-1.2743449521027987,0.09090909090909091,1.0,1.0,5/31,9.27%,TSC2;RUBCN;LGALS3;PTPN1;NEDD4L
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5941983514312917,1.2741232352637968,0.1111111111111111,0.784792573468993,1.0,7/19,9.68%,ATP2B4;HCN2;ATP1B2;KCNJ8;SLC9A1;SLC6A1;SLC8A1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.8412229018911286,-1.2739931569719187,0.1232876712328767,1.0,1.0,2/6,11.09%,ADAMTS9;MANBA
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),-0.8229100047395915,-1.273887102051686,0.12857142857142856,1.0,1.0,2/8,9.32%,DIP2B;KLF15
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.6654159576676897,-1.273651460827088,0.16666666666666666,1.0,1.0,5/16,22.88%,PELI1;SMAD6;ERBIN;MAPKAPK2;ADAM17
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.7993604895394191,-1.2736482263268591,0.16216216216216217,1.0,1.0,3/8,10.20%,TGFB2;RARB;FGFR2
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.7372869235484607,-1.2732255231780416,0.08974358974358974,1.0,1.0,1/15,1.16%,ZFP36L2
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.7873573391168681,-1.2732001150957524,0.11494252873563218,1.0,1.0,2/9,12.38%,TGFB1;TGFBR1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.6650445725175882,-1.2726983619997365,0.10869565217391304,1.0,1.0,8/35,12.50%,NRCAM;SPTBN4;ATL1;ANK3;FGFR2;PLP1;CCK;GRM7
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.8102051986393365,-1.2722445802329094,0.14814814814814814,1.0,1.0,2/7,6.42%,CST3;TGFB1
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.7629414583061129,-1.2714505809526753,0.07058823529411765,1.0,1.0,3/12,7.99%,OS9;SELENOS;RHBDD1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.7053275490845343,1.271320504561895,0.25,0.7880239560776258,1.0,4/7,11.54%,ATM;HMBOX1;FEM1B;LDB2
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.7362801599136612,-1.2712017577457908,0.07865168539325842,1.0,1.0,3/19,4.30%,ENO1;CRY1;PGK1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6953004142316096,-1.270924099318541,0.1724137931034483,1.0,1.0,5/18,12.69%,ZFPM1;UBA5;VEGFA;PTPN2;RPS14
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.619957227156395,-1.2707854166767327,0.04081632653061224,1.0,1.0,29/90,17.91%,SLC2A3;STC1;ENO1;F3;SLC2A1;GLRX;VEGFA;PDK1;PGK1;PDK3;ADM;HDLBP;CCN2;NEDD4L;MT2A;DDIT4;ADORA2B;GBE1;JUN;WSB1;CDKN1B;HSPA5;PPARGC1A;ERRFI1;LDHA;DUSP1;GPC4;CCN1;PAM
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.7722860222061001,-1.270654646239343,0.12987012987012986,1.0,1.0,5/13,14.90%,OS9;MARCHF6;RPS27A;AMFR;TRIM13
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.7026156573942782,-1.2701190754123504,0.09090909090909091,1.0,1.0,4/19,1.67%,GJA1;NRG1;ADAMTS9;ZFPM1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.7494169931771062,-1.270088978200769,0.15714285714285714,1.0,1.0,2/11,4.34%,NDUFB9;NDUFV1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.668210365746872,-1.269982114886775,0.06741573033707865,1.0,1.0,11/34,17.68%,BTD;CPD;PANK2;ALDH1L1;MCCC2;ACOT11;MTHFD2L;PLAAT3;ACBD6;MIPEP;PLPP3
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.7697141044030809,-1.269484418533725,0.1728395061728395,1.0,1.0,2/8,4.25%,PDE4B;NOS1AP
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.8693551702395863,-1.2691432882335758,0.1323529411764706,1.0,1.0,1/5,0.53%,TAF7
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.8259099040432744,-1.269110360484161,0.10843373493975904,1.0,1.0,2/6,15.99%,SDCBP;RAB7A
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.7637555439163383,-1.2687874380163413,0.075,1.0,1.0,7/13,10.16%,VEGFA;TENM3;NKD1;STAT3;AGTPBP1;IFT122;FBN1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.6316969587449499,-1.2687503531793742,0.11702127659574468,1.0,1.0,19/61,19.26%,PRKACA;RHEB;EPM2A;ATP6V1E1;ATP6V1G1;TSC2;SLC38A9;SNX6;ATP6V1H;LZTS1;C9ORF72;ATP6V1D;EXOC1;WAC;TRIM13;TBK1;LRRK2;SESN1;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.7350373476515742,-1.2683829876660193,0.11494252873563218,1.0,1.0,4/10,22.50%,NR4A3;IGFBP5;CCN4;DOCK4
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.708001613424202,-1.268031529919367,0.08433734939759036,1.0,1.0,8/17,22.55%,ZFP36L2;TGFB1;ANGEL2;CDKN1B;RGCC;BTG2;BTG1;HECA
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.48590349032758434,1.2675820781067741,0.0,0.7947512588335366,1.0,11/51,8.81%,BCAM;GPRC5C;ARHGEF10L;FKBP9;CDC42BPB;ARHGEF17;MYO1D;ADCY6;PLXNB2;PTPN21;NFE2L1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.7588021214397053,-1.2670866948405302,0.2,1.0,1.0,2/7,7.60%,NECTIN2;CEP57
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.7821239809962419,-1.2669459130290142,0.15,1.0,1.0,1/7,2.00%,SYT1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.6670551248924056,-1.2667345165982606,0.07692307692307693,1.0,1.0,7/35,13.80%,PRKACA;CSNK1D;TUBA1A;CEP57;CCP110;ATAD5;NINL
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.65668066293648,-1.266521815958497,0.1724137931034483,1.0,1.0,5/29,3.60%,WWC1;SLC22A6;CRMP1;SPTBN4;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.7223193221978363,-1.2664967423705011,0.09782608695652174,1.0,1.0,6/17,14.14%,WWC1;WWC2;DIP2B;NKD1;MT3;CDKN1B
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.7876354165552637,1.266472528576374,0.3,0.7897200719604184,1.0,1/5,0.54%,AP3M1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.7876354165552637,1.266472528576374,0.3,0.7897200719604184,1.0,1/5,0.54%,AP3M1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.7376520957133533,-1.2660664735692881,0.1125,1.0,1.0,5/17,14.90%,OS9;MARCHF6;RPS27A;AMFR;TRIM13
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.6216634866466644,-1.2657580734940377,0.08602150537634409,1.0,1.0,29/78,22.47%,RHEB;RIPOR1;SEC13;WIPI1;ATP6V1E1;ATP6V1G1;SLC38A9;SZT2;EIF2AK2;SIK2;NPRL3;ATP6V1H;SREBF1;ATP6V1D;HSPA5;LRRK2;ITFG2;LAMP2;STK24;SESN1;PRKAG2;WRN;SREBF2;CPEB4;MAPK1;LARS1;EIF2AK4;PPARA;GABARAPL1
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.7687631025836045,-1.2656955808039716,0.1095890410958904,1.0,1.0,3/8,13.43%,ZFPM1;PDE4B;IL18
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.6911571698670864,1.2653703544108619,0.23333333333333334,0.7880384168437465,1.0,3/6,11.07%,CACNA1C;CACNA1D;MAPK14
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),-0.7409874601780533,-1.264978190013755,0.15942028985507245,1.0,1.0,4/9,20.44%,NRXN3;NCAM2;ASTN2;NLGN1
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.7773171749184524,-1.2644705198266375,0.1506849315068493,1.0,1.0,2/8,2.42%,CYP3A5;SPTLC3
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.7447285494541882,-1.2643845580466313,0.09523809523809523,1.0,1.0,3/16,6.45%,ZC3H7A;TUT7;ZC3H7B
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.6314335395978607,-1.2643411703062275,0.053763440860215055,1.0,1.0,13/76,9.46%,STC1;WWC1;SRGN;HS3ST5;RHEB;GJA1;MCC;WWC2;TGFB1;ADM;ROBO1;SMAD6;ACOT11
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.7265272694613407,-1.264105252147648,0.2125,1.0,1.0,3/12,15.76%,VEGFA;GOLGA4;ZFYVE27
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.7965291403570949,-1.263863868086011,0.13253012048192772,1.0,1.0,4/8,12.38%,TGFB2;TGFB1;USP15;TGFBR1
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.6831814935525338,-1.2628079806362378,0.13793103448275862,1.0,1.0,7/26,13.59%,RIPOR1;RHOJ;RHOB;ARHGAP5;CDC42EP4;ROCK2;CFL1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.7239901018345323,1.2623408553944397,0.10344827586206896,0.7918904743609365,1.0,2/7,14.49%,PLA2G4C;ABHD2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.5020432557021723,1.2618295955189194,0.15789473684210525,0.7892509255546422,1.0,3/16,4.54%,ATP2B4;NUS1;ZDHHC21
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.8166763922723497,-1.2617024108493993,0.16129032258064516,1.0,1.0,1/5,3.60%,VEGFA
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.8210405431806013,-1.261031325128316,0.14814814814814814,1.0,1.0,2/5,13.71%,RHEB;CLOCK
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.7869695264813231,-1.260646269368791,0.13253012048192772,1.0,1.0,3/10,12.87%,SOD1;LPCAT3;SREBF1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.7799403122101588,-1.2606398722405228,0.08433734939759036,1.0,1.0,2/10,3.80%,OS9;SELENOS
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.6578143873307928,-1.2604783816096565,0.0967741935483871,1.0,1.0,9/37,16.61%,ZFPM1;KDM1A;HABP4;NFKBIA;JUN;GOLGA2;SYMPK;MITD1;LRRK2
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.6533368883427992,-1.2604734931103196,0.16091954022988506,1.0,1.0,9/37,17.32%,HSPA4L;LPIN1;NAA11;PIAS2;JAM3;SNAP91;PRKAR2A;PEBP1;TLE4
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.7127011784719852,-1.2603052146278992,0.16470588235294117,1.0,1.0,9/15,25.43%,TWIST1;DDX3X;EIF2AK2;HIF1A;IL18;ADAM17;LPL;APP;MBP
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.7334205867631309,-1.2602641702659934,0.17073170731707318,1.0,1.0,3/10,12.16%,HABP4;DDX3X;CDC123
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.7793720140341385,-1.2597968025683028,0.21428571428571427,1.0,1.0,2/6,5.57%,SOAT1;NECAB1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.7336644969675916,-1.2597319730329495,0.10714285714285714,1.0,1.0,4/13,15.04%,CTSL;ROCK2;ERRFI1;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.8036572604046917,-1.2590278946834994,0.17105263157894737,1.0,1.0,2/5,18.80%,PDCD4;DNAJA1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.6533585154109344,-1.2587217523494025,0.11494252873563218,1.0,1.0,11/31,23.87%,VEGFA;CD44;DDX3X;EPHA7;MT3;NAIP;DELE1;BEX3;RAF1;ARL6IP5;MALT1
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.7545178953952663,-1.2586628948959435,0.19480519480519481,1.0,1.0,2/10,3.69%,WWC1;WWC2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.8560880395285511,-1.2586376174149647,0.04225352112676056,1.0,1.0,2/5,13.07%,VEGFA;JCAD
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.6069603012487863,1.256926972431992,0.23809523809523808,0.8002483052131794,1.0,2/10,12.69%,BCL2;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.8408190971917435,-1.2565826866662484,0.13333333333333333,1.0,1.0,1/6,6.05%,AKAP8
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.7941532123334295,-1.2564920901719403,0.1506849315068493,1.0,1.0,5/8,16.38%,SYT1;PLAA;NEDD4L;RIMS2;RIMS1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.7941532123334295,-1.2564920901719403,0.1506849315068493,1.0,1.0,5/8,16.38%,SYT1;PLAA;NEDD4L;RIMS2;RIMS1
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.706145506984295,-1.2561350144089318,0.1686746987951807,1.0,1.0,7/22,15.71%,TRAF3IP1;IFT122;IFT52;IFT140;IFT57;DYNC2LI1;WDR19
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.8208139164602923,-1.25574063043328,0.1388888888888889,1.0,1.0,1/6,0.93%,SOD1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.7263715885808564,-1.255673332599225,0.14285714285714285,1.0,1.0,3/13,6.02%,HS3ST5;IFITM3;NECTIN2
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.74972159928036,1.2555268232403125,0.32,0.8004540733034343,1.0,1/5,3.97%,CDC42
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.6828132062229307,-1.2555257516811131,0.1411764705882353,1.0,1.0,10/23,16.76%,SLC23A2;SLC7A2;SLC16A12;SLC1A2;SLC16A7;SLC3A2;SLC36A4;SLC1A1;LRRC8B;SLC13A3
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6361424160801977,1.2555144080775822,0.2692307692307692,0.7961505567802974,1.0,4/9,11.07%,HDAC9;NOTCH1;HDAC1;MAPK14
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.8288175027999247,-1.2551070353498843,0.1232876712328767,1.0,1.0,1/6,2.09%,GLRB
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.7378328800508581,-1.254898551404653,0.11688311688311688,1.0,1.0,5/10,13.99%,SLC7A2;SLC1A2;SLC47A1;SLC3A2;SLC1A1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.7212335759158878,1.2544560542273493,0.2692307692307692,0.7949603624785831,1.0,2/7,5.47%,MCU;DAPK2
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.8691921336585824,-1.25414640805408,0.10144927536231885,1.0,1.0,1/5,2.31%,HABP4
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.7634022259566214,-1.253633217951345,0.09333333333333334,1.0,1.0,2/9,12.69%,RPS21;RPS14
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.6747926173251263,1.2535987744517023,0.15625,0.7934894663658602,1.0,2/8,4.19%,NUS1;OSBPL6
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.6902880569228916,-1.2531314347797966,0.13793103448275862,1.0,1.0,3/20,3.99%,SLC22A6;MGST1;SLCO1A2
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.8238816302891105,-1.2528295254726016,0.1,1.0,1.0,2/6,10.33%,SPTLC3;SPTLC1
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.8090502081116806,-1.2522743553043323,0.16666666666666666,1.0,1.0,1/5,9.01%,BRD1
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.736855626508334,1.25163993656124,0.3142857142857143,0.795827681735545,1.0,1/5,1.05%,IL34
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.5061888032389178,1.2513177062456575,0.06666666666666667,0.7926260514045597,1.0,2/30,2.76%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.8166683860776787,-1.2511471554227438,0.15584415584415584,1.0,1.0,2/6,10.20%,ROBO2;FGFR2
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.7654349066204371,-1.2510278317044075,0.08974358974358974,1.0,1.0,1/11,1.92%,CSNK1D
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.7761628480341539,-1.250025284464941,0.19480519480519481,1.0,1.0,2/11,5.18%,TWIST1;HDAC2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.7393361192665451,-1.250023617269885,0.2571428571428571,1.0,1.0,1/7,3.77%,TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.6936979580612288,-1.2491771219757857,0.13095238095238096,1.0,1.0,9/22,20.64%,SYT1;PLAA;NEDD4L;RIMS2;GOLGA4;ZFYVE27;RIMS1;PPIB;SEMA4D
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.6891856325370491,-1.2489634306493875,0.1411764705882353,1.0,1.0,8/18,18.59%,EPM2A;TSC2;SZT2;DDIT4;UBR1;NPRL3;ITFG2;SESN1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.6201848210604969,-1.248045898873991,0.10416666666666667,1.0,1.0,17/75,17.74%,RIPOR1;RRAS2;WASF1;RHOB;DNMT1;RAP1B;SHC2;KRAS;PLD1;JUN;ARHGAP5;CDC42EP4;ROCK2;CFL1;GPSM2;FARP2;BRAP
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.6886902361784348,-1.2476418000536567,0.10227272727272728,1.0,1.0,8/23,20.89%,SOD1;PDCD4;SOD2;RAP1B;CFL1;PITPNA;HNRNPF;P4HB
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.8221376477931077,-1.2473187493315898,0.08860759493670886,1.0,1.0,4/8,8.51%,CEMIP2;CD44;TGFB1;CEMIP
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6213878997022425,-1.247152567084834,0.12087912087912088,1.0,1.0,35/63,31.75%,RPS21;RPS4X;RPL28;RPL34;RPL21;RPLP2;RPS27A;RPL19;SRP14;RPS14;RPLP1;RPL13A;RPL18;RPL27;RPL35A;RPL5;RPL31;RPL41;RPL24;RPL27A;RPS12;RPS18;RPL37;RPL36;RPL32;RPL9;RPS20;RPS8;RPL37A;RPS2;RPS24;SRP54;RPL11;RPL3;RPL14
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.6157338236627141,-1.2467595915968002,0.13829787234042554,1.0,1.0,21/54,23.29%,PRKACA;GRINA;IGFBP2;NFKBIA;RHOB;SOD2;OLFM1;PTPRD;CDC5L;MGAT1;CCK;CA2;RAB27A;BTG2;DNAJA1;AGO2;CHKA;EIF2S3;DDX21;BTG1;IRF1
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.8449335410374867,-1.2465034406581654,0.125,1.0,1.0,1/5,3.50%,SSH1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.6171616519806501,-1.2454244166226274,0.10588235294117647,1.0,1.0,9/34,16.63%,TBC1D20;CDKL1;TBC1D8;CCP110;DCDC2;IFT140;DYNC2LI1;TAPT1;USP6NL
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.7954130309733284,-1.2454188130643415,0.11428571428571428,1.0,1.0,2/7,4.23%,VEGFA;TGFB2
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.5716271942863008,-1.2453691764636683,0.05,1.0,1.0,34/155,20.44%,STX6;CSE1L;RAB28;SEC13;ARL5A;TSC2;IPO5;IPO9;COG7;NUP153;XPO4;NUP133;TGFB1;NAPG;NUP88;STAT3;SYNDIG1;ARF4;TBC1D8;AP2A1;SNX6;USO1;GGA3;RAB7A;STRADB;USP6NL;KIF13B;LAMP2;AP4E1;TMED4;NSF;RAB18;APPL2;NLGN1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.682886078074941,-1.245068273446456,0.14444444444444443,1.0,1.0,4/22,14.93%,PRKACA;PDK3;HIF1A;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.5572385960029713,1.244171200407198,0.25,0.809497588080546,1.0,2/17,0.50%,HSPA1A;CD58
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.7300686334336517,-1.2427574173281999,0.1518987341772152,1.0,1.0,1/14,0.53%,TAF7
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.7666220790811618,-1.24157028061572,0.14473684210526316,1.0,1.0,1/11,4.23%,TGFB2
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.7097820782695873,-1.2411222952920187,0.11538461538461539,1.0,1.0,10/15,22.32%,SLC7A2;SLC38A4;SLC38A9;SLC7A14;SLC3A2;SLC36A4;SLC6A17;SLC38A10;SLC7A11;SLC6A20
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.7199881398058137,-1.2411016557831251,0.14814814814814814,1.0,1.0,7/12,23.00%,SLC7A2;SLC1A2;SLC3A2;SLC36A4;SLC1A1;SLC6A20;ARL6IP5
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.8204618721498349,-1.2409848430022399,0.14814814814814814,1.0,1.0,3/6,12.38%,TWIST1;FGFR2;TGFBR1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.6235855609128981,-1.240570784452792,0.16091954022988506,1.0,1.0,3/38,2.71%,SEC24A;CTSL;SEC13
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.48427706408262416,1.2404736759966815,0.11764705882352941,0.8167715233661782,1.0,3/29,3.32%,JPH2;RYR2;CACNA1C
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.8326584736612161,-1.2403050504862796,0.18055555555555555,1.0,1.0,3/5,16.61%,RBX1;SASH1;LRRK2
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.7455096977521449,-1.2398617479371619,0.2,1.0,1.0,6/10,23.29%,CD55;ERAP1;TRIM5;APPL2;BIRC2;IRF1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.6767502182934466,-1.2394192228116976,0.13829787234042554,1.0,1.0,21/41,24.97%,CSF1;IFITM3;IFIT3;HERC6;EIF2AK2;EPSTI1;PROCR;ELF1;GBP2;NCOA7;CMTR1;SP110;C1S;TRIM5;LPAR6;DDX60;IFI44;IRF1;WARS1;IFI44L;PSMA3
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.7178882346933871,1.239370987879024,0.25,0.8162544702811185,1.0,1/7,1.04%,NFU1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.6699330836115064,-1.2392676073712936,0.0989010989010989,1.0,1.0,2/30,1.24%,SRSF12;HNRNPL
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6021612558125292,-1.2392522302534545,0.18085106382978725,1.0,1.0,36/68,31.75%,RPS21;RPS4X;RPL28;RPL34;RPL21;RPLP2;RPS27A;RPL19;SRP14;RPS14;RPLP1;RPL13A;RPL18;RPL27;RPL35A;RPL5;RPL31;RPL41;RPL24;RPL27A;RPS12;RPS18;RPL37;RPL36;RPL32;RPL9;RPS20;SEC62;RPS8;RPL37A;RPS2;RPS24;SRP54;RPL11;RPL3;RPL14
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.778083061491893,-1.239152693149736,0.14666666666666667,1.0,1.0,4/8,20.55%,KLF2;SMAD6;ASS1;SREBF2
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.7311523328670673,-1.239128472712615,0.22077922077922077,1.0,1.0,1/10,0.68%,STX6
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6054397548573901,-1.239100063292949,0.125,1.0,1.0,38/76,29.44%,RPS21;RPS4X;RPL28;RPL34;RPL21;UPF3A;RPLP2;RPS27A;RPL19;PABPC1;RPS14;RPLP1;ETF1;PPP2R2A;RPL13A;RPL18;SMG7;RPL27;RPL35A;RPL5;RPL31;RPL41;RPL24;RPL27A;RPS12;RPS18;RPL37;RPL36;RPL32;RPL9;RPS20;RPS8;RPL37A;RPS2;NCBP1;UPF2;EIF4G1;RPS24
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.8181651557681932,-1.2388476988566341,0.16666666666666666,1.0,1.0,2/5,9.65%,KCNE4;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.7947408183431883,-1.2379247065781016,0.16455696202531644,1.0,1.0,3/10,14.14%,IPO5;LATS2;CDKN1B
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.6975795941165168,-1.2378771420635108,0.13793103448275862,1.0,1.0,3/15,6.42%,CSE1L;XPO4;TGFB1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.8102376103154794,-1.2376784883552556,0.1686746987951807,1.0,1.0,1/6,7.21%,FADS2
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.8023264613114318,-1.2372147519377534,0.1951219512195122,1.0,1.0,2/6,10.20%,ROBO2;FGFR2
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),-0.7869585147710001,-1.2368666593542659,0.0975609756097561,1.0,1.0,3/10,15.04%,PRKACA;ROCK2;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.7455292650781581,-1.2365447868320047,0.12087912087912088,1.0,1.0,4/14,12.38%,TGFB2;TGFB1;SDCBP;TGFBR1
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.8404877614636876,-1.2365206062233065,0.13114754098360656,1.0,1.0,2/5,9.97%,MLPH;PTGR1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.7627686886325504,-1.2363014056242405,0.1375,1.0,1.0,3/11,10.20%,TGFB2;HDAC2;FGFR2
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.6199408900401219,-1.236176779095012,0.13978494623655913,1.0,1.0,34/64,31.75%,RPS21;RPS4X;RPL28;RPL34;RPL21;RPS27A;RPL19;RPS14;RPLP1;ETF1;RPL13A;RPL18;ZC3H15;RPL27;RPL35A;RPL5;RPL31;RPL41;RPL24;RPL27A;RPS12;RPS18;RPL37;RPL36;RPL32;RPL9;RPS20;RPS8;RPL37A;RPS2;RPS24;RPL11;RPL3;RPL14
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.6241877876120917,-1.2354698436012121,0.17647058823529413,1.0,1.0,8/33,12.25%,NRCAM;VEGFA;DNER;SPOCK1;DDIT4;GPM6A;DCDC2;CCK
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.6773400251475526,-1.2353970868904878,0.1348314606741573,1.0,1.0,8/24,20.89%,SOD1;PDCD4;SOD2;RAP1B;CFL1;PITPNA;HNRNPF;P4HB
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.7594052897487015,-1.235231818672005,0.1375,1.0,1.0,3/12,14.35%,RNMT;CMTR1;CCNH
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.7594052897487015,-1.235231818672005,0.1375,1.0,1.0,3/12,14.35%,RNMT;CMTR1;CCNH
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.8091747642264415,-1.2350613129280195,0.12658227848101267,1.0,1.0,1/6,1.32%,TWIST1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.5787580913848233,1.2347299645149006,0.11764705882352941,0.8270575038108907,1.0,2/16,1.78%,ST3GAL2;GLB1
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.6584020620168658,-1.2343112259215345,0.16091954022988506,1.0,1.0,11/27,21.54%,SOD1;SOD2;PRKCI;SNX6;HIF1A;MT3;NAIP;PPARGC1A;UNC5B;CPEB4;NONO
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.6326390047117543,-1.2341985228051195,0.16129032258064516,1.0,1.0,5/24,15.99%,EPN1;SNX6;PTPN2;ERRFI1;RAB7A
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.6853419286506347,-1.2341766324058403,0.14606741573033707,1.0,1.0,8/25,17.91%,GNPAT;AGPAT4;PDSS2;SREBF1;SCD;PRLR;LSS;PAM
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.8210244648414313,-1.233349773445684,0.1875,1.0,1.0,2/6,16.39%,AKAP8;CAMK2D
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.7036895154632579,-1.233209328754927,0.1951219512195122,1.0,1.0,6/14,19.34%,MDGA2;SPOCK1;AGTPBP1;ZC4H2;SIN3A;NR4A2
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.8128137703481932,-1.2332023965985883,0.16,1.0,1.0,2/6,8.50%,BTD;MCCC2
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.7878129511274273,-1.233008742748263,0.14285714285714285,1.0,1.0,2/7,3.60%,KDM1A;VEGFA
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.6765634015092032,-1.2322878970683506,0.0963855421686747,1.0,1.0,9/22,22.44%,ANK3;AFDN;GGA3;GOLGA4;VAMP5;RAB7A;PREPL;NSF;RILPL1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.753948267333215,-1.2316774810315543,0.20833333333333334,1.0,1.0,3/9,10.69%,TSC2;TGFB1;MT3
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.8209706353817469,-1.2313273996133545,0.2112676056338028,1.0,1.0,1/5,0.93%,SOD1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.7042166439065949,1.2310907012276857,0.3333333333333333,0.8307178871910914,1.0,2/6,9.07%,LMCD1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7042166439065949,1.2310907012276857,0.3333333333333333,0.8307178871910914,1.0,2/6,9.07%,LMCD1;SLC9A1
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.6998365355047008,1.230562971165591,0.3103448275862069,0.8283487881286093,1.0,4/6,9.68%,HCN2;SLC9A1;SLC6A1;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.6469866452778859,1.2304862263626122,0.21428571428571427,0.8242766272371982,1.0,2/11,2.16%,A2M;CNOT7
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.8082811177854559,-1.2300766376857133,0.16455696202531644,1.0,1.0,1/5,9.66%,PRKCB
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.7532208952269054,-1.2296932921260986,0.19047619047619047,1.0,1.0,3/12,12.45%,ENO1;NPRL3;C9ORF72
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.8124153713883338,-1.2289028531345656,0.18055555555555555,1.0,1.0,1/5,4.11%,AKIRIN1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.6967119775942755,-1.2288448158740544,0.17647058823529413,1.0,1.0,6/19,15.71%,FSIP2;CSNK1D;IFT122;IFT140;ATP6V1D;WDR19
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.7770195782897148,-1.2286527469650326,0.17721518987341772,1.0,1.0,2/10,7.38%,TET3;CTR9
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.6806858110358619,-1.2286154310300346,0.23076923076923078,1.0,1.0,4/14,10.17%,CREM;MCF2L2;PDE10A;SLC7A14
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.6805405942276228,1.228382104057063,0.22727272727272727,0.8270632181899068,1.0,2/6,16.27%,NSFL1C;APC
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.624249569488676,-1.2281284311611727,0.15730337078651685,1.0,1.0,8/35,15.68%,ZFP36L2;ZFPM1;TGFB1;ZFPM2;ANKRD26;PTPRQ;CMKLR1;TMEM64
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.5410129892096316,1.2280798127350459,0.3333333333333333,0.8242515579967105,1.0,5/23,5.09%,TAGLN;MEF2D;ITGA7;SOX6;LARGE1
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.6896332940461293,1.2276368612139466,0.2777777777777778,0.8217422642187352,1.0,1/8,1.04%,NFU1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.7538158143358937,-1.227599207174775,0.18518518518518517,1.0,1.0,2/10,7.38%,TET3;CTR9
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.7802225391642552,-1.2270834977445493,0.136986301369863,1.0,1.0,3/8,10.39%,CSF1;FBN1;PRXL2A
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.833743988907411,-1.226592016460939,0.15942028985507245,1.0,1.0,2/5,10.33%,SPTLC3;SPTLC1
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.833743988907411,-1.226592016460939,0.15942028985507245,1.0,1.0,2/5,10.33%,SPTLC3;SPTLC1
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.7775608965949439,-1.2265294673566964,0.12162162162162163,1.0,1.0,2/7,5.91%,TMSB4X;DDX3X
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.8019224166878538,-1.2264199443034334,0.15714285714285714,1.0,1.0,1/5,10.20%,FGFR2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.7820176818256492,-1.226013893593394,0.15492957746478872,1.0,1.0,2/6,10.69%,MT2A;MT3
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.6124131977199744,-1.2257744589667812,0.0989010989010989,1.0,1.0,28/72,22.05%,PRKACA;SYT1;GLRB;KCND2;GRIN1;PDE7B;SLC1A2;KCNQ3;GABRE;SNAP25;SDCBP;GRIK1;PRKAR1A;PLP1;GRIA3;GRM7;DLGAP1;SLC1A1;PMP22;SLC12A6;PRKAR2A;CAMKK2;GRIK2;NLGN1;MINK1;MAPK1;GABBR2;NOVA1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.810133262113496,-1.2257723921069732,0.22972972972972974,1.0,1.0,1/5,3.04%,TAF1B
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.7900674486380568,-1.2246942358090542,0.20833333333333334,1.0,1.0,4/6,19.00%,OS9;UBAC2;UBE2J1;ERLEC1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.7900674486380568,-1.2246942358090542,0.20833333333333334,1.0,1.0,4/6,19.00%,OS9;UBAC2;UBE2J1;ERLEC1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.7900674486380568,-1.2246942358090542,0.20833333333333334,1.0,1.0,4/6,19.00%,OS9;UBAC2;UBE2J1;ERLEC1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.7673001390348073,-1.2246140506003873,0.18823529411764706,1.0,1.0,5/9,21.71%,USP15;ANKRD17;NPLOC4;DDX60;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.8004186066990537,-1.2245670641509436,0.1506849315068493,1.0,1.0,2/6,7.23%,CSNK1D;NKD1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.6905214274485802,-1.2242989399596982,0.14102564102564102,1.0,1.0,4/17,9.40%,NDUFB9;NDUFV1;COX4I1;COX6C
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.6905214274485802,-1.2242989399596982,0.14102564102564102,1.0,1.0,4/17,9.40%,NDUFB9;NDUFV1;COX4I1;COX6C
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.6973266617617934,-1.2241278586082338,0.19540229885057472,1.0,1.0,8/16,26.44%,ENO1;TMSB4X;HIF1A;PPARGC1A;PPARA;APP;PID1;INSR
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.7965271070543694,-1.2229355344071737,0.17333333333333334,1.0,1.0,1/6,7.96%,STAT3
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.6777297317260932,-1.222895384172713,0.21839080459770116,1.0,1.0,7/18,17.68%,GNPAT;AGPAT4;PLAA;ENPP2;GPX4;PLAAT3;PLPP3
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.5668417901728604,1.222888620466259,0.16666666666666666,0.8323633188717612,1.0,4/22,8.13%,PKN1;ADGRA2;RHOA;PTP4A3
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.7086465171775961,-1.2227752924064577,0.2,1.0,1.0,2/10,3.60%,KDM1A;VEGFA
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.8248424759031511,-1.2226901537244164,0.1282051282051282,1.0,1.0,2/5,8.93%,UBA5;AGTPBP1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.6420785621079043,-1.2225094141143393,0.13333333333333333,1.0,1.0,10/35,17.37%,CSF1;SOD1;SOD2;PRKCI;SNX6;MT3;NAIP;PPARGC1A;LRRK2;UNC5B
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.6149451429492665,-1.2219921240589142,0.15217391304347827,1.0,1.0,5/53,3.88%,MID1;GLRB;GPR161;TENM3;NXN
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.7582469521631297,-1.2212529932320866,0.2692307692307692,1.0,1.0,3/8,20.55%,KLF2;ASS1;SREBF2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.6065041134976542,-1.2198677320642908,0.09278350515463918,1.0,1.0,24/70,21.29%,FSIP2;CSNK1D;MTCH2;RIPOR1;COG7;DDX3X;RPA1;ALDH3A2;IFT122;IFT140;UBAC2;ATP6V1D;GBP2;WASHC2C;TRAM1;LRRK2;LAMP2;DNAJA1;SERP1;SSB;XPA;GAK;RAB11A;MDM2
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.7003561500123876,-1.2190528218994718,0.18055555555555555,1.0,1.0,4/9,17.60%,BASP1;TGFB2;WNT2B;CSDE1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.6437212235090459,-1.2188337730710108,0.15730337078651685,1.0,1.0,5/31,8.10%,KDM1A;ROBO2;VEGFA;PTPRD;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.6722691797613283,-1.2187493743041549,0.1625,1.0,1.0,7/22,21.43%,VEGFA;CD44;DDX3X;MT3;NAIP;BEX3;RAF1
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.8228807026522069,-1.2186442875113557,0.12307692307692308,1.0,1.0,2/5,6.02%,CTSL;NECTIN2
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.8228807026522069,-1.2186442875113557,0.12307692307692308,1.0,1.0,2/5,6.02%,CTSL;NECTIN2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.7717932409092484,-1.2183923103423624,0.2054794520547945,1.0,1.0,1/8,3.01%,WIPI1
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.8008004640840236,-1.2183404734436423,0.22972972972972974,1.0,1.0,3/6,10.69%,NR4A3;STAT3;MT3
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.7193570657685289,-1.218084020783783,0.16470588235294117,1.0,1.0,2/12,10.02%,TAF7;TBPL1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.7930132880218532,1.217655464792069,0.35,0.8438034661826314,1.0,2/5,5.23%,NFU1;YAE1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.7971214962846802,-1.217510843957646,0.15789473684210525,1.0,1.0,1/6,1.32%,TWIST1
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.5522930603832558,1.2173472453238097,0.2727272727272727,0.8407485928988546,1.0,1/14,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.6085991602656522,-1.2161184389862663,0.13541666666666666,1.0,1.0,18/60,17.43%,TWIST1;ELOB;VEGFA;KCND2;PGK1;PSMB1;PSMD14;RPS27A;RBX1;HIF1A;MT3;PSMA4;PSMB2;FMN2;PSMA7;HIF3A;RGCC;MDM4
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.6440825375648533,1.21604711085818,0.2631578947368421,0.8400910378707385,1.0,1/9,0.02%,JPH2
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8468094289780745,-1.2156757477049611,0.1506849315068493,1.0,1.0,1/5,9.71%,RPS27A
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8468094289780745,-1.2156757477049611,0.1506849315068493,1.0,1.0,1/5,9.71%,RPS27A
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.7686035798105837,-1.2140561751773817,0.1566265060240964,1.0,1.0,2/9,3.52%,ANK3;GLRX
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.7491735345451127,-1.213642619356824,0.18292682926829268,1.0,1.0,5/8,19.23%,PURB;LGALS3;PRKCB;RUNX1;MYSM1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.7033928617471362,-1.2136179208988034,0.17567567567567569,1.0,1.0,6/13,13.99%,SLC7A2;SLC1A2;SLC47A1;SLC3A2;SLC36A4;SLC1A1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.7346469158105454,-1.2135755950077054,0.18421052631578946,1.0,1.0,2/9,3.64%,NR4A3;CD44
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.6686291616824014,-1.2132532650219707,0.21176470588235294,1.0,1.0,6/19,19.84%,ANK3;GGA3;GOLGA4;VAMP5;PREPL;NSF
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.7358021705328813,-1.2125334311533411,0.20253164556962025,1.0,1.0,3/12,7.34%,TWIST1;TGFB1;NIBAN2
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.693976153168284,-1.212339751534977,0.19767441860465115,1.0,1.0,2/15,8.31%,WWC1;PTPN1
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.6290251171716126,-1.2118627949022382,0.18478260869565216,1.0,1.0,13/42,20.41%,UVSSA;HMGN1;RPA1;RPS27A;RNF111;RBX1;PARP1;CCNH;FAN1;FANCC;POLK;POLA1;XPA
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.8016775608173947,-1.2118509959934602,0.2054794520547945,1.0,1.0,3/5,10.20%,NELL1;EIF2AK2;FGFR2
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.6831578699994432,-1.2117329041426388,0.21951219512195122,1.0,1.0,2/13,6.42%,VEGFA;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.7220430314268484,-1.2115386029205168,0.18292682926829268,1.0,1.0,2/10,3.77%,VEGFA;TMSB4X
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.7038024903730276,-1.2114375481131463,0.20481927710843373,1.0,1.0,8/18,21.77%,CYP3A5;LIPA;AKR1C2;PRLR;LSS;HSD17B4;NPC1;AKR1C1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5217766352294215,1.2110573128400521,0.25,0.8519160733516526,1.0,2/13,2.93%,ERBB4;NOTCH1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.5951233670448837,-1.2105793794496666,0.10204081632653061,1.0,1.0,20/78,15.93%,WWC1;GJA1;PRSS23;KAZN;SLC7A2;SLC2A1;CD44;DHRS3;TMEM164;THSD4;SH3BP5;MLPH;OLFM1;SEMA3B;FHL2;ELF1;AMFR;SLC1A1;PLAAT3;RHOBTB3
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.716827678678905,-1.2104937985508433,0.20253164556962025,1.0,1.0,5/8,22.32%,SLC3A2;SLC36A4;SLC6A17;SLC1A1;SLC6A20
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.6774349012042777,-1.2104127712107755,0.2222222222222222,1.0,1.0,3/21,5.18%,TWIST1;TGFB2;HDAC2
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.5970435732747462,-1.2101177702184662,0.15306122448979592,1.0,1.0,32/77,22.30%,SLC2A3;CSF1;KLF2;NR4A3;F3;PDE4B;VEGFA;CD44;NFKBIA;RHOB;SOD2;SLC16A6;PTPRE;MAP3K8;TANK;CEBPD;JUN;SGK1;IL18;GEM;DUSP1;PLPP3;CCN1;BTG2;NR4A2;PHLDA1;NAMPT;SAT1;DRAM1;PER1;BIRC2;BTG1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.7405242028498824,-1.210021664016197,0.21794871794871795,1.0,1.0,3/9,3.64%,TPT1;KDM1A;CD44
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.8091078218344621,-1.2099244240962714,0.16666666666666666,1.0,1.0,2/6,7.63%,DHRS3;ALDH3A2
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),-0.6895282483639861,-1.209642066222739,0.19101123595505617,1.0,1.0,5/21,20.19%,NELL1;TP63;ZHX3;CCN1;CCN4
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.8205060246484968,-1.2093758925827287,0.20588235294117646,1.0,1.0,2/6,8.65%,CD44;ENPP2
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.7266468037338605,-1.2090795930115519,0.19753086419753085,1.0,1.0,4/14,15.80%,ENO1;PGK1;MANBA;LDHA
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.6665325681217603,1.2088256049200456,0.18181818181818182,0.8546745951716188,1.0,4/6,14.07%,DEK;CDKN1A;EP300;PML
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.6525174343417993,-1.208394705453785,0.21176470588235294,1.0,1.0,8/23,26.15%,SYT1;MCTP2;RIMS2;SNCAIP;RIMS1;NSF;RAB12;RAB8B
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.6736288159606802,-1.2080335746850108,0.21518987341772153,1.0,1.0,2/21,3.60%,CSF1;VEGFA
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.6426702528949535,-1.2078694788830935,0.1595744680851064,1.0,1.0,8/32,18.19%,OS9;SELENOS;MARCHF6;AMFR;HSPA5;TRIM13;UBE2J1;NPLOC4
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),-0.7433616192092478,-1.207214541041859,0.25675675675675674,1.0,1.0,2/8,8.05%,LPIN1;SELENOI
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.7706784496483767,-1.2069564128376669,0.2,1.0,1.0,2/10,4.30%,ENO1;PGK1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.6864619436844861,-1.2066765496681215,0.18823529411764706,1.0,1.0,3/14,7.99%,GLRB;MARCHF6;RHBDD1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),-0.8133096173019436,-1.2065784058752138,0.15789473684210525,1.0,1.0,1/5,1.32%,TWIST1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.7567741693534402,-1.2060520153455008,0.2222222222222222,1.0,1.0,2/9,3.64%,KDM1A;CD44
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.6432681806821986,-1.2057303989974617,0.20238095238095238,1.0,1.0,3/20,10.69%,SOD1;XRCC4;MT3
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.7416119471592086,-1.2055991542486364,0.19047619047619047,1.0,1.0,1/7,1.16%,ZFP36L2
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6094790649254794,1.205483957305819,0.2857142857142857,0.8601642091969687,1.0,1/7,3.88%,ATM
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.7307699280678877,-1.2052666689637295,0.2159090909090909,1.0,1.0,6/10,21.99%,NR4A3;PPARGC1A;ACADL;PRKAG2;APPL2;PPARA
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.525681425459843,1.2051969010974646,0.1875,0.8568402511970747,1.0,1/19,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.7192005212164019,-1.2049506300031474,0.2125,1.0,1.0,1/9,2.25%,BASP1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.7438828698731963,-1.2046177480047016,0.24,1.0,1.0,2/7,8.34%,VAV3;CD38
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6030079877222544,1.2042925254716557,0.30434782608695654,0.855859095158336,1.0,1/8,0.02%,JPH2
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.6636497949422276,-1.203403901521746,0.21428571428571427,1.0,1.0,4/17,16.61%,TSC2;RUBCN;LZTS1;LRRK2
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.6256739169187266,-1.2029413253989725,0.1875,1.0,1.0,5/20,15.00%,VEGFA;DDX3X;EPHA7;PDGFD;ERRFI1
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.765966108170009,-1.2028215048601547,0.21794871794871795,1.0,1.0,2/7,3.95%,GNPAT;NCEH1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.6563709801947967,-1.2026456069924898,0.19753086419753085,1.0,1.0,9/22,26.36%,SYT1;RIMS2;RAB27A;STXBP6;SYTL4;NSF;RAB12;RAB8B;CLASP2
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.7190803851972758,-1.2025112878049893,0.20833333333333334,1.0,1.0,4/8,21.23%,DHX29;EIF2S2;MCTS1;EIF2S3
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.6401369450148721,-1.202355515358109,0.16853932584269662,1.0,1.0,8/34,15.04%,ZFPM1;NR4A3;PURB;LGALS3;CTR9;PRKCB;SIN3A;RUNX1
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.7089480431657041,-1.2022424530990097,0.2564102564102564,1.0,1.0,4/13,10.20%,BASP1;VEGFA;SMCHD1;FGFR2
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.6876412975012065,-1.2018583138923098,0.2077922077922078,1.0,1.0,5/14,22.39%,COG2;NAPG;GOSR1;NSF;COG6
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.7561631249955786,-1.2016556167274917,0.2597402597402597,1.0,1.0,1/9,1.10%,CHST11
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.7144744572525235,-1.2014031612876501,0.20253164556962025,1.0,1.0,3/11,12.38%,TWIST1;VEGFA;TGFBR1
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.5874351062101111,1.2012387604925234,0.25,0.8612650440554263,1.0,1/11,1.35%,ADGRA2
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.7544185772211671,-1.2007348517673262,0.23529411764705882,1.0,1.0,3/7,20.08%,MORF4L1;EP400;MORF4L2
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.6808681718554799,-1.2006320991063666,0.19753086419753085,1.0,1.0,3/16,18.46%,HDAC2;CST3;BTRC
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.7700004456185118,-1.200321383680256,0.18309859154929578,1.0,1.0,1/6,1.78%,ASPA
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.5298281655703785,1.2002309868703698,0.15,0.8599080590474276,1.0,1/17,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.658184133867117,-1.200087949132051,0.16049382716049382,1.0,1.0,4/19,7.32%,SEC13;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),-0.7389578319391974,-1.199806307727719,0.21621621621621623,1.0,1.0,2/6,14.45%,NRG1;TAPT1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.756888434757898,-1.1990712447082463,0.20253164556962025,1.0,1.0,2/9,6.85%,SOD1;SOD2
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.7423142800328775,-1.1989671234841208,0.16883116883116883,1.0,1.0,3/10,15.00%,SH3BP5;SNX6;ERRFI1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.7133481861485482,-1.1989544727802635,0.20987654320987653,1.0,1.0,2/15,9.00%,SMOC1;IFT122
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.7198726163849152,-1.1988748570301475,0.20987654320987653,1.0,1.0,2/12,9.72%,PELI1;SDCBP
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.7950996707978297,-1.1985521120402554,0.24096385542168675,1.0,1.0,3/6,12.38%,TGFB2;TGFB1;TGFBR1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.697129499086441,-1.1985307741734037,0.25675675675675674,1.0,1.0,4/11,20.91%,LPIN1;SELENOI;PLAAT3;CHKA
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.6335255058119272,-1.1984661750011965,0.25,1.0,1.0,7/26,20.21%,LPIN1;MMUT;ALDH3A2;HADHA;HSD17B4;ACADL;ECHDC1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.7819359601090174,-1.1981858404061243,0.27631578947368424,1.0,1.0,2/5,19.34%,VEGFA;NR4A2
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5780907426473911,-1.198056564930123,0.06060606060606061,1.0,1.0,36/205,14.14%,MID1;PRKACA;CSF1;SOD1;TWIST1;PELI1;IFITM3;IFIT3;F3;VEGFA;CD44;TMSB4X;NFKBIA;PDCD4;PSMB1;NCAM1;TGFB1;SOD2;CTR9;STAT3;MAP3K8;PSMD14;MT2A;RPS27A;RBX1;RAP1B;HIF1A;MT3;PSMA4;CEBPD;PSMB2;IL18;CFL1;GBP2;PITPNA;CDKN1B
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.7206917605872729,1.1980180394046063,0.3103448275862069,0.8617745616005643,1.0,3/5,10.17%,RNF185;ATXN3;TMEM259
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.7951709497136945,-1.1973777427141887,0.12987012987012986,1.0,1.0,2/8,2.05%,TWIST1;NR4A3
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.7583643003906951,-1.1972879346028293,0.2777777777777778,1.0,1.0,3/7,13.43%,LGALS3;CEBPD;IL18
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.7135410248572136,-1.1972288930952428,0.21518987341772153,1.0,1.0,5/11,23.99%,LPIN1;GK5;PLAAT3;LMF1;LPL
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.6259506778659968,-1.1972222711913976,0.17391304347826086,1.0,1.0,6/28,10.59%,MCC;TGFB2;RHOJ;GLUL;ENPP2;HIF1A
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.6852456930642762,-1.1967739489419789,0.14772727272727273,1.0,1.0,6/20,15.74%,TGFB2;TGFB1;STAT3;HIF1A;JUN;TEAD1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5326512370106362,1.1966422837337773,0.10526315789473684,0.8621803816868064,1.0,2/18,2.93%,ATP2B4;NOTCH1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.6964647854251801,-1.196491657836551,0.18823529411764706,1.0,1.0,7/15,17.73%,MCTP2;RIMS2;SNCAIP;RIMS1;LRRK2;DTNBP1;PREPL
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.7566196868321773,-1.1964258908620735,0.1728395061728395,1.0,1.0,3/6,20.66%,CNIH3;NLGN1;MINK1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.7185765691585786,-1.1961306578917332,0.2077922077922078,1.0,1.0,6/10,24.72%,EIF2AK2;HIF1A;IL18;ADAM17;LPL;APP
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.7395986512399416,-1.1959169363836066,0.24675324675324675,1.0,1.0,2/7,9.32%,BASP1;KLF15
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.7256295509621914,-1.195597102836189,0.32894736842105265,1.0,1.0,3/9,16.38%,RIMS2;RNF10;RIMS1
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.7298422829973503,-1.1955770611101824,0.2125,1.0,1.0,3/9,9.00%,VEGFA;TENM3;IFT122
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.7644872769063884,-1.1955615270467472,0.20833333333333334,1.0,1.0,4/5,19.98%,SLC22A6;PRKCI;RIMS1;FBLN5
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.6036538965762234,-1.1954805021420363,0.125,1.0,1.0,20/71,18.80%,SOD1;ANKH;IFITM3;EMP1;CD44;TGFB2;PDCD4;RHOB;SOD2;LGALS3;CD38;JUN;IL18;CDKN1B;ETF1;CLU;GPX4;GSR;BTG2;DNAJA1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.6606155890862773,-1.195238214356035,0.20238095238095238,1.0,1.0,6/18,24.53%,IFITM3;IFIT3;GBP2;STAT1;IRF1;HLA-B
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.6606155890862773,-1.195238214356035,0.20238095238095238,1.0,1.0,6/18,24.53%,IFITM3;IFIT3;GBP2;STAT1;IRF1;HLA-B
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.6529168592323907,-1.195066489119782,0.25,1.0,1.0,4/18,13.32%,KLF2;SSH1;NEDD4L;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.6709606364105606,-1.1950360267342226,0.2441860465116279,1.0,1.0,5/18,17.43%,NELL1;CST3;FMN2;AZIN1;MDM4
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.7448445719555924,-1.194825721597975,0.17105263157894737,1.0,1.0,4/9,14.92%,PSMB1;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.4441453371539934,1.19473737050457,0.15384615384615385,0.8641215614673085,1.0,5/35,3.32%,CAV2;ATP2B4;TRPC6;RYR2;CACNA1C
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.7501812267063152,-1.1945794058077395,0.25333333333333335,1.0,1.0,2/7,9.23%,GLUL;SNAP25
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.8017248519194049,-1.194458457074265,0.21333333333333335,1.0,1.0,3/6,18.80%,MTCH2;LRRK2;DNAJA1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.765123434154154,-1.1941935371277799,0.21951219512195122,1.0,1.0,2/8,15.99%,SDCBP;RAB7A
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.69634259021679,-1.1941250890558832,0.21518987341772153,1.0,1.0,3/13,10.20%,TGFB2;GPM6A;FGFR2
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.7570158391726365,-1.1939174244759867,0.23684210526315788,1.0,1.0,1/7,3.09%,SPTBN4
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.48501156816114116,1.1936462308795346,0.25,0.8632871509073016,1.0,5/27,8.44%,ATP10A;PRELID2;ABCA3;ATP8B2;ATP8A1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.7894269600681352,-1.1935843672344117,0.2804878048780488,1.0,1.0,2/5,16.39%,VEGFA;CAMK2D
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.5876542262508924,1.1933562317709985,0.25,0.8603763335395572,1.0,1/12,0.02%,JPH2
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.740408716445622,-1.1930512822979937,0.19480519480519481,1.0,1.0,3/11,8.10%,VEGFA;EFNB2;ROBO1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.7972222996834986,-1.192920992872867,0.15789473684210525,1.0,1.0,1/5,4.90%,SZT2
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.832398955601681,-1.192455659599572,0.21333333333333335,1.0,1.0,4/5,16.61%,FHL1;NEDD4L;CAMK2D;LRRK2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.5910496634787991,-1.1920879262498791,0.16129032258064516,1.0,1.0,19/81,20.49%,PRKACA;ZFP36L2;CSNK1D;TUBA1A;PSMB1;CEP57;PSMD14;RPS27A;CCP110;PSMA4;PSMB2;NINL;PSMA7;RGCC;ANAPC4;YWHAG;BTRC;APPL2;SKP1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.8170415590372908,-1.1920507227165393,0.1780821917808219,1.0,1.0,1/5,1.16%,ZFP36L2
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.5905785409359449,-1.192046086713002,0.20212765957446807,1.0,1.0,9/42,16.63%,TBC1D20;CDKL1;TBC1D8;NPRL3;DCDC2;IFT140;C9ORF72;DYNC2LI1;USP6NL
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.788068864124214,-1.1916833403085005,0.19444444444444445,1.0,1.0,2/7,11.32%,SOD1;PXDN
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.7912847992813072,-1.1915562958929775,0.23684210526315788,1.0,1.0,2/5,13.91%,CRY1;SIN3A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.6269600773827466,-1.1912749635625735,0.23333333333333334,1.0,1.0,12/30,22.55%,IPO5;PDCD4;RHOB;TGFB1;LATS2;ANGEL2;CDKN1B;TSPYL2;DUSP1;BTG2;BTG1;HECA
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.7512734085161972,-1.1908641319134885,0.2345679012345679,1.0,1.0,1/7,4.23%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.6614762848924962,1.1908526210471377,0.2857142857142857,0.8640194231664007,1.0,2/10,0.50%,HSPA1A;CD58
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.7253199394381606,-1.190628939875387,0.27710843373493976,1.0,1.0,1/7,6.09%,XPO4
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.7696110368555437,-1.1898778065941682,0.2361111111111111,1.0,1.0,2/5,5.20%,MGST1;SLC16A12
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.7277138965344144,-1.189868519508313,0.2857142857142857,1.0,1.0,4/9,7.75%,CSF1;VEGFA;LGALS3;JAM3
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.7048142923357341,-1.1898076169174236,0.20512820512820512,1.0,1.0,3/13,13.43%,ZFPM1;PDE4B;IL18
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.5873561416471625,-1.1893893179952464,0.14130434782608695,1.0,1.0,15/70,20.63%,STX6;TBC1D20;COG2;CSNK1D;CSNK1A1;COG7;GOLGA8A;GOLGA8B;FAM174B;GOLGA2;LRRK2;USP6NL;NPLOC4;TMED4;GAK
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6469866434754503,-1.1892162279370062,0.2441860465116279,1.0,1.0,11/26,29.99%,RPA1;RPS27A;RBX1;PARP1;WRN;XPA;RAD23B;POT1;PURA;GTF2H1;ASCC3
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.6089825833383471,-1.1890943581442794,0.25,1.0,1.0,15/39,21.88%,RHEB;SEC13;ATP6V1E1;ATP6V1G1;SLC38A9;SZT2;EIF2AK2;NPRL3;ATP6V1H;ATP6V1D;ITFG2;SESN1;MAPK1;LARS1;EIF2AK4
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.6876727970726095,-1.1889985767842128,0.21428571428571427,1.0,1.0,2/16,2.03%,GNPAT;AGPAT4
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.6360069626801069,1.1888843461206198,0.375,0.8652116062254135,1.0,1/7,0.67%,GPRC5C
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.6672741102553825,-1.1885412290733346,0.22972972972972974,1.0,1.0,2/17,4.34%,NDUFB9;NDUFV1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.6672741102553825,-1.1885412290733346,0.22972972972972974,1.0,1.0,2/17,4.34%,NDUFB9;NDUFV1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5708632679595329,-1.1882799913081306,0.17391304347826086,1.0,1.0,14/68,12.47%,SRGN;SOD1;SYT1;HABP4;VEGFA;TMSB4X;TGFB2;PROS1;TGFB1;SCCPDH;SNAP25;RIMS2;ANXA5;TF
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.7356545943802486,-1.1879206997563565,0.25333333333333335,1.0,1.0,5/8,23.28%,NEDD4L;CAMK2D;HECW1;NEDD4;STK39
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.7457210122299642,-1.187674035305033,0.24096385542168675,1.0,1.0,3/9,9.65%,NOS1AP;KCNE4;KCNQ1
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.7051562174284467,-1.1874659798271998,0.24324324324324326,1.0,1.0,2/9,3.60%,NRG1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.7194209978581632,-1.18742516058672,0.2125,1.0,1.0,2/12,8.64%,SSH1;STMN1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.5864134426683022,-1.1874245402291317,0.21739130434782608,1.0,1.0,10/44,18.73%,NELL1;DDX3X;CST3;EIF2AK2;GIGYF2;CNOT8;IGF2BP2;RPL13A;IGFBP5;BTG2
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.782954119401922,-1.187361660924054,0.3055555555555556,1.0,1.0,3/5,20.55%,KLF2;ASS1;SREBF2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.7257274070951962,-1.1873403578592048,0.27631578947368424,1.0,1.0,6/10,25.06%,NEDD4L;CAMK2D;HECW1;NEDD4;STK39;GOPC
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.7494853164105891,-1.1872022479621969,0.3333333333333333,1.0,1.0,1/6,3.99%,SLCO1A2
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.6833864044191186,-1.1871732114491895,0.22784810126582278,1.0,1.0,5/18,21.01%,MAP3K8;RPS27A;BTRC;SKP1;MAPK1
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),-0.7736009337639819,-1.1866643663525678,0.25,1.0,1.0,2/6,10.79%,ATL1;LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.5500244873056587,1.1858055290976215,0.3,0.8707549991014856,1.0,3/11,13.60%,AFAP1L2;HIP1;ARAP1
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.7522986217609657,-1.185638721984289,0.21739130434782608,1.0,1.0,1/7,0.93%,SOD1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),-0.7361250601479571,-1.1853151414020624,0.21951219512195122,1.0,1.0,2/9,15.18%,NAA11;NAA15
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.7722296957455131,-1.1852918676314155,0.20270270270270271,1.0,1.0,3/7,13.43%,IGFBP2;PRKAR1A;IL18
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.6318344009299904,-1.185285093925523,0.25882352941176473,1.0,1.0,4/21,6.42%,F3;VEGFA;TMSB4X;TGFB1
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),-0.7415578524272746,-1.1852403118371677,0.2875,1.0,1.0,3/7,12.38%,NRG1;TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.7634580211008903,-1.1851405850229202,0.2,1.0,1.0,5/8,23.28%,NEDD4L;CAMK2D;HECW1;NEDD4;STK39
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.7813532553664597,-1.185123306410415,0.25,1.0,1.0,3/6,10.79%,ENO1;RHBDD1;LPCAT3
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.6332222469731936,1.1847960565413964,0.27586206896551724,0.8702588323236873,1.0,1/6,1.63%,HEY2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.7551138242225544,-1.184660676745817,0.2289156626506024,1.0,1.0,3/6,22.50%,NR4A3;IGFBP5;DOCK4
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.6147128698306656,-1.1845728625101883,0.20212765957446807,1.0,1.0,18/52,28.83%,GLUL;ALDH3A2;XIST;BCKDHB;HSPH1;CA2;LDHA;HSD17B4;ACADL;ACSL4;PTS;DLD;PPARA;GABARAPL1;METAP1;ACO2;SERINC1;ACADVL
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.6877697267048752,-1.184442622403082,0.24675324675324675,1.0,1.0,6/12,10.69%,ITGA5;NIBAN2;PTPN1;PRKCB;HIF1A;MT3
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5503072867854132,1.1842868830497328,0.25,0.8682268452454507,1.0,5/13,12.87%,DERL1;RNF185;FBXL17;ATXN3;VCP
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.7727622868312007,-1.1840618879024307,0.27941176470588236,1.0,1.0,1/5,2.84%,LPIN1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.5731064052984827,-1.1840048653917579,0.12371134020618557,1.0,1.0,23/92,23.54%,RNMT;TEFM;TAF7;ELOB;TAF1B;CTR9;GLIS3;TBPL1;CEBPD;RTF1;POLR1C;PARP1;CCNH;PWP1;PKNOX1;NR4A2;CCNK;FUBP3;AFF4;DDX21;SETX;NFIX;SUPT16H
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.7141581545688944,-1.1833582465337311,0.25,1.0,1.0,6/10,24.72%,TGFB1;CEMIP;UBE2K;PRKAG2;MAPK1;APP
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.771917154134617,-1.1832074621326543,0.2261904761904762,1.0,1.0,3/7,16.38%,MCTP2;SNCAIP;RIMS1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.6135797230293686,-1.1831207810224003,0.2127659574468085,1.0,1.0,17/44,23.99%,GNPAT;BTD;CYP3A5;PDHX;PANK2;MCCC2;ACOT11;PTGR1;ALDH1A2;LDHA;ACSL4;NPC1;DLD;AKR1C1;PPARA;GLO1;LPL
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.7664214016782984,-1.1824030289130474,0.24,1.0,1.0,1/6,1.67%,ZFPM1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.7123815868497065,-1.182351519931444,0.22666666666666666,1.0,1.0,3/9,13.99%,GJA1;SLC1A2;SLC1A1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.8075293624694768,-1.1821579323875735,0.23170731707317074,1.0,1.0,1/5,1.49%,PELI1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.8075293624694768,-1.1821579323875735,0.23170731707317074,1.0,1.0,1/5,1.49%,PELI1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.7216381793873893,-1.1820158284818254,0.27848101265822783,1.0,1.0,8/11,24.75%,GLRX;DUT;CMPK1;TXNRD1;GUK1;GSR;AK4;AK9
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5930670014737176,1.1820068938142543,0.3103448275862069,0.8709121596315388,1.0,2/10,4.53%,ATP2B4;PKIA
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.7813832656121298,-1.1819907305632695,0.1917808219178082,1.0,1.0,3/5,17.51%,JAM3;RAP1B;FARP2
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.4980953099656743,1.1818471547889602,0.25,0.8673688609756046,1.0,6/19,12.69%,PDGFA;CDK6;SKI;CDKN1A;MORC3;DAB2IP
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),-0.7521364053210582,-1.1815156068678523,0.2222222222222222,1.0,1.0,4/8,15.04%,CST3;TGFB1;IL18;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.6707730119269851,-1.1811318508210993,0.23255813953488372,1.0,1.0,7/16,21.99%,GRIN1;HDAC2;TGFB1;RUNX1;RAB27A;RGCC;PPARA
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.6011700046493499,-1.1806197962883982,0.17708333333333334,1.0,1.0,14/55,14.14%,CSE1L;DUT;NUP153;RPA1;CTCF;MELK;STMN1;DNMT1;RAD21;CCP110;DONSON;PRKDC;RBBP7;CDKN1B
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.609950864862959,-1.1805841483551323,0.28735632183908044,1.0,1.0,15/38,21.88%,RHEB;SEC13;ATP6V1E1;ATP6V1G1;SLC38A9;SZT2;EIF2AK2;NPRL3;ATP6V1H;ATP6V1D;ITFG2;SESN1;MAPK1;LARS1;EIF2AK4
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.8036025513889185,-1.1804221246080857,0.22972972972972974,1.0,1.0,2/5,11.79%,XRCC4;PRKDC
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.6821458542148795,-1.1803526025136835,0.24691358024691357,1.0,1.0,2/13,7.92%,ALDH3A2;PEX3
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.6583286660594305,-1.1803178353290638,0.21794871794871795,1.0,1.0,4/18,7.32%,SEC13;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.6583286660594305,-1.1803178353290638,0.21794871794871795,1.0,1.0,4/18,7.32%,SEC13;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.7063969920392612,-1.180159527536877,0.275,1.0,1.0,1/11,3.60%,VEGFA
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.662897790453717,-1.1800804118713661,0.2077922077922078,1.0,1.0,10/16,31.37%,SOAT1;LIMA1;CLU;NPC1;AKR1C1;SCARB1;STX12;ABCA8;LDLRAP1;ABCA5
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.6416657693432626,-1.1799068224010967,0.26373626373626374,1.0,1.0,13/29,30.04%,SOD1;SOD2;HIF1A;JUN;CAMKK2;STK24;MAPK1;FYN;APTX;EGFR;AGAP3;ADAM9;MAPK9
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.7135230902585431,-1.1798475630504153,0.2289156626506024,1.0,1.0,4/11,16.76%,SLC22A6;SLCO1A2;LRRC8B;SLC13A3
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.6673191057524258,-1.1797266058826228,0.2808988764044944,1.0,1.0,6/18,17.88%,RPA1;CTCF;XRCC4;RAD21;TERF2IP;TNKS
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.6145559527617842,-1.1796577461018969,0.2413793103448276,1.0,1.0,7/28,24.72%,TWIST1;SELENOS;STAT3;CLU;MAPKAPK2;LPL;APP
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5456329241074953,1.179536020869599,0.22727272727272727,0.8710636293066013,1.0,2/11,2.93%,ERBB4;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.629399403301284,1.1791344763456095,0.2857142857142857,0.8684783571025007,1.0,2/7,1.85%,A2M;PDGFA
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.6209311215159931,-1.1788896705120122,0.13829787234042554,1.0,1.0,19/52,21.29%,ELOB;SLC2A1;WASF3;WASF1;WIPF1;NUP133;NAPG;DARS1;SPG7;PPARGC1A;FANCC;WDR19;TEAD1;RIMS1;TSPAN4;MDM4;LIN7A;ST13;MDM2
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.7553289272970787,-1.1787034731344876,0.2898550724637681,1.0,1.0,3/5,22.88%,GALNT11;APH1B;ADAM17
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.6869432254723731,-1.1786844866879596,0.23076923076923078,1.0,1.0,3/15,12.78%,SRSF12;SRSF10;SRSF5
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.7284088655208205,-1.1786124424915612,0.2564102564102564,1.0,1.0,4/8,20.44%,GRIN1;RIMS2;RIMS1;NLGN1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6353393731155168,1.1776994142002495,0.21739130434782608,0.8689771813333278,1.0,2/7,12.38%,CHMP4B;CORO1C
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.7008196876946293,-1.1771010676336602,0.2222222222222222,1.0,1.0,8/11,25.90%,GRIN1;EPHA7;MT3;DELE1;BEX3;BIRC2;FYN;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.7599359234348024,-1.1769665609547617,0.26582278481012656,1.0,1.0,2/7,13.43%,CSF1;IL18
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.721887081351404,-1.1763520209793483,0.2441860465116279,1.0,1.0,4/11,16.39%,NR4A3;ROCK2;PARP1;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.8152587035868096,-1.1758999918476027,0.2465753424657534,1.0,1.0,2/5,10.61%,LGALS3;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.8152587035868096,-1.1758999918476027,0.2465753424657534,1.0,1.0,2/5,10.61%,LGALS3;PTPN2
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.6139502120320418,-1.1758630811401662,0.19767441860465115,1.0,1.0,14/35,28.86%,RIPOR1;WIPI1;SREBF1;LRRK2;LAMP2;STK24;WRN;SREBF2;PPARA;LPL;RRAGB;MAP1LC3B;WDR45B;EIF4G1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.6411918336292688,-1.1758134778762388,0.19767441860465115,1.0,1.0,8/28,20.41%,UVSSA;HMGN1;RPA1;RPS27A;RBX1;CCNH;POLK;XPA
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.6598517045803923,1.1752894968853,0.3157894736842105,0.87126166164608,1.0,2/6,4.54%,ADCY9;ZDHHC21
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.6908935359853845,-1.1751609636849503,0.22988505747126436,1.0,1.0,3/11,13.96%,MTMR9;TGFB1;SYMPK
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.5852309409634717,1.175124721877303,0.25,0.8679387052989186,1.0,1/5,8.00%,RHOT1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.6959722213949806,-1.1749412266040782,0.2465753424657534,1.0,1.0,4/11,17.12%,LPIN1;ENPP2;MT3;ACADL
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.7250282082679621,-1.17493723396265,0.2926829268292683,1.0,1.0,2/10,8.96%,CTR9;DNMT1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.7305029686703358,-1.1747141293353758,0.2702702702702703,1.0,1.0,2/8,3.60%,CSF1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.6964997275378276,-1.1746607073522346,0.3037974683544304,1.0,1.0,2/12,7.09%,RUBCN;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.6112653936648421,-1.174282291894282,0.25274725274725274,1.0,1.0,3/22,15.00%,EPN1;PTPN2;ERRFI1
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.7040922970507789,-1.1742506640166674,0.2698412698412698,1.0,1.0,3/8,16.38%,SYT1;RIMS2;RIMS1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.40928347951249233,1.1739917702487719,0.14285714285714285,0.8668027788402429,1.0,10/61,5.82%,TAGLN;RCAN2;LMOD1;OPCML;ITGA7;FAM13C;GPRC5B;NFASC;RASL12;TNS2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.7039570149845038,-1.1738609057419613,0.28,1.0,1.0,3/8,17.29%,PDCD4;PRKCI;RGCC
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5440839407736715,1.1736728818587072,0.37037037037037035,0.8640054045434981,1.0,3/11,5.68%,TNIP1;TRAF6;MAP3K1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.6119890550262244,1.1734305286380344,0.34615384615384615,0.8612796906536848,1.0,2/10,3.32%,SCN1A;CACNA1C
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.636233254161927,-1.1732469305059745,0.2823529411764706,1.0,1.0,7/23,19.26%,SEC13;NUP153;NUP133;NUP88;HIF1A;RANBP2;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.7422751581280485,-1.1731060765013341,0.2916666666666667,1.0,1.0,1/5,2.05%,NR4A3
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.6243311305270013,-1.172894891715185,0.17204301075268819,1.0,1.0,10/39,19.00%,OS9;SELENOS;MARCHF6;RHBDD1;AMFR;HSPA5;TRIM13;UBE2J1;NPLOC4;ERLEC1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.7427618292537571,-1.1728840267968026,0.2875,1.0,1.0,4/7,21.77%,PLAA;PTGR1;AKR1C2;AKR1C1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.5871175767195137,1.1727184449607295,0.4,0.8595715356045858,1.0,1/6,1.46%,PRKG1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.5959414236325443,-1.1726844296193928,0.2235294117647059,1.0,1.0,12/38,18.47%,ZFP36L2;ZFPM1;TGFB2;TGFB1;MELK;ARIH2;FGFR2;WNT2B;NOTCH2;RUNX1;KIRREL3;PGM3
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.6218039572474384,-1.1720151990431307,0.23863636363636365,1.0,1.0,13/34,26.91%,SOD1;ATP6V1G1;ACO1;FTH1;MT2A;MT3;TF;SKP1;NDFIP1;SLC40A1;APP;ATP6V0D1;CP
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.7075834929578667,-1.1715227041795817,0.27848101265822783,1.0,1.0,1/8,3.80%,SELENOS
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.6154196458251459,-1.1713252391663949,0.16666666666666666,1.0,1.0,10/38,16.30%,NELL1;NKAIN3;ELAVL3;CRMP1;DNER;SNAP25;PURG;NXPH1;SNAP91;CDK14
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.6860229500052422,-1.171071298777028,0.2976190476190476,1.0,1.0,9/18,28.92%,RPA1;RPS27A;RBX1;PARP1;CCNH;XPA;RAD23B;RPA3;GTF2H1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.7236200129382414,-1.170597444946894,0.25333333333333335,1.0,1.0,2/9,7.92%,ALDH3A2;PEX3
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.6654734087803766,1.1704476113080369,0.3235294117647059,0.8629689643934184,1.0,1/5,8.39%,MYL9
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.678369608127459,-1.1698063337871318,0.2727272727272727,1.0,1.0,3/13,9.00%,GPR161;SUFU;IFT122
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.8080839855936512,-1.1696461368266864,0.22784810126582278,1.0,1.0,1/5,10.55%,RAP1B
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.6629758534218048,-1.1694305769203275,0.2235294117647059,1.0,1.0,5/21,16.56%,KDM1A;PTPN1;SPIDR;PARP1;GPC4
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.660056084818281,-1.1693722882426172,0.3048780487804878,1.0,1.0,2/19,3.60%,STC1;VEGFA
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.5900519655523276,-1.16915343544497,0.25842696629213485,1.0,1.0,13/63,14.92%,PRKACA;CSNK1D;FHL1;TUBA1A;PSMB1;CEP57;PSMD14;RBX1;CCP110;PSMA4;PSMB2;NINL;PSMA7
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.5767749840955418,-1.1687470914303641,0.22340425531914893,1.0,1.0,14/55,15.28%,FAT3;PCDH17;ELAVL3;CRMP1;ROBO2;DCLK1;PTPRD;UNC5D;SNAP25;DENND2A;PLP1;PURG;FMN2;SNAP91
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.7522031938326075,-1.1685699796711375,0.28125,1.0,1.0,4/7,23.99%,MT3;PLAAT3;ACADL;LPL
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.6518945449997323,-1.1682734093332008,0.26436781609195403,1.0,1.0,4/18,19.17%,KDM1A;AKAP8;PPARGC1A;TET1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.6297024499444264,-1.1679419999846548,0.20652173913043478,1.0,1.0,3/23,6.42%,IPO5;XPO4;TGFB1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.5663224198507399,-1.167913935294867,0.22916666666666666,1.0,1.0,31/81,28.38%,DDX52;DHX29;RPL28;WDR43;GLUL;RPL34;RPL21;RPLP2;RPL19;NOP58;RPS14;RPLP1;RPL13A;RPL18;RPL27;RPL35A;RPL5;RPL31;RPL41;RPL24;RPL27A;RPL37;RPL36;EIF2A;RPL32;LAS1L;TEX10;RPL9;RCL1;RPL37A;RPS2
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.666563485455942,1.1672248330834103,0.2608695652173913,0.8684027576004009,1.0,1/6,1.38%,RYR2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.6959709817734343,-1.167212094284403,0.24096385542168675,1.0,1.0,3/13,9.65%,FHL1;NOS1AP;KCNQ1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.6616338472040454,-1.1670887392542948,0.3,1.0,1.0,3/14,6.42%,SRA1;AKIRIN1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.7294662272557725,-1.166937578237196,0.2463768115942029,1.0,1.0,1/7,9.99%,RAD21
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.6024221287188506,1.1667661292284495,0.36,0.8665459161138305,1.0,2/8,5.13%,ATP2B4;DDI2
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.6121310337782944,-1.1662054263670418,0.27058823529411763,1.0,1.0,8/22,27.25%,ZFP36L2;TUT7;GIGYF2;ROCK2;METTL16;TARDBP;RC3H2;CNOT1
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.7136343528496554,-1.1660945375182068,0.3076923076923077,1.0,1.0,2/9,7.72%,IFITM3;EIF2AK2
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.7118781929145066,-1.1660679446915823,0.25316455696202533,1.0,1.0,4/11,12.22%,ZFPM1;TGFB1;FGFR2;MYL3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.7031680269435473,-1.1658782751206043,0.2727272727272727,1.0,1.0,5/14,24.24%,RPS27A;RBX1;PARP1;XPA;RAD23B
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.6935071038690921,-1.1658073591904268,0.24050632911392406,1.0,1.0,6/14,21.31%,ETV5;SOAT1;CEBPD;SCD;STEAP4;SAT1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.6479967018326006,-1.1656268841769863,0.313953488372093,1.0,1.0,9/24,23.00%,NRG1;PIP4P2;RUBCN;LGALS3;NDFIP2;RAB7A;MTMR2;NDFIP1;ARL6IP5
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.6565577002769982,1.1656029193059156,0.3103448275862069,0.8663802579702942,1.0,2/6,4.22%,NOTCH1;LIN7C
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.5779033101892843,1.1655941348159782,0.3333333333333333,0.8627400047855449,1.0,1/14,0.03%,ZBTB7C
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.7108707955485167,-1.165590100742308,0.32051282051282054,1.0,1.0,4/8,20.25%,KDM1A;LRRK2;NAP1L1;APPL2
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.5919616202911641,-1.1655677536361038,0.1702127659574468,1.0,1.0,10/53,13.73%,SRGN;CSF1;TGFB2;TGFB1;RARS1;PRKCB;DARS1;HIF1A;IL18;GBP2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.6738301670359638,-1.1654662551612234,0.24096385542168675,1.0,1.0,7/17,12.38%,NRG1;TGFB2;TGFB1;ZFPM2;FGFR2;MYL3;TGFBR1
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.7151695318970828,-1.1654468817153112,0.2727272727272727,1.0,1.0,2/10,6.42%,TGFB2;TGFB1
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5768548545076843,-1.1651518568564945,0.25,1.0,1.0,13/55,14.92%,PELI1;NFKBIA;PSMB1;MAP3K8;PSMD14;RPS27A;RBX1;HIF1A;TANK;PSMA4;PSMB2;GBP2;PSMA7
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.7364274226611566,-1.1651258754726566,0.33783783783783783,1.0,1.0,2/6,4.25%,PDE4B;NOS1AP
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.6690886451703852,-1.1648662770888638,0.26582278481012656,1.0,1.0,8/24,18.83%,WWC1;KDM1A;GOSR1;PARP1;CAMK2D;LRRK2;ADGRE2;REEP5
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.7295744978410309,-1.1648148274479269,0.2597402597402597,1.0,1.0,1/6,0.88%,PRKACA
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.6191679140448417,-1.1646374740508467,0.23170731707317074,1.0,1.0,7/21,23.99%,CYP3A5;DHRS3;ALDH1A2;GPC4;ABCA4;AKR1C1;LPL
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.7426476520157772,-1.164592729779918,0.30434782608695654,1.0,1.0,1/6,8.62%,SEC11A
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.6065242073612901,-1.1642236860084463,0.18181818181818182,1.0,1.0,10/43,16.04%,WIPI1;VEGFA;SEC11A;DDIT4;SSR1;RPS14;ATF6;HSPA5;DCP2;TSPYL2
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.639563511477898,-1.1641319677874058,0.25287356321839083,1.0,1.0,10/24,28.07%,CST3;RPS27A;GGA3;SNCAIP;APH1B;TSPAN5;MDM2;APP;SIAH1;GSN
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6623014042972555,-1.1640828639288796,0.2289156626506024,1.0,1.0,7/18,22.27%,NR4A3;OGN;PRKDC;IL18;IGFBP5;CCN4;STAT1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.6051318282343806,-1.1636651609586417,0.20454545454545456,1.0,1.0,10/36,19.45%,PELI1;MARCHF6;NEDD4L;ARIH2;RBX1;AMFR;ZNRF1;UBE2K;UBE2B;RNF34
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.6686655304994839,-1.1635694979746782,0.29333333333333333,1.0,1.0,3/12,8.02%,VEGFA;DDX3X;PDGFD
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.6081628923520278,-1.163065945049442,0.26373626373626374,1.0,1.0,7/40,12.25%,NRCAM;SPTBN4;ATL1;ANK3;FGFR2;DCDC2;CCK
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.642685873339784,-1.1630605397171756,0.3023255813953488,1.0,1.0,7/19,20.95%,SZT2;SIK2;HSPA5;ITFG2;SESN1;PRKAG2;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.6535830045928096,-1.162454259466156,0.2247191011235955,1.0,1.0,5/19,14.55%,EFNB2;TGFB2;EPHA7;DDIT4;CLU
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.6902333170308528,-1.1622613454494497,0.20689655172413793,1.0,1.0,2/12,6.42%,IPO5;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.6902333170308528,-1.1622613454494497,0.20689655172413793,1.0,1.0,2/12,6.42%,IPO5;TGFB1
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.6212847176514779,-1.1622343844505698,0.2289156626506024,1.0,1.0,6/23,18.08%,DHRS3;COL11A1;ADGRV1;PITPNA;ATF6;COL18A1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.5551357414095378,-1.161675814321199,0.21428571428571427,1.0,1.0,34/97,28.38%,DDX52;RPL28;TUT7;WDR43;RPL34;RPL21;INTS8;RPLP2;RPL19;NOP58;RPS14;RPLP1;RPL13A;RPL18;INTS4;RPL27;RPL35A;INTS2;AGO2;SSB;RPL5;RPL31;RPL41;RPL24;RPL27A;RPL37;RPL36;RPL32;LAS1L;TEX10;RPL9;RCL1;RPL37A;RPS2
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.697586667031611,-1.1616556284068174,0.23333333333333334,1.0,1.0,1/12,3.78%,NCKAP5
prerank,PanglaoDB_Augmented_2021__B Cells,-0.6383490249159806,-1.1612307838003455,0.30434782608695654,1.0,1.0,5/22,13.06%,IFIT3;CD55;BACH2;CD38;SCD
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),-0.7439519442543749,-1.1607890744358584,0.25675675675675674,1.0,1.0,2/6,14.10%,RUBCN;FYCO1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.645233830325649,-1.160720685689265,0.23863636363636365,1.0,1.0,3/25,7.72%,MID1;TGFB2;EIF2AK2
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.6912220254135552,-1.160550510112236,0.25,1.0,1.0,5/13,17.77%,CD44;ARHGAP24;ITGA5;TMEFF2;CCN1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.7140084672572663,-1.1604175607891163,0.2976190476190476,1.0,1.0,2/8,6.50%,NFKBIA;SUFU
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6520403356432695,-1.1601949459843068,0.2875,1.0,1.0,4/12,21.23%,DHX29;EIF2S2;MCTS1;EIF2S3
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.640621412513303,-1.1597994053881846,0.2682926829268293,1.0,1.0,7/22,19.26%,SEC13;NUP153;NUP133;NUP88;HIF1A;RANBP2;PRKAG2
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.7408283683869397,-1.1596640459445664,0.2702702702702703,1.0,1.0,2/7,10.69%,MT2A;MT3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.6978823268817738,-1.1594912739094634,0.2236842105263158,1.0,1.0,7/17,20.41%,RPA1;RPS27A;RBX1;PARP1;FAN1;POLK;XPA
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.7909548911377714,-1.1594490426521533,0.23076923076923078,1.0,1.0,3/6,12.38%,TWIST1;FGFR2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.6997369620902992,-1.1592601806360816,0.22535211267605634,1.0,1.0,3/10,13.32%,S1PR3;VEGFA;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.7537259244743071,-1.1589336334522728,0.3150684931506849,1.0,1.0,2/5,13.48%,PTPN2;FRMD5
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),-0.7344819926377171,-1.158689856080225,0.3150684931506849,1.0,1.0,2/8,9.57%,GRIN1;FARSB
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.6762660432678944,-1.1576079546021845,0.2891566265060241,1.0,1.0,6/16,17.88%,KDM1A;HABP4;NFKBIA;JUN;SIN3A;TNKS
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.6649948045608599,-1.1571005460198511,0.2716049382716049,1.0,1.0,2/14,5.63%,NRG1;OLFM2
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.7607871362544195,-1.1566426216132506,0.31645569620253167,1.0,1.0,1/5,2.64%,CRY1
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.7421528643832291,-1.156176572942947,0.25,1.0,1.0,1/7,0.93%,SOD1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.6775376271880889,-1.1559278828226036,0.30864197530864196,1.0,1.0,1/9,1.16%,ZFP36L2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.6937359541692463,-1.1558344726096403,0.2839506172839506,1.0,1.0,3/10,18.38%,GNA14;CMKLR1;LPAR6
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.5441654187947494,-1.1550600151972765,0.23232323232323232,1.0,1.0,11/79,10.36%,SRGN;CTSL;ADAMTS9;F3;CPD;SUFU;ADGRV1;ERAP1;SPG7;PITRM1;UFSP2
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.6624804018713175,-1.15502903538398,0.2962962962962963,1.0,1.0,2/16,7.24%,NR4A3;PRKCI
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.4990185172330724,1.1543551385015316,0.2631578947368421,0.8921293062611115,1.0,5/17,11.17%,WTIP;CNOT7;CELF1;CNOT6;MOV10
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.6471541843170269,-1.1541806648333437,0.2823529411764706,1.0,1.0,7/24,10.69%,PRAG1;CRMP1;EFNB2;HDAC2;SPOCK1;CBFA2T2;MT3
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7007263798560411,-1.1541119541337135,0.3561643835616438,1.0,1.0,5/8,25.47%,STAT3;PTPN1;PRLR;STAT6;LYN
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.6106165073695938,-1.1536351325804126,0.2717391304347826,1.0,1.0,9/48,21.60%,PRKACA;CSNK1D;TUBA1A;CEP57;CCP110;NINL;YWHAG;RAB11A;SCLT1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.7641365515422323,-1.1535815813603398,0.32432432432432434,1.0,1.0,2/5,10.07%,CD55;HSPH1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.5601198018493245,1.153477790033328,0.2916666666666667,0.8909399159008717,1.0,2/10,3.86%,BCL2L1;BCL2L11
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.6397913492927331,-1.1534505141968285,0.27380952380952384,1.0,1.0,5/17,13.31%,ATP6V1E1;ATP6V1G1;ATP6V1H;TF;ATP6V1D
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.6030151997831557,-1.1531854964144952,0.2553191489361702,1.0,1.0,5/26,9.69%,ASPA;BLMH;GLUL;MCCC2;BCKDHB
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.7145008829423327,-1.1531229532033345,0.24050632911392406,1.0,1.0,4/11,17.01%,TMEM232;DNAH7;MYO16;GFAP
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.659299469595054,-1.153112840524111,0.3375,1.0,1.0,5/14,15.28%,ELAVL3;DNER;GRIN1;NXPH1;SNAP91
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.6530154211355704,1.1530918616621009,0.38461538461538464,0.8881584611307113,1.0,3/6,14.64%,MFHAS1;YWHAB;URI1
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.6587589549071775,-1.1530879004486732,0.2839506172839506,1.0,1.0,4/13,15.28%,CRMP1;STMN1;PURG;SNAP91
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.667387638155733,-1.1529328959286604,0.25287356321839083,1.0,1.0,3/16,15.18%,NAA11;CLOCK;NAA15
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.46329962001866654,1.1529118799827716,0.3157894736842105,0.8848530283430506,1.0,1/17,0.64%,SNAP29
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.5417460241604517,1.1526874852296738,0.24,0.8821195151247343,1.0,2/9,3.75%,SOX5;SOX6
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.5897965148324732,-1.1525696036351274,0.23595505617977527,1.0,1.0,6/31,17.42%,GNPAT;LPIN1;ACOT11;GPX4;PPARGC1A;ACSL4
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.6073798905639356,-1.1525040002925757,0.21978021978021978,1.0,1.0,12/48,21.01%,SYT1;ANK3;ADGRV1;MT2A;MT3;TF;JUN;CDKN1B;CAMK2D;LRRK2;NLGN1;MAPK1
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.5759612422654772,-1.1520244071504329,0.17582417582417584,1.0,1.0,9/56,16.61%,PRKACA;ZFPM1;KDM1A;STK4;AMFR;GOLGA2;SYMPK;MITD1;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.5905468725408988,-1.1518627586941965,0.25842696629213485,1.0,1.0,9/38,19.26%,TAF7;TSC2;SH3BP5;PTPN1;PTPRQ;CDKN1B;DTNBP1;YWHAG;PRKAG2
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6738678873604914,1.151822829391037,0.35714285714285715,0.8815331286265956,1.0,1/5,1.46%,PRKG1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.6322678163898563,-1.15180599982752,0.29069767441860467,1.0,1.0,5/23,12.38%,ROBO2;VEGFA;TGFB2;TRAF3IP1;TGFBR1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.5997178608298701,-1.1517638587218504,0.2976190476190476,1.0,1.0,10/29,26.69%,SYT1;GLUL;SLC1A2;SNAP25;SLC1A1;RIMS1;LIN7A;SYN3;STXBP1;SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.7102151772480141,-1.151745887351208,0.3037974683544304,1.0,1.0,2/10,8.51%,GRIN1;CEMIP
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),-0.7995753922637686,-1.15130177932192,0.30666666666666664,1.0,1.0,2/5,14.93%,PTPN2;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.6575260631598706,-1.150959734524229,0.25882352941176473,1.0,1.0,1/17,0.22%,WWC1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.6201087468635083,-1.1508993373083474,0.25287356321839083,1.0,1.0,6/34,10.73%,WWC1;SLC7A2;EFNB2;ARFGEF3;SHROOM3;SHC2
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.697042318708037,-1.1507298421484942,0.3013698630136986,1.0,1.0,2/11,16.61%,SUFU;LRRK2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.5576034287258048,1.1506239106749652,0.2857142857142857,0.8813567297420395,1.0,3/18,5.26%,INF2;MCU;VPS35
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.7433778820419353,-1.1506210930995064,0.2345679012345679,1.0,1.0,1/7,4.16%,ARHGAP24
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.5689197494227136,-1.1506054786517295,0.2903225806451613,1.0,1.0,12/39,20.25%,APIP;ATL1;SOD2;SLC1A2;TRPA1;GOLGA2;ALDH1A2;RNF213;ELAVL1;STEAP4;KCNC2;APPL2
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.6623617472588816,-1.1502547058142216,0.32558139534883723,1.0,1.0,3/13,6.42%,ANKH;TWIST1;TGFB1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.6429800286248484,-1.1498956780635676,0.3076923076923077,1.0,1.0,4/15,8.47%,SLCO1A2;SLC16A12;SLC16A6;SLC16A7
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.6157950502289415,-1.1496591338731679,0.3111111111111111,1.0,1.0,9/27,24.72%,ZC3H7A;RBM4B;ZC3H7B;PUM3;METTL16;PER1;METAP1;EIF2A;APP
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.5925318364716858,-1.1494839956520206,0.29213483146067415,1.0,1.0,9/35,18.59%,EPM2A;TSC2;SPTLC1;C9ORF72;FYCO1;WAC;TRIM13;TBK1;SESN1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.6673560721544045,1.1494368120853808,0.44,0.8810472471189681,1.0,3/5,26.95%,PRKAA1;BMP6;SCAP
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.7492698140970626,-1.1491998311668683,0.3026315789473684,1.0,1.0,1/5,3.89%,MGST1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.7492698140970626,-1.1491998311668683,0.3026315789473684,1.0,1.0,1/5,3.89%,MGST1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.7394646073876125,-1.149096493186868,0.32926829268292684,1.0,1.0,1/7,0.93%,SOD1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.6056274645481509,-1.1489477966229171,0.26436781609195403,1.0,1.0,6/23,18.08%,DHRS3;COL11A1;ADGRV1;PITPNA;ATF6;COL18A1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.6146366846161315,-1.1487692297411174,0.2978723404255319,1.0,1.0,6/27,16.61%,ZFPM1;KDM1A;GOLGA2;SYMPK;MITD1;LRRK2
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.63223409723326,-1.1477299022815532,0.30864197530864196,1.0,1.0,4/16,17.09%,PITRM1;AGK;MIPEP;PMPCB
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.7198113088110245,-1.1475883019674313,0.37037037037037035,1.0,1.0,2/10,6.22%,PDK1;PDK3
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.6736627027082389,1.147364051163259,0.2903225806451613,0.8822139763871045,1.0,1/5,1.85%,PDGFA
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.7616916152866015,-1.1472499530295086,0.19736842105263158,1.0,1.0,3/8,14.21%,DIP2B;DDX3X;TERF2IP
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.6895676177842671,-1.1472493154458097,0.225,1.0,1.0,3/13,13.54%,PRKACA;PSMD14;UCHL5
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.5752134996942578,-1.1469420544254774,0.25,1.0,1.0,12/39,21.88%,KDM1A;UVSSA;RHBDD1;PARP1;ZRANB3;MAP3K4;POLK;UBE2B;WRN;XPA;NEDD4;EIF2AK4
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.7207912116858545,-1.146732732062474,0.3026315789473684,1.0,1.0,2/8,9.74%,MIGA1;SPG7
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.5607160453496758,1.1464111150176075,0.2692307692307692,0.8812363676808957,1.0,2/8,3.75%,SOX5;SOX6
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.6838717348647607,-1.146113968139875,0.2894736842105263,1.0,1.0,2/12,10.00%,ARHGAP15;EPSTI1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.5600688528561225,-1.145854230228557,0.23958333333333334,1.0,1.0,14/67,12.38%,PRKACA;CSF1;SMOC1;PURB;TGFB1;ST7;LGALS3;EIF2AK2;CCN2;PTPRQ;PRKCB;FGFR2;CEBPD;TGFBR1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.6969833502089535,-1.145709651285325,0.2875,1.0,1.0,3/11,8.31%,NR4A3;PDGFD;PTPN1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.697519052307731,-1.1455772487008173,0.35526315789473684,1.0,1.0,3/8,9.66%,VAV3;CD38;PRKCB
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.7164185988118477,-1.1453989515005039,0.3048780487804878,1.0,1.0,2/8,3.18%,CAMKMT;PCMT1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.6297096862529155,-1.1453643995289473,0.3170731707317073,1.0,1.0,8/23,21.03%,SEC13;NUP153;NUP133;NUP88;HIF1A;RANBP2;PRKAG2;SCARB2
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.6465911304541623,-1.1452610024358225,0.3048780487804878,1.0,1.0,4/15,16.05%,PRKACA;CRY1;PRKAR1A;PRKAR2A
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5713132887697093,-1.144877582874739,0.24444444444444444,1.0,1.0,11/52,12.47%,SRGN;SOD1;HABP4;VEGFA;TMSB4X;TGFB2;PROS1;TGFB1;SCCPDH;ANXA5;TF
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.6666836924350631,-1.1448561965346276,0.2875,1.0,1.0,8/17,19.18%,SLC23A2;SLC38A4;SLC38A9;SLC16A7;SLC36A4;SLC38A10;SLC13A3;SLC7A11
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.6864120502933926,-1.144491644510378,0.35802469135802467,1.0,1.0,1/8,5.01%,ESR2
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.7619012196695826,-1.1443549790930805,0.3246753246753247,1.0,1.0,4/6,17.29%,HDAC2;TGFB1;RUNX1;RGCC
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.7619012196695826,-1.1443549790930805,0.3246753246753247,1.0,1.0,4/6,17.29%,HDAC2;TGFB1;RUNX1;RGCC
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.7619012196695826,-1.1443549790930805,0.3246753246753247,1.0,1.0,4/6,17.29%,HDAC2;TGFB1;RUNX1;RGCC
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.6683384949883513,1.144336484549248,0.3333333333333333,0.8835890407156837,1.0,2/6,4.79%,CSPG4;ARSB
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.5991543314995885,-1.1441827952019428,0.3409090909090909,1.0,1.0,5/29,18.25%,STX6;KDM1A;AFDN;PARP1;TRIM5
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.7189195482302154,-1.1441655046863957,0.3780487804878049,1.0,1.0,2/10,6.45%,ZC3H7A;ZC3H7B
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5007692316188531,1.1441531981204112,0.35294117647058826,0.8804959031854054,1.0,4/19,12.13%,TTC7A;PIK3CD;PIP4K2B;SMG1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.5749276989031409,-1.1439167066817635,0.3111111111111111,1.0,1.0,4/37,9.71%,CTSL;MARCHF6;RHBDD1;RPS27A
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.5617232838960544,-1.1436477398650384,0.3125,1.0,1.0,11/54,20.75%,RHEB;ARHGAP31;RRAS2;DNMT1;SHC2;KRAS;PLD1;JUN;BRAP;RAB18;RIN2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.7275597818980293,-1.1435802014463474,0.3013698630136986,1.0,1.0,2/8,17.57%,HABP4;AFF2
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.638301253522863,-1.1434841991309213,0.34146341463414637,1.0,1.0,10/26,28.92%,RPA1;RPS27A;RBX1;PARP1;FAN1;POLK;XPA;IHO1;RPA3;GTF2H1
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.6845565624444636,-1.143473295130822,0.3333333333333333,1.0,1.0,2/13,9.72%,PELI1;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.6745907107146175,-1.1430169919233044,0.3048780487804878,1.0,1.0,4/11,21.08%,VEGFA;POMZP3;AGO2;SMURF2
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.7278627507003614,-1.1429369129095641,0.3116883116883117,1.0,1.0,1/7,3.60%,VEGFA
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.7149196747608046,-1.1428036663629282,0.3111111111111111,1.0,1.0,4/7,26.71%,MTMR9;SMG7;MTMR2;MTMR1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.5939330693524761,-1.1419664248100132,0.2696629213483146,1.0,1.0,7/34,10.69%,STC1;TPT1;TMCO1;SLC10A7;MT2A;TMEM165;MT3
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.6719269329079747,-1.1417161380416312,0.2727272727272727,1.0,1.0,4/15,15.82%,KDM1A;SPIDR;TERF2IP;ZRANB3
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.6761602284812088,1.1415989426466346,0.36363636363636365,0.8837995936159995,1.0,2/6,2.93%,MYH11;NOTCH1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.7525619538325652,-1.141561251559074,0.24285714285714285,1.0,1.0,1/5,12.76%,POMP
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.5626955518544842,-1.1413107904342472,0.2736842105263158,1.0,1.0,32/73,31.75%,DDX52;RPL28;WDR43;RPL34;RPL21;RPLP2;RPL19;NOP58;RPS14;RPLP1;RPL13A;RPL18;RPL27;RPL35A;RPL5;RPL31;RPL41;RPL24;RPL27A;RPL37;RPL36;RPL32;LAS1L;TEX10;RPL9;RCL1;RPL37A;RPS2;RPS24;RPL11;RPL3;RPL14
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.6407374573502305,-1.1409053975109544,0.27848101265822783,1.0,1.0,4/20,7.32%,SEC13;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.7291874657758719,-1.1408323020351374,0.33783783783783783,1.0,1.0,3/8,17.68%,SPTLC3;SPTLC1;PLPP3
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.6411882700126275,-1.1408056813201988,0.2804878048780488,1.0,1.0,3/16,13.43%,NRG1;MT3;IL18
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5462856486935735,-1.1406485935673891,0.1958762886597938,1.0,1.0,46/109,29.44%,RPS21;RPS4X;RPL28;TUT7;RPL34;RPL21;UPF3A;RPLP2;RPS27A;RPL19;PABPC1;RPS14;RPLP1;CNOT8;ETF1;PPP2R2A;RPL13A;DCP2;RPL18;SMG7;CSDE1;RPL27;PATL1;RPL35A;RPL5;RPL31;RPL41;RPL24;RPL27A;NBDY;RPS12;RPS18;RPL37;RPL36;RPL32;RC3H2;RPL9;CNOT1;RPS20;RPS8;RPL37A;RPS2;NCBP1;UPF2;EIF4G1;RPS24
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.7443007703467018,-1.1405886326928198,0.36363636363636365,1.0,1.0,3/5,23.28%,OXSR1;ADAM17;STK39
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.7443007703467018,-1.1405886326928198,0.36363636363636365,1.0,1.0,3/5,23.28%,OXSR1;ADAM17;STK39
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.7449958975782878,1.1404435442030094,0.3333333333333333,0.883662872481511,1.0,3/5,17.21%,NOTCH1;P2RX4;MLIP
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.7600085834830472,-1.1404264143858414,0.23943661971830985,1.0,1.0,2/5,6.42%,TGFB2;TGFB1
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6622028616956083,-1.1401249117109349,0.22988505747126436,1.0,1.0,7/20,20.41%,RPA1;RPS27A;FAN1;FANCC;WDR48;RNF168;XPA
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.5835360318431398,1.1396317591251774,0.2692307692307692,0.8825680612061041,1.0,1/8,0.87%,HDAC9
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.6597955810147955,-1.1395017932241005,0.3698630136986301,1.0,1.0,4/10,21.88%,TBC1D20;PPIB;CCNK;EIF2AK4
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.6323661793458739,-1.1394850099019496,0.3493975903614458,1.0,1.0,10/25,26.91%,SOD1;ATP6V1G1;ACO1;FTH1;TF;SKP1;NDFIP1;SLC40A1;ATP6V0D1;CP
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.6192774205559345,-1.1394176472017479,0.2891566265060241,1.0,1.0,8/18,22.32%,SLC38A4;SLC38A9;SLC47A1;SLC3A2;SLC36A4;SLC38A10;SLC7A11;SLC6A20
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.7253067987532792,-1.139063265701946,0.28205128205128205,1.0,1.0,2/8,8.98%,SRGN;SMAD6
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.5386291509855922,-1.1384713436495297,0.17346938775510204,1.0,1.0,6/93,3.88%,COL4A6;MID1;GJA1;WWC2;TENM3;NXN
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.6842415795545245,-1.138223968711258,0.32142857142857145,1.0,1.0,3/12,9.65%,ANK3;NOS1AP;KCNQ1
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.6677959105435544,-1.1378500048425306,0.2808988764044944,1.0,1.0,2/15,2.03%,GNPAT;AGPAT4
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.6677959105435544,-1.1378500048425306,0.2808988764044944,1.0,1.0,2/15,2.03%,GNPAT;AGPAT4
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.6330091466177952,-1.1372531208790864,0.30337078651685395,1.0,1.0,3/18,4.23%,ADAMTS9;VEGFA;TGFB2
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.6835742480922129,-1.1372231392229357,0.36486486486486486,1.0,1.0,2/9,14.73%,PEX3;PLAAT3
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.6168349652594551,-1.137148614356352,0.25842696629213485,1.0,1.0,7/32,15.96%,SSH1;PLEKHH2;LIMA1;STMN1;HDGFL3;CLU;NAV3
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.6946660860662395,-1.1371205477006368,0.28378378378378377,1.0,1.0,2/8,8.81%,GJA1;SLC47A1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.7363742890920847,-1.136986144116838,0.3170731707317073,1.0,1.0,7/8,24.83%,ENO1;TMSB4X;PARP1;PPARGC1A;PPARA;AK4;PID1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.7557650051889575,-1.1369349946908347,0.25,1.0,1.0,2/5,7.96%,NR4A3;STAT3
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.6963721848599367,-1.1368953991037056,0.2987012987012987,1.0,1.0,2/6,19.26%,LSS;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6692527668177867,-1.1367650494157016,0.3563218390804598,1.0,1.0,4/13,16.39%,NR4A3;ROCK2;PARP1;CAMK2D
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.7689029017864537,-1.1365016519163407,0.34615384615384615,1.0,1.0,3/7,17.88%,PARP6;PARP1;TNKS
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.6789608496256555,-1.1363498659110154,0.32098765432098764,1.0,1.0,4/11,20.07%,KLF2;NOS1AP;CLU;ASS1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.6789608496256555,-1.1363498659110154,0.32098765432098764,1.0,1.0,4/11,20.07%,KLF2;NOS1AP;CLU;ASS1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.691906453278251,-1.1362483502386322,0.25925925925925924,1.0,1.0,6/10,21.99%,PDCD4;STAT3;HIF1A;APPL2;PER1;PPARA
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.6229166934033306,-1.1361267409710079,0.27380952380952384,1.0,1.0,8/18,22.27%,GJA1;NR4A3;DNMT1;JUN;IL18;IGFBP5;CCN4;STAT1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.5951616611931109,-1.1360148955624332,0.25609756097560976,1.0,1.0,6/34,7.34%,EPN1;ADAMTS9;KLF2;TGFB2;PGK1;NIBAN2
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.5864756905383758,-1.135914464009921,0.29411764705882354,1.0,1.0,14/42,21.90%,VEGFA;TENM3;TGFB2;SPOCK1;PTPRD;DDIT4;TGFBR1;WNT2B;RUNX1;ACSL4;SMARCA1;NR4A2;ADNP2;ATP8A2
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.6862246097980466,-1.1358324667915314,0.35365853658536583,1.0,1.0,3/9,12.38%,NRG1;TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.6273320031430136,-1.1354020062523784,0.3103448275862069,1.0,1.0,5/22,15.04%,ZFPM1;UBA5;PTPN2;RPS14;RUNX1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.6004804300222921,-1.1353554218472295,0.3068181818181818,1.0,1.0,6/24,13.31%,ATP6V1E1;ATP6V1G1;FTH1;ATP6V1H;TF;ATP6V1D
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.6712788830794346,-1.1348024606904825,0.2926829268292683,1.0,1.0,5/17,19.08%,CRY1;UVSSA;CLOCK;ZRANB3;UBE2B
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.6658731391655984,-1.1347288286363748,0.3058823529411765,1.0,1.0,4/15,5.65%,CSNK1D;RIPOR1;ARL5A;COG7
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.747270133006996,-1.1346804909702068,0.323943661971831,1.0,1.0,1/5,10.11%,AFDN
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.6315670120074799,-1.1346676522783548,0.3,1.0,1.0,6/25,12.38%,TWIST1;TGFB2;TGFB1;OLFM1;SDCBP;TGFBR1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.6883823492582297,-1.1345544390240039,0.28,1.0,1.0,8/16,28.92%,RPA1;RPS27A;RBX1;PARP1;POLK;XPA;RPA3;GTF2H1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.6672972558684297,-1.1344916557345843,0.2840909090909091,1.0,1.0,5/20,12.38%,TGFB2;TGFB1;SMAD6;SDCBP;TGFBR1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.6572508921292365,-1.134267029677725,0.3372093023255814,1.0,1.0,4/16,10.11%,TENM3;EPHA7;TGFB1;AFDN
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.5794930794403583,-1.134166992292629,0.25274725274725274,1.0,1.0,17/52,21.81%,CSF1;KLF2;NFKBIA;TGFB1;NKD1;NEDD4L;SLC25A37;ROCK2;IL18;CDKN1B;CLU;RAB7A;WWP1;NSF;SMURF2;HECW1;NEDD4
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.5270278086635849,-1.133991301243709,0.15,1.0,1.0,44/188,21.81%,OS9;UBA5;ELOB;SELENOS;UVSSA;PIAS2;MARCHF6;NUP153;NUP133;NUP88;CTR9;NEDD4L;ARIH2;RPS27A;RNF111;RBX1;UBR1;HIF1A;PRKDC;KLHL7;RTF1;AMFR;KLHL2;WAC;TRIM13;NAE1;HIF3A;UBE2L3;RNF213;WWP1;BRAP;TRIM5;BTRC;UBE2K;RANBP2;UBE2B;RNF168;RNF34;SKP1;DCUN1D4;SMURF2;MDM2;HECW1;NEDD4
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.5701243837701098,1.1330222372532697,0.2631578947368421,0.8973761637523425,1.0,1/8,0.88%,ST3GAL2
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.6773548096979325,-1.132756380873196,0.2857142857142857,1.0,1.0,5/14,26.36%,SDCBP;RAB7A;RAB27A;SYTL4;CLASP2
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6571247130686694,-1.132616837446362,0.29069767441860467,1.0,1.0,4/16,20.70%,TAF1B;PWP1;NR4A2;FUBP3
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.6720471308203595,-1.132244644887058,0.20987654320987653,1.0,1.0,3/17,6.42%,SOD1;GRIN1;TGFB1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.5439375461739958,-1.1315821927031042,0.23958333333333334,1.0,1.0,31/93,22.61%,PRKACA;SYT1;GLRB;KCND2;GRIN1;PDE7B;SLC1A2;KCNQ3;GABRE;SNAP25;SDCBP;GRIK1;PRKAR1A;PLP1;GRIA3;GRM7;DLGAP1;SLC1A1;PMP22;SLC12A6;PRKAR2A;RIMS1;CAMKK2;GRIK2;LIN7A;NLGN1;MINK1;MAPK1;GABBR2;NOVA1;SYN3
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.7354745330930768,-1.131484580840516,0.3333333333333333,1.0,1.0,2/7,15.97%,SSH1;ABCC9
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5042035445275748,1.131402252641375,0.23076923076923078,0.8982259711387082,1.0,2/17,2.16%,SLIT3;CNOT7
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.6321409855295101,1.1313312493889511,0.25,0.894889626967301,1.0,3/6,12.87%,DERL1;RNF185;VCP
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.6780505883314712,-1.131297206852276,0.3880597014925373,1.0,1.0,5/8,28.23%,NIBAN2;CFL1;NR2C2;RACK1;B4GALT5
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.7274677534371279,-1.1310580758952602,0.3333333333333333,1.0,1.0,1/7,5.18%,HDAC2
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.5295250944311731,1.1308358404808163,0.2222222222222222,0.8922659681708998,1.0,1/14,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.7120320897395772,-1.13027382211567,0.36,1.0,1.0,1/7,3.01%,WIPI1
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.7055894786283842,-1.1301141084061623,0.36619718309859156,1.0,1.0,1/5,13.86%,GNAL
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.5989347148783563,-1.130089171121571,0.3411764705882353,1.0,1.0,6/28,19.26%,TAF7;TSC2;CDKN1B;DTNBP1;YWHAG;PRKAG2
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.6262836064194213,-1.1300465440613519,0.3448275862068966,1.0,1.0,6/22,10.67%,TSC2;PTPRE;PTPN1;PRKCB;PTPN2;SIK2
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.5915102280760799,-1.129180619743332,0.34177215189873417,1.0,1.0,15/29,31.98%,PELI1;TGFB1;STAT3;SMAD6;SCD;ERBIN;PPARA;MAPKAPK2;ADAM17;STRN3;GGT7;TAB2;ASXL1;FOXO1;GPX3
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.751249953066049,-1.129166098665265,0.3246753246753247,1.0,1.0,2/6,14.21%,DDX3X;TERF2IP
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.7516369586041761,-1.1290301018537647,0.3333333333333333,1.0,1.0,1/5,2.68%,RIPOR1
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.5475453102342418,-1.1289515715211387,0.26804123711340205,1.0,1.0,35/104,24.15%,RPS21;RPS4X;RPL28;RPL34;RPL21;RARS1;RPLP2;FARSB;DARS1;RPS27A;RPL19;YARS1;PPA1;RPS14;RPLP1;ETF1;RPL13A;RPL18;ZC3H15;RPL27;RPL35A;AGO2;RPL5;RPL31;RPL41;LARS1;RPL24;RPL27A;RPS12;RPS18;RPL37;WARS1;RPL36;EPRS1;RPL32
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.7166476021102601,-1.128932209352961,0.3424657534246575,1.0,1.0,4/8,14.50%,CTSL;PGK1;C1R;C1RL
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.7779762835944929,-1.1284829135981473,0.3194444444444444,1.0,1.0,3/5,21.53%,CRY1;CLOCK;PER1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.6879705046181336,-1.1284746821356093,0.32051282051282054,1.0,1.0,5/10,17.52%,GJA1;NR4A3;DNMT1;JUN;IGFBP5
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.6539340907324108,-1.1284122138827173,0.3176470588235294,1.0,1.0,6/14,9.65%,ANK3;KCND2;KCNE4;GNA14;SCN3A;KCNQ1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.6888496386798464,-1.1281220410852209,0.2926829268292683,1.0,1.0,3/12,12.84%,TWIST1;MED14;JUN
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.7375154505859904,-1.1280664341111952,0.3037974683544304,1.0,1.0,3/7,12.47%,ACO1;HIF1A;TF
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.663790789905679,-1.1280084276407913,0.3125,1.0,1.0,7/16,28.92%,RPS27A;RNF111;RBX1;PARP1;XPA;RAD23B;GTF2H1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.6189204760707339,-1.1279274987527166,0.3058823529411765,1.0,1.0,9/22,25.84%,KDM1A;HDAC2;GMPS;ATAD5;PARP1;NAP1L1;SUPT16H;NASP;FUBP1
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.7592223504975454,-1.127434775614742,0.30864197530864196,1.0,1.0,2/6,3.77%,ENO1;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.7592223504975454,-1.127434775614742,0.30864197530864196,1.0,1.0,2/6,3.77%,ENO1;TMSB4X
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.6029866718095729,-1.1274029914605996,0.31868131868131866,1.0,1.0,4/25,15.04%,ZFPM1;NR4A3;SIN3A;RUNX1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.6152614547583117,-1.1272243878525432,0.2926829268292683,1.0,1.0,1/17,2.08%,KDM1A
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6539033977204304,-1.1265754168883764,0.35365853658536583,1.0,1.0,5/16,15.11%,CD55;CD44;GYPC;SLC25A37;VAMP5
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.7669281651090486,-1.126544926381481,0.3246753246753247,1.0,1.0,3/5,21.15%,USP15;ANKRD17;DDX60
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.728246102553086,-1.1263050104147623,0.3188405797101449,1.0,1.0,3/6,23.00%,PDK1;STK24;ARL6IP5
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.6246714560285377,-1.1261570603495579,0.3023255813953488,1.0,1.0,10/28,26.91%,SOD1;ATP6V1G1;ACO1;FTH1;TF;SKP1;NDFIP1;SLC40A1;ATP6V0D1;CP
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.6136995877638698,1.1258769031129237,0.4473684210526316,0.9029163082896993,1.0,3/5,24.63%,NUMA1;SMC6;SIRT2
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.5491632811176107,-1.1254075114582274,0.31313131313131315,1.0,1.0,10/69,22.57%,HNRNPL;PCBP3;RBMS2;DDX3X;RBM39;HNRNPC;AGO2;HNRNPF;NOVA1;SETX
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.691680410139641,-1.1253950718583747,0.36,1.0,1.0,1/8,1.78%,ASPA
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.6269776368141005,-1.1253568649398187,0.2891566265060241,1.0,1.0,9/17,29.53%,TGFB1;STAT3;IL18;SLC1A1;LRRK2;IGFBP5;ARL6IP5;STRN3;GGT7
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.7999506722898311,-1.1248225692207372,0.34782608695652173,1.0,1.0,2/5,11.79%,ZFP36L2;PRKDC
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.7522098078537929,-1.1244434548754172,0.28378378378378377,1.0,1.0,3/6,18.25%,CD55;SASH1;TRIM5
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.6201275565679908,-1.124349255031413,0.313953488372093,1.0,1.0,3/20,6.42%,STC1;ADAMTS9;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.7317573012912058,-1.124320031835964,0.32051282051282054,1.0,1.0,2/6,21.17%,ATAD5;RAB11A
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.6840143237571501,-1.124216405481411,0.2962962962962963,1.0,1.0,1/8,1.16%,ZFP36L2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.6888705016780821,-1.1238846707000003,0.4025974025974026,1.0,1.0,4/7,30.09%,FYCO1;SETX;INSR;UVRAG
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.6278251614037929,-1.123747361251938,0.32142857142857145,1.0,1.0,5/18,16.70%,FADS2;PTGR1;SCD;GPX4;HSD17B4
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.5804717599525672,-1.12363133263262,0.2727272727272727,1.0,1.0,4/51,4.08%,TAF7;CSF1;SOD1;TSC2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.5750861103912213,-1.1232749034540037,0.3488372093023256,1.0,1.0,9/26,29.50%,DDX3X;ANKRD17;RGCC;ANAPC4;RAB11A;ADAM17;EGFR;EIF4G1;RDX
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.7039515950912247,-1.1232527591819814,0.3076923076923077,1.0,1.0,2/6,16.47%,ACOT11;ACBD6
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.7039515950912247,-1.1232527591819814,0.3076923076923077,1.0,1.0,2/6,16.47%,ACOT11;ACBD6
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.6207907671408158,1.1229828862211373,0.3611111111111111,0.907351637761621,1.0,2/6,5.77%,SMYD3;SETD7
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.7766519057392618,-1.1226832460418148,0.3013698630136986,1.0,1.0,2/5,19.03%,SLC1A2;STEAP4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.7766519057392618,-1.1226832460418148,0.3013698630136986,1.0,1.0,2/5,19.03%,SLC1A2;STEAP4
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.621638266518341,-1.1221558432375673,0.36585365853658536,1.0,1.0,8/18,27.85%,CYP3A5;ENPP2;ERAP1;LNPEP;PDXDC1;ENPEP;CPQ;SIAH1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.6884863342101147,-1.1221147982343491,0.3048780487804878,1.0,1.0,8/10,25.90%,GRIN1;STAT3;ROCK2;APH1B;FYN;MBP;LYN;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.4293144642519196,1.1219421269274281,0.16666666666666666,0.9066194402238826,1.0,3/41,2.45%,NIBAN1;ATP2B4;MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.7560491282296113,-1.121938078062285,0.2361111111111111,1.0,1.0,2/5,15.96%,HOMER2;NAV3
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.761994043497707,-1.1218818850451013,0.2972972972972973,1.0,1.0,2/5,17.68%,SPTLC3;PLPP3
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.7479039565470812,-1.1216084841147975,0.3013698630136986,1.0,1.0,2/6,14.90%,IFITM3;TRIM13
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.7317851647199122,-1.1215638044338039,0.35802469135802467,1.0,1.0,2/6,6.42%,EFNB2;TGFB1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.6146850609542439,-1.121305053306037,0.3493975903614458,1.0,1.0,2/14,3.18%,CAMKMT;PCMT1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.631587590338165,-1.1211763377276431,0.32926829268292684,1.0,1.0,1/18,5.91%,DDX3X
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.7077850396370584,-1.1209100428594203,0.3333333333333333,1.0,1.0,3/6,22.05%,PCBP3;IGF2BP2;NOVA1
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.6742422908759826,-1.1205076197314907,0.27848101265822783,1.0,1.0,7/12,24.72%,GRIN1;RIMS2;RIMS1;LRRK2;MTMR2;NLGN1;APP
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.5983551396591109,-1.120394653629141,0.32098765432098764,1.0,1.0,10/19,28.83%,WIPI1;MYDGF;SSR1;HSPA5;TSPYL2;SERP1;EXTL2;ATP6V0D1;VAPB;ACADVL
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.5262974763619639,1.1198121789826212,0.29411764705882354,0.9091893144432899,1.0,6/16,14.30%,BCL9;BCL9L;HDAC1;EP300;PYGO1;TCF7L1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.640576450980266,-1.1197968077609588,0.35714285714285715,1.0,1.0,2/14,6.42%,RUBCN;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.5663329420159411,-1.1197055695950735,0.2857142857142857,1.0,1.0,9/53,18.18%,STC1;RHOB;ROBO1;AFDN;TMEFF2;FRMD5;NAV3;IGFBP5;STK24
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5868673194036947,-1.1193752206749945,0.3058823529411765,1.0,1.0,6/31,11.49%,RARRES1;EMP1;LGALS3;GYPC;TP63;SLC25A37
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.7743657700308744,-1.1191998966652406,0.33783783783783783,1.0,1.0,3/5,20.55%,LPCAT3;SREBF1;SREBF2
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.7743657700308744,-1.1191998966652406,0.33783783783783783,1.0,1.0,3/5,20.55%,LPCAT3;SREBF1;SREBF2
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.5752869051303282,-1.1191889594143898,0.29213483146067415,1.0,1.0,8/37,10.69%,STC1;TPT1;TMCO1;SLC10A7;NEDD4L;ATP1B3;TMEM165;MT3
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.6903578547645286,-1.1189122951274748,0.32432432432432434,1.0,1.0,2/10,7.92%,ALDH3A2;PEX3
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.6986493545471395,-1.1184003887753795,0.3373493975903614,1.0,1.0,4/8,26.36%,TGFB1;RUNX1;RGCC;CLASP2
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.6077785650373413,-1.1183154512706568,0.35365853658536583,1.0,1.0,3/12,20.44%,JAM3;HEG1;NLGN1
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.7010814228944128,1.1180429020193199,0.2857142857142857,0.9112764601420883,1.0,1/5,3.37%,MCU
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.5836867098317723,-1.1177521781998694,0.25882352941176473,1.0,1.0,19/39,29.16%,SYT1;TGFB2;PLAA;DDX3X;NEDD4L;SDCBP;RIMS2;TGFBR1;GOLGA4;ZFYVE27;RIMS1;ADNP2;SEMA4D;ADAM17;AKAP6;EGFR;NCBP1;EIF4G1;KLHL22
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.6797406618768137,-1.1173617580021884,0.2682926829268293,1.0,1.0,6/8,31.37%,SOAT1;NPC1;SCARB1;STX12;ABCA8;ABCA5
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.7036066383633741,-1.1167702445465113,0.36,1.0,1.0,6/8,25.51%,PDK3;AKR1C2;AKR1C1;LPL;PID1;IRS1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.567106635350265,1.1166855857350035,0.2608695652173913,0.9117539784935378,1.0,2/8,7.71%,NOTCH1;RHOA
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.761750263662653,-1.1165697971066204,0.34615384615384615,1.0,1.0,2/5,9.66%,LPIN1;PRKCB
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.5754724836799289,-1.1160935847450109,0.26136363636363635,1.0,1.0,12/58,16.05%,VAV3;SLC2A1;TSC2;PDK1;GNA14;PPP2R1B;PRKCB;ACTR3;CFL1;CDKN1B;TBK1;PRKAR2A
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.5271362917773568,-1.1147281906820345,0.15151515151515152,1.0,1.0,39/197,16.61%,PRAG1;PRKACA;CSNK1D;CSNK1G2;PDK1;TGFB2;PGK1;CSNK1A1;DCLK1;CDKL1;EPHA7;PDK3;TGFB1;OXSR1;PANK2;FGGY;PRKCI;EIF2AK2;MAPK6;STAT3;MELK;STK4;LATS2;PRKCB;DGKI;SIK2;AGK;PRKDC;GK5;NRBP1;TGFBR1;SGK1;ROCK2;TBK1;MAK;CDK14;CAMK2D;STRADB;LRRK2
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.6391898894904673,-1.1147183428520129,0.3157894736842105,1.0,1.0,7/18,20.44%,SYT1;DGKI;GRIK1;GRM7;LRRK2;TSHZ3;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.3788936454793089,1.1145146803529593,0.25,0.9141916364532592,1.0,2/35,1.02%,HSPA1A;MECOM
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.6095109396042421,-1.114513728455367,0.4074074074074074,1.0,1.0,3/19,14.55%,TWIST1;STAT3;CLU
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.6095109396042421,-1.114513728455367,0.4074074074074074,1.0,1.0,3/19,14.55%,TWIST1;STAT3;CLU
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.657013957173129,-1.1137962151709508,0.38823529411764707,1.0,1.0,3/15,6.84%,WASF3;WASF1;DIAPH1
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.7301651068252353,-1.1130346870543493,0.4074074074074074,1.0,1.0,2/7,16.70%,FADS2;HSD17B4
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.7002449280160424,-1.1128916977291459,0.36231884057971014,1.0,1.0,1/8,3.99%,SLCO1A2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.6095988902396128,-1.112847566247961,0.3103448275862069,1.0,1.0,6/18,18.49%,KDM1A;SMCHD1;SPIDR;TERF2IP;PARP1;WDR48
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.6143166748856086,-1.112541890819694,0.2875,1.0,1.0,8/16,29.50%,DDX3X;ANKRD17;RGCC;ADAM17;EGFR;STXBP4;EIF4G1;RDX
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.6798699312384432,-1.1125146447613474,0.3253012048192771,1.0,1.0,8/16,28.83%,PDK1;PDK3;PANK2;ACADL;PPARA;NCOR2;RORA;ACADVL
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.6193483515694608,-1.1122317512597086,0.3253012048192771,1.0,1.0,3/14,17.29%,PDCD4;PRKCI;RGCC
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7604675683361277,-1.1121660180389523,0.3170731707317073,1.0,1.0,2/5,13.43%,TGFB1;IL18
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.6048643777988423,-1.1121533537656039,0.38823529411764707,1.0,1.0,5/25,9.65%,FHL1;DPP6;NOS1AP;NEDD4L;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.6563145863237851,-1.1119272256571358,0.40789473684210525,1.0,1.0,4/9,29.62%,EAPP;TCERG1;SUPT16H;SUPT6H
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.6727069046736591,-1.1118845956394101,0.358974358974359,1.0,1.0,1/8,3.60%,VEGFA
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.6691692304822541,-1.1118457802370685,0.32142857142857145,1.0,1.0,2/12,8.51%,ANK3;CEMIP
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.7407917207524068,-1.1113345367423912,0.3582089552238806,1.0,1.0,1/7,0.78%,GNPAT
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.6433176636192028,-1.111332680504341,0.3372093023255814,1.0,1.0,3/16,10.34%,GJA1;GRIN1;SNX6
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.7243461226256402,-1.1112506906646296,0.35,1.0,1.0,1/7,6.42%,TGFB1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.5182760013362546,-1.1109256363288378,0.18,1.0,1.0,27/140,22.05%,RNMT;SRSF12;PRKACA;HNRNPL;SRSF10;RBM4B;RBM17;CDC5L;CCAR1;RAVER2;PABPC1;SRSF5;DDX42;HNRNPC;SYMPK;CMTR1;CCNH;PPARGC1A;CSTF3;ALKBH5;DDX46;ELAVL1;HNRNPF;TRA2B;NONO;CPSF2;NOVA1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.6058066067937611,-1.110865589280245,0.3493975903614458,1.0,1.0,5/16,15.99%,ATP6V1E1;ATP6V1G1;ATP6V1H;ATP6V1D;RAB7A
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.6820887100428793,-1.1107879003911887,0.3835616438356164,1.0,1.0,2/9,10.33%,SPTLC3;SPTLC1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.7362396202416046,-1.110649732863405,0.3333333333333333,1.0,1.0,3/5,26.10%,BTRC;NLGN1;RORA
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.698257683436278,-1.1104827218457203,0.3125,1.0,1.0,1/8,1.40%,NRG1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.7319911085125324,-1.1103755254210728,0.37037037037037035,1.0,1.0,2/6,19.71%,DDX3X;AGO2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.5773271919256622,1.1103403719422058,0.4,0.9211895809174621,1.0,1/9,3.37%,MCU
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.7545029073664893,-1.1103274288079699,0.35064935064935066,1.0,1.0,2/5,9.54%,ROBO2;ALCAM
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.7134162807396006,-1.1101180313555774,0.36231884057971014,1.0,1.0,2/5,17.74%,PTPN1;BRAP
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.5515655133129534,-1.1097453978470384,0.3953488372093023,1.0,1.0,9/36,23.00%,SLC22A6;SLCO1A2;PEX3;SLC47A1;ARRDC2;RAB7A;ABCA4;CHKA;ARL6IP5
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.6784989678692279,-1.1097019810422435,0.345679012345679,1.0,1.0,2/11,12.69%,DDX52;RPS14
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.7572154441174079,-1.1095770950240755,0.3815789473684211,1.0,1.0,2/5,12.38%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.6473572948068497,-1.109552594359376,0.35365853658536583,1.0,1.0,4/15,17.68%,ANK3;CD44;AFDN;PLPP3
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.5901204709135422,1.1094860875385186,0.4090909090909091,0.9197169221888297,1.0,3/9,5.72%,LMOD1;IQGAP2;ARPC5
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.726571155735047,-1.1093572996091703,0.3181818181818182,1.0,1.0,2/5,21.71%,DDX3X;BIRC2
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.6508166464667733,-1.1093229377988245,0.3116883116883117,1.0,1.0,2/11,1.07%,PRKACA;GJA1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.6014728473467873,-1.1087946269764017,0.35526315789473684,1.0,1.0,2/21,4.34%,NDUFB9;NDUFV1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.672044947197836,-1.1087454289586482,0.35526315789473684,1.0,1.0,6/14,28.92%,RPS27A;RBX1;PARP1;XPA;RAD23B;GTF2H1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.5628946282663018,-1.1086512106885213,0.3258426966292135,1.0,1.0,10/34,26.44%,SEC13;NUP153;NUP133;NUP88;HIF1A;RANBP2;PRKAG2;PPARA;APP;INSR
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.5663256966703959,-1.108583773635679,0.3522727272727273,1.0,1.0,16/42,25.47%,PRKACA;MUCL1;PSMB1;PSMD14;KRAS;PSMA4;PSMB2;PSMA7;BTRC;SKP1;PAK1;RAF1;FYN;MALT1;PSMA3;LYN
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.5663256966703959,-1.108583773635679,0.3522727272727273,1.0,1.0,16/42,25.47%,PRKACA;MUCL1;PSMB1;PSMD14;KRAS;PSMA4;PSMB2;PSMA7;BTRC;SKP1;PAK1;RAF1;FYN;MALT1;PSMA3;LYN
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.5663256966703959,-1.108583773635679,0.3522727272727273,1.0,1.0,16/42,25.47%,PRKACA;MUCL1;PSMB1;PSMD14;KRAS;PSMA4;PSMB2;PSMA7;BTRC;SKP1;PAK1;RAF1;FYN;MALT1;PSMA3;LYN
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.5697035065576778,-1.108441417141972,0.35555555555555557,1.0,1.0,7/29,15.85%,TMSB4X;NFKBIA;PDCD4;DDX3X;EIF2AK2;TERF2IP;SASH1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.5917362236223459,-1.108331319378386,0.37142857142857144,1.0,1.0,3/18,18.84%,UBA5;GOLGA2;MCTS1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.6717575856610168,-1.1071988280899998,0.38235294117647056,1.0,1.0,4/6,25.23%,TGFB2;WNT2B;CSDE1;KITLG
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.5483561361636449,-1.1070293892393108,0.2653061224489796,1.0,1.0,13/78,8.98%,ZFP36L2;TWIST1;ZFPM1;SRA1;NFKBIA;PDCD4;TGFB1;SUFU;CTR9;ADGRV1;ZFPM2;ANKRD26;SMAD6
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.6856092148398365,-1.1064367804010335,0.3561643835616438,1.0,1.0,4/10,15.04%,CTSL;ROCK2;ERRFI1;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.6026702297745573,-1.1064000784453512,0.3176470588235294,1.0,1.0,8/20,22.88%,RHEB;ACOT11;LGR4;LNPEP;NOVA1;MAP2K6;LAMA4;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.5803223701209419,-1.1063913281814188,0.3888888888888889,1.0,1.0,7/29,16.61%,RUBCN;MTMR9;STAT3;MT3;LZTS1;GOLGA2;LRRK2
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.7377356684728933,-1.1059435731408047,0.40540540540540543,1.0,1.0,3/5,23.12%,CMPK1;ENTPD4;AK4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.6502617491132934,-1.1057969473826503,0.3815789473684211,1.0,1.0,2/13,7.96%,TWIST1;STAT3
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.6289259080276239,1.1057926292822249,0.375,0.9264351906090739,1.0,2/7,5.60%,COL5A2;SKI
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.5587270110798052,-1.1055099634119525,0.26,1.0,1.0,22/74,24.72%,NRCAM;SPTBN4;ATL1;ANK3;DCLK1;ALCAM;GPM6A;FGFR2;DCDC2;CCK;MYO16;SGK1;LRRK2;DTNBP1;NLGN1;MINK1;PAK1;EIF2AK4;TAOK3;FARP1;APBB1;APP
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.5463385992551506,-1.1053878692636052,0.375,1.0,1.0,13/44,26.83%,STX6;SNX6;DENND2A;GOSR1;WASHC2C;RHOBTB3;RAB7A;PREPL;VPS50;VPS51;SNX2;SLC66A2;RAB6A
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.6508050562692259,-1.1049903165648585,0.35,1.0,1.0,4/12,26.04%,DDX3X;TBK1;IRF1;RIOK3
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.6633208502846747,-1.1046245749565151,0.38666666666666666,1.0,1.0,2/11,9.20%,VEGFA;SEMA3B
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.5999490946938626,-1.1045104580511038,0.32941176470588235,1.0,1.0,8/22,22.88%,RHEB;ACOT11;LGR4;LNPEP;NOVA1;MAP2K6;LAMA4;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.6692717412358877,-1.1044191510256056,0.29411764705882354,1.0,1.0,2/11,8.51%,ANK3;CEMIP
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.662285532215396,1.1043544579206837,0.3333333333333333,0.9273822975178581,1.0,2/5,9.75%,FGF13;ULK2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.6237475244478116,-1.1043319605185473,0.35714285714285715,1.0,1.0,8/17,23.28%,ANK3;GLRX;NEDD4L;FGF14;CAMK2D;HECW1;NEDD4;STK39
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.5649404003393796,-1.104054626391469,0.36666666666666664,1.0,1.0,11/38,16.35%,ELOB;VEGFA;PSMB1;PSMD14;RPS27A;RBX1;HIF1A;PSMA4;PSMB2;PSMA7;HIF3A
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5543750274824959,1.1040030612338578,0.4090909090909091,0.9251239377078425,1.0,4/10,9.82%,CDC42;MYH9;RHOA;GULP1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.715909224922137,-1.1036984483351373,0.39473684210526316,1.0,1.0,3/5,21.99%,PAG1;ASS1;PPARA
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.5938587272594721,1.1035379621124344,0.3333333333333333,0.9229231600661034,1.0,1/6,0.60%,MOCS1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.7019885392770469,-1.1033200324539088,0.3875,1.0,1.0,3/8,9.41%,ANK3;GLRX;ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.5361445818304937,-1.1032420558036102,0.3163265306122449,1.0,1.0,22/102,17.77%,NELL1;CSF1;GJA1;TWIST1;NRCAM;AKIRIN1;TGFB2;TGFB1;OLFM1;CCN2;SDCBP;TP63;CMKLR1;TGFBR1;ZC4H2;IL18;ZHX3;SIN3A;TCF4;TMEM64;RGCC;CCN1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.5459020292118038,-1.1031845306603039,0.3684210526315789,1.0,1.0,19/54,26.44%,PRKACA;NR4A3;LPIN1;SELENOS;PRKCI;PRKAR1A;PRKDC;PARP1;DENND4C;PRKAR2A;NR4A2;TSHR;CPEB2;EPRS1;IRS1;RAB12;PKM;RAB8B;INSR
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.6161282122555203,1.1029085811834365,0.42857142857142855,0.9213084638881578,1.0,2/7,6.41%,BCL2L1;BCL2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.6939981255754388,-1.1028470328034616,0.3698630136986301,1.0,1.0,6/10,28.92%,RPA1;RBX1;PARP1;XPA;RPA3;GTF2H1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.6939981255754388,-1.1028470328034616,0.3698630136986301,1.0,1.0,6/10,28.92%,RPA1;RBX1;PARP1;XPA;RPA3;GTF2H1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.6039065484863881,-1.1028427755487429,0.35,1.0,1.0,8/22,25.43%,TWIST1;SELENOS;STAT3;MAPKAPK2;LPL;HLA-B;APP;MBP
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.5173820994226921,-1.1027768191330993,0.25,1.0,1.0,33/163,15.96%,NELL1;BTD;NRG1;NRCAM;GLRB;CRMP1;ROBO2;SLC2A1;VEGFA;DNER;DCLK1;SZT2;TGFB1;SPOCK1;ALDH3A2;ADGRV1;STAT3;ROBO1;SPG7;GPM6A;GRIK1;DPYSL2;ARNT2;NAIP;TGFBR1;ZC4H2;IGF2BP2;NOTCH2;ALDH1A2;PMP22;TEAD1;ZIC4;NAV3
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.657655295436659,-1.1026868818524538,0.42857142857142855,1.0,1.0,4/10,16.61%,ADGRV1;PRKAR1A;PRKAR2A;LRRK2
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.6181283700526883,1.1025615737587344,0.34375,0.9190973427290973,1.0,1/7,0.23%,NOX4
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.6539072559180051,-1.1025590318539809,0.36585365853658536,1.0,1.0,2/11,10.59%,DDX3X;HIF1A
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.6304935289026619,-1.1024091703856647,0.4418604651162791,1.0,1.0,4/16,23.73%,CTR9;STAT3;STAT1;STAT6
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.6302169559622004,-1.1021518414612215,0.3488372093023256,1.0,1.0,3/17,10.34%,GJA1;GRIN1;SNX6
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.6156938564649923,-1.1014704504931345,0.3373493975903614,1.0,1.0,4/16,26.04%,DDX3X;TBK1;IRF1;RIOK3
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.7552101949505359,-1.101385732210006,0.3787878787878788,1.0,1.0,2/5,12.50%,HOMER2;GRM7
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.7476391914612632,-1.100606899071977,0.3698630136986301,1.0,1.0,1/5,2.00%,SYT1
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.7159518416639639,-1.100490932149385,0.3888888888888889,1.0,1.0,2/8,15.28%,SMAP1;SNAP91
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.5818070907221282,-1.1000471110436,0.36585365853658536,1.0,1.0,4/26,7.32%,PIAS2;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.659207831009215,-1.0999215650691236,0.425,1.0,1.0,2/13,7.96%,CTR9;STAT3
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.6799767261109909,-1.0991728002892933,0.4084507042253521,1.0,1.0,2/6,10.69%,STAT3;MT3
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.6017571487776949,1.0989819684061843,0.21428571428571427,0.9266803423372663,1.0,2/5,22.15%,MEF2C;COL13A1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.5096694456337822,-1.0989053222664693,0.26,1.0,1.0,70/181,29.44%,CSF1;RPS21;PRSS23;IGFBP2;PCMT1;RPS4X;RPL28;PAPPA;CST3;RPL34;GALNT11;RPL21;SEC11A;RPLP2;FARSB;DARS1;RPS27A;SPG7;FBN1;RPL19;MANBA;ADORA2B;PRKDC;TF;RPS14;RPLP1;MGAT4A;RPL13A;RPL18;APH1B;UBE2L3;FBXO22;IGFBP5;CCN1;RPL27;RPL35A;AGO2;SERP1;RPL5;RPL31;P4HB;RPL41;RPL24;RPL27A;VCAN;TGOLN2;RPS12;ADAM17;RPS18;FSTL1;RPL37;WARS1;RPL36;RPL32;ITIH2;APP;CHRM3;RAB12;CP;RPL9;PARP4;RPS20;YME1L1;RPS8;RPL37A;RPS2;FN1;EIF4G1;LAMB1;RPS24
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.6552815094848374,-1.0984460454894656,0.3246753246753247,1.0,1.0,1/11,3.01%,WIPI1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.6778685040859693,-1.0983704472044586,0.3466666666666667,1.0,1.0,3/10,19.99%,ATL1;ZFYVE27;RAB18
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.552766450022776,-1.0983640788056133,0.35555555555555557,1.0,1.0,6/38,8.47%,SLC2A3;SLC7A2;SLC2A1;SLC16A12;SLC1A2;SLC16A7
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.552766450022776,-1.0983640788056133,0.35555555555555557,1.0,1.0,6/38,8.47%,SLC2A3;SLC7A2;SLC2A1;SLC16A12;SLC1A2;SLC16A7
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.6754899847311002,1.0983408519749216,0.3793103448275862,0.9246670412254394,1.0,1/5,5.09%,LARGE1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.7119155298745528,-1.0979073455992623,0.3466666666666667,1.0,1.0,1/7,2.59%,CAMKMT
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.7312061697552927,-1.09781782376758,0.38028169014084506,1.0,1.0,3/8,17.15%,RPA1;RPS27A;POLK
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.6874671500033436,-1.0976471759912882,0.3950617283950617,1.0,1.0,2/7,19.94%,HIF1A;SYBU
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.6626508652215178,-1.097153885100437,0.37662337662337664,1.0,1.0,5/11,25.47%,STAT3;PTPN1;PRLR;STAT6;LYN
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.7617177667066316,-1.0970676249133646,0.34328358208955223,1.0,1.0,2/5,7.79%,VEGFA;ADGRV1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.6437296485723542,-1.0959173644515636,0.3950617283950617,1.0,1.0,5/12,29.53%,SCD;ACSS3;PAM;FAR2;GGT7
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.4464014214823747,1.0955188282005335,0.2727272727272727,0.9287652215901375,1.0,8/30,9.83%,LMOD1;CDC42;SYNPO2;BIN1;NCK1;EVL;CARMIL1;NTF3
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.594065842161283,-1.0953177033075354,0.32967032967032966,1.0,1.0,9/32,16.61%,CSF1;EFNB2;RRAS2;DDIT4;CLU;PPARGC1A;TBK1;NAE1;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.6779033979369188,-1.0948158806264572,0.34146341463414637,1.0,1.0,3/12,14.14%,IPO5;LATS2;CDKN1B
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.49382814582869866,1.0943845469745805,0.2857142857142857,0.9283176084846171,1.0,2/29,2.76%,HSPA1A;BCL2L1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.4472493170739724,1.094065466551761,0.3333333333333333,0.9256034201977908,1.0,5/21,9.52%,NSUN3;TFB1M;MTERF4;TRDMT1;TARBP1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.6280621225369325,-1.0938523511491947,0.43529411764705883,1.0,1.0,6/14,29.45%,UBA5;UFSP2;RUNX1;PAK1;CNOT1;STRN3
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.6817004395763557,-1.0938097007792276,0.4235294117647059,1.0,1.0,1/8,3.60%,VEGFA
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6299879478512034,1.0937311850879867,0.35,0.9231865039874967,1.0,1/7,3.97%,CDC42
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.5324035034817655,-1.0936748408600714,0.3333333333333333,1.0,1.0,30/78,28.38%,DDX52;RPL28;WDR43;RPL34;RPL21;RPLP2;RPL19;PRKDC;NOP58;RPS14;RPLP1;RPL13A;RPL18;RPL27;RPL35A;RPL5;RPL31;RPL41;RPL24;RPL27A;RPL37;RPL36;RPL32;LAS1L;RIOK3;TEX10;RPL9;RCL1;RPL37A;RPS2
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.5633553406518191,-1.0931985167120515,0.30927835051546393,1.0,1.0,7/66,11.51%,STC1;GJA1;MCC;RHOB;ROBO1;AFDN;TMEFF2
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.5555928373042719,-1.0931273473447778,0.3548387096774194,1.0,1.0,10/46,14.92%,PELI1;NFKBIA;PSMB1;MAP3K8;PSMD14;RPS27A;RBX1;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.6365854321611383,-1.0930713992457084,0.42857142857142855,1.0,1.0,4/14,23.73%,CTR9;STAT3;STAT1;STAT6
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.5747507327406904,-1.0927057005288818,0.3181818181818182,1.0,1.0,14/40,25.47%,SRGN;SOD1;CADM1;EIF2AK2;IGF2BP2;TBK1;RGCC;LGR4;POLA1;CCN4;PER1;MAPKAPK2;HLA-B;LYN
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.7327351290117363,-1.092535013181912,0.45714285714285713,1.0,1.0,1/5,10.61%,PTPN2
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.6916809293282555,-1.09222656631811,0.43037974683544306,1.0,1.0,2/9,8.96%,KDM1A;DNMT1
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.7245281193619948,-1.092091098430272,0.32432432432432434,1.0,1.0,3/5,25.47%,TGFB1;IL18;LYN
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),-0.6992838531900772,-1.0920045342733489,0.323943661971831,1.0,1.0,1/5,8.11%,GABRE
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.6396490777098476,-1.0919768102838936,0.4125,1.0,1.0,2/11,13.43%,IGFBP2;IL18
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.6561837408429483,-1.0917961702887364,0.38961038961038963,1.0,1.0,4/10,25.90%,GRIN1;FARSB;KCNC2;GRIN2B
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.5611730101670775,-1.0913780302860374,0.3448275862068966,1.0,1.0,11/45,21.39%,TEFM;RPA1;PSMB1;PSMD14;RPS27A;PSMA4;PSMB2;PSMA7;POLA1;WRN;DDX21
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.7122434418750021,-1.0913216019835885,0.4268292682926829,1.0,1.0,1/8,1.26%,CYP3A5
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.6070427299933945,-1.0911949558532557,0.3116883116883117,1.0,1.0,7/15,29.50%,DDX3X;ANKRD17;RGCC;ADAM17;EGFR;EIF4G1;RDX
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.6157072055625212,-1.090940108385398,0.3717948717948718,1.0,1.0,5/16,19.48%,GLRB;GABRE;SLC1A1;SLC12A6;ANO2
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.6713914484296566,-1.0909193879934862,0.3717948717948718,1.0,1.0,2/10,7.75%,TGFB2;JAM3
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.5720818384126635,-1.0905713167418354,0.33695652173913043,1.0,1.0,4/34,10.20%,ZFP36L2;CD44;CEP57;FGFR2
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.5677658885996288,-1.0904714480004818,0.3655913978494624,1.0,1.0,7/36,11.27%,PRAG1;TGFB2;PRKCI;NIBAN2;GALNT11;STAT3;TP63
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.41844804781774475,1.0900361012438613,0.375,0.9300382717665906,1.0,8/23,14.07%,BCL2L1;BCL2L11;ATM;BCL2;EP300;IFI16;MSH2;PML
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.5626775389217054,-1.0895735343499413,0.358695652173913,1.0,1.0,9/39,7.96%,CSE1L;SEC13;TSC2;IPO5;IPO9;NUP153;NUP133;NUP88;STAT3
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.6316878367643621,-1.0894806240230164,0.39080459770114945,1.0,1.0,5/12,22.32%,SLC7A2;SLC3A2;SLC36A4;ABCC9;SLC6A20
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.6732390286625344,-1.0894359534290072,0.40476190476190477,1.0,1.0,1/12,4.64%,WASF1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.6424953268581451,-1.0893521238839983,0.36764705882352944,1.0,1.0,2/11,16.47%,ACOT11;ACBD6
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),-0.6749689113454383,-1.0892809534052645,0.352112676056338,1.0,1.0,2/7,20.44%,PTPRD;NLGN1
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),-0.6749689113454383,-1.0892809534052645,0.352112676056338,1.0,1.0,2/7,20.44%,PTPRD;NLGN1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.7152296140042614,-1.0890099643876052,0.39473684210526316,1.0,1.0,1/5,10.10%,SMCHD1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.7072967595230872,-1.0888621040302895,0.3717948717948718,1.0,1.0,1/8,3.35%,SRA1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.6655882637933042,-1.088821897870763,0.42105263157894735,1.0,1.0,4/14,21.71%,RPS27A;TANK;TBK1;BIRC2
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.6655882637933042,-1.088821897870763,0.42105263157894735,1.0,1.0,4/14,21.71%,RPS27A;TANK;TBK1;BIRC2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.6349584646706307,-1.088675175738408,0.3493975903614458,1.0,1.0,1/14,1.07%,GJA1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.5364755612828203,1.0883091248472816,0.3333333333333333,0.9316804161268557,1.0,1/9,1.21%,TNIP1
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.727132653602283,-1.0878150832910662,0.4025974025974026,1.0,1.0,1/8,0.90%,CSF1
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.6764933490570749,-1.0865800559511725,0.4025974025974026,1.0,1.0,3/13,13.43%,CSF1;NFKBIA;IL18
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.619523053066849,-1.0864977103915545,0.4117647058823529,1.0,1.0,4/18,17.68%,SPTLC3;SPTLC1;AGK;PLPP3
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.5758035250950477,1.0864653192713274,0.391304347826087,0.9338604332012989,1.0,3/10,6.68%,PGF;NUS1;PIK3CD
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.5623377402809435,-1.0864217381586028,0.42045454545454547,1.0,1.0,5/34,8.55%,GJA1;CDH20;CDH18;JAM3;CDH12
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.6712114284535049,-1.0859617667334214,0.410958904109589,1.0,1.0,2/10,6.39%,NUP153;NUP133
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.7048873036058432,-1.0853290979347616,0.4666666666666667,1.0,1.0,2/7,9.65%,NEDD4L;KCNQ1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.5458275775097042,-1.0852926276370858,0.3516483516483517,1.0,1.0,11/57,16.58%,PRKACA;NRG1;VEGFA;TGFB2;STK4;MT3;PRKAR1A;IL18;PRLR;PRKAR2A;STRADB
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.530405523141565,-1.084825137617445,0.2857142857142857,1.0,1.0,24/91,18.25%,PRAG1;IGFBP2;CD55;TSC2;DHRS3;NCAM1;TGFB1;GALNT11;PTPN1;FGFR2;PTPN2;SIK2;DCDC2;ELF1;AMFR;CLU;RUNX1;TSPYL2;LRRK2;DTNBP1;IGFBP5;BRAP;YWHAG;TRIM5
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.5924403834690817,-1.0842584224573542,0.33707865168539325,1.0,1.0,2/20,7.26%,DIAPH1;TRAF3IP1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.6116599661242109,1.0837858039514718,0.3157894736842105,0.9376287093688274,1.0,2/7,8.59%,PRKG1;SLIT2
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.5907089441471974,-1.0836604715600449,0.3695652173913043,1.0,1.0,6/37,12.38%,TWIST1;TGFB2;TGFB1;OLFM1;SDCBP;TGFBR1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.5929451403708543,-1.0836223536888039,0.3763440860215054,1.0,1.0,11/31,24.71%,WASF1;DCLK1;GPM6A;MYO16;SGK1;LRRK2;DTNBP1;MINK1;PAK1;TAOK3;SNX2
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.6700633045069818,-1.0835825632366933,0.35,1.0,1.0,3/9,20.44%,SYNDIG1;RAB27A;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.6040852313904832,1.0835366675095195,0.36,0.9349781412044441,1.0,1/6,3.13%,INPP5F
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.7280621116193828,-1.0834472104063542,0.39436619718309857,1.0,1.0,2/5,11.79%,LGALS3;PRKDC
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.532005993333334,-1.083416446214812,0.28125,1.0,1.0,16/66,20.49%,PRKACA;PPME1;CSNK1D;TUBA1A;AKAP8;CEP57;MELK;CCP110;NINL;CCNH;PPP2R2A;CDK14;YWHAG;BTRC;PHLDA1;SKP1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.5672454987465352,-1.0832889443636733,0.4235294117647059,1.0,1.0,10/28,31.14%,CTSL;AP2A1;RAB7A;MDM2;MALT1;RAB12;YME1L1;AFG1L;AP2B1;AP2A2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.6656843542115143,-1.0826684382563065,0.4155844155844156,1.0,1.0,4/9,27.17%,SCD;HSD17B4;ACSL4;FAR2
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.5960931860865918,-1.0826624937941838,0.3764705882352941,1.0,1.0,7/24,19.26%,SEC13;NUP153;NUP133;NUP88;HIF1A;RANBP2;PRKAG2
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.5510976347595258,-1.082633744094001,0.38461538461538464,1.0,1.0,8/43,17.80%,S1PR3;GPR161;GNA14;ADM;ADGRG2;GNAL;LGR4;ADGRE2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.35028215815291897,1.0824718257015762,0.14285714285714285,0.934987336461618,1.0,6/54,5.75%,HSPA1A;LEMD3;BCL9;ITGA3;SKI;BCL9L
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.5030035156697235,-1.0821883924034716,0.3434343434343434,1.0,1.0,33/159,19.99%,STX6;RAB28;SEC13;ATP6V1E1;ANK3;ATP6V1G1;ARL5A;OLFM2;COG7;NAPG;SLC10A7;SYNDIG1;ARF4;PRKCB;TBC1D8;AP2A1;SNX6;USO1;ATP6V1H;GGA3;TF;ARRDC2;ATP6V1D;CLU;GOLGA4;VAMP5;RAB7A;USP6NL;PREPL;LAMP2;TMED4;NSF;RAB18
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.5299292998334301,-1.0818892660920065,0.3263157894736842,1.0,1.0,36/78,29.53%,RPS21;RPS4X;RPL28;RPL34;RPL21;RPLP2;FARSB;DARS1;RPS27A;RPL19;RPS14;RPLP1;RPL13A;RPL18;RPL27;RPL35A;AGO2;RPL5;RPL31;RPL41;RPL24;RPL27A;RPS12;RPS18;RPL37;WARS1;RPL36;RPL32;RPL9;RPS20;RPS8;RPL37A;RPS2;EIF4G1;RPS24;GGT7
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.7102843502255141,-1.0817329128841062,0.38028169014084506,1.0,1.0,4/5,29.02%,NR4A3;LRRK2;RACK1;PDE8A
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.5928948266422017,-1.081460711714117,0.34408602150537637,1.0,1.0,6/25,10.20%,ZFPM1;TGFB2;RARB;TGFB1;IFT122;FGFR2
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.6437257655755821,-1.0803706669680857,0.44871794871794873,1.0,1.0,4/10,15.71%,IFT122;IFT140;DYNC2LI1;WDR19
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.6864788058129407,-1.0803578193573269,0.35443037974683544,1.0,1.0,1/8,2.68%,RIPOR1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.7341195432630501,-1.0802733076767628,0.3815789473684211,1.0,1.0,2/5,9.63%,ALDH1L1;MTHFD2L
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.7341195432630501,-1.0802733076767628,0.3815789473684211,1.0,1.0,2/5,9.63%,ALDH1L1;MTHFD2L
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.6679089345871134,-1.080035038335631,0.4,1.0,1.0,3/8,26.36%,TGFB1;RGCC;CLASP2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.7264394374776186,-1.0799928150340896,0.3902439024390244,1.0,1.0,3/5,26.71%,MTMR9;MTMR2;MTMR1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.5875958733495951,1.0799478259663617,0.36363636363636365,0.9389055094618138,1.0,2/10,6.41%,CD4;BCL2
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.5856295865261636,-1.0797887248135682,0.4148936170212766,1.0,1.0,6/26,11.27%,ROBO2;TGFB2;PRKCI;STAT3;ROBO1;TP63
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.6366158026946765,-1.079773642732324,0.42857142857142855,1.0,1.0,3/13,10.69%,DIP2B;SEMA3B;MT3
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.7381189754535991,-1.0796897704367554,0.4264705882352941,1.0,1.0,3/5,10.61%,ZFPM1;FBN1;PTPN2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.626360263460403,-1.0789195343894158,0.4864864864864865,1.0,1.0,4/13,12.22%,SOD1;KCNQ1;SGCZ;MYL3
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.7338185192712415,-1.0786614643272237,0.38235294117647056,1.0,1.0,2/5,24.72%,CLU;APP
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.6940348132607457,-1.0786455767079974,0.35714285714285715,1.0,1.0,2/6,12.67%,MT3;SLC39A11
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.6914941850067123,-1.078511386263889,0.45121951219512196,1.0,1.0,1/5,2.06%,IFITM3
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.6965942622513555,-1.07819651541128,0.425,1.0,1.0,4/6,29.26%,TERF2IP;PARP1;POT1;TERF1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.6834087473620397,-1.0781755972291267,0.3116883116883117,1.0,1.0,3/8,14.35%,TAF1B;POLR1C;CCNH
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.6834087473620397,-1.0781755972291267,0.3116883116883117,1.0,1.0,3/8,14.35%,TAF1B;POLR1C;CCNH
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.6244249469223657,-1.0775516420181823,0.367816091954023,1.0,1.0,6/17,19.79%,CD44;SLC25A37;ELF1;RAB27A;ADGRE2;WRN
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.5531995025785749,-1.0774473162281692,0.3978494623655914,1.0,1.0,10/45,20.41%,HDAC2;HMGN1;NUP133;RPS27A;RBX1;FAM50A;PARP1;GEM;EZH1;XPA
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.6905930510656426,-1.0770341041918248,0.38028169014084506,1.0,1.0,5/7,29.16%,GPR137C;LARS1;RRAGB;SIK3;KLHL22
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.6402671932255091,-1.0767320127042976,0.37349397590361444,1.0,1.0,1/12,1.07%,GJA1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.6606112110553111,-1.0763323210418332,0.4375,1.0,1.0,4/10,12.27%,CSF1;AKIRIN1;JAM3;CMKLR1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),-0.6206433873505065,-1.0759392479091627,0.36,1.0,1.0,3/11,19.59%,INTS8;INTS4;INTS2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6127903318334551,-1.0759182027807717,0.43529411764705883,1.0,1.0,8/19,17.52%,GJA1;NR4A3;PDCD4;SOD2;DNMT1;JUN;CDKN1B;IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.7162950869255144,-1.075867881396009,0.38666666666666666,1.0,1.0,2/6,10.59%,NR4A3;HIF1A
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.7168832007251253,-1.0758120531186204,0.36486486486486486,1.0,1.0,1/6,2.00%,SYT1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.5353751597541857,-1.075810177618473,0.3764705882352941,1.0,1.0,11/36,24.52%,TBC1D20;CDKL1;TBC1D8;DCDC2;IFT140;PLD1;DYNC2LI1;USP6NL;CAPZB;TBC1D15;MYO10
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.7211825202068991,-1.0758046823543055,0.4189189189189189,1.0,1.0,2/6,8.98%,ZFPM1;SMAD6
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.6803367813129838,-1.0755088004658695,0.38666666666666666,1.0,1.0,4/8,19.77%,RARRES1;STAT3;PRLR;KDM3A
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.6347072818867359,-1.0753781823608124,0.3698630136986301,1.0,1.0,4/7,25.23%,TGFB2;WNT2B;CSDE1;KITLG
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.6459978067839183,-1.0752984860425245,0.3783783783783784,1.0,1.0,3/10,20.67%,PRKCI;LRRC7;ERBIN
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.6653555812292435,1.075069742948816,0.391304347826087,0.9491214448661899,1.0,3/6,9.71%,GUCY1B1;IRAG1;PDE3A
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.6533819384812234,-1.0750163292040753,0.46987951807228917,1.0,1.0,2/11,14.93%,DIP2B;PPARGC1A
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.6734745219137255,-1.0750026508283914,0.44871794871794873,1.0,1.0,5/11,26.78%,PLAA;UBAP1;NEDD4;MVB12B;TOM1L1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),-0.6796719619211915,-1.074971853109685,0.36619718309859156,1.0,1.0,1/5,4.08%,TSC2
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.5640598275584962,-1.07491260649942,0.45263157894736844,1.0,1.0,12/35,21.59%,ELAVL3;SPTBN4;PHYHIPL;SNAP25;LRFN5;MT3;NXPH1;SNAP91;GFAP;CADM2;KCNC2;GABBR2
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),-0.5694863591415142,-1.0748578739619932,0.3829787234042553,1.0,1.0,9/41,13.45%,NELL1;PRKACA;TWIST1;SMOC1;SUFU;SMAD6;FGFR2;TP63;ZHX3
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.6285948514718412,-1.0747680853675678,0.43529411764705883,1.0,1.0,3/15,13.99%,GJA1;JAM3;SLC1A1
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.5414988965474642,-1.0743594259292477,0.391304347826087,1.0,1.0,14/46,22.05%,PCDH17;ELAVL3;ROBO2;DPP6;PHYHIPL;UNC5D;SNAP25;UNC79;SNAP91;RIMS1;EZH1;CADM2;BMP5;NOVA1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.6606306809827598,-1.0739418930278952,0.4358974358974359,1.0,1.0,5/9,30.75%,MIGA1;SPG7;EEA1;CHCHD3;AFG3L2
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.6959318742431203,-1.073834316714997,0.4266666666666667,1.0,1.0,2/8,17.56%,SLC3A2;COLEC12
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.679476812962036,-1.0732137440648133,0.43243243243243246,1.0,1.0,3/8,21.99%,GRIN1;RAB27A;PPARA
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7002362933632371,-1.0729565204233376,0.40540540540540543,1.0,1.0,2/5,9.40%,COX4I1;COX6C
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.6106423538185061,-1.072928612211446,0.36046511627906974,1.0,1.0,4/15,9.00%,TSC2;TGFB2;TGFB1;IFT122
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.6106423538185061,-1.072928612211446,0.36046511627906974,1.0,1.0,4/15,9.00%,TSC2;TGFB2;TGFB1;IFT122
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.5700763842913535,-1.072856894064984,0.38095238095238093,1.0,1.0,7/24,15.60%,APIP;GRIN1;SOD2;FARSB;TRPA1;GOLGA2;ALDH1A2
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.7036780361000361,-1.0728137807891946,0.4375,1.0,1.0,3/6,21.15%,USP15;ANKRD17;DDX60
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.5810579392209215,-1.0726992407356477,0.3902439024390244,1.0,1.0,6/18,23.99%,DHRS3;ALDH3A2;GPC4;ABCA4;AKR1C1;LPL
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.6731428770253026,-1.0725422064240717,0.4342105263157895,1.0,1.0,5/9,25.51%,PDK3;SCD;LPL;PID1;IRS1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.6479341259495763,-1.0724704392704543,0.4634146341463415,1.0,1.0,3/9,13.32%,SRGN;TGFB1;ROCK2
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.3381526372716466,1.0723014299802054,0.3333333333333333,0.9538854740515621,1.0,13/100,8.39%,TAGLN;ACTA2;LMOD1;COL14A1;ITGA8;TPM2;COL5A2;TNS2;DLC1;MYLK;PRRX1;FLNA;MYL9
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.6580874270560869,-1.0721794615649198,0.44,1.0,1.0,6/8,30.78%,SYNDIG1;SNAP25;RIMS1;NLGN1;PCLO;PIP5K1C
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.577843640296784,1.0721391049662272,0.4166666666666667,0.950918073767812,1.0,4/15,4.85%,CTNNA3;CACNA1C;CACNB2;BIN1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.5062910709708347,-1.0718530355115345,0.3917525773195876,1.0,1.0,11/101,8.67%,SRGN;TBC1D20;COG2;CSNK1D;ATL1;ANK3;CSNK1A1;TOR1AIP2;COG7;GOLGA8A;GOLGA8B
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.6511374639723055,-1.0713573855324803,0.4383561643835616,1.0,1.0,2/9,9.79%,TSC2;GIGYF2
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.6093968609400903,-1.0712654347739534,0.3870967741935484,1.0,1.0,4/15,10.61%,ROBO2;ROBO1;SEMA3B;PTPN2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.49362612454229937,1.0708349609450543,0.42105263157894735,0.9520551532166941,1.0,1/16,0.02%,JPH2
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.7131966490026597,-1.0705439338443508,0.4230769230769231,1.0,1.0,3/5,24.83%,PARP1;PPARA;PID1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.614582671411778,-1.0704280642689612,0.4024390243902439,1.0,1.0,8/20,24.83%,SSH1;PDK3;PANK2;ARF4;RNF34;PPARA;NCOR2;PID1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.589639002452577,-1.0701774196497005,0.43373493975903615,1.0,1.0,2/18,5.26%,SOAT1;LIPA
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.6919600711454408,-1.0700690632400658,0.4146341463414634,1.0,1.0,1/5,7.38%,CTR9
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.5990412697231629,1.0697722648858001,0.4166666666666667,0.9483168170099853,1.0,1/5,0.76%,ARHGEF10L
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.5990412697231629,1.0697722648858001,0.4166666666666667,0.9483168170099853,1.0,1/5,0.76%,ARHGEF10L
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.585273374957472,-1.0697674514953015,0.43373493975903615,1.0,1.0,9/19,31.23%,PABPC1;ANGEL2;HNRNPC;ELAVL1;MAPKAPK2;TARDBP;YBX3;YBX1;CIRBP
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.6668601774321754,-1.0697639714336773,0.3888888888888889,1.0,1.0,3/9,17.77%,CD44;TMEFF2;CCN1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6163566383325578,-1.069260542590035,0.38372093023255816,1.0,1.0,8/16,32.80%,SMCHD1;TERF2IP;ZRANB3;TP53BP1;POT1;TERF1;SHLD2;POLR2F
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.6140765114243681,-1.0690087484981605,0.46511627906976744,1.0,1.0,5/20,14.86%,TWIST1;KDM1A;SPIDR;TERF2IP;FMN2
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.5899749351418092,-1.0689259150410377,0.4111111111111111,1.0,1.0,3/23,10.34%,GJA1;GRIN1;SNX6
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.5690136804322029,-1.0687376581171155,0.39325842696629215,1.0,1.0,7/27,21.88%,KDM1A;RHBDD1;PARP1;POLK;XPA;NEDD4;EIF2AK4
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.566420171873919,-1.0687282334325998,0.42528735632183906,1.0,1.0,8/30,21.05%,S1PR3;GPR161;ADM;ADGRG2;GNAL;LGR4;ADGRE2;TSHR
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.5057839256769552,-1.0683937413209479,0.3711340206185567,1.0,1.0,24/103,19.99%,BTD;NRCAM;ROBO2;SLC2A1;DNER;DCLK1;SZT2;GRIN1;EPHA7;SPOCK1;ALDH3A2;STAT3;DDIT4;GRIK1;ARNT2;SLC6A17;ZIC4;WWP1;SMARCA1;AFF2;PTS;NR4A2;SH3GL3;RAB18
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.6135942030983086,-1.0683845523728015,0.4578313253012048,1.0,1.0,6/14,22.43%,PDCD4;SASH1;MAP3K4;DNAJA1;PAK1;TAOK3
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.5205443809022439,-1.0681513445955573,0.3333333333333333,1.0,1.0,18/74,22.05%,NELL1;PRDM6;PCBP3;MTMR9;CTCF;HIF1A;ROCK2;IGF2BP2;AFF2;TRIM5;PRDM10;CGGBP1;ADNP2;MTMR2;FUBP3;SCARB2;AFF4;NOVA1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.6110949084666797,-1.0680668512956168,0.4625,1.0,1.0,3/11,26.44%,HIF1A;APP;INSR
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.633082087769713,-1.0679268234022268,0.45121951219512196,1.0,1.0,2/8,16.28%,ZC3H12B;CSTF3
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.5946821576539513,-1.0676779668183818,0.33707865168539325,1.0,1.0,6/22,15.15%,NFKBIA;AZI2;RPS27A;TANK;ROCK2;TBK1
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.6380328373094293,-1.0672770190907823,0.39080459770114945,1.0,1.0,2/11,8.10%,PRAG1;ROBO1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.4961780806820605,-1.0672550161779681,0.3402061855670103,1.0,1.0,39/125,33.13%,SRSF12;HNRNPL;STRAP;SRSF10;RBM4B;RBM17;CDC5L;CCAR1;RAVER2;PABPC1;SRSF5;DDX42;HNRNPC;SYMPK;CSTF3;DDX46;ELAVL1;HNRNPF;TRA2B;NONO;CPSF2;NOVA1;RSRC1;SF3B1;TRA2A;PRPF3;NCBP1;RALY;SFPQ;WBP4;CWC22;PRMT7;YBX1;UBL5;SPEN;SRSF2;DHX15;POLR2F;RNPC3
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.6002622651642331,1.0671741900555691,0.28,0.9511510231029379,1.0,3/5,8.59%,SLIT3;RHOA;SLIT2
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.7214629186894896,-1.0667448576184624,0.4266666666666667,1.0,1.0,1/6,3.64%,CD44
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.65209494200986,1.0666096430466467,0.48,0.9496741660045889,1.0,1/5,9.38%,NEK4
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.6389793027643407,-1.066598023942663,0.47435897435897434,1.0,1.0,2/13,3.69%,WWC1;WWC2
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.6167620954810114,-1.0662740224276397,0.4125,1.0,1.0,5/13,15.99%,ATP6V1E1;ATP6V1G1;ATP6V1H;ATP6V1D;RAB7A
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.5039055267591029,-1.0660128370992998,0.3655913978494624,1.0,1.0,14/69,15.60%,ANKH;ETV5;EMP1;GLRX;CFH;TOR1AIP2;SEMA3B;SNAP25;GYPC;CMKLR1;PTBP2;CA2;SNAP91;ALDH1A2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.6030803681675473,-1.06601102835565,0.38823529411764707,1.0,1.0,1/15,1.07%,GJA1
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.6400432240296537,-1.0659387592558471,0.4024390243902439,1.0,1.0,6/10,30.04%,MT2A;MT3;JUN;MAPK1;EGFR;MAPK9
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.6400432240296537,-1.0659387592558471,0.4024390243902439,1.0,1.0,6/10,30.04%,MT2A;MT3;JUN;MAPK1;EGFR;MAPK9
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.44848608513527677,1.0658672805672347,0.38461538461538464,0.948620060056435,1.0,4/17,1.95%,HDAC9;ADGRA2;HEY2;HEYL
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.6024094909252812,-1.0655279129928683,0.4418604651162791,1.0,1.0,3/16,18.19%,TRAF3IP1;TBK1;NPLOC4
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.5185160854493565,-1.0653013408279248,0.35353535353535354,1.0,1.0,24/105,21.81%,OS9;RNF19A;PSMD14;NEDD4L;ARIH2;RPS27A;RNF111;RBX1;AMFR;NDFIP2;UBE2L3;RNF213;ANAPC4;FBXO22;NPLOC4;BTRC;UBE2K;UBE2B;RNF168;RNF34;NDFIP1;SMURF2;MDM2;NEDD4
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.6634551330924023,-1.065271129315088,0.47368421052631576,1.0,1.0,5/11,28.19%,UBA5;NAE1;UBA1;DESI2;UBA2
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5807082656483135,-1.0647419963118385,0.44047619047619047,1.0,1.0,6/18,22.88%,ANKRD17;NAIP;TF;GBP2;COLEC12;ADAM17
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.506434028769197,1.0635965270269763,0.35294117647058826,0.9516113728197189,1.0,2/11,1.97%,ATP2B4;LMCD1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.6022133010029442,-1.0635030423127974,0.38636363636363635,1.0,1.0,4/16,9.00%,TSC2;TGFB2;TGFB1;IFT122
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.4002458330989779,1.063320530733751,0.21428571428571427,0.9493280967134539,1.0,2/25,1.67%,HSPA1A;SERPINH1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.6645983057616962,1.0622798800465956,0.4,0.9488428977496595,1.0,1/5,1.47%,NT5C3A
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.5522699276944146,-1.0615962110021995,0.4418604651162791,1.0,1.0,11/35,30.09%,COG7;ARF4;ATP9B;PLPP3;NSF;ARFGAP3;ERGIC2;RAB6A;COG4;GOLPH3;UVRAG
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.59323137727677,-1.061548687922292,0.42857142857142855,1.0,1.0,6/21,21.88%,KDM1A;RHBDD1;PARP1;POLK;NEDD4;EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.6146078315592619,-1.0615393419260364,0.4383561643835616,1.0,1.0,1/6,6.02%,NECTIN2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.6544438971088834,-1.0611655558027318,0.4418604651162791,1.0,1.0,2/10,10.10%,TWIST1;SMCHD1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.552399117720049,1.0611445373911108,0.38461538461538464,0.948620060056435,1.0,2/7,8.06%,ATM;DLG5
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.6275902120082746,-1.0610695811171225,0.45,1.0,1.0,8/15,25.00%,IPO5;SLC38A9;UBR1;SESN1;CPEB4;LARS1;FYN;RRAGB
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6529828724719771,1.0610621475016742,0.4482758620689655,0.945890111995294,1.0,2/5,7.71%,TRAF6;RHOA
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.7202719569882179,-1.0610169845340534,0.4675324675324675,1.0,1.0,2/5,14.80%,CTR9;WAC
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.6947292230502209,-1.060952878926535,0.36231884057971014,1.0,1.0,1/5,15.00%,ERRFI1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.6025886100452926,-1.060843177149843,0.40963855421686746,1.0,1.0,3/12,10.69%,VEGFA;HIF1A;MT3
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.6780595419437,-1.060779703045969,0.3924050632911392,1.0,1.0,3/7,24.26%,TERF2IP;TNKS;POT1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.6839012512139937,-1.0605477146640652,0.42105263157894735,1.0,1.0,4/6,28.64%,TGFB1;ALDH1A2;ARL13B;PTCH1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.6934353628850018,-1.059719451765786,0.4342105263157895,1.0,1.0,4/8,23.29%,LGR4;APPL2;BIRC2;IRF1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.5664450668224495,-1.0595986648314817,0.4482758620689655,1.0,1.0,3/29,11.09%,ADAMTS9;MARCHF6;MANBA
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.5848278750800029,-1.059554388062192,0.42168674698795183,1.0,1.0,3/19,9.86%,AKIRIN1;ENPP2;ACTR3
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.5834933868234514,-1.059540082583173,0.44047619047619047,1.0,1.0,8/20,31.95%,NIBAN2;CFL1;NR2C2;CLASP2;INSR;B4GALT5;TRIP12;SEPTIN7
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.5210505356375406,1.0594467951536106,0.3,0.9468551855260974,1.0,4/10,12.87%,DERL1;RNF185;ATXN3;VCP
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.6834313910707674,-1.0593358237131383,0.38666666666666666,1.0,1.0,3/7,14.35%,TAF1B;POLR1C;CCNH
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.5192426029185819,1.0591615381723707,0.2857142857142857,0.9443691164202398,1.0,4/16,4.42%,HEYL;NOTCH3;NOTCH1;PPARD
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.6218144945462545,-1.0586941538621826,0.37037037037037035,1.0,1.0,5/15,10.61%,TSC2;PTPRE;PTPN1;PRKCB;PTPN2
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.584079279588869,1.058472048003057,0.4117647058823529,0.9436892226889769,1.0,3/8,11.24%,GLB1;GPC6;GPC5
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.6981544070205692,-1.0584003370473185,0.44,1.0,1.0,3/6,17.91%,MT2A;MT3;PAM
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.67692677136331,-1.0581992712801147,0.42105263157894735,1.0,1.0,2/6,13.43%,CD55;IL18
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.6394959898872926,-1.0580088650169766,0.48,1.0,1.0,3/11,19.79%,RPA1;RAD21;WRN
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.46048762488226663,1.0578699182801752,0.3,0.9425769665738435,1.0,3/15,4.85%,MYH11;HEY2;BIN1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.6731136496843951,-1.0575427103018946,0.5128205128205128,1.0,1.0,1/8,6.06%,MTMR9
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.6612367106713409,-1.0574825272580808,0.44594594594594594,1.0,1.0,1/8,3.80%,SELENOS
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.6630291030303923,-1.0567511195488055,0.43373493975903615,1.0,1.0,4/10,22.36%,NOS1AP;DIAPH1;CAMK2D;FYN
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.6033720677284399,-1.0567038366563604,0.42528735632183906,1.0,1.0,2/23,11.09%,ADAMTS9;MANBA
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.5519832285468268,-1.0560134009209852,0.38636363636363635,1.0,1.0,8/31,21.81%,NEDD4L;MT2A;HIF1A;MT3;PPP3CA;PAM;AHCYL1;NEDD4
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.5921881482848037,1.0553358771083858,0.32142857142857145,0.9465518477161956,1.0,2/6,5.30%,MERTK;WDFY4
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.6987177559151225,-1.055312939866048,0.4626865671641791,1.0,1.0,3/6,23.00%,SLC1A2;SLC1A1;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.6795473933812123,-1.055199215603075,0.44,1.0,1.0,2/8,10.61%,NFKBIA;PTPN2
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.6551745314201519,-1.0550791503373749,0.4675324675324675,1.0,1.0,5/12,27.33%,RPA1;RPS27A;NPLOC4;RCHY1;RPA3
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.5778156423927328,-1.0549267327100638,0.37209302325581395,1.0,1.0,5/31,7.96%,CTSL;NR4A3;ROBO2;SRA1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.48822695110193587,1.0539567003266272,0.26666666666666666,0.9469564488188218,1.0,1/15,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.6579596288291375,-1.0539281792394852,0.43478260869565216,1.0,1.0,1/8,4.23%,TGFB2
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.5604049603932328,-1.0539173182438923,0.42696629213483145,1.0,1.0,5/32,20.36%,HNRNPL;HNRNPC;NT5E;WRN;HNRNPF
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.6163436702611537,1.0537080237171637,0.42857142857142855,0.9445827653791922,1.0,1/5,3.88%,ATM
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.5577332586081335,-1.0534281059164716,0.4125,1.0,1.0,7/28,18.75%,SOD1;CPD;SEC11A;ERAP1;MIPEP;GSR;LNPEP
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5242215707204483,-1.0532141233174035,0.3473684210526316,1.0,1.0,1/33,0.40%,EPN1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.5759057430520655,-1.0529021474833336,0.4883720930232558,1.0,1.0,12/27,26.16%,SUFU;IFT122;FGFR2;ARMC9;DCDC2;UCHL5;TTC23;BTRC;EVC;INTU;RORA;RACK1
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.6904133443085081,-1.0527664662664706,0.4810126582278481,1.0,1.0,3/5,29.26%,TERF2IP;POT1;TERF1
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.6361743367453069,-1.0527130681509205,0.4666666666666667,1.0,1.0,4/10,22.60%,PDK1;CD38;PPIB;CD9
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.6616544598249294,-1.0527073421454243,0.44594594594594594,1.0,1.0,2/8,20.41%,POLA1;XPA
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.6008072359588779,-1.0526803960321993,0.4268292682926829,1.0,1.0,4/9,28.99%,WDR43;ELAVL1;CNOT1;PTN
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.6434568937711018,-1.0526152732882583,0.4827586206896552,1.0,1.0,4/13,17.68%,CYP3A5;DGKI;LPCAT3;PLPP3
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.6315765156456483,-1.0523116858418116,0.4305555555555556,1.0,1.0,1/9,7.26%,TRAF3IP1
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.6904214263369508,-1.0522469597838444,0.45588235294117646,1.0,1.0,1/5,5.46%,RUBCN
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.51483672441926,-1.0519279178939145,0.422680412371134,1.0,1.0,22/89,23.79%,PRKACA;CSNK1D;CSNK1G2;CSNK1A1;PDK3;PRKCI;STK4;LATS2;PRKCB;PRKDC;TGFBR1;SGK1;ROCK2;TBK1;CAMK2D;LRRK2;TNKS;UHMK1;MAPK1;MAPKAPK2;STK39;NLK
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.5788045932480135,-1.0516387436271024,0.3291139240506329,1.0,1.0,10/19,28.92%,TAF1B;POLR1C;SYMPK;CCNH;CSTF3;CPSF2;SETX;TAF1D;NCBP1;GTF2H1
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.6111672953758437,-1.0515227599951034,0.48717948717948717,1.0,1.0,3/10,26.44%,HIF1A;APP;INSR
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.6111672953758437,-1.0515227599951034,0.48717948717948717,1.0,1.0,3/10,26.44%,HIF1A;APP;INSR
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.36195057551697735,1.0505990201901763,0.3333333333333333,0.9501650438676017,1.0,6/46,7.17%,BCAM;ITGA7;ITGA8;ITGA3;DLC1;ITGB5
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.7002152055867659,-1.050388249155139,0.4605263157894737,1.0,1.0,2/5,15.51%,CRACD;WASHC2C
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.5031307994110645,-1.0499721945551028,0.3939393939393939,1.0,1.0,26/143,15.71%,PRKACA;CSNK1D;TUBA1A;TTC8;PTPDC1;LZTFL1;NUDCD3;TRAF3IP1;GALNT11;CEP57;ARF4;IFT122;ACTR3;CCP110;ARMC9;IFT52;DCDC2;IFT140;IFT57;DYNC2LI1;ATP6V1D;BBOF1;NINL;EXOC1;MAK;WDR19
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.6374640636161274,-1.04956007992181,0.5263157894736842,1.0,1.0,4/12,10.16%,VEGFA;TENM3;IFT122;FBN1
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.6651756355602372,-1.0495213328558726,0.41333333333333333,1.0,1.0,6/10,31.34%,LPCAT3;SREBF1;ACADL;SREBF2;ACADVL;LDLRAP1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.5798161071613958,-1.049419790071619,0.4939759036144578,1.0,1.0,8/21,32.37%,SMAP1;TF;CLU;SNAP91;LRPAP1;PIK3CB;LDLRAP1;SGIP1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.5711640212084478,1.0493725404372238,0.37037037037037035,0.950267467288487,1.0,1/9,3.88%,ATM
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.48715810727744396,-1.049095629816169,0.40404040404040403,1.0,1.0,37/115,33.13%,SRSF12;HNRNPL;SRSF10;RBM4B;RBM17;CDC5L;CCAR1;RAVER2;PABPC1;SRSF5;DDX42;HNRNPC;SYMPK;CSTF3;DDX46;ELAVL1;HNRNPF;TRA2B;NONO;CPSF2;NOVA1;RSRC1;SF3B1;TRA2A;PRPF3;NCBP1;RALY;SFPQ;WBP4;CWC22;YBX1;UBL5;SPEN;SRSF2;DHX15;POLR2F;RNPC3
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.6229353557807563,-1.0489551779468442,0.4305555555555556,1.0,1.0,2/8,16.24%,ESR2;CALCOCO1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.6522227806757774,-1.04861495197199,0.4819277108433735,1.0,1.0,2/8,10.69%,ZFP36L2;MT3
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.601621463374076,-1.048539934990185,0.44047619047619047,1.0,1.0,3/13,10.41%,PDE7B;PDE7A;RIMS2
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.6973340036292264,-1.0485055450342022,0.4266666666666667,1.0,1.0,1/5,3.49%,ANK3
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.6066118340644261,-1.0484941784094934,0.4625,1.0,1.0,3/13,16.05%,PRKACA;PRKAR1A;PRKAR2A
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.4901163620207326,-1.0481395820754507,0.42,1.0,1.0,52/175,24.22%,HNRNPL;RPS21;SEC13;TAF1B;RPS4X;RPL28;RBMS2;NUP153;NUP133;FYTTD1;RPL34;NUP88;RPL21;RPLP2;FARSB;DARS1;RPS27A;RPL19;RPS14;SRSF5;RPLP1;RBM39;SYMPK;RPL13A;RPL18;SMG7;PWP1;ALKBH5;TSPAN5;RPL27;RANBP2;RPL35A;NR4A2;AGO2;HNRNPF;RPL5;FUBP3;RPL31;RPL41;CPSF2;NOVA1;RPL24;RPL27A;SETX;RPS12;RPS18;RPL37;WARS1;RPL36;LMF1;RPL32;THOC2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.4463299905890083,1.048089328413957,0.46153846153846156,0.9509760818809148,1.0,4/15,4.36%,PDGFA;ATP1B2;CDC42;QRICH2
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.5220765071428686,-1.0477794640318283,0.4,1.0,1.0,3/27,12.27%,TMSB4X;NFKBIA;CMKLR1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.6214989858702653,-1.0476958577941808,0.4318181818181818,1.0,1.0,1/10,1.41%,ADAMTS9
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.5681599587660517,-1.0475847715153959,0.46511627906976744,1.0,1.0,4/27,7.32%,SEC13;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.5681599587660517,-1.0475847715153959,0.46511627906976744,1.0,1.0,4/27,7.32%,SEC13;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.36370525264705994,1.0473018970965973,0.36363636363636365,0.9499721816724194,1.0,2/22,1.92%,PKN1;ERBB4
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.6672186079480299,-1.0472886358173368,0.48,1.0,1.0,4/7,32.80%,TERF2IP;POT1;TERF1;POLR2F
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.6672186079480299,-1.0472886358173368,0.48,1.0,1.0,4/7,32.80%,TERF2IP;POT1;TERF1;POLR2F
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.6951202140622557,-1.0472339961496806,0.45588235294117646,1.0,1.0,3/6,20.49%,GOLGA2;BTRC;SKP1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.6376239154629082,-1.0470868531041957,0.4411764705882353,1.0,1.0,3/10,8.55%,CDH20;CDH18;CDH12
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.48622921513179274,1.046996186067965,0.3333333333333333,0.9476978989272392,1.0,3/28,2.06%,A2M;SORBS2;C2ORF72
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.5171619826503705,-1.0465970877926845,0.42105263157894735,1.0,1.0,15/65,20.49%,PRKACA;PPME1;CSNK1D;TUBA1A;CEP57;MELK;CCP110;NINL;CCNH;PPP2R2A;CDK14;YWHAG;BTRC;PHLDA1;SKP1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.7110924854373158,-1.0465348648464823,0.4931506849315068,1.0,1.0,1/5,3.80%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3797619316199162,1.0463003437581329,0.5,0.9464988166305486,1.0,7/55,8.27%,HSPA1A;LEMD3;NOTCH1;SKI;BCL9L;RBPMS2;PPM1A
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.6278633526325812,-1.0462752248251124,0.4358974358974359,1.0,1.0,2/14,12.69%,DDX52;RPS14
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.6704254281421883,-1.0462019928308375,0.4626865671641791,1.0,1.0,1/5,3.60%,VEGFA
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.6901721446147778,1.0459328771353185,0.4090909090909091,0.9443206452660758,1.0,1/6,0.28%,CAV2
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.49862199142520547,1.0458288462161933,0.391304347826087,0.9415240279081828,1.0,2/10,3.75%,SOX5;SOX6
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.6651141322756227,-1.045626941859372,0.5185185185185185,1.0,1.0,4/10,23.29%,IFITM3;UBE2K;STAT1;IRF1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.29548563293646296,1.0455722487319759,0.0,0.9391653750724837,1.0,9/104,4.99%,NIBAN1;PGF;IL34;ERBB4;SLCO3A1;DSTYK;PTGES3;MERTK;CD4
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.5436273447212236,-1.04540541937545,0.43010752688172044,1.0,1.0,9/39,15.04%,ZFP36L2;PSMB1;EIF2AK2;PSMD14;PSMA4;PRKDC;PSMB2;PSMA7;RUNX1
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.6900687994377815,-1.0451648070338535,0.45,1.0,1.0,4/7,28.64%,TGFB2;TGFBR1;BMP5;PTCH1
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.6230709853866181,-1.0445593896248306,0.484375,1.0,1.0,3/8,20.35%,INTS8;INTS2;SSB
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.5183946289012343,-1.0445061102397866,0.40816326530612246,1.0,1.0,26/81,25.47%,OMG;DCLK1;ADGRV1;STMN1;GPM6A;PLP1;HDGFL3;GRM7;MYO16;SGK1;ZFYVE27;MICALL2;LRRK2;DTNBP1;BTG2;NLGN1;MINK1;UHMK1;RAB11A;PAK1;NEDD4;TAOK3;GPM6B;APP;PTPRM;LYN
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.678323247908611,-1.0437771106081797,0.4931506849315068,1.0,1.0,2/6,15.00%,SNX6;ERRFI1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5845740876234897,-1.0435306587001278,0.44155844155844154,1.0,1.0,7/15,31.14%,TGFB1;AP2A1;NEDD4;SNX25;AP2B1;UVRAG;AP2A2
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.46586328308429187,1.043445693513199,0.3333333333333333,0.9418132852657739,1.0,1/21,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.6457573726722811,-1.0432607608460898,0.475,1.0,1.0,2/9,19.71%,TUT7;AGO2
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.6248245337746665,-1.0431264901021127,0.43243243243243246,1.0,1.0,1/11,2.00%,SYT1
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.5493829408600319,-1.0430948146069177,0.43478260869565216,1.0,1.0,8/41,17.90%,SRGN;F3;NAA11;CPD;PITRM1;NAA15;APH1B;TSPAN5
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.4901562025812945,1.0430022061154705,0.42857142857142855,0.9396773795695117,1.0,6/20,12.95%,HDAC9;CD4;PIK3CD;GPR89B;ITGB1;MSH2
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.5333030099491144,-1.0429512891702006,0.4666666666666667,1.0,1.0,5/55,13.57%,SRSF12;HNRNPL;SRSF10;RBM39;KHDRBS2
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.6205489350926281,-1.0429002026003564,0.4358974358974359,1.0,1.0,1/12,2.00%,SYT1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.5831828607935621,-1.0426521229127652,0.475,1.0,1.0,9/15,30.78%,SYT1;SNAP25;RIMS2;RIMS1;LIN7A;SYN3;STXBP1;PCLO;PIP5K1C
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.6135237862927326,-1.0425050895803523,0.5061728395061729,1.0,1.0,1/12,2.99%,TUBA1A
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.5387004881624651,-1.0424294278204267,0.4945054945054945,1.0,1.0,12/55,21.81%,TSC2;SPOCK1;PTPN1;RAP1B;NRG3;SNCAIP;SGK1;ROCK2;CAMK2D;GFAP;SEMA4D;NEDD4
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.5547914371097239,-1.0420055789440732,0.45161290322580644,1.0,1.0,4/25,20.44%,SYT1;ADGRV1;CAMK2D;NLGN1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.5838164315751628,-1.0418624268216135,0.4605263157894737,1.0,1.0,7/20,25.95%,SYT1;DNAJC6;SNAP91;NLGN1;GAK;SYNJ2;DNM3
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.576190835882126,-1.041765841080909,0.4625,1.0,1.0,7/14,32.72%,ALDH1L1;MTHFD2L;ASS1;GCLC;MTHFD1L;ME2;SLC19A1
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.6226904378098339,-1.0416354223477038,0.4520547945205479,1.0,1.0,3/12,10.73%,SYT1;PHYHIPL;SHC2
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.5767891256214961,-1.0414835840652685,0.45,1.0,1.0,6/20,19.48%,GLRB;GABRE;SLC25A3;SLC1A1;SLC12A6;ANO2
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.5364634308946435,-1.041328889674346,0.4044943820224719,1.0,1.0,14/50,25.11%,EPM2A;TSC2;C9ORF72;ATF6;WAC;TRIM13;TBK1;LRRK2;CAMKK2;TRIM5;SESN1;EIF2AK4;TMEM59;DCN
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.63516264717517,-1.040900966022138,0.4342105263157895,1.0,1.0,7/17,24.72%,TGFB1;CEMIP;DDIT4;UBE2K;PRKAG2;MAPK1;APP
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.36668893244838285,1.0407380728208244,0.2857142857142857,0.9423764001613728,1.0,7/48,4.30%,RCAN2;CSRNP3;SORBS2;EDN3;C2ORF72;FAM13C;NFASC
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.636604767034545,1.0402383788570326,0.5,0.9409436857277723,1.0,1/5,0.64%,SNAP29
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.5114057277546248,-1.0397888693596564,0.43157894736842106,1.0,1.0,32/90,34.80%,PRKACA;HNRNPL;RBMS2;TUT7;SRSF5;RBM39;HNRNPC;PPARGC1A;CSTF3;ALKBH5;HNRNPF;NONO;NOVA1;SETX;RSRC1;TCERG1;TARDBP;SF3B1;KIN;CELF2;PRPF3;NCBP1;SFPQ;WBP4;PRMT9;SRSF2;DHX15;RNPC3;PRPF8;PPIG;XRN2;CPSF6
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.6768129416978459,-1.0394666732516407,0.4473684210526316,1.0,1.0,2/8,12.69%,PRKDC;RPS14
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.41286370440709386,1.039407347529179,0.2727272727272727,0.9398301576104178,1.0,6/43,7.48%,SH3RF3;MECOM;MFHAS1;TRAF6;MTURN;TNFRSF19
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.5586702592358823,1.039199803296069,0.4,0.9375208685981206,1.0,1/6,10.59%,EP300
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.5126459864465781,-1.0389122596176006,0.45263157894736844,1.0,1.0,19/90,17.88%,PRKACA;CSNK1D;CSNK1G2;NAA11;CSNK1A1;PDK3;PRKCI;STK4;LATS2;PRKCB;PRKDC;TGFBR1;SGK1;ROCK2;PARP1;TBK1;CAMK2D;LRRK2;TNKS
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.5649879180199546,-1.0387489415665516,0.5,1.0,1.0,12/29,15.28%,ELAVL3;PHYHIPL;VEGFA;UNC5D;SCN3A;ENPP2;SNAP25;ALCAM;TRPA1;CCK;UNC79;SNAP91
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.6036771907897155,-1.0384613260786242,0.44155844155844154,1.0,1.0,1/11,3.60%,VEGFA
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.6689299022405419,-1.0382800011567357,0.46511627906976744,1.0,1.0,3/7,23.43%,NAA11;NAA15;METAP1
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.5404923162673649,-1.0382178368004589,0.4367816091954023,1.0,1.0,13/38,20.16%,ELAVL3;KCND2;CDH20;KCNQ3;SNAP25;CCK;GRIA3;NXPH1;SNAP91;GFAP;NR4A2;CADM2;KCNC2
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.687743197058073,-1.0382048034942273,0.4594594594594595,1.0,1.0,2/5,15.65%,EMP1;PMP22
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.6886330146937241,-1.037454021384409,0.47761194029850745,1.0,1.0,1/5,3.80%,SELENOS
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.5887147484948071,-1.0371537261591552,0.4578313253012048,1.0,1.0,6/17,23.29%,SRGN;PTPRE;GBP2;ADGRE2;DDX60L;IRF1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.6533834653626482,-1.0370171784350062,0.5135135135135135,1.0,1.0,1/10,0.85%,HS3ST5
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.5184454478350362,-1.036654179884141,0.4418604651162791,1.0,1.0,12/37,23.11%,SLC7A2;SLC38A4;SLC7A14;SLC3A2;ARRDC2;RAB7A;ATP11B;SLC7A11;SCARB2;SLC6A20;ARL6IP5;SLC44A1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.6333638909215975,-1.0359627913324991,0.5238095238095238,1.0,1.0,3/11,16.39%,FHL1;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.6390769206573268,-1.0357062031415345,0.4533333333333333,1.0,1.0,4/11,21.11%,HS3ST5;GLCE;EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.49622687158457135,-1.0353221509507697,0.4329896907216495,1.0,1.0,18/69,17.68%,PGK1;PLAA;EPHA7;FRA10AC1;TGFB1;PANK2;PTPRD;STAT3;MINPP1;AGK;GK5;PPA1;GPX4;PLAAT3;NUDT5;PPP3CA;LRRK2;PLPP3
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.5778330320104905,-1.0349712213878854,0.4936708860759494,1.0,1.0,2/18,2.68%,TBC1D20;RIPOR1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.5623050412467308,-1.0347991125522935,0.4457831325301205,1.0,1.0,8/25,24.78%,DPM1;MGAT1;TMEM165;MGAT4A;UBE2J1;PGM3;MCFD2;FUT8
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.680281253680366,-1.034754153539784,0.5,1.0,1.0,4/7,28.83%,PANK2;ACADL;RORA;ACADVL
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.5752639733725253,-1.0347483941728874,0.48717948717948717,1.0,1.0,2/15,6.00%,HMGN1;WDR43
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.5712931060662203,-1.034672909731801,0.4691358024691358,1.0,1.0,5/20,19.48%,GLRB;GABRE;SLC1A1;SLC12A6;ANO2
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.5263612475901157,-1.034636530655196,0.4489795918367347,1.0,1.0,14/62,21.84%,TGFB2;PDCD4;TGFB1;SMAD6;RPS27A;RNF111;USP15;HIVEP1;TGFBR1;JUN;USP9Y;APPL2;SMURF2;BMP5
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.5568764257429885,-1.0344813733190086,0.4943820224719101,1.0,1.0,12/32,24.53%,MID1;CD44;NCAM1;MT2A;GBP2;RPL13A;CAMK2D;TRIM5;STAT1;IRF1;EPRS1;HLA-B
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6091315159671404,-1.034464809258695,0.45,1.0,1.0,3/10,22.64%,TGFB1;PTBP2;NCOR2
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.6416033671819122,-1.0343102239156787,0.47435897435897434,1.0,1.0,2/7,16.94%,RAB7A;STXBP6
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.43493764242184335,1.034268023289035,0.35,0.9483460112163203,1.0,2/19,2.53%,HSPA1A;CDK6
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.5339057458497437,-1.0340860150650053,0.42696629213483145,1.0,1.0,6/36,9.72%,MID1;VEGFA;TGFB2;EIF2AK2;CCN2;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.6495560315731964,-1.0340012793963047,0.5238095238095238,1.0,1.0,6/10,31.02%,ROCK2;CLU;LYN;SP1;EPHA4;RANBP9
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.5376607772396435,1.0337899810248268,0.4782608695652174,0.9467418073635447,1.0,3/11,5.10%,SERGEF;NOTCH1;PNKD
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.5803889969470368,-1.0335188551579502,0.3977272727272727,1.0,1.0,7/21,14.89%,DDX3X;TRAF3IP1;JAM3;SMAD6;CLU;HSPA5;RPL13A
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.4733801093693724,1.0334805638550306,0.34782608695652173,0.9448751488230798,1.0,2/9,5.77%,MECOM;SETD7
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.43354764588126904,1.033092200461436,0.375,0.942884217832838,1.0,2/23,1.21%,SPRY3;TNIP1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.6371762231352942,-1.0327204847909748,0.56,1.0,1.0,5/7,23.77%,ANGEL2;HNRNPC;ELAVL1;MAPKAPK2;TARDBP
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.5071295872602002,1.0326158938270085,0.3684210526315789,0.9413115305596383,1.0,3/10,16.25%,NELFA;SUPT5H;DHX9
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.6641036309419586,-1.0324293176429216,0.5063291139240507,1.0,1.0,3/6,28.86%,STAT3;AGO2;EIF4G1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.6641036309419586,-1.0324293176429216,0.5063291139240507,1.0,1.0,3/6,28.86%,STAT3;AGO2;EIF4G1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.48847883705283146,-1.0319774088975326,0.41,1.0,1.0,56/391,14.33%,WWC1;TAF7;SCML1;PRDM6;ENO1;ETV5;TWIST1;NRG1;ZFPM1;KLF2;NR4A3;KDM1A;BASP1;CRY1;JDP2;VEGFA;WWC2;CREM;ESR2;HDAC2;PDCD4;RARB;CTCF;TGFB1;SUFU;NIBAN2;CTR9;HCFC2;ZMYM5;CBFA2T2;STAT3;GLIS3;CD38;ZFPM2;NEDD4L;ZNF608;RPS27A;SDCBP;FGFR2;SAP130;SNX6;MT3;FHL2;HIVEP1;TP63;RCOR1;RTF1;RPS14;JUN;ZHX3;EID1;CLOCK;SIN3A;FOXP2;CDKN1B;PARP1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.6779299156427241,-1.0314145687021903,0.5,1.0,1.0,4/7,31.39%,RPA1;PARP1;RPA3;PARG
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.5633979980665771,-1.0310954935324845,0.4482758620689655,1.0,1.0,4/20,12.38%,VEGFA;TGFB2;TRAF3IP1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5761915549566928,-1.0309687040915558,0.42857142857142855,1.0,1.0,6/20,20.55%,ARIH2;SREBF1;MICALL2;LRRK2;UBE2L3;SREBF2
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6950210158789956,-1.0309422949522693,0.42105263157894735,1.0,1.0,2/5,21.37%,STMN1;PAK1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.48395720928787195,-1.0308012730609584,0.43,1.0,1.0,40/165,21.81%,PELI1;RNF19A;MARCHF6;PSMB1;HERC6;BLMH;FBXL13;PSMD14;NEDD4L;ARIH2;RPS27A;RBX1;PSMA4;PSMB2;AMFR;WSB1;ZNRF1;PSMA7;UBE2J1;SASH1;UBE2L3;RNF213;WWP1;ANAPC4;FBXO22;TNKS;TRIM5;BTRC;LNPEP;UBE2K;UBE2B;RNF168;RNF34;SKP1;SMURF2;DZIP3;MDM2;HECW1;BIRC2;NEDD4
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.5634754911796863,-1.0303743125901308,0.4883720930232558,1.0,1.0,6/22,20.21%,ALDH3A2;HADHA;PPARGC1A;HSD17B4;ACADL;ECHDC1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.5796658627401653,-1.0302157661971243,0.4936708860759494,1.0,1.0,2/14,9.86%,AKIRIN1;ACTR3
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.6215333783675075,-1.0297925590273047,0.5,1.0,1.0,2/12,10.11%,NUP153;AFDN
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.541226076854574,-1.029447771970266,0.4235294117647059,1.0,1.0,3/23,14.69%,SEC13;NUP133;PPP2R2A
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.541226076854574,-1.029447771970266,0.4235294117647059,1.0,1.0,3/23,14.69%,SEC13;NUP133;PPP2R2A
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.6311369225897875,1.0290892498097137,0.5,0.9474731614702063,1.0,3/6,6.39%,NSUN3;TFB1M;MTERF4
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.6008549227069042,-1.0287838980210524,0.5,1.0,1.0,3/14,3.64%,CTSL;ADAMTS4;CD44
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.6008549227069042,-1.0287838980210524,0.5,1.0,1.0,3/14,3.64%,CTSL;ADAMTS4;CD44
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.5102350739980062,-1.0286236612356785,0.4421052631578947,1.0,1.0,15/67,23.54%,TAF7;HDAC2;RPA1;TP63;RBBP7;SGK1;MDM4;PRKAG2;RNF34;WRN;RPL5;MDM2;MAP2K6;RPL37;SUPT16H
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.6035743450432822,-1.028434407243039,0.44047619047619047,1.0,1.0,1/14,0.22%,WWC1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.49401825105672875,-1.0283027792683959,0.43010752688172044,1.0,1.0,13/76,12.56%,FAT3;NRG1;ELAVL3;SYT1;HOMER2;CRMP1;DCLK1;EPHA7;LZTFL1;SNAP25;LINGO2;SLC25A36;PURG
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5913280364761375,-1.0282997258423896,0.5227272727272727,1.0,1.0,5/19,17.35%,NR4A3;NCEH1;LGALS3;TGFBR1;NRP2
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.4870380587971822,-1.0278770315893793,0.47959183673469385,1.0,1.0,25/114,21.81%,PRKACA;RHEB;ATP6V1E1;ATP6V1G1;SLC38A9;RUBCN;MTMR9;STAT3;SNX6;MT3;ATP6V1H;C9ORF72;SREBF1;GOLGA2;ATP6V1D;EXOC1;ATF6;LRRK2;GFAP;WDR41;TRIM5;PRKAG2;SREBF2;DRAM1;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.4891764763186634,-1.0277675362587504,0.422680412371134,1.0,1.0,15/82,13.32%,MID1;WWC1;VEGFA;CD44;MYDGF;TGFB2;TGFB1;EIF2AK2;PDGFD;ROBO1;CCN2;FGFR2;MT3;JCAD;ROCK2
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.6438899610779714,-1.0276903488264402,0.4864864864864865,1.0,1.0,4/7,17.43%,ZFPM1;TGFB2;NOTCH2;MDM4
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.4932262794688725,-1.0276445894159045,0.4444444444444444,1.0,1.0,7/59,7.38%,PDE4B;SELENOS;MGST1;PLAA;PDCD4;PDK3;CTR9
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.590909033294276,-1.0273522653359983,0.5194805194805194,1.0,1.0,7/15,28.82%,PTPN1;PTPRQ;PTPN2;DUSP1;DUSP16;PTPN9;PTPRZ1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.6683918815915699,-1.0269530085324026,0.4594594594594595,1.0,1.0,3/6,28.23%,FARP2;APP;B4GALT5
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.5648610649203287,-1.0268356624142954,0.45348837209302323,1.0,1.0,3/16,16.45%,SOAT1;MT3;LSS
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.64059023866792,-1.0267200374642493,0.4625,1.0,1.0,2/9,10.59%,TGFB1;HIF1A
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.6744130805014084,-1.0267121631395784,0.5303030303030303,1.0,1.0,3/5,25.54%,ACO1;ASS1;ACO2
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.539952182542316,-1.0265974216129954,0.4891304347826087,1.0,1.0,8/32,21.17%,CSNK1D;GOLGA8A;GOLGA8B;GOLGA2;SMC3;TNKS;MAP9;RAB11A
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.6805266387435323,-1.0264918259416,0.569620253164557,1.0,1.0,1/5,7.04%,FGGY
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.5180157786486567,-1.026487071739775,0.4367816091954023,1.0,1.0,7/33,8.14%,ELAVL3;CRMP1;PROS1;EPHA7;NCAM1;UNC5D;TSHZ1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5467025738196525,-1.0264523690761342,0.45555555555555555,1.0,1.0,8/31,15.04%,PSMB1;EIF2AK2;PSMD14;PSMA4;PRKDC;PSMB2;PSMA7;RUNX1
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.6649271299118932,-1.0263460783429137,0.4864864864864865,1.0,1.0,1/7,3.74%,ATP6V1G1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.5597562468712118,1.0263453509308145,0.45454545454545453,0.9517812301374512,1.0,3/9,5.09%,ST3GAL2;TNIP1;LARGE1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.5509871811845116,-1.026024637551274,0.47674418604651164,1.0,1.0,3/21,11.66%,MICOS10;SPG7;AGK
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.5581516552849494,1.0258217121761717,0.35,0.9503970043973903,1.0,1/9,0.65%,SCN1A
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.6050739558039147,-1.0257671776015047,0.4880952380952381,1.0,1.0,9/16,34.65%,STAT3;ERBIN;STAT1;FYN;STAT6;IRS1;PRNP;STAT5B;CACNA1B
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.6668395189694467,-1.0257300849373494,0.5121951219512195,1.0,1.0,1/6,2.06%,IFITM3
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.6059757864394781,-1.0256438086303814,0.5064935064935064,1.0,1.0,4/11,21.11%,CHST11;GLCE;EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.5492038658311327,-1.0254060630243196,0.5057471264367817,1.0,1.0,5/21,15.48%,ANK3;RHOB;STMN1;ROCK2;MITD1
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.521368776094754,1.0253467620374253,0.5,0.9488540396343206,1.0,3/9,11.97%,NSFL1C;CHMP4B;TOR1AIP1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.5340712149374491,-1.024734147993674,0.47674418604651164,1.0,1.0,9/26,26.74%,TGFB2;FGFR2;ANKRD17;CDKN1B;RGCC;MDM2;ADAM17;APP;EGFR
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.6389096250353965,-1.024354994477258,0.4666666666666667,1.0,1.0,2/9,16.61%,NECTIN2;LRRK2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.6519982267359786,-1.0242509453473136,0.4625,1.0,1.0,2/8,10.59%,TGFB2;HIF1A
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.5573461776451566,-1.0239812074697152,0.45977011494252873,1.0,1.0,9/33,12.84%,CSF1;CD44;TGFB1;STAT3;MAP3K8;PTPN1;CD38;PTPN2;JUN
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.5940902633121579,1.0238748421581874,0.5,0.9503529429034431,1.0,1/6,1.44%,EDN3
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.575058883613918,-1.0236182158386278,0.4823529411764706,1.0,1.0,3/16,17.31%,RPS27A;RGCC;ANAPC4
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.5303856766781742,-1.0235696430181052,0.4888888888888889,1.0,1.0,5/34,11.66%,SPTLC3;CSNK1G2;ALDH3A2;SPTLC1;AGK
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),-0.6900489113956543,-1.0235013680943257,0.5333333333333333,1.0,1.0,3/8,25.51%,PTPN2;PPARGC1A;IRS1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.594155099167221,-1.0232388715396188,0.5060240963855421,1.0,1.0,6/16,32.58%,CTR9;STAT3;STAT1;PID1;ST3GAL6;ST18
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.4741801596325336,-1.0232144475874885,0.41,1.0,1.0,32/199,16.16%,COL4A6;CSF1;NRG1;NR4A3;MPZL1;ATP6V1E1;VAV3;VEGFA;ATP6V1G1;TSC2;EFNB2;GRIN1;EPHA7;CEP57;STAT3;PDGFD;STMN1;DDIT4;SDCBP;GIGYF2;ACTR3;FGFR2;AP2A1;PTPN2;SHC2;ATP6V1H;ATP6V1D;ROCK2;ANKS1B;PRLR;ZFYVE27;APH1B
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.5192493753029215,1.0226832118416038,0.4583333333333333,0.9507796392068857,1.0,1/7,2.45%,MFHAS1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.5003497983633336,-1.0225229443841866,0.5054945054945055,1.0,1.0,19/57,25.47%,NR4A3;VAV3;PSMB1;PSMD14;PSMA4;PSMB2;JUN;PSMA7;PPP3CA;BTRC;SKP1;MAPK1;PAK1;MALT1;GRB2;PPP3CB;PSMA3;GAB2;LYN
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.6315691641183866,-1.022446759921066,0.4880952380952381,1.0,1.0,4/12,29.50%,AFDN;RAP1B;PDE4D;RDX
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.6735088449853917,-1.022283136997469,0.47058823529411764,1.0,1.0,1/5,7.09%,LGALS3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6827551041681872,-1.0216688139695622,0.5135135135135135,1.0,1.0,2/6,11.79%,SMCHD1;PRKDC
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.5694428976328867,-1.0211938752132252,0.43373493975903615,1.0,1.0,7/25,25.51%,CRY1;STAT3;ROCK2;IGFBP5;STAT1;STAT6;IRS1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.5749336402005072,1.0200062167320467,0.4583333333333333,0.9547149720981413,1.0,3/7,2.93%,HEY2;HEYL;NOTCH1
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.6388614320074296,-1.0199824847968426,0.48148148148148145,1.0,1.0,1/9,4.64%,WASF1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.6084294275700819,-1.0199792451305827,0.47435897435897434,1.0,1.0,3/13,16.05%,PRKACA;PRKAR1A;PRKAR2A
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.6674421119700633,-1.0199463633797423,0.5072463768115942,1.0,1.0,2/5,13.29%,KCNQ1;SGK1
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.47313184445753304,-1.0199452422278326,0.5102040816326531,1.0,1.0,20/96,20.16%,ELAVL3;SYT1;PHYHIPL;PCBP3;DHRS3;DNAJC6;HIVEP2;CCN2;SNAP25;PRKCB;CCK;TRIM9;DLGAP1;NXPH1;SNAP91;ZIC4;ACSL4;KCNQ5;CADM2;KCNC2
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.6883198962015411,-1.0199161102088625,0.5070422535211268,1.0,1.0,2/5,6.42%,SRA1;TGFB1
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),-0.6485188412220136,-1.0198438632008804,0.5,1.0,1.0,3/7,33.05%,SGK1;EIF2AK4;PRNP
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.5773497562870372,-1.0191037904055433,0.5185185185185185,1.0,1.0,4/16,15.96%,HOMER2;PDE4B;RUNX1;NAV3
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.48062497063812465,-1.0190270229896008,0.45454545454545453,1.0,1.0,49/230,22.72%,PRAG1;PRKACA;CSNK1D;CRY1;CSNK1G2;PDK1;TGFB2;CSNK1A1;DCLK1;CDKL1;PDK3;TGFB1;OXSR1;PRKCI;EIF2AK2;MAPK6;STK33;MELK;STK4;LATS2;PRKCB;FGFR2;USP15;SIK2;PRKDC;NRBP1;TGFBR1;SGK1;ROCK2;CCNH;TBK1;MAK;CDK14;CAMK2D;STRADB;LRRK2;TNKS;CAMKK2;STK24;PRKAG2;MINK1;UHMK1;MAPK1;PAK1;EIF2AK4;FYN;TAOK3;MAPKAPK2;MAP2K6
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6225386858897073,1.0190189894548043,0.5,0.9539701662299881,1.0,3/5,9.68%,RYR2;CASP7;SLC8A1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.5966620770204974,-1.0185224385000142,0.5061728395061729,1.0,1.0,2/10,18.91%,IPO5;RANBP2
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.5350820544969195,1.0180977507652902,0.4117647058823529,0.9532956604912844,1.0,2/8,2.93%,ARL6;NOTCH1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.5309435098502195,-1.0179940445075906,0.45454545454545453,1.0,1.0,10/23,27.65%,GRIN1;CNIH3;GRIA3;DLGAP1;LRRC7;NLGN1;MINK1;APP;GRIN2B;GRIA4
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.5352325503123845,1.0179557156628325,0.4,0.950753929931285,1.0,2/6,2.93%,ARL6;NOTCH1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.48141656227137103,-1.0178319815853758,0.45454545454545453,1.0,1.0,51/180,27.85%,OS9;PELI1;RNF19A;PLAA;MARCHF6;PSMB1;PSMD14;NEDD4L;ARIH2;RNF111;RBX1;APPBP2;PSMA4;PSMB2;TRIM9;AMFR;CLOCK;ZNRF1;TRIM13;PSMA7;UBAP1;NDFIP2;UBE2L3;RNF213;WWP1;ANAPC4;FBXO22;NPLOC4;BTRC;UBE2K;UBE2B;RNF168;RNF34;NDFIP1;SMURF2;MDM2;HECW1;BIRC2;NEDD4;OTUD7A;RAD23B;PSMA3;RCHY1;UBA1;MVB12B;FBXL4;TOM1L1;RC3H2;AGAP3;FBXL7;SIAH1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.6616457622668293,-1.0176094419069863,0.56,1.0,1.0,2/6,12.34%,MINPP1;PPA1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.6280385923797714,-1.0172210625704703,0.5,1.0,1.0,4/10,13.91%,TWIST1;TGFB1;NIBAN2;SIN3A
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.5747947235848155,-1.016927328288421,0.5121951219512195,1.0,1.0,6/19,24.33%,SOD1;RHOB;STK24;FYN;SETX;APTX
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.559039427445425,-1.0168682708490617,0.475,1.0,1.0,5/17,15.99%,ATP6V1E1;ATP6V1G1;ATP6V1H;ATP6V1D;RAB7A
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.6963444049700888,-1.0167956539053082,0.5194805194805194,1.0,1.0,5/7,22.33%,ARMC9;DCDC2;UCHL5;TTC23;EVC
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.6449424320720019,-1.0167051550122768,0.5324675324675324,1.0,1.0,3/7,33.05%,APP;INSR;PRNP
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.5796279375580317,-1.0166558399614523,0.5125,1.0,1.0,2/14,8.34%,VAV3;CD38
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.5959998159773827,-1.0165594852880646,0.47435897435897434,1.0,1.0,6/19,21.81%,PTPRD;NEDD4L;LZTS1;SEMA4D;HECW1;NEDD4
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.543733026930078,-1.0164331542401035,0.5056179775280899,1.0,1.0,7/24,25.95%,NRCAM;DNER;GPM6A;KIRREL3;NLGN1;FARP1;DNM3
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.48301777374614235,-1.01635655053171,0.4444444444444444,1.0,1.0,17/120,12.45%,DOK6;NRCAM;ROBO2;NRXN3;SPTBN4;ATL1;ANK3;EFNB2;EPHA7;NCAM1;NIBAN2;UNC5D;ROBO1;SEMA3B;FGFR2;CCK;C9ORF72
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.5071200795416932,-1.0162961075453942,0.5,1.0,1.0,14/46,21.85%,CSNK1G2;NXN;CSNK1A1;DDX3X;RPS27A;RBX1;WNT2B;GPC4;LRRK2;PLPP3;BTRC;NR4A2;SKP1;DIXDC1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.5147234101476255,-1.016088754338712,0.49473684210526314,1.0,1.0,11/47,15.04%,TAF7;CD44;MGST1;TGFB2;ARID3A;PTPRE;PROCR;ELF1;CMKLR1;NOTCH2;RUNX1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.5217132354520075,1.0160726702419804,0.3225806451612903,0.9526787477745703,1.0,1/6,4.99%,CD4
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.6727002083052589,-1.0157588752414748,0.52,1.0,1.0,2/6,6.42%,CST3;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.4811439216878709,-1.015635316212908,0.49,1.0,1.0,41/285,14.33%,WWC1;TAF7;PRDM6;ENO1;ETV5;TWIST1;ZFPM1;KLF2;NR4A3;KDM1A;CRY1;JDP2;VEGFA;WWC2;CREM;ESR2;HDAC2;RARB;CTCF;SUFU;CTR9;HCFC2;ZMYM5;STAT3;GLIS3;ZFPM2;NEDD4L;ZNF608;RPS27A;SDCBP;FGFR2;SAP130;FHL2;HIVEP1;RTF1;RPS14;JUN;EID1;SIN3A;FOXP2;PARP1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.6545340673484216,-1.0155466848152586,0.5205479452054794,1.0,1.0,1/5,13.32%,ROCK2
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.33100573580083403,1.0154312032724635,0.6666666666666666,0.9512634557102319,1.0,7/78,3.91%,TAGLN;SLIT3;LMOD1;CSPG4;COL14A1;SOX6;COL5A2
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.6318594192745443,-1.0150425116392527,0.4935064935064935,1.0,1.0,4/7,29.26%,PRKDC;TERF2IP;POT1;TERF1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),-0.5946922057094939,-1.0146709635885451,0.4411764705882353,1.0,1.0,3/9,29.71%,PTPRD;NLGN1;PCLO
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.3727855775069734,1.0145890799435215,0.375,0.9507675843743235,1.0,4/35,3.61%,JPH2;GRIN2A;FGF13;CACNB2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.5602278078159375,-1.0144283417562514,0.5584415584415584,1.0,1.0,4/17,15.04%,KDM1A;UBA5;UFSP2;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.59055764201641,-1.0143839285463547,0.5063291139240507,1.0,1.0,5/11,28.07%,PDCD4;PRKCI;RGCC;SFRP4;GSN
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.5156590309922023,-1.01395752854406,0.46808510638297873,1.0,1.0,13/44,19.70%,ELAVL3;PCBP3;GRIN1;HIVEP2;TSHZ1;SNAP25;PLP1;GRIA3;DLGAP1;NXPH1;SNAP91;PKP4;CADM2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.36866212521127684,1.0138736118014104,0.4375,0.9498528768239501,1.0,5/41,3.37%,ATP2B4;TRPC6;GRIN2A;CACNA1C;MCU
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.47318743205724867,-1.0137873080483868,0.47,1.0,1.0,47/217,22.72%,WWC1;ARHGAP15;TAF7;VAV3;ARHGAP31;VEGFA;WWC2;TMSB4X;ARHGAP24;RHOJ;NFKBIA;ARHGEF9;HDAC2;RPA1;RHOB;STK4;DDIT4;PRKAR1A;TP63;CMKLR1;RBBP7;ARHGAP5;SGK1;FAM13A;MCF2L;PRKAR2A;LRRK2;RASGRF2;MDM4;ITFG2;STARD13;PRKAG2;RNF34;WRN;ULK4;NLGN1;RPL5;MINK1;ARHGAP28;MAPK1;MDM2;PAK1;AKAP13;BIRC2;TAOK3;NF2;MAP2K6
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.5074338758311545,-1.013700470373037,0.532608695652174,1.0,1.0,30/74,26.16%,HSPA4L;TGFB1;PTPRE;SLC35D1;PITPNC1;DDIT4;CCP110;TP63;SLC3A2;PROCR;ELP1;JUN;RPL18;TSPYL2;WWP1;KIF13B;SESN1;BTG2;SLC7A11;CCNK;HINT1;MDM2;SAT1;DRAM1;BTG1;RPS12;RPL36;APP;RCHY1;RACK1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.5961004527340004,-1.0136705911913149,0.5432098765432098,1.0,1.0,4/15,22.69%,CTSL;RPS27A;ALPK1;MAPKAPK2
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.6523746170048027,-1.013654020219371,0.5,1.0,1.0,3/8,16.44%,PPP2R2A;PPP3CA;DUSP1
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.6493359622113299,-1.0134998778789734,0.5,1.0,1.0,3/5,24.72%,GRIN1;CPEB4;APP
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.4380358847368938,1.0133408385483285,0.3333333333333333,0.9484583230210302,1.0,4/13,14.83%,CDKN1A;MAPK14;PML;TBX2
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6025797918357076,-1.0133065964457286,0.44594594594594594,1.0,1.0,3/8,29.40%,RBM17;RSRC1;SFPQ
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.5354016074276056,-1.0132078482800548,0.47674418604651164,1.0,1.0,5/28,8.70%,WIPI1;PIGL;DPM1;GLUL;PIGG
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.665772561668466,-1.0130196080240859,0.5,1.0,1.0,3/5,32.89%,ACADL;ACADVL;ETFDH
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.6107630330085771,-1.0128685102779584,0.47191011235955055,1.0,1.0,6/12,30.94%,USP15;ANKRD17;SASH1;DDX60;RIOK3;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.539323250883244,-1.0126739316964326,0.47560975609756095,1.0,1.0,7/27,14.92%,FHL1;PSMB1;PSMD14;RBX1;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.6050338536230324,-1.0126551814790934,0.5070422535211268,1.0,1.0,5/8,35.72%,CMTR1;VIRMA;METTL16;WTAP;NSUN2
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.6652813981537241,-1.012518253181185,0.525,1.0,1.0,2/6,16.39%,ANK3;CAMK2D
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.5090418985184639,-1.0123325881925687,0.5,1.0,1.0,12/52,13.48%,PRAG1;TWIST1;NRG1;TMSB4X;RHOB;TGFB1;TMSB10;DIAPH1;ENPP2;SGK1;ROCK2;FRMD5
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.5266524545414728,-1.012244727239576,0.4772727272727273,1.0,1.0,6/34,7.96%,SEC13;NUP153;NUP133;TGFB1;NUP88;STAT3
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.5591560186120828,-1.0122286139536418,0.47191011235955055,1.0,1.0,6/25,13.99%,VEGFA;EFNB2;TGFB1;ADM;TGFBR1;SLC1A1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.4836768934339048,-1.012047627760325,0.48484848484848486,1.0,1.0,37/156,21.96%,OS9;PELI1;SELENOS;PLAA;MARCHF6;PSMB1;FBXL13;PSMD14;NEDD4L;RPS27A;RBX1;UBR1;APPBP2;PSMA4;PSMB2;TRIM9;AMFR;CLOCK;ZNRF1;HSPA5;TRIM13;PSMA7;UBE2J1;WWP1;ANAPC4;NPLOC4;BTRC;UBE2K;UBE2B;RNF34;SKP1;SMURF2;MDM2;HECW1;BIRC2;NEDD4;NEMF
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.5341794685198289,-1.0117303793752899,0.5113636363636364,1.0,1.0,15/37,28.80%,KDM1A;CRY1;RBX1;NDFIP2;LRRK2;UBE2L3;NDFIP1;DCUN1D4;BIRC2;MALT1;RCHY1;RPS2;PRICKLE1;UBE3A;DCUN1D2
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6225701454358586,-1.0117038271216638,0.5066666666666667,1.0,1.0,4/10,20.53%,GOLGA2;BTRC;SKP1;RPL5
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.544086115083659,1.0115954691201559,0.47619047619047616,0.9501681956093625,1.0,3/10,4.85%,IL34;NOTCH1;BIN1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.5329226158112794,-1.0112336851261392,0.5384615384615384,1.0,1.0,9/29,22.88%,PRKACA;SELENOS;ADM;PRKAR1A;ADORA2B;PRKAR2A;TSHR;FYN;ADAM17
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.6341337530906443,-1.0103726434053129,0.5189873417721519,1.0,1.0,1/7,1.07%,GJA1
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.5343840768327945,-1.0103345822928091,0.4578313253012048,1.0,1.0,6/25,21.81%,PELI1;ARIH2;TRIM5;UBE2B;RNF168;NEDD4
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.5244239152339447,-1.0101015549916585,0.48314606741573035,1.0,1.0,6/28,14.75%,NFKBIA;LGALS3;MGAT1;CEBPD;ANXA5;SUSD6
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.5201227935569538,-1.009728199124235,0.46153846153846156,1.0,1.0,11/30,26.91%,MCC;RHOB;GLUL;SCD;KIF13B;PHLDA1;ASS1;AKR1C1;ITIH2;SAMD5;CP
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.5099295737622733,-1.0096991611786021,0.4842105263157895,1.0,1.0,9/55,6.42%,TP53TG5;ENO1;GJA1;FHL1;TGFB2;ESR2;DIP2B;DDX3X;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.5963646303391849,-1.009335494611789,0.47619047619047616,1.0,1.0,4/14,15.96%,PLEKHH2;LIMA1;HDGFL3;NAV3
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.5677871731917905,-1.009159602339799,0.5301204819277109,1.0,1.0,8/14,30.78%,SYT1;SNAP25;RIMS1;LIN7A;SYN3;STXBP1;PCLO;PIP5K1C
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.4002554362636198,1.0084971912361242,0.36363636363636365,0.9543764839072079,1.0,4/48,2.06%,ZBTB7C;RALGPS1;SORBS2;C2ORF72
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.595252081259022,1.0082703442598995,0.4230769230769231,0.9522113745077032,1.0,1/5,4.85%,BIN1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.6795089536289477,-1.0082388755362028,0.5135135135135135,1.0,1.0,4/5,24.83%,SELENOS;PRKCB;APPL2;PID1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.6917867382400084,-1.0079672771389618,0.5714285714285714,1.0,1.0,4/6,24.81%,RHBDD1;RUNX1;LRRK2;TMEM59
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.6086777343291243,-1.0078975640785701,0.48148148148148145,1.0,1.0,7/10,36.12%,CST3;LRRK2;TMEM59;CAMK2N1;EPHA4;PRNP;TIMP2
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.651156237085994,-1.0075400514541963,0.5595238095238095,1.0,1.0,4/8,29.81%,ROCK2;CLU;SP1;EPHA4
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.6214424563596628,-1.0072474201979993,0.4605263157894737,1.0,1.0,1/8,3.47%,SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.67461277643169,-1.0070261193313137,0.5230769230769231,1.0,1.0,3/6,23.28%,OXSR1;ADAM17;STK39
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.6044270125244351,-1.006693785311221,0.5189873417721519,1.0,1.0,3/8,25.64%,AKIRIN1;BTG1;BOC
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.5704925250433448,-1.006354024540258,0.5061728395061729,1.0,1.0,4/14,21.17%,PRKACA;PRKAR1A;PRKAR2A;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.6663027650483369,-1.0062248293531544,0.5,1.0,1.0,4/5,33.42%,APP;PTN;EPHA4;ABL1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.5160380424136686,-1.0062118793366375,0.5274725274725275,1.0,1.0,11/47,14.55%,NRG1;VEGFA;DDX3X;RPA1;TGFB1;LGALS3;RBX1;RAP1B;SPIDR;PARP1;CLU
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.5042729331018962,-1.0060612374219582,0.5,1.0,1.0,10/43,17.29%,ZFP36L2;FHL1;PSMB1;PSMD14;RBX1;PSMA4;PSMB2;MYO16;PSMA7;RGCC
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.4750833820212397,-1.0059997442025785,0.5151515151515151,1.0,1.0,37/139,24.97%,CSF1;PRSS23;ELOB;PSMB1;CST3;FBXL13;RHBDD1;PSMD14;RBX1;FBN1;HIF1A;PSMA4;PSMB2;TF;RBBP7;MGAT4A;WSB1;KLHL2;PSMA7;NAE1;HIF3A;FBXO22;IGFBP5;CCN1;BTRC;KLHL5;SKP1;P4HB;WDTC1;RAB11A;VCAN;TGOLN2;DCAF5;FSTL1;ITIH2;APP;PSMA3
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.5990856540217478,-1.0059626947819222,0.48,1.0,1.0,2/11,7.58%,NR4A3;BORCS5
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.6265610705109319,-1.00595939529005,0.5679012345679012,1.0,1.0,2/10,10.59%,TGFB1;HIF1A
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.6416959722032946,-1.0058731196039337,0.5125,1.0,1.0,1/9,0.88%,PRKACA
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.47736934573537115,-1.005864092039481,0.45454545454545453,1.0,1.0,13/100,9.54%,DOK6;ROBO2;NRXN3;SPTBN4;VEGFA;EFNB2;EPHA7;NCAM1;NIBAN2;UNC5D;ROBO1;SEMA3B;ALCAM
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.48473534914304384,-1.0055481052331958,0.5555555555555556,1.0,1.0,32/107,24.40%,ELOB;SLC2A1;ANK3;WASF3;RHOJ;WASF1;WIPF1;TGFB1;NAPG;LIMA1;DARS1;SPG7;RAD21;PARVB;PPARGC1A;FANCC;WDR19;TEAD1;ZFYVE27;RIMS1;TSPAN4;MDM4;PAWR;LIN7A;ST13;NLGN1;MDM2;SPAG16;EPRS1;REPS2;POT1;GPM6B
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.5329549258478283,-1.0051395935027594,0.5274725274725275,1.0,1.0,11/34,23.79%,OXSR1;PRKDC;TGFBR1;ROCK2;TBK1;CAMK2D;LRRK2;TNKS;MAPK1;STK39;NLK
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5679833588185399,-1.004913659668457,0.5185185185185185,1.0,1.0,3/16,13.43%,VAV3;CD38;IL18
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.5807862732227226,1.0045282117726209,0.45454545454545453,0.9583716312838435,1.0,2/5,5.60%,NOTCH1;SKI
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.5675511692346116,-1.0044164943069307,0.40963855421686746,1.0,1.0,5/23,17.42%,FADS2;GPX4;HSD17B4;ACADL;ACSL4
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.3279880453998463,1.0043925925293256,0.5,0.9559205706678384,1.0,9/45,12.69%,RALGPS1;SPRY3;NOTCH1;DLC1;STARD8;OPHN1;MAPKAP1;ARHGAP44;DAB2IP
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.48322853089814183,-1.0042291438934692,0.5204081632653061,1.0,1.0,50/132,28.86%,RPS21;TAF1B;DUT;RPS4X;RPL28;RPA1;RPL34;RPL21;RPLP2;TBRG1;FARSB;DARS1;RPS27A;RPL19;DONSON;RPS14;RPLP1;RPL13A;RPL18;PWP1;RPL27;POLA1;RPL35A;NR4A2;NAP1L1;AGO2;WRN;EXT1;RPL5;FUBP3;RPL31;RPL41;RPL24;RPL27A;RPS12;RPS18;RPL37;WARS1;RPL36;RPL32;KIN;RPL9;RPS20;RPA3;RPS8;RPL37A;B4GALT5;GOLPH3;RPS2;EIF4G1
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.6043697456191345,-1.00422328192936,0.47674418604651164,1.0,1.0,4/14,17.88%,PARP6;ARF4;PARP1;TNKS
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.6024500979079419,-1.0038653372734094,0.55,1.0,1.0,1/11,3.27%,SOAT1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.6108406854837137,-1.0034531620984735,0.5641025641025641,1.0,1.0,1/8,13.06%,SCD
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.538583542708654,-1.0033639298076231,0.5057471264367817,1.0,1.0,5/23,14.53%,SMOC1;TGFB2;FBN1;CPAMD8;ATF6
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.6483351357687943,-1.0033420747403163,0.56,1.0,1.0,4/7,29.90%,NMNAT2;CMPK1;AK4;NMNAT3
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.3305260633411931,1.0031896119210588,0.5,0.956439929193017,1.0,7/80,5.82%,TAGLN;ACTA2;LMOD1;COL14A1;ACADSB;IGFBP7;TNS2
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.6535626715474343,-1.0029798911140224,0.4266666666666667,1.0,1.0,5/7,29.30%,TGFB1;TGFBR1;GRAMD1A;PTCH1;TGFBR2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.5431373203936449,-1.0029712324984006,0.48148148148148145,1.0,1.0,5/18,23.54%,EAPP;HMGN1;CCNK;TCERG1;SUPT16H
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.6050318842239195,-1.0029116055860063,0.5189873417721519,1.0,1.0,1/11,10.03%,PITRM1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.48289636135788866,-1.0027722411043662,0.5106382978723404,1.0,1.0,17/62,26.83%,STX6;AP2A1;SNX6;DENND2A;GOSR1;WASHC2C;RHOBTB3;RAB7A;PREPL;GAK;VPS50;VPS51;EEA1;SNX2;CCDC91;SLC66A2;RAB6A
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.5820623820043704,-1.0025502433461406,0.5180722891566265,1.0,1.0,4/18,13.91%,TGFB1;GLUL;LATS2;SIN3A
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.6554140282510685,-1.002450984241512,0.5194805194805194,1.0,1.0,2/5,10.59%,VEGFA;HIF1A
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.61373652985331,-1.0021281603059007,0.5058823529411764,1.0,1.0,4/9,21.77%,PLAA;PTGR1;AKR1C2;AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.4664293589134456,-1.0020134625064732,0.5050505050505051,1.0,1.0,27/153,14.22%,CSF1;GJA1;NRG1;S1PR3;NR4A3;KDM1A;VEGFA;EFNB2;TGFB2;RPS4X;EAPP;HDAC2;TGFB1;PRKCI;PDGFD;ZFPM2;CCAR1;SDCBP;TBC1D8;FGFR2;SSR1;KRAS;CDC123;TGFBR1;IL18;CNOT8;AKR1C2
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.5139977707337317,-1.0019562132408213,0.5454545454545454,1.0,1.0,9/29,31.34%,TGFB1;ADM;NEDD4;CD9;GRB2;DNM3;SNX25;UVRAG;LDLRAP1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.5137585006536111,-1.0018747746287944,0.5319148936170213,1.0,1.0,17/51,27.36%,RPA1;PSMB1;PSMD14;RPS27A;RBX1;PSMA4;PSMB2;PARP1;CCNH;TCF4;PSMA7;NAP1L1;XPA;RAD23B;PSMA3;RPA3;ANP32B
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.46829100543631663,-1.001801627017724,0.52,1.0,1.0,56/246,21.81%,OS9;PELI1;RNF19A;ELOB;SELENOS;UVSSA;MARCHF6;PSMB1;HERC6;BLMH;CTR9;FBXL13;PSMD14;NEDD4L;ARIH2;RPS27A;RNF111;RBX1;UBR1;HIF1A;PSMA4;PRKDC;KLHL7;RTF1;PSMB2;AMFR;WSB1;KLHL2;ZNRF1;WAC;TRIM13;PSMA7;UBE2J1;SASH1;HIF3A;RNF10;UBE2L3;RNF213;WWP1;FBXO22;BRAP;TNKS;TRIM5;BTRC;LNPEP;UBE2K;UBE2B;RNF168;RNF34;SKP1;SMURF2;DZIP3;MDM2;HECW1;BIRC2;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.30075579663142826,1.0017916980191452,0.5,0.9571464833441649,1.0,14/139,6.33%,ZBTB7C;HSPA1A;NOX4;ERBB4;CNOT7;H2AC6;CDK6;NOTCH1;IGFBP7;SKI;TNS2;TOB1;CELF1;DLC1
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.6795715210677682,-1.0016347827335188,0.527027027027027,1.0,1.0,2/5,14.55%,PLP1;CLU
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.5673204427736964,-1.0016339584442193,0.44047619047619047,1.0,1.0,6/17,31.56%,TTC8;APP;DGCR2;MAGT1;NF1;C12ORF57
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.5175670850567202,1.0009368636134894,0.5416666666666666,0.9566163576240461,1.0,1/9,0.88%,ST3GAL2
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.6203356592722251,-1.000581038134246,0.5,1.0,1.0,3/9,12.27%,CSF1;AKIRIN1;CMKLR1
prerank,MSigDB_Hallmark_2020__Myogenesis,0.4824110864853724,1.0,1.0,0.9577911044908675,1.0,21/83,8.13%,TAGLN;MYH11;LDB3;MEF2D;MYOM1;ADCY9;ITGA7;NOTCH1;DTNA;TPM2;PKIA;BIN1;LARGE1;MYH9;DAPK2;IGFBP7;MYLK;ITGB5;CDKN1A;PLXNB2;PTP4A3
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.6927987585892886,-0.9997844531495284,0.475,1.0,1.0,3/6,11.65%,NCKAP5;STMN1;HDGFL3
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.6447022639261425,-0.9997623840661353,0.581081081081081,1.0,1.0,6/11,24.89%,NMNAT2;CMPK1;NUDT5;GUK1;AK4;FHIT
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.5060185479300843,-0.9995720923132799,0.5402298850574713,1.0,1.0,10/51,16.16%,VAV3;EFNB2;GRIN1;EPHA7;SDCBP;ACTR3;AP2A1;ROCK2;ANKS1B;APH1B
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.4143449506390137,0.9993568338745519,0.4375,0.9566650721605376,1.0,3/27,2.28%,SCN1A;HCN2;ATP1B2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.49775691954912243,-0.9993302492599486,0.5051546391752577,1.0,1.0,14/53,16.04%,TP53TG5;ENO1;GJA1;FHL1;TGFB2;ESR2;DDX3X;TGFB1;MT2A;MT3;RBBP7;CDKN1B;NOTCH2;TSPYL2
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.6614732433445378,-0.9989216625780524,0.5753424657534246,1.0,1.0,2/6,4.23%,ZFPM1;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.5079078567621969,-0.9987483386918931,0.5217391304347826,1.0,1.0,6/40,11.55%,PRKACA;ADM;LGALS3;TRAF3IP1;PRKAR1A;ADORA2B
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.4223435652717694,0.9987439931768357,0.42857142857142855,0.9554827646399564,1.0,1/15,2.93%,NOTCH1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.5987048136221698,-0.9987239943166438,0.5375,1.0,1.0,2/12,10.61%,ZFP36L2;PTPN2
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.6533369338389754,-0.9978352090517679,0.5857142857142857,1.0,1.0,1/5,16.61%,LRRK2
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.5009764454395272,-0.9978277247886368,0.5208333333333334,1.0,1.0,25/64,29.19%,TENM3;TGFB2;STMN1;GPM6A;PLP1;HDGFL3;RUNX1;ZFYVE27;MICALL2;DTNBP1;BTG2;NLGN1;UHMK1;RAB11A;NEDD4;ATP8A2;THOC2;GPM6B;APP;PTPRM;LYN;UGCG;B4GALT5;MYT1L;LAMB1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.5118163002725413,-0.9975524801433039,0.5161290322580645,1.0,1.0,6/54,10.73%,CSF1;MPZL1;EPHA7;PTPRD;FGFR2;SHC2
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.6159812819232218,-0.9975249818535952,0.49382716049382713,1.0,1.0,6/10,26.74%,ALDH3A2;TRAM1;SERP1;TRAM2;APP;EGFR
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.6445985451443065,-0.9973485076918803,0.525,1.0,1.0,1/8,4.64%,WASF1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.5052058709539065,-0.9970333552657368,0.5,1.0,1.0,12/40,15.97%,TAF7;GRIN1;SCN3A;SLC47A1;NEDD4L;SLC3A2;SLC36A4;SLC6A17;SGK1;SLC1A1;NDFIP2;ABCC9
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.4739482510227772,-0.9970256453871855,0.5204081632653061,1.0,1.0,17/88,15.35%,CSF1;TWIST1;F3;RIPOR1;VEGFA;TGFB1;SOD2;STAT3;PDGFD;CEMIP;SEMA3B;CCAR1;SDCBP;TGFBR1;ROCK2;HSPA5;PPP3CA
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.6734479876202295,-0.996923586713538,0.5256410256410257,1.0,1.0,2/5,20.89%,P4HA3;P4HB
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.6734479876202295,-0.996923586713538,0.5256410256410257,1.0,1.0,2/5,20.89%,P4HA3;P4HB
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.5090718315010943,0.9967487233654247,0.4230769230769231,0.9577444113818345,1.0,2/10,2.88%,GPRC5C;TINAGL1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.571120252152794,-0.9966629273698068,0.5487804878048781,1.0,1.0,7/13,22.60%,MLPH;FGFR2;HIF1A;CEBPD;RUNX1;BTG1;CD9
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.644900700979661,-0.9966242694067584,0.5316455696202531,1.0,1.0,3/9,27.20%,GRIK2;APP;SLC4A10
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.6584186524173967,-0.9961143267126893,0.547945205479452,1.0,1.0,3/7,21.01%,MAP3K4;TNKS;MAPK1
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.6531711647943913,-0.9959177569301977,0.527027027027027,1.0,1.0,3/7,9.65%,KCNE4;ATP1B3;KCNQ1
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.5493150193521358,-0.9956751429279072,0.5411764705882353,1.0,1.0,7/21,24.91%,TRMT9B;DTWD2;NSUN6;TRMT13;SSB;WDR6;TYW1B
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.5285667069649087,-0.9954854981053133,0.6043956043956044,1.0,1.0,5/33,22.57%,TWIST1;MED14;JUN;CCNC;SETX
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.6620954578162712,-0.9951726030573931,0.5316455696202531,1.0,1.0,1/8,2.88%,CD55
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.5945684157396219,-0.9951487143698392,0.5294117647058824,1.0,1.0,4/13,12.27%,CSF1;AKIRIN1;LGALS3;CMKLR1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.5019030687146762,-0.9950602950029934,0.4842105263157895,1.0,1.0,10/53,14.66%,OS9;UBA5;TMCO1;SELENOS;CREB3L2;MARCHF6;RHBDD1;JUN;ATF6;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.5354684560295616,-0.9950033193831042,0.5308641975308642,1.0,1.0,7/26,14.92%,FHL1;PSMB1;PSMD14;RBX1;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.6311347828776823,-0.9950032210064543,0.48717948717948717,1.0,1.0,3/8,12.27%,CSF1;AKIRIN1;CMKLR1
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.6562761709721064,-0.9949858203499145,0.5277777777777778,1.0,1.0,1/5,25.51%,IRS1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.5911997694942768,-0.9949775641987116,0.5064935064935064,1.0,1.0,2/11,19.71%,TUT7;AGO2
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.6021548307606879,-0.994836918164916,0.5119047619047619,1.0,1.0,2/11,12.22%,PRKACA;MYL3
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.6728902363104279,-0.9947074267299958,0.5416666666666666,1.0,1.0,3/5,24.75%,NT5E;AK4;AK9
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.5313448822087283,-0.9945741784593598,0.5056179775280899,1.0,1.0,11/37,23.43%,CAMKMT;CD55;TMSB4X;EFNB2;ERAP1;STK24;TRIM5;APPL2;BIRC2;IRF1;METAP1
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),-0.6683191135731468,-0.9945547003947829,0.527027027027027,1.0,1.0,4/6,24.61%,PTPRD;LRFN5;GPC4;LRRC4C
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.5330145609623166,0.9945423854949326,0.4,0.9585940868916172,1.0,2/6,16.33%,HACD2;TECR
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.5330145609623166,0.9945423854949326,0.4,0.9585940868916172,1.0,2/6,16.33%,HACD2;TECR
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6815971295699297,-0.9944229221751552,0.625,1.0,1.0,2/5,6.42%,CSF1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.5042546527916054,-0.9942952001857532,0.5376344086021505,1.0,1.0,6/40,14.45%,AKIRIN1;ACTR3;GPM6A;CCP110;CDC42EP4;TAPT1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.6778447208548017,-0.9936774863361532,0.6025641025641025,1.0,1.0,4/6,28.83%,ACADL;APPL2;WDTC1;ACADVL
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.5885338148639014,-0.9934150622003308,0.5609756097560976,1.0,1.0,4/11,28.83%,ACADL;PRKAG2;WDTC1;ACADVL
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.6267084316661508,-0.9931603346764196,0.6296296296296297,1.0,1.0,2/7,22.27%,STAT3;STAT1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.478753734380329,-0.9925513809858004,0.5208333333333334,1.0,1.0,18/84,21.37%,PRAG1;CRMP1;TENM3;EFNB2;HDAC2;SPOCK1;CSMD3;PRKCI;CBFA2T2;MT3;CFL1;LRRC7;LRRK2;KIF13B;ULK4;GAK;SCARB2;PAK1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.5756100754894737,-0.9922830985274653,0.5641025641025641,1.0,1.0,2/12,10.22%,WIPI1;AP2A1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.60911124536563,-0.9921845744026951,0.5131578947368421,1.0,1.0,1/9,1.92%,CSNK1D
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.6228680480483977,-0.9916597601875783,0.52,1.0,1.0,7/9,36.99%,PRKCB;ELF1;RUNX1;LYN;ELF2;CBFB;CD81
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.46392904408451874,-0.9914509449943018,0.49,1.0,1.0,96/383,24.83%,WWC1;TAF7;ETV5;TWIST1;ZFPM1;KLF2;NR4A3;KDM1A;LPIN1;VEGFA;MYDGF;AKIRIN1;TGFB2;NFKBIA;GRIN1;EAPP;KANSL3;HDAC2;RARB;PLAG1;DDX3X;TGFB1;TET3;STAT3;GLIS3;CDC5L;ARF4;ZFPM2;KLF15;RPS27A;RNF111;ACTR3;FGFR2;HIF1A;HSF2;HIVEP1;TP63;PAXBP1;ARNT2;PRKDC;ELF1;MED14;JUN;SREBF1;IL18;PLAGL1;CLOCK;SIN3A;NCOA7;PARP1;ATF6;CHCHD2;TCF4;PPARGC1A;RUNX1;TBK1;PPP3CA;TEAD1;SENP1;CALCOCO1;RNF10;RGCC;SMARCA1;CCN1;TNKS;CEBPZ;PRDM10;TET1;MYSM1;NR4A2;AGO2;SREBF2;CCNK;FUBP3;NAMPT;CRLF3;PER1;PTOV1;BMP5;PPARA;CCNC;STAT1;SETX;NFIX;IRF1;TP53BP1;TCERG1;SUPT16H;STAT6;BCLAF3;APBB1;NR2C2;ELK3;PPP3CB;APP;PID1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.523193986974895,-0.9913065288421314,0.5681818181818182,1.0,1.0,9/31,20.86%,ZFP36L2;GIGYF2;PABPC1;ROCK2;CNOT8;PRR5L;BTG2;AGO2;METTL16
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.5809206576689026,-0.9908515510777176,0.5443037974683544,1.0,1.0,7/15,31.00%,DPM1;MGAT1;UBE2J1;MCFD2;FUT8;MAGT1;UGGT2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.5809206576689026,-0.9908515510777176,0.5443037974683544,1.0,1.0,7/15,31.00%,DPM1;MGAT1;UBE2J1;MCFD2;FUT8;MAGT1;UGGT2
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.36207603921892656,0.9907781524983819,0.5,0.9658784012326641,1.0,4/39,5.94%,ATP2B4;BCL2L1;ITGA3;ACTB
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.4828605146539045,-0.9904729570787275,0.5531914893617021,1.0,1.0,43/91,33.73%,DUT;PGK1;HDAC2;RPL34;EIF2S2;PSMD14;CCT4;PSMA4;PSMB2;PABPC1;SLC25A3;HNRNPC;ETF1;PSMA7;RPL18;LDHA;EIF1AX;UBE2L3;PWP1;NAP1L1;SSB;TRA2B;DDX21;GLO1;EPRS1;TARDBP;RAD23B;RACK1;VDAC1;DDX18;UBA2;RPS2;NCBP1;XRCC6;HSP90AB1;HSPD1;RPL14;SRSF2;PSMD1;CANX;DHX15;RPS6;PSMC6
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.5858122571774433,-0.9904224250761995,0.5308641975308642,1.0,1.0,5/16,10.61%,TSC2;PTPRE;PTPN1;PRKCB;PTPN2
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.4904153519878873,-0.9902515866668516,0.4666666666666667,1.0,1.0,10/48,18.91%,SEC13;NUP153;NUP133;FYTTD1;NUP88;SRSF5;SYMPK;SMG7;ALKBH5;RANBP2
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.4904153519878873,-0.9902515866668516,0.4666666666666667,1.0,1.0,10/48,18.91%,SEC13;NUP153;NUP133;FYTTD1;NUP88;SRSF5;SYMPK;SMG7;ALKBH5;RANBP2
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.58278984929752,-0.9901529942592576,0.49382716049382713,1.0,1.0,4/10,24.72%,SNX6;ERRFI1;ADAM17;APP
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.5813079463361156,-0.9900125813131246,0.5512820512820513,1.0,1.0,3/10,17.29%,VEGFA;AFDN;RGCC
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.5682418750605384,-0.9896303767860055,0.5061728395061729,1.0,1.0,2/12,6.79%,DDX3X;OXSR1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.6097446170107839,-0.9893281961911388,0.6075949367088608,1.0,1.0,1/12,4.23%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.53310935743091,-0.9892332618261993,0.5777777777777777,1.0,1.0,4/28,16.83%,PLAA;NEDD4L;SGK1;RAB27A
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.5152622134388666,-0.9887868513177311,0.5434782608695652,1.0,1.0,13/43,26.44%,CSF1;VEGFA;NFKBIA;TGFB1;MT3;CHCHD2;NSF;AKR1C1;PPARA;SFRP4;GRB2;PID1;INSR
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.37602932291668284,0.9886615752620628,0.6,0.9678384066577999,1.0,6/38,8.27%,HSPA1A;LEMD3;SKI;BCL9L;LTBP1;PPM1A
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.5741968229272197,-0.9884557668505439,0.5185185185185185,1.0,1.0,4/11,31.95%,CCP110;TAPT1;CEP120;SEPTIN7
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.5994029806397752,-0.9879604156994362,0.575,1.0,1.0,4/9,30.41%,MYSM1;INSR;PTN;TRIP12
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.5431357745372942,-0.9875621183955308,0.5238095238095238,1.0,1.0,11/21,27.65%,HOMER2;GRIN1;GRIK1;GRIA3;GRM7;GRIK2;CPEB4;APP;GNAQ;GRIN2B;GRIA4
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.5307633065699653,-0.9873414581360553,0.5,1.0,1.0,3/21,7.09%,NR4A3;CADM1;LGALS3
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.6096185195730988,-0.9870483845749706,0.5,1.0,1.0,2/8,21.94%,RIMS2;SNX19
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.6857441066996279,-0.9868303481606032,0.5882352941176471,1.0,1.0,2/5,24.72%,CLU;APP
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.5644891778348446,-0.9867340403763987,0.5432098765432098,1.0,1.0,3/12,7.09%,PDE4B;TGFB2;LGALS3
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.5644891778348446,-0.9867340403763987,0.5432098765432098,1.0,1.0,3/12,7.09%,PDE4B;TGFB2;LGALS3
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.5990428280928866,-0.9866566975372081,0.5263157894736842,1.0,1.0,1/8,3.60%,VEGFA
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.6387380409544521,-0.9865632601733423,0.5633802816901409,1.0,1.0,1/5,4.53%,NFKBIA
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.5097123049057599,-0.986534226211752,0.5287356321839081,1.0,1.0,11/40,17.01%,ELAVL3;CRMP1;PHYHIPL;DNER;DCLK1;PLEKHH2;PLP1;ARNT2;NXPH1;SNAP91;GFAP
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.6545732024107372,-0.9865272987326916,0.55,1.0,1.0,3/6,28.83%,ACADL;WDTC1;ACADVL
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.5836700571204296,-0.9864570710456022,0.5789473684210527,1.0,1.0,4/12,22.88%,TGFB1;RHBDD1;APH1B;ADAM17
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.6697201916548398,-0.9860985589355239,0.5194805194805194,1.0,1.0,2/5,12.97%,TGFB2;SNCAIP
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.565714874991761,-0.98592476341406,0.5833333333333334,1.0,1.0,6/12,37.27%,TGFB1;IRS1;FLT1;PTK2B;CD81;AMBRA1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.6379127051969182,-0.9858663499687897,0.5352112676056338,1.0,1.0,1/6,9.72%,SDCBP
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.6651139332496918,-0.9857819347608306,0.5789473684210527,1.0,1.0,3/5,31.37%,CLU;SCARB1;ABCA5
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.5252312334541949,0.9857245724450862,0.52,0.9732999570326984,1.0,2/8,6.30%,SYNE3;SYNE2
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.3866409053414012,0.9856263255791151,0.47058823529411764,0.9707424427486884,1.0,2/24,1.35%,PGF;ADGRA2
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.6130251171690753,-0.9854373727970513,0.5316455696202531,1.0,1.0,3/9,26.85%,KCNQ1;CAMK2D;CELF2
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.4592514957790055,-0.9852857019923484,0.57,1.0,1.0,16/151,11.46%,STX6;GJA1;RAB28;SEC13;WIPI1;ARL5A;COG7;NAPG;JAM3;SYNDIG1;ARF4;TBC1D8;AP2A1;SNX6;USO1;GGA3
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.5415876515691266,-0.9852435521692271,0.5625,1.0,1.0,5/16,20.07%,SPTLC3;SPTLC1;AGK;PAM;ASS1
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.644710869726702,-0.9851856432614534,0.6,1.0,1.0,2/5,10.19%,JAM3;SHROOM3
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.6603564333921408,-0.9848569761958873,0.5853658536585366,1.0,1.0,2/5,29.50%,MTMR2;RDX
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.6673373085465536,-0.98465504576268,0.5694444444444444,1.0,1.0,3/5,27.57%,RBX1;SKP1;FBXL7
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.6551737475246553,-0.9845551673935092,0.5584415584415584,1.0,1.0,1/6,8.64%,STMN1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.5745294902541943,-0.9843309009900971,0.5641025641025641,1.0,1.0,3/12,13.91%,SUFU;LATS2;SIN3A
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.5847244369389566,-0.9843064313093134,0.5416666666666666,1.0,1.0,5/9,35.72%,CMTR1;VIRMA;METTL16;WTAP;NSUN2
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.573763669407953,-0.9842419652972604,0.5316455696202531,1.0,1.0,6/13,29.53%,TGFB1;STAT3;EGFR;NRIP1;STRN3;GGT7
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.5188932911061509,0.9840561962596841,0.47368421052631576,0.972090440095299,1.0,1/8,0.14%,MYH11
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.5078441942002311,-0.9839132660972988,0.5617977528089888,1.0,1.0,17/43,32.58%,F3;DDX3X;ROBO1;IFT57;SENP1;BEX3;ARL6IP5;MALT1;RACK1;SLC22A2;ANP32B;CASP8AP2;GSN;COL4A3;APAF1;HSPD1;ST18
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.615288523817541,-0.9833846287757699,0.5176470588235295,1.0,1.0,4/10,12.38%,VEGFA;FGFR2;ARNT2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.5912615685023839,-0.9833287836281642,0.5432098765432098,1.0,1.0,2/7,16.61%,CMKLR1;LRRK2
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.3458225497134725,0.9832833779723185,0.5,0.9715365402806934,1.0,11/68,7.23%,BCAM;GPRC5C;ARHGEF10L;LMOD1;NTN4;FKBP9;RASL12;ARHGEF17;TNS2;ITGB5;ADCY6
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.5146983156122544,-0.9832298133099299,0.5368421052631579,1.0,1.0,8/36,22.88%,TGFB2;TGFB1;SDCBP;RNF111;TGFBR1;CCN1;BMP5;ADAM17
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.5920538969885397,-0.9828253863066693,0.5333333333333333,1.0,1.0,3/8,33.93%,STAT3;IRS1;STAT5B
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.5920538969885397,-0.9828253863066693,0.5333333333333333,1.0,1.0,3/8,33.93%,STAT3;IRS1;STAT5B
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.4668002167748492,-0.9827498359376987,0.5483870967741935,1.0,1.0,14/61,15.69%,HSPA4L;PRSS23;HOMER2;CD44;PDCD4;OLFM1;ALDH3A2;SEMA3B;COX6C;AMFR;CA2;SGK1;PLAAT3;PRLR
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.4582773496656829,0.9826985896490986,0.5555555555555556,0.9701325154849278,1.0,2/16,1.92%,NRG2;ERBB4
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.6239781039396094,-0.9826207207436198,0.5,1.0,1.0,6/8,37.14%,IL18;SCARB1;LPL;RORA;ANGPTL4;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.5309203612426329,-0.9821825126255042,0.5802469135802469,1.0,1.0,12/24,29.16%,TGFB2;DDX3X;SDCBP;TGFBR1;ADNP2;ADAM17;AKAP6;INSR;EGFR;NCBP1;EIF4G1;KLHL22
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.5981279800167854,-0.9817211500571988,0.5487804878048781,1.0,1.0,5/7,34.58%,DLGAP1;ROCK2;APP;TMEM108;AKAP9
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.5800250644552621,-0.9817076209761382,0.5903614457831325,1.0,1.0,3/12,27.36%,XPO4;UHMK1;ANP32B
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.5116781151073058,-0.9811268807735993,0.47191011235955055,1.0,1.0,9/39,24.22%,CSE1L;NUP153;XPO4;TGFB1;SRSF5;STRADB;NEMF;MALT1;THOC2
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.5343694148406587,-0.9811091701722224,0.620253164556962,1.0,1.0,1/21,0.37%,SRGN
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.5393389157533319,-0.9810449042000915,0.5,1.0,1.0,5/21,20.64%,ROBO2;ROBO1;GOLGA4;ZFYVE27;SEMA4D
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.5687190704016032,-0.980935163558659,0.5647058823529412,1.0,1.0,3/15,16.78%,TGFB2;TGFB1;UBE2L3
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.5546570775843763,-0.9809229332833752,0.5529411764705883,1.0,1.0,5/18,24.72%,RBM4B;PUM3;METAP1;EIF2A;APP
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.6683575656814847,-0.9808007129261669,0.5857142857142857,1.0,1.0,3/5,33.05%,APP;INSR;PRNP
prerank,MSigDB_Hallmark_2020__Coagulation,-0.4976999830099796,-0.9807814375943977,0.5632183908045977,1.0,1.0,11/35,17.97%,PRSS23;F3;CFH;PROS1;ARF4;FBN1;C1R;TF;CLU;C1S;LAMP2
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.6590601044435394,-0.9800846758105932,0.6585365853658537,1.0,1.0,4/5,29.30%,TGFB1;TGFBR1;RORA;TGFBR2
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.4833340468972789,-0.9792142371134732,0.5483870967741935,1.0,1.0,12/78,15.80%,ATP6V1E1;PDHX;ATP6V1G1;NDUFV1;COX4I1;COX6C;HADHA;ATP6V1H;SLC25A3;ATP6V1D;GPX4;LDHA
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.4379663974137076,0.9791834137296512,0.3076923076923077,0.9754821310760354,1.0,4/14,9.79%,RYR2;DTNA;SLC8A1;RCSD1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6387282217037987,-0.979171387830981,0.6,1.0,1.0,2/5,19.11%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),-0.6374845738670549,-0.9791366359908544,0.5405405405405406,1.0,1.0,2/5,22.69%,PTGR1;MAPKAPK2
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.3122822123245711,0.9790172633643452,0.5,0.9730446629316422,1.0,12/62,9.15%,BCAM;ARHGEF10L;C2ORF72;NOTCH3;GPRC5B;CDC42BPB;ARHGEF17;MAGI1;ADCY6;PTPN21;GPC6;AGAP1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.5992969552010572,-0.9790104793376547,0.525,1.0,1.0,2/11,17.31%,DUSP1;ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.5493034440957999,-0.9789733010546956,0.5517241379310345,1.0,1.0,7/26,16.61%,EFNB2;DDIT4;MT3;CDKN1B;CLU;TRIM13;LRRK2
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.5526621244964997,-0.9789442163092704,0.5189873417721519,1.0,1.0,6/26,19.34%,NR4A3;SMAD6;ERAP1;PPARGC1A;STEAP4;NR4A2
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5703353016069879,-0.9787643624695258,0.5930232558139535,1.0,1.0,3/17,19.17%,CTR9;DNMT1;TET1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.5095344029083203,-0.9787300610405811,0.5161290322580645,1.0,1.0,14/49,23.91%,COL4A6;TGFB2;P4HA3;COL11A1;PXDN;COL6A3;TGFBR1;COL7A1;PPIB;COL18A1;P4HB;COL4A5;COL23A1;LOXL3
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.694612193887491,-0.9787115474336358,0.6231884057971014,1.0,1.0,1/5,6.42%,TGFB1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.5424137007895334,-0.9786272483064705,0.5604395604395604,1.0,1.0,10/25,20.16%,KCND2;KCNQ3;ATP1B3;KCNQ1;ABCC9;KCNH7;SLC9A9;NALCN;KCNQ5;KCNC2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.6544987158348441,-0.978368493743206,0.6111111111111112,1.0,1.0,1/5,9.31%,ERAP1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.5769405976780053,-0.9783058820134536,0.5641025641025641,1.0,1.0,2/10,10.59%,HDAC2;HIF1A
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.6542583198315898,-0.9782126369580558,0.5394736842105263,1.0,1.0,1/5,1.67%,ZFPM1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.6288470263342453,-0.9781181711070976,0.5466666666666666,1.0,1.0,2/6,20.35%,DDX3X;SSB
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.5124765561982813,-0.9779643480352785,0.5955056179775281,1.0,1.0,10/45,15.85%,TWIST1;F3;VEGFA;MYDGF;RHOB;ITGA5;PRKCB;HIF1A;RUNX1;SASH1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.5510242664092311,-0.9774449786738161,0.5232558139534884,1.0,1.0,4/19,19.08%,CTR9;RBX1;WAC;UBE2B
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.4815832055302185,0.9772343221510394,0.3157894736842105,0.9755767052800839,1.0,2/11,7.71%,CDC42;RHOA
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.5084116680290817,-0.9770651763005966,0.5604395604395604,1.0,1.0,10/39,21.99%,OMG;SOD2;ALDH1L1;CD38;PLD1;SGK1;ANKUB1;LRRK2;CPEB4;PPARA
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.6356721515057435,-0.9767190551407858,0.52,1.0,1.0,6/6,36.51%,RBX1;NAE1;DCUN1D4;DCUN1D2;DCUN1D1;UBA3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.49113409953980985,-0.9760171186610236,0.532608695652174,1.0,1.0,9/52,12.41%,CSF1;NFKBIA;RPS4X;HDAC2;DDX3X;TGFB1;UPF3A;PRKDC;PLD1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.5381761427365617,-0.9757775540584392,0.5555555555555556,1.0,1.0,5/16,23.54%,EAPP;WDR43;RNF168;TCERG1;SUPT16H
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.682826720167585,-0.9755194821529892,0.5416666666666666,1.0,1.0,1/5,13.18%,GOLGA2
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.6283160625608326,-0.9754516001240019,0.6081081081081081,1.0,1.0,4/6,28.15%,ABCC9;AKR1C1;STAT1;NDUFS4
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.5887208620880885,-0.9754409900727061,0.5569620253164557,1.0,1.0,3/12,17.15%,RPA1;RPS27A;POLK
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.582905379476526,-0.9751799383355334,0.5277777777777778,1.0,1.0,2/12,13.18%,CSNK1D;GOLGA2
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.5742528098453137,-0.9751511988495111,0.6071428571428571,1.0,1.0,4/12,27.05%,PRKAR1A;PRKAR2A;UBE2B;PDE4D
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.6721509374094392,-0.9751275980346726,0.5897435897435898,1.0,1.0,1/6,4.23%,TGFB2
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.5630935005418902,-0.9749423587437429,0.5555555555555556,1.0,1.0,1/15,0.85%,HS3ST5
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.534177641541205,-0.974374796287308,0.5882352941176471,1.0,1.0,1/17,0.93%,SOD1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.5729795475525338,-0.9742617701713376,0.5813953488372093,1.0,1.0,7/14,37.47%,SRSF10;TRA2B;SF3B1;PRPF3;PRPF8;SF3B3;SF3A3
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.4664068458938533,-0.9742276695442015,0.6122448979591837,1.0,1.0,27/104,21.81%,PELI1;PLAA;MARCHF6;PSMB1;RHBDD1;PSMD14;NEDD4L;RBX1;APPBP2;PSMA4;PSMB2;TRIM9;CLOCK;ZNRF1;TRIM13;PSMA7;WWP1;BTRC;UBE2K;ERLEC1;UBE2B;RNF34;SMURF2;MDM2;HECW1;BIRC2;NEDD4
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.4794680978328688,-0.9739387504086043,0.4946236559139785,1.0,1.0,10/51,18.91%,SEC13;NUP153;NUP133;FYTTD1;NUP88;SRSF5;SYMPK;SMG7;ALKBH5;RANBP2
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.6045172997279297,-0.9737309439543175,0.5875,1.0,1.0,1/8,8.96%,DNMT1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.5059064816490296,-0.9734698819496876,0.5113636363636364,1.0,1.0,12/43,26.15%,SYT1;TSC2;PTPN1;RIMS2;PLD1;LRRK2;NSF;MAPK1;RAB11A;SCARB1;RAB12;RAB8B
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.32636867190266244,0.9733021763617544,0.7142857142857143,0.9825854561577058,1.0,1/51,0.08%,HSPA1A
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.6485369056498975,-0.9732981970338749,0.5833333333333334,1.0,1.0,3/5,28.88%,GBE1;PRKAG2;PHKB
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.6470631113899941,-0.9732359605243333,0.5857142857142857,1.0,1.0,1/5,10.11%,AFDN
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.48814615669325684,-0.9727224799483074,0.5463917525773195,1.0,1.0,14/96,12.38%,COL4A6;ADAMTS4;ADAMTS9;SMOC1;CD44;ST7;THSD4;ITGA5;COL11A1;JAM3;FBN1;PXDN;COL6A3;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.39311654781412775,0.9725916439189148,0.42105263157894735,0.9817114575002641,1.0,2/27,4.39%,ATP2B4;ITGA3
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.6148213609792686,-0.9720911693643185,0.5952380952380952,1.0,1.0,5/10,33.42%,EIF2AK4;APP;PTN;EPHA4;ABL1
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.5548404310841314,-0.9720798624484861,0.6309523809523809,1.0,1.0,4/15,27.36%,CTCF;EZH1;NAP1L1;ANP32B
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.5595257867085435,-0.9720304239234298,0.5875,1.0,1.0,2/14,14.93%,NR4A3;PPARGC1A
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.4862628665569529,-0.9718671662198403,0.5463917525773195,1.0,1.0,13/95,11.88%,COL4A6;ADAMTS4;ADAMTS9;SMOC1;CD44;ST7;THSD4;ITGA5;COL11A1;JAM3;FBN1;PXDN;COL6A3
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.5222866758051161,-0.9716664122824117,0.5227272727272727,1.0,1.0,8/33,15.04%,PSMB1;EIF2AK2;PSMD14;PSMA4;PRKDC;PSMB2;PSMA7;RUNX1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.4587731548790197,-0.971452120435115,0.59,1.0,1.0,33/177,18.18%,STC1;CSF1;F3;RIPOR1;VEGFA;TMSB4X;RHOB;TGFB1;TMSB10;SOD2;NKD1;STAT3;PDGFD;ROBO1;CEMIP;ENPP2;SEMA3B;CCAR1;SDCBP;AFDN;TMEFF2;TGFBR1;SGK1;ROCK2;FRMD5;HSPA5;PPP3CA;SASH1;NAV3;PRR5L;IGFBP5;CCN1;STK24
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.5661693600357423,-0.9703223944938925,0.5844155844155844,1.0,1.0,4/15,14.33%,CD55;LGALS3;IL18;PARP1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.4682532244122826,-0.9702967793927486,0.5959595959595959,1.0,1.0,20/110,15.71%,RTTN;TTC8;PTPDC1;LZTFL1;NUDCD3;ARMC2;TRAF3IP1;GALNT11;ARF4;IFT122;ACTR3;CCP110;ARMC9;IFT52;DCDC2;IFT140;ATP6V1D;EXOC1;MAK;WDR19
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.5543970686636831,-0.9690331358261829,0.5348837209302325,1.0,1.0,7/18,26.44%,SELENOS;PRKCI;PRKAG2;APPL2;PID1;IRS1;INSR
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.5052129234577398,-0.9689691244582618,0.5978260869565217,1.0,1.0,19/47,34.15%,SRSF10;HNRNPC;PPARGC1A;TRA2B;NONO;NOVA1;RSRC1;TCERG1;TARDBP;SF3B1;PRPF3;NCBP1;SFPQ;WBP4;SRSF2;DHX15;RNPC3;PRPF8;PPIG
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.6370537074438074,-0.9689635112516923,0.64,1.0,1.0,3/7,21.99%,SNX6;ERRFI1;PPARA
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.5926021521864302,-0.9689327014391503,0.5443037974683544,1.0,1.0,2/11,19.26%,NOS1AP;PRKAG2
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.5261355372475869,-0.968870419691955,0.5113636363636364,1.0,1.0,9/28,32.80%,CEP57;FGFR2;HNRNPF;MAPK1;SETX;GRB2;NCBP1;SPRED1;POLR2F
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.6400949260336442,-0.9687039747223744,0.5333333333333333,1.0,1.0,1/5,21.17%,RAB11A
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.6513731815505279,-0.9685891855929493,0.5866666666666667,1.0,1.0,3/7,21.81%,TGFB1;UHMK1;NEDD4
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.5757076231760678,-0.9682403089422078,0.5662650602409639,1.0,1.0,3/13,11.63%,PTRH2;ITGA5;ANKRD13C
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.37939884402926227,0.968011984173431,0.375,0.9894747472991334,1.0,6/33,12.24%,HEY2;CDKN1A;MED24;MOV10;ATF7IP;RUNX2
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.5693006009949442,-0.9679220032391326,0.5432098765432098,1.0,1.0,2/13,17.51%,WASF1;FARP2
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.519860430422635,-0.9677880504204243,0.5747126436781609,1.0,1.0,4/30,15.99%,TBC1D20;DDX3X;PABPC1;RAB7A
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.5447002059363911,-0.9673991179636673,0.5714285714285714,1.0,1.0,1/14,3.60%,VEGFA
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.5956782096031092,-0.9669261978975375,0.5921052631578947,1.0,1.0,2/8,11.10%,AGTPBP1;AGBL1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.6266892301199665,-0.966682771507935,0.5324675324675324,1.0,1.0,2/6,9.65%,GJA1;KCNQ1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.5354021848646713,-0.9666818346800485,0.5542168674698795,1.0,1.0,6/18,20.25%,APIP;SOD2;TRPA1;GOLGA2;ALDH1A2;APPL2
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.41730929836610303,0.9661719325888766,0.391304347826087,0.9915462088634254,1.0,6/18,11.99%,MYH9;ACTB;HSPB1;FLNA;MYL9;ACTN1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.45106842306875533,-0.9661666102302481,0.6363636363636364,1.0,1.0,27/120,21.37%,CSF1;F3;RIPOR1;VEGFA;TGFB2;PLAA;TGFB1;SOD2;STAT3;PDGFD;CEMIP;ENPP2;SEMA3B;CCAR1;SDCBP;HIF1A;TGFBR1;ROCK2;HSPA5;PPP3CA;CCN1;AGO2;CCN4;SEMA4D;SMURF2;RAB11A;PAK1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.47759392359929864,-0.9659435358279761,0.53125,1.0,1.0,13/71,15.74%,TAF7;NR4A3;TAF1B;ESR2;RARB;CCN2;TBPL1;NRBP1;POLR1C;CCNH;PPARGC1A;NOTCH2;TEAD1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.6287361474223447,-0.9659040891419676,0.6029411764705882,1.0,1.0,1/8,5.72%,NUP153
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.5037145472002309,-0.9659007490205546,0.5876288659793815,1.0,1.0,8/49,14.81%,TGFB2;TGFB1;SMAD6;RPS27A;USP15;TGFBR1;JUN;USP9Y
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.6563006322931668,-0.9657240128183955,0.6351351351351351,1.0,1.0,3/5,31.89%,SMCHD1;TP53BP1;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.5538777724142727,-0.9653405897193855,0.6049382716049383,1.0,1.0,1/14,3.60%,VEGFA
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.6021131646331142,-0.9652738390338267,0.581081081081081,1.0,1.0,1/8,10.10%,SMCHD1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.5826913339098523,-0.9652707121004324,0.524390243902439,1.0,1.0,2/11,6.61%,PTRH2;ITGA5
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.5806383777128327,-0.9652164115381434,0.5844155844155844,1.0,1.0,4/12,21.29%,KDM1A;TRIM13;WRN;MDM2
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.5848214835857387,-0.9650751671857679,0.5972222222222222,1.0,1.0,3/10,22.27%,DDX3X;TBK1;STAT1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5813160598254838,-0.9648376622628668,0.5769230769230769,1.0,1.0,5/12,17.52%,OGN;PDCD4;SOD2;CDKN1B;IGFBP5
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.6289437088661601,-0.9647413186052813,0.6363636363636364,1.0,1.0,2/6,22.27%,STAT3;STAT1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.44844736011572206,-0.9647195706070878,0.73,1.0,1.0,106/455,23.43%,PRAG1;HS3ST5;PRKACA;CSF1;PRSS23;CSNK1D;CSNK1G2;ELOB;WIPI1;SSH1;GLRX;PDK1;TGFB2;CSNK1A1;DCLK1;COG7;CDKL1;PPP1CC;PSMB1;PDK3;CST3;TGFB1;OXSR1;PARP6;PRKCI;PTPRE;FBXL13;PPP2R1B;EIF2AK2;MAPK6;PTPRD;RHBDD1;MELK;PTPN1;ARF4;STK4;MGAT1;PSMD14;LATS2;PRKCB;RBX1;FBN1;HIF1A;SIK2;MT3;MANBA;PSMA4;PRKDC;NRBP1;PSMB2;TGFBR1;TF;RBBP7;GOLGA2;SGK1;ROCK2;MGAT4A;WSB1;PARP1;KLHL2;PPP2R2A;PSMA7;TBK1;MAK;PPP3CA;NAE1;CDK14;HIF3A;CAMK2D;DUSP1;STRADB;LRRK2;UBE2L3;ATG4B;FBXO22;IGFBP5;NPC1;CCN1;TNKS;CAMKK2;STK24;BTRC;PRKAG2;MAN2A1;SERP1;MTMR2;KLHL5;SKP1;MINK1;P4HB;WDTC1;MAPK1;RAB11A;PAK1;EIF2AK4;PPP2R3A;FYN;VCAN;TAOK3;TRIOBP;TGOLN2;MAPKAPK2;DCAF5;FSTL1;STK39;METAP1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.5287927378802382,0.9642220432222116,0.5,0.993725721617258,1.0,3/8,18.73%,ZNF143;CHD8;RPTOR
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.2937496491053898,0.9642059208384816,0.5,0.9910769473428571,1.0,10/60,11.09%,INPP4B;INPP5F;PLA2G4C;MTMR14;PIK3CD;PIP4K2B;SLC27A1;PIP5K1B;MTMR12;MTMR10
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.49481925460638704,-0.9641883700814833,0.59375,1.0,1.0,9/60,14.81%,ZFP36L2;TGFB2;TGFB1;SMAD6;RPS27A;USP15;TGFBR1;JUN;USP9Y
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.5685349500955583,-0.9638530076994503,0.625,1.0,1.0,3/16,10.69%,OMG;DIP2B;MT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.37062519660944776,0.9638150618276221,0.5714285714285714,0.9890651013766705,1.0,2/28,4.39%,ATP2B4;ITGA3
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.4920860108699205,-0.9637894645592326,0.5760869565217391,1.0,1.0,13/39,26.44%,LPIN1;SELENOS;PRKCI;PRKDC;PARP1;DENND4C;CPEB2;EPRS1;IRS1;RAB12;PKM;RAB8B;INSR
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.5264522334750048,-0.9637246564322598,0.5853658536585366,1.0,1.0,3/18,3.60%,NRCAM;CRMP1;VEGFA
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.5347884019770213,-0.9634378341928135,0.5357142857142857,1.0,1.0,5/14,17.99%,PDE4B;TGFB2;LGALS3;ADGRE2;PPIB
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.5158466311409455,-0.9630869026634141,0.5617977528089888,1.0,1.0,9/27,28.92%,IPO5;LATS2;CDKN1B;CCNH;RGCC;CCNK;ADAM17;EGFR;GTF2H1
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),-0.6198428049571982,-0.9629211684984219,0.6172839506172839,1.0,1.0,2/8,20.66%,RAP1B;MINK1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),-0.6198428049571982,-0.9629211684984219,0.6172839506172839,1.0,1.0,2/8,20.66%,RAP1B;MINK1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.6140015698711295,-0.9626244590474196,0.5875,1.0,1.0,3/8,21.99%,NR4A3;PPARGC1A;PPARA
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.5264890335132294,0.9624205224829941,0.5,0.9897255492851414,1.0,3/7,19.48%,ACTB;APPL1;ZDHHC2
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.6754739671267307,-0.9623989246581557,0.6578947368421053,1.0,1.0,2/5,24.72%,EIF2AK4;APP
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.574779046258909,-0.9619259968504431,0.5802469135802469,1.0,1.0,2/9,19.17%,DNMT1;TET1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.35608562018650003,0.9617634528447684,0.5,0.9885538854922143,1.0,6/26,8.73%,ARHGEF10L;CDC42;SYNPO2;RHOA;EVL;CARMIL1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.4814102509848003,0.9617039118055734,0.5217391304347826,0.9860648146750969,1.0,5/14,11.72%,ZDHHC15;VPS35;ARHGAP22;ARHGAP44;PDLIM5
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.5926324842531954,-0.9616615459080478,0.5972222222222222,1.0,1.0,3/9,22.27%,DDX3X;TBK1;STAT1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.5027725938574961,-0.9615067996171345,0.5777777777777777,1.0,1.0,12/31,31.62%,F3;ROBO1;IFT57;SENP1;BEX3;RACK1;SLC22A2;ANP32B;CASP8AP2;COL4A3;APAF1;HSPD1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.6155905630410795,-0.9615035392667174,0.6,1.0,1.0,2/7,18.21%,PLPP3;PTS
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.654555783715761,-0.9614572347089948,0.6164383561643836,1.0,1.0,1/5,6.78%,GLUL
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.5050359241133813,-0.9611063791745926,0.6263736263736264,1.0,1.0,8/37,21.68%,PRAG1;ROBO1;STMN1;HEG1;LPAR6;STARD13;RAF1;AKAP13
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.5017172682204861,-0.9609978464568095,0.5185185185185185,1.0,1.0,5/21,20.35%,TRMT9B;DTWD2;NSUN6;ZBTB8OS;SSB
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.5246070030319889,-0.9607349573272264,0.6024096385542169,1.0,1.0,7/20,33.56%,ALCAM;C9ORF72;NRP2;EIF2AK4;PPP3CB;HSP90AB1;TMEM108
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.46877363252953674,-0.9606176266149299,0.5425531914893617,1.0,1.0,19/52,30.78%,TWIST1;MYDGF;TSC2;TGFB2;PDGFD;IL18;UNC5B;SEMA4D;MAPK1;NEDD4;DCN;LYN;INSR;EGFR;FLT1;PIK3CB;FN1;KDR;PIP5K1C
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.5706769047672073,-0.9606014040693485,0.5609756097560976,1.0,1.0,3/9,22.27%,SIN3A;EIF2AK4;STAT1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.6555708522346366,-0.9601802484428132,0.5909090909090909,1.0,1.0,3/5,25.06%,NEDD4L;GPM6B;GOPC
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.449926477072899,-0.9594901053179765,0.6185567010309279,1.0,1.0,37/150,24.43%,RNMT;TAF7;NR4A3;ELOB;ESR2;RARB;CTR9;INTS8;GLIS3;CCN2;TBPL1;CEBPD;RTF1;NRBP1;ELL2;SYMPK;PARP1;CCNH;PPARGC1A;NOTCH2;INTS4;TEAD1;CSTF3;PKNOX1;NR4A2;INTS2;CCNK;AFF4;DDX21;CPSF2;PPARA;SETX;NCOR2;NFIX;SUPT16H;NR2C2;DEAF1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.6380591522169695,-0.9593364310813385,0.6075949367088608,1.0,1.0,3/6,20.98%,NMNAT2;NAXD;NAMPT
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.5856955660137304,-0.9592359630594685,0.5866666666666667,1.0,1.0,3/8,31.34%,APH1B;ADAM17;LDLRAP1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.44507360284686115,0.9590982562862865,0.4666666666666667,0.990013643206473,1.0,2/17,3.97%,HDAC9;CDC42
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.4993990024479154,-0.9589835929007781,0.5568181818181818,1.0,1.0,9/35,17.35%,NR4A3;F3;VEGFA;MYDGF;FGFR2;HIF1A;TGFBR1;NOTCH2;NRP2
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.5525220727855558,-0.9589742533922927,0.5853658536585366,1.0,1.0,3/17,3.49%,NKAIN3;SPTBN4;ANK3
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.5555317171445942,-0.9589337402526664,0.55,1.0,1.0,7/19,27.33%,RPA1;RPS27A;POLK;POLA1;WRN;ZBTB1;RPA3
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5181496626915202,-0.9587322950636912,0.5357142857142857,1.0,1.0,6/26,14.92%,PSMB1;PSMD14;RPS27A;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.5659263629368088,0.9583931912307363,0.48484848484848486,0.9887042461731863,1.0,2/5,20.69%,TENT4B;PARN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.6245485731325952,-0.9580909576613488,0.5526315789473685,1.0,1.0,1/5,7.96%,STAT3
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.4819639164858222,-0.9577315668226292,0.550561797752809,1.0,1.0,6/42,16.63%,ARHGAP24;GARNL3;TBC1D8;SIPA1L2;RALGAPA2;USP6NL
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.47062492504371406,-0.9575738613817136,0.5604395604395604,1.0,1.0,14/41,23.70%,HS3ST5;CHST11;OGN;SLC10A7;CEMIP;DSE;OMD;GLCE;GPC4;EXT1;CHSY1;CSGALNACT1;VCAN;CHST15
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),-0.6433432764870012,-0.9575358638365072,0.5675675675675675,1.0,1.0,1/5,7.96%,STAT3
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5128021634467534,-0.9574632452787732,0.5747126436781609,1.0,1.0,15/35,35.22%,DUT;RPA1;TBRG1;DONSON;POLA1;NAP1L1;WRN;KIN;RPA3;MCMBP;ORC3;REV3L;PTMS;RAD17;RPAIN
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5623432329366518,-0.9574610734367998,0.5903614457831325,1.0,1.0,5/11,37.27%,TGFB1;IRS1;FLT1;PTK2B;AMBRA1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.40248878648751424,0.9572673527626234,0.5,0.9886565656057591,1.0,1/16,1.02%,MECOM
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.6307486971815344,-0.9570732602225746,0.6164383561643836,1.0,1.0,1/5,10.14%,CCP110
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.5734008134856052,-0.9566741267424308,0.6153846153846154,1.0,1.0,2/11,8.34%,VAV3;CD38
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.6151062395099176,-0.9565795738041255,0.5733333333333334,1.0,1.0,1/6,0.90%,CSF1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.5953250471807487,-0.9561767007281108,0.6235294117647059,1.0,1.0,6/12,29.26%,HNRNPC;PARP1;DCP2;TNKS;POT1;TERF1
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.661040096237975,-0.9559772244622663,0.5753424657534246,1.0,1.0,1/5,19.71%,AGO2
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.5035541959912044,-0.9558831387086197,0.5568181818181818,1.0,1.0,9/40,15.85%,TWIST1;F3;VEGFA;MYDGF;RHOB;PRKCB;HIF1A;RUNX1;SASH1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.4761408581181239,-0.9550497281140652,0.5698924731182796,1.0,1.0,5/53,6.50%,KDM1A;TMSB4X;NFKBIA;HDAC2;SUFU
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.5660333253511293,-0.955047495718184,0.6,1.0,1.0,6/18,24.04%,DHX29;DDX3X;RPS14;RPL5;RPL24;EIF2A
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.5980156516587205,-0.9548036024550743,0.611764705882353,1.0,1.0,3/10,13.59%,NCKAP5;STMN1;CFL1
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.46374972797504915,-0.9547568817277952,0.6145833333333334,1.0,1.0,20/89,26.04%,SOD1;MTCH2;PDCD4;ENPP2;ATP1B3;LPCAT3;TANK;CMPK1;GBE1;GPX4;OMD;ACADL;YWHAG;REEP5;DLD;SCARB1;LAMA4;LPL;ACO2;RIOK3
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.35302948111278604,0.9546471331541228,0.625,0.9928001315777477,1.0,4/38,1.85%,SPRY3;IL34;EDN3;PDGFA
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.5328967474522258,-0.9545649734607725,0.5647058823529412,1.0,1.0,5/17,15.04%,CD44;CREB3L2;TGFB1;WNT2B;RUNX1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.6295293100505494,-0.9545495766123874,0.5945945945945946,1.0,1.0,3/5,29.13%,PMP22;CD9;EPB41L3
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.4816836654638025,-0.9544895969271112,0.5617977528089888,1.0,1.0,12/39,24.97%,TMSB4X;NFKBIA;PSMB1;PSMD14;PSMA4;PSMB2;PSMA7;BIRC2;STAT1;ADAM17;MAP3K14;PSMA3
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.4632832182886827,-0.9544581236792665,0.5979381443298969,1.0,1.0,18/81,16.39%,TP53TG5;ENO1;GJA1;FHL1;TGFB2;ESR2;DDX3X;TGFB1;SPOCK1;SDCBP;MT3;TGFBR1;NRG3;RBBP7;SGK1;CDKN1B;TSPYL2;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.4753956943933384,-0.9542966295510229,0.5957446808510638,1.0,1.0,17/53,27.25%,DDX3X;EIF2AK2;GIGYF2;ROCK2;CNOT8;IGF2BP2;RPL13A;IGFBP5;BTG2;AGO2;METTL16;CPEB4;EIF2AK4;CPEB2;EPRS1;RACK1;CNOT1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.4696127832929211,-0.9538376738659288,0.5760869565217391,1.0,1.0,14/37,30.35%,MYDGF;TGFB2;PDGFD;IL18;UNC5B;SEMA4D;NEDD4;DCN;LYN;INSR;FLT1;PIK3CB;FN1;KDR
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.48196692729930535,-0.953821342305891,0.5777777777777777,1.0,1.0,17/48,24.72%,SYT1;MCTP2;RIMS2;DGKI;GRIK1;GRM7;NRG3;SNCAIP;DLGAP1;BTBD9;RIMS1;LRRK2;GRIK2;NLGN1;SYN3;LRRC4C;APP
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.5190759670224889,0.9537695609039885,0.44,0.9924806754403172,1.0,1/8,1.10%,WTIP
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),-0.6351558730747506,-0.9533321435404735,0.6133333333333333,1.0,1.0,2/5,22.52%,CPEB4;CPEB2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.47965632644758543,0.9530045076961116,0.35294117647058826,0.9919023340533942,1.0,2/9,8.59%,PDGFA;SLIT2
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.5153583960552753,-0.9527262798746547,0.5568181818181818,1.0,1.0,7/23,16.56%,OGN;CEMIP2;CD44;TGFB1;CEMIP;OMD;GPC4
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.5198294472682599,-0.9525056134261461,0.6309523809523809,1.0,1.0,3/31,8.10%,ROBO2;OMG;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.5242830920979255,-0.9524503526470798,0.5862068965517241,1.0,1.0,5/23,10.79%,SELENOS;TRAF3IP1;LRFN5;PTPN2;LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.6118110020383858,-0.9517079274210576,0.6081081081081081,1.0,1.0,1/7,2.88%,CD55
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.6163035531313555,-0.9516823424774388,0.5949367088607594,1.0,1.0,5/6,36.79%,ELF1;RUNX1;LYN;ELF2;CBFB
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.5150721865308714,-0.9516255467630751,0.5795454545454546,1.0,1.0,4/26,12.90%,TGFB2;DDX3X;TGFB1;DELE1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5657010569117578,-0.9513532463398362,0.6626506024096386,1.0,1.0,7/15,30.72%,SDCBP;UCHL5;WAC;FHIT;USP14;HSP90AB1;RPL11
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.5040964600508134,-0.9512377415114788,0.5697674418604651,1.0,1.0,5/23,20.44%,NEDD4L;TF;CLU;APPL2;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.5402861056679332,-0.9510773969831787,0.6067415730337079,1.0,1.0,6/15,26.74%,CST3;FMN2;AZIN1;MDM4;PPARA;EGFR
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.6173075251959861,-0.9508718814393112,0.6301369863013698,1.0,1.0,5/8,33.64%,FGFR2;NOTCH2;STXBP4;KLF9;CASK
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.601071352400941,-0.9508300994559944,0.5662650602409639,1.0,1.0,2/8,18.25%,TRIM13;TRIM5
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.46450846843343885,0.9506961324618195,0.4230769230769231,0.9950519685116507,1.0,3/11,7.82%,HDAC9;ELK4;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.5327369379536493,-0.950152613522341,0.5764705882352941,1.0,1.0,4/13,14.83%,NRCAM;ZC4H2;SIN3A;TCF4
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.5613793966561597,-0.9501408608558128,0.5930232558139535,1.0,1.0,1/11,0.93%,SOD1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.6245808921710283,-0.9499085531398639,0.6176470588235294,1.0,1.0,1/6,6.02%,NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.4543156892609265,-0.9497755124494643,0.67,1.0,1.0,30/145,17.39%,CSF1;GJA1;TWIST1;KLF2;F3;ANK3;VEGFA;NOS1AP;DDX3X;CTCF;TGFB1;OLFM1;STAT3;ROBO1;PTPN1;DNMT1;AFDN;RIMS2;HIF1A;MT3;KRAS;TGFBR1;ROCK2;CLU;PPARGC1A;CALCOCO1;RIMS1;RAB27A;RGCC;DTNBP1
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.6005005081049418,-0.949668178404475,0.6623376623376623,1.0,1.0,1/7,6.78%,GLUL
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.48554926592105996,-0.9496317397466254,0.5568181818181818,1.0,1.0,19/44,39.39%,HNRNPL;NUP153;DDX21;CCT8;CNOT1;EIF4G1;YBX1;NUP107;NUP205;DHX15;PRPF8;DCAF1;ZDHHC5;NSUN2;SF3B3;NUP160;MCM3AP;ABCB10;NUP98
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.5533233932280688,-0.9495805285111366,0.6097560975609756,1.0,1.0,1/15,2.31%,HABP4
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.49443350021581056,-0.9495171073846055,0.5930232558139535,1.0,1.0,8/33,19.84%,ANK3;GGA3;EXOC1;GOLGA4;VAMP5;STXBP6;PREPL;NSF
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.5094016693650433,-0.9494982683179457,0.6049382716049383,1.0,1.0,4/21,16.16%,TGFB1;RHBDD1;ERAP1;APH1B
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.514013272581676,-0.9491053626185707,0.5617977528089888,1.0,1.0,12/31,20.16%,KCND2;KCNE4;KCNQ3;ATP1B3;KCNQ1;SLC12A6;ABCC9;KCNH7;SLC9A9;NALCN;KCNQ5;KCNC2
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.4956638083443294,-0.9490560842443393,0.5714285714285714,1.0,1.0,3/26,13.54%,PRKACA;PSMD14;UCHL5
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.5441514202320474,-0.9490205236246841,0.6097560975609756,1.0,1.0,8/13,40.45%,RAP1B;ROCK2;RACK1;GSN;BCAS3;PTK2B;RIPOR2;KANK1
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.40347712550815573,0.9487797147845398,0.5882352941176471,0.9965435459977158,1.0,7/17,9.82%,SLC35F1;TTC7A;SLC26A3;SMOC2;ANPEP;PMEPA1;GULP1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.48171269696231367,-0.9487652455987353,0.6627906976744186,1.0,1.0,7/47,18.91%,SEC13;PPP1CC;NUP133;STMN1;GPSM2;TNKS;RANBP2
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.5557574833913489,-0.9482660854991242,0.6081081081081081,1.0,1.0,5/12,29.53%,ERAP1;LNPEP;ENPEP;CPQ;GGT7
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.5725657822056469,-0.9482476190915081,0.5443037974683544,1.0,1.0,2/16,7.72%,IFITM3;EIF2AK2
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.6066921705767692,-0.9482357397675698,0.5789473684210527,1.0,1.0,6/9,37.14%,IL18;SCARB1;LPL;RORA;ANGPTL4;NR1H3
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.48511718575080554,-0.9478216296130413,0.5730337078651685,1.0,1.0,4/49,2.50%,STC1;PRKACA;TPT1;TMCO1
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.5906015989406548,-0.9477485886841812,0.5897435897435898,1.0,1.0,2/7,19.94%,HIF1A;SYBU
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6422814198890043,-0.9474958186989718,0.6,1.0,1.0,2/5,15.82%,DONSON;ZRANB3
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.5579944200471606,-0.9473745667729998,0.5921052631578947,1.0,1.0,9/14,29.16%,GPR137C;SZT2;C9ORF72;ITFG2;SESN1;LARS1;RRAGB;SIK3;KLHL22
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.6434719414374019,-0.9473682738053275,0.6323529411764706,1.0,1.0,2/5,27.28%,PRKCB;ZDHHC17
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.6179305985874327,-0.9472841396201475,0.6197183098591549,1.0,1.0,4/7,28.72%,CTR9;TET1;AASS;NSD1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.6454432239327748,-0.9470655345504814,0.6056338028169014,1.0,1.0,2/5,21.54%,HIF1A;NONO
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4416215698895322,0.9468283310661482,0.4583333333333333,0.9988029344786308,1.0,3/10,2.93%,HEY2;HEYL;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.5123185264299583,-0.9467498416019904,0.6263736263736264,1.0,1.0,3/25,10.93%,IPO5;TGFB1;CCT4
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.47766111687314394,-0.9464601557401731,0.6631578947368421,1.0,1.0,18/56,25.47%,ARMC2;LIMA1;STMN1;GPM6A;PLP1;HDGFL3;ZFYVE27;MICALL2;DTNBP1;BTG2;NLGN1;UHMK1;RAB11A;NEDD4;GPM6B;APP;PTPRM;LYN
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.4923150564591923,-0.9464482145391035,0.6063829787234043,1.0,1.0,19/46,33.76%,VEGFA;TGFB2;RHOB;ENPP2;HIF1A;ROCK2;SASH1;NRP2;RIN2;RAB11A;SCARB1;CLASP2;PIK3CB;ADAM9;KDR;PRKCA;BCAS3;ABL1;PTK2B
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.45176673597434097,0.946117236648809,0.4666666666666667,0.9977557714124236,1.0,2/11,6.30%,SYNE3;SYNE2
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.491367454380698,0.9461159832521363,0.4827586206896552,0.9951709119009926,1.0,1/5,1.38%,RYR2
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.5409411541256651,-0.9461031544068653,0.6136363636363636,1.0,1.0,10/23,26.09%,VEGFA;TGFB1;FGFR2;ARNT2;TGFBR1;ALDH1A2;BMP5;DEAF1;FUT8;KIAA1217
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.5118379013643082,-0.9459801972913779,0.6363636363636364,1.0,1.0,8/31,18.81%,GLRB;GRIN1;SLC1A2;TRPA1;SLC1A1;SLC12A6;SLC9A9;ATP11B
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.5810521323934085,-0.9458770209910143,0.6493506493506493,1.0,1.0,5/11,32.41%,RPA1;POLA1;PURA;RPA3;ORC3
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.5634749258258847,-0.9458767976573534,0.550561797752809,1.0,1.0,1/9,1.32%,TWIST1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.6097361043004867,-0.9456323822745214,0.6521739130434783,1.0,1.0,3/6,33.03%,IRS1;INSR;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.6097361043004867,-0.9456323822745214,0.6521739130434783,1.0,1.0,3/6,33.03%,IRS1;INSR;SORBS1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.5043358251284309,-0.9454919164808017,0.6363636363636364,1.0,1.0,5/30,10.33%,SPTLC3;CSNK1G2;ALDH3A2;SCCPDH;SPTLC1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.5787871021876814,-0.9450283189928211,0.6265060240963856,1.0,1.0,4/12,20.49%,CTR9;WAC;RNF168;SKP1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.5393505165109052,-0.9447479865999507,0.5949367088607594,1.0,1.0,7/16,28.78%,PABPC1;SYMPK;CSTF3;AHCYL1;CPSF2;APP;GRSF1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.5393505165109052,-0.9447479865999507,0.5949367088607594,1.0,1.0,7/16,28.78%,PABPC1;SYMPK;CSTF3;AHCYL1;CPSF2;APP;GRSF1
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.5865346704221094,-0.9447096433877321,0.6,1.0,1.0,3/9,9.66%,SLC2A1;NEDD4L;PRKCB
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.6259396956202421,-0.9446689098379433,0.6111111111111112,1.0,1.0,1/7,6.05%,AKAP8
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.5675239225792028,-0.9446368868761585,0.6052631578947368,1.0,1.0,1/10,4.53%,NFKBIA
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.5033476528819669,-0.944299966864922,0.5909090909090909,1.0,1.0,6/31,8.65%,VEGFA;CD44;EPHA7;TGFB1;ITGA5;ENPP2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.49658354690875434,0.9441713776622976,0.5416666666666666,0.9970172976616216,1.0,1/5,0.28%,CAV2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.4923302400267994,0.9435125702488645,0.5909090909090909,0.9961249785518287,1.0,3/10,16.63%,VPS35;PTTG1IP;FAF1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.44143797362768217,-0.9434142274601411,0.66,1.0,1.0,71/204,28.85%,WWC1;RHEB;GJA1;NRG1;PELI1;F3;SEC13;VEGFA;MYDGF;TGFB2;NOS1AP;SLC38A9;PDCD4;DDX3X;TGFB1;EIF2AK2;ADGRV1;PDGFD;PRKCB;FGFR2;USP15;ANKRD17;TGFBR1;JCAD;ROCK2;IL18;TERF2IP;AKR1C2;IQCJ-SCHIP1;TRIM13;TBK1;SASH1;NDFIP2;UNC5B;TRIM5;TMED4;ALPK1;NLGN1;SEMA4D;NDFIP1;DDX60;DDX21;LARS1;AKAP13;BIRC2;NEDD4;FYN;RPL37;MALT1;MAP3K14;GRB2;APP;RRAGB;DCN;GAB2;KITLG;LYN;IRS1;RACK1;MIER1;INSR;EGFR;FLT1;ZDHHC17;RPS20;SIAH1;TFG;GOLPH3;GCNT2;PIK3CB;FN1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.5656667431006318,-0.9432003146577904,0.6027397260273972,1.0,1.0,3/9,31.11%,RBBP7;NASP;MIS18BP1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.5656667431006318,-0.9432003146577904,0.6027397260273972,1.0,1.0,3/9,31.11%,RBBP7;NASP;MIS18BP1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.5656667431006318,-0.9432003146577904,0.6027397260273972,1.0,1.0,3/9,31.11%,RBBP7;NASP;MIS18BP1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.6187716204986562,-0.9428589421122299,0.6266666666666667,1.0,1.0,5/6,37.76%,CCT4;CCT8;LARP7;CCT6A;CCT3
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.6187716204986562,-0.9428589421122299,0.6266666666666667,1.0,1.0,5/6,37.76%,CCT4;CCT8;LARP7;CCT6A;CCT3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5463789257962893,-0.9427326931350082,0.6309523809523809,1.0,1.0,3/15,9.41%,FHL1;NEDD4L;ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.4306148700609351,0.9426731679894268,0.5,0.9958327222192247,1.0,5/26,7.48%,SH3RF3;MFHAS1;TRAF6;MTURN;TNFRSF19
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.6006227869617136,-0.9426449732278119,0.5970149253731343,1.0,1.0,4/6,36.57%,AP2A1;AP2B1;AP2A2;AP2M1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.6006227869617136,-0.9426449732278119,0.5970149253731343,1.0,1.0,4/6,36.57%,AP2A1;AP2B1;AP2A2;AP2M1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.6110170189246362,-0.9424832425431932,0.5945945945945946,1.0,1.0,3/6,33.05%,MT2A;APP;PRNP
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.40974151173324524,0.9422913652248768,0.45,0.9943540683185473,1.0,3/16,9.03%,PSMF1;QRICH2;OPHN1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.40779610743300054,0.9420792415848057,0.5,0.9922341269346616,1.0,8/37,9.72%,LMOD1;CSRP2;CDC42BPB;OBSCN;MYH9;ITGB5;RHOA;EPB41L5
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.4543726549925005,-0.9419769148591188,0.6428571428571429,1.0,1.0,24/112,18.07%,KLF2;F3;TGFB2;GRIN1;ITGA5;PRKCI;STAT3;ROBO1;PRKCB;FGFR2;RIMS2;ARMC9;HIF1A;MT3;TP63;DCDC2;TGFBR1;JCAD;UCHL5;SASH1;RIMS1;LRRK2;TSPAN5;TTC23
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5852081290756577,-0.9414672329694642,0.6103896103896104,1.0,1.0,4/8,26.95%,ANKRD17;APPL2;DDX60;MYO18A
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.6189104246166732,-0.9414375104792562,0.6075949367088608,1.0,1.0,5/6,37.76%,CCT4;CCT8;TERF1;CCT6A;CCT3
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.46040944257018684,-0.9411893592696082,0.6263736263736264,1.0,1.0,18/56,25.47%,VAV3;PSMB1;PSMD14;PSMA4;PSMB2;JUN;PSMA7;PPP3CA;BTRC;SKP1;MAPK1;PAK1;MALT1;GRB2;PPP3CB;PSMA3;GAB2;LYN
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.6544605465624965,-0.9411773132178474,0.6527777777777778,1.0,1.0,1/5,17.56%,COLEC12
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),-0.6291471787566498,-0.9408140729449446,0.6376811594202898,1.0,1.0,3/6,21.81%,NEDD4L;CAMK2D;NEDD4
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.6150304573656907,-0.9406609088764045,0.6363636363636364,1.0,1.0,2/6,18.69%,PANK2;DCAKD
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.6150304573656907,-0.9406609088764045,0.6363636363636364,1.0,1.0,2/6,18.69%,PANK2;DCAKD
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.6150304573656907,-0.9406609088764045,0.6363636363636364,1.0,1.0,2/6,18.69%,PANK2;DCAKD
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.6150304573656907,-0.9406609088764045,0.6363636363636364,1.0,1.0,2/6,18.69%,PANK2;DCAKD
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.5611671139677081,-0.9404969138756891,0.6404494382022472,1.0,1.0,2/15,13.32%,ROBO2;ROCK2
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5374016783633444,-0.9402671352420843,0.6190476190476191,1.0,1.0,2/16,14.90%,IFITM3;TRIM13
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.4878333836437444,-0.940202911717863,0.6222222222222222,1.0,1.0,9/36,17.29%,NRG1;VEGFA;TGFB1;LGALS3;SDCBP;SPIDR;CLU;RAB7A;RGCC
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.6283583570589604,-0.9396720680993997,0.6363636363636364,1.0,1.0,1/5,12.59%,GBE1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.6283583570589604,-0.9396720680993997,0.6363636363636364,1.0,1.0,1/5,12.59%,GBE1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.49186519256506045,-0.9396093397260628,0.6304347826086957,1.0,1.0,11/36,32.68%,PTPN1;PTPN2;ELF1;RUNX1;BIRC2;STAT1;RACK1;CYLD;HSP90AB1;MADD;RBCK1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.4687539127447747,0.9394392100411946,0.6153846153846154,0.9963718470140694,1.0,1/13,0.33%,ATP2B4
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.5303059178455021,-0.9393448265482326,0.6190476190476191,1.0,1.0,2/20,9.27%,DDX3X;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.591631733695833,0.9393345655283325,0.5,0.9865581773278955,1.0,3/5,16.27%,ATM;TPR;APC
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.591631733695833,0.9393345655283325,0.5,0.9865581773278955,1.0,3/5,16.27%,ATM;TPR;APC
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.591631733695833,0.9393345655283325,0.5,0.9865581773278955,1.0,3/5,16.27%,ATM;TPR;APC
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.591631733695833,0.9393345655283325,0.5,0.9865581773278955,1.0,3/5,16.27%,ATM;TPR;APC
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.6063834911388679,-0.9393258685984192,0.6338028169014085,1.0,1.0,3/6,33.75%,NAMPT;SH3PXD2B;PGRMC2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.5832633414947163,-0.9392795733918444,0.6233766233766234,1.0,1.0,3/9,21.54%,SOD2;HIF1A;NONO
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.43137156415853195,-0.9391866895704823,0.71,1.0,1.0,38/193,20.63%,TBC1D20;COG2;CSNK1D;ATL1;RANBP10;WASF3;CSNK1A1;TOR1AIP2;COG7;NECTIN2;ARMC2;GOLGA8A;DIAPH1;PRKCI;PEX3;GOLGA8B;AGTPBP1;DPYSL2;FAM174B;SLC25A36;GOLGA2;CFL1;WDR73;PARP1;CHCHD2;PLAAT3;PPARGC1A;RAB7A;GEM;LRRK2;USP6NL;FMNL2;NPLOC4;REEP5;TMED4;RAB18;CAPZB;GAK
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.44834782558354624,-0.9390263760276363,0.6428571428571429,1.0,1.0,31/123,24.01%,PRKACA;SRA1;TSC2;TGFB2;PDCD4;RHOB;TGFB1;STAT3;TBRG1;SDCBP;FGFR2;ANKRD17;CDC123;TGFBR1;JUN;PLAGL1;CDKN1B;NOTCH2;TSPYL2;DUSP1;RGCC;UHMK1;CRLF3;MDM2;BIRC2;NF2;MAP2K6;WDR6;IRF1;TARDBP;APBB1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.47143654946154245,-0.9389524583425208,0.6413043478260869,1.0,1.0,12/53,17.51%,NRG1;VEGFA;DDX3X;TGFB1;LGALS3;TRAF3IP1;EIF2AK2;SPIDR;CLU;HSPA5;GFAP;FARP2
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.6391302143312266,-0.9387511221003351,0.6081081081081081,1.0,1.0,1/5,0.90%,CSF1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.5007295447178791,-0.9386042892022236,0.6309523809523809,1.0,1.0,9/29,25.47%,TGFB2;NECTIN2;ERAP1;COLEC12;APPL2;BIRC2;IRF1;HLA-B;LYN
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6212460483989994,-0.9383191584604964,0.6133333333333333,1.0,1.0,3/5,33.76%,TSHZ3;NLGN1;PTK2B
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),-0.6155162939907624,-0.9381076368801065,0.6567164179104478,1.0,1.0,1/5,20.44%,NLGN1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),-0.6155162939907624,-0.9381076368801065,0.6567164179104478,1.0,1.0,1/5,20.44%,NLGN1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.5281232599557292,-0.9377441075300388,0.6,1.0,1.0,5/25,16.21%,WASF3;WASF1;DIAPH1;CFL1;MICALL2
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.5680006205377753,-0.9376143178399339,0.5135135135135135,1.0,1.0,1/9,9.72%,SDCBP
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.6274041187815635,-0.937447353577462,0.6486486486486487,1.0,1.0,1/5,20.35%,SSB
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.5225330363446886,-0.9364415808545026,0.6,1.0,1.0,5/19,28.63%,WIPI1;GABARAPL1;MAP1LC3B;WDR45B;ATG12
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.4573012933762555,-0.9363215071229313,0.6428571428571429,1.0,1.0,18/126,12.38%,COL4A6;CTSL;ADAMTS4;ADAMTS9;SMOC1;CD44;TGFB2;P4HA3;TGFB1;ST7;THSD4;ITGA5;COL11A1;JAM3;FBN1;PXDN;COL6A3;TGFBR1
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.49430753434037084,-0.9360862183893305,0.6444444444444445,1.0,1.0,10/42,16.28%,RNMT;PDE4B;DUT;DGUOK;SDCBP;RBX1;POLR1C;GPX4;GUK1;CSTF3
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.5532402352690676,-0.9355202229191132,0.5833333333333334,1.0,1.0,6/11,24.72%,ALDH3A2;EMC3;TRAM1;SERP1;TRAM2;APP
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.4876853291279466,-0.9353677477022665,0.5581395348837209,1.0,1.0,3/26,14.69%,SEC13;NUP133;PPP2R2A
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.452707209096477,0.9352735438565992,0.5,0.9942700734907013,1.0,1/13,0.87%,HDAC9
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.6101633737115985,-0.9350509817808117,0.6533333333333333,1.0,1.0,4/5,36.99%,JAM2;CD9;ADAM12;CD81
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.514231573661159,-0.9349976763611945,0.611764705882353,1.0,1.0,5/21,28.63%,WIPI1;GABARAPL1;MAP1LC3B;WDR45B;ATG12
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.5267256001066629,-0.9349860293545031,0.6,1.0,1.0,2/19,14.93%,FYCO1;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.6181820037252415,-0.9345910646158537,0.6363636363636364,1.0,1.0,4/5,37.76%,CCT4;CCT8;CCT6A;CCT3
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.5254294004079016,-0.9344465855946403,0.6463414634146342,1.0,1.0,6/22,27.67%,TMSB4X;ERAP1;APPL2;BIRC2;IRF1;CYLD
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.6121370252080112,-0.9344081790600082,0.6417910447761194,1.0,1.0,1/5,8.98%,SMAD6
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.6173769920978948,-0.9342911793276356,0.6538461538461539,1.0,1.0,2/5,33.76%,PRLR;PTK2B
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.58653339418711,-0.9340771957838516,0.6125,1.0,1.0,5/10,21.01%,CSF1;AKIRIN1;CMKLR1;MTUS1;MAPK1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.586922828630563,0.9339151817409604,0.6111111111111112,0.9945988107761271,1.0,1/5,3.78%,DTNA
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.5749947500848378,-0.9338968995431977,0.6,1.0,1.0,4/7,38.59%,XKR4;RHOBTB1;MEGF10;RAC1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.6241362711535402,-0.9336833785563147,0.618421052631579,1.0,1.0,1/5,18.21%,PTS
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.5617644965422397,-0.933529414381093,0.5915492957746479,1.0,1.0,2/7,22.88%,APH1B;ADAM17
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.6273997281028552,-0.9334293916500628,0.647887323943662,1.0,1.0,1/5,2.00%,SYT1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.4546602411593541,-0.9334166665899641,0.6451612903225806,1.0,1.0,13/78,10.59%,TWIST1;F3;CEMIP2;VEGFA;MYDGF;TGFB2;PGK1;RHOJ;RHOB;GLUL;NIBAN2;PRKCB;HIF1A
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.5077743870501846,-0.9332561757072805,0.5975609756097561,1.0,1.0,9/22,33.98%,OLFM2;RIMS2;SNX19;RAB12;ARFGAP3;RAB8B;GOLPH3;CANX;SEL1L
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.46365697616368423,0.9330855837984601,0.5333333333333333,0.9946494474783025,1.0,1/9,1.44%,EDN3
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.4707788120292717,-0.9330182065004125,0.7052631578947368,1.0,1.0,30/75,29.65%,TAF7;TWIST1;TSC2;TGFB1;TRAF3IP1;SMAD6;DDIT4;PRKDC;C9ORF72;TERF2IP;ERRFI1;PRR5L;LRRK2;DTNBP1;PLPP3;YWHAG;PRKAG2;SEMA4D;WARS1;TARDBP;PID1;GNAQ;LYN;LDLRAD4;RACK1;PDE4D;SNX25;EIF4G1;CAMK2N1;NF1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.37374886364584997,0.9330064115456318,0.45454545454545453,0.9923834331758989,1.0,5/43,3.61%,ATP2B4;TRPC6;RYR2;CACNA1C;CACNB2
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.48174869251875496,0.9326280124121183,0.5416666666666666,0.990541331631161,1.0,1/7,9.83%,NTF3
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.421568017705395,0.9322507545728566,0.4166666666666667,0.9891748572554231,1.0,3/17,5.54%,BTBD2;CDK6;ERCC6
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.597306368052342,-0.9322411515955327,0.6052631578947368,1.0,1.0,1/6,27.00%,USP14
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.47481101442521184,-0.9319101285108108,0.6210526315789474,1.0,1.0,12/45,17.01%,ETV5;ELAVL3;CRMP1;PHYHIPL;DCLK1;SYNDIG1;SNAP25;PLP1;ARNT2;NXPH1;SNAP91;GFAP
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.5741286660200036,-0.9317416023945511,0.6197183098591549,1.0,1.0,3/10,19.59%,INTS8;INTS4;INTS2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.531332722035417,-0.9313202213452313,0.6436781609195402,1.0,1.0,2/18,8.64%,TRAF3IP1;STMN1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.35278947103529834,0.93123450274822,0.6666666666666666,0.9890742250043086,1.0,6/46,6.68%,NOX4;HDAC9;MFHAS1;PLA2G4C;AFAP1L2;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.5777251445523314,-0.9308941131182042,0.5211267605633803,1.0,1.0,1/7,3.60%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.5520539865088099,-0.9308521920346607,0.65,1.0,1.0,3/11,26.04%,TGFB2;EIF2AK4;RIOK3
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.5419213618871219,-0.9305681850188745,0.6419753086419753,1.0,1.0,3/15,6.44%,VEGFA;TGFB1;ADM
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.5037389763286158,-0.9301241986445812,0.5802469135802469,1.0,1.0,3/16,14.45%,NRG1;SEMA3B;TAPT1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.5293503872661086,-0.9298029767542577,0.632183908045977,1.0,1.0,6/16,19.28%,MUCL1;GALNT15;GALNT11;GALNT10;GALNT7;XXYLT1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.5383284852372228,-0.9297833282326289,0.6363636363636364,1.0,1.0,3/10,20.49%,TAPT1;HSPA5;SKP1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.4443014215927634,-0.9293299730545282,0.6767676767676768,1.0,1.0,31/97,31.39%,RPA1;DNMT1;RPS27A;RAD21;PRKDC;TERF2IP;PARP1;FAN1;FANCC;ZRANB3;POLK;NT5E;POLA1;BTG2;UBE2B;WRN;XPA;DDX21;POT1;USP3;PURA;ZBTB1;PARP4;RPA3;GTF2H1;TERF1;SMC1A;UVRAG;XRCC6;UHRF2;PARG
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.475694754838268,-0.9287991120136422,0.6210526315789474,1.0,1.0,8/46,11.55%,PRKACA;SELENOS;ADM;LRFN5;PTPN2;PRKAR1A;LPCAT3;ADORA2B
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.4683370380428757,-0.9287745813151342,0.6129032258064516,1.0,1.0,9/59,12.41%,PCDH17;CRMP1;PHYHIPL;DCLK1;PTPRD;UNC5D;SNAP25;ARNT2;PLD1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.5484828806361418,-0.9282511488193494,0.6447368421052632,1.0,1.0,4/15,9.12%,PIGL;DPM1;PIGG;SCCPDH
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.4629476380089692,-0.9280812876326124,0.6458333333333334,1.0,1.0,13/68,17.52%,NR4A3;SSH1;TGFB1;DIAPH1;KCNQ1;RAP1B;SPIDR;ROCK2;IL18;SLC1A1;LRRK2;UBE2L3;IGFBP5
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.48802724554144244,-0.9279445433288975,0.6129032258064516,1.0,1.0,7/27,21.29%,KDM1A;RHOB;TANK;SPIDR;CLOCK;WRN;MDM2
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.44155919930383475,-0.9278270890506276,0.696969696969697,1.0,1.0,18/155,14.93%,WWC1;WWC2;CREM;ESR2;SRSF10;PLAG1;SUFU;CTR9;HCFC2;STAT3;ZNF138;CCAR1;HIF1A;ARNT2;TGFBR1;CLOCK;TERF2IP;PPARGC1A
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),-0.48078275509528884,-0.9274883813858401,0.6888888888888889,1.0,1.0,5/33,14.93%,CRY1;STAT3;HIF1A;PTPN2;PPARGC1A
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.5348849250538835,-0.9272131638003303,0.6097560975609756,1.0,1.0,7/19,27.33%,RPA1;RPS27A;POLK;NPLOC4;RCHY1;ZBTB1;RPA3
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5646179695207352,-0.9271117237431015,0.6024096385542169,1.0,1.0,5/13,34.26%,NUDT5;ENTPD4;RNASEH2C;NCBP1;XRN2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.5689675632756681,-0.9269209364846615,0.6282051282051282,1.0,1.0,4/8,30.37%,RGCC;ADAM17;EGFR;HSP90AB1
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.5806079721806788,-0.9268453101035041,0.6666666666666666,1.0,1.0,6/10,30.85%,MT3;GBE1;PRKAG2;PID1;PHKB;LEPR
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.4786948315375396,-0.9266022343285925,0.6382978723404256,1.0,1.0,11/40,20.75%,SLC2A1;EFNB2;CST3;HIF1A;CEBPD;CMKLR1;CA2;LRRK2;NRP2;SEMA4D;RIN2
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.6300668700979009,-0.9265240958828391,0.6578947368421053,1.0,1.0,4/6,31.37%,NFKBIA;PPARA;ITGAV;ABCA5
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.5919697094088082,-0.9264303054867385,0.6753246753246753,1.0,1.0,3/8,32.38%,DDIT4;EIF4G1;SPRED1
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.5994579310329968,-0.9263903191729678,0.6666666666666666,1.0,1.0,3/6,31.87%,FGFR2;SRP54;CLMP
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.5352052709702123,-0.9263236274745235,0.6,1.0,1.0,7/15,35.48%,TSC2;PPARA;RACK1;PIK3CB;PHLPP2;PLEKHA1;PHLPP1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.5449208118674622,-0.9263132474476167,0.6428571428571429,1.0,1.0,4/15,20.69%,PTPN1;NDFIP2;DNAJA1;NDFIP1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.4789570613303886,-0.9262385362651919,0.6888888888888889,1.0,1.0,16/46,25.95%,NRCAM;ANK3;DNER;PTPRD;GPM6A;LRFN5;ZC4H2;GPC4;LRRK2;KIRREL3;NLGN1;NEDD4;FARP1;LRRC4C;APP;DNM3
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.44722104026014203,-0.9261449368644463,0.6526315789473685,1.0,1.0,20/87,19.18%,AGPAT4;RNF19A;SLC2A1;RANBP10;ALDH1L1;GMPS;MINPP1;KLF3;SDCBP;USP15;GYPC;SLC25A37;CA2;ELL2;EZH1;TSPAN5;LAMP2;BTRC;BTG2;SLC7A11
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.5479167646206508,-0.9260104851202741,0.6707317073170732,1.0,1.0,4/10,23.91%,VEGFA;FGFR2;HECA;LOXL3
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.5741775902192195,-0.9257563727890045,0.726027397260274,1.0,1.0,1/8,4.31%,PIP4P2
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.5189586312163972,-0.9257544627525357,0.6097560975609756,1.0,1.0,5/19,15.85%,PDCD4;DDX3X;EIF2AK2;TERF2IP;SASH1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5391926333687359,-0.9253371318324958,0.6282051282051282,1.0,1.0,7/12,40.45%,RAP1B;ROCK2;RACK1;BCAS3;PTK2B;RIPOR2;KANK1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.46501231038162916,-0.9253227294852318,0.7282608695652174,1.0,1.0,14/58,15.28%,FAT3;ELAVL3;ROBO2;PHYHIPL;DCLK1;EPHA7;HIVEP2;ROBO1;SNAP25;PURG;NXPH1;SLC1A1;UNC79;SNAP91
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.6350356395274389,-0.9252789982491053,0.6515151515151515,1.0,1.0,1/5,3.89%,MGST1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.5466158027341509,-0.9250565963361881,0.6585365853658537,1.0,1.0,1/13,3.60%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.45276246107974033,-0.9249721309248614,0.7070707070707071,1.0,1.0,12/89,10.95%,WWC1;TWIST1;EPM2A;WWC2;TMSB4X;TSC2;DDX3X;PDE10A;DDIT4;UBR1;TANK;NPRL3
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.4891349658830722,-0.9249512552027646,0.6704545454545454,1.0,1.0,8/29,22.88%,PRKACA;ADM;PRKAR1A;ADORA2B;PRKAR2A;TSHR;FYN;ADAM17
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.49584688104548674,-0.9249433663549624,0.6629213483146067,1.0,1.0,4/23,20.63%,ANK3;PTPRD;NLGN1;GAK
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5421573266066324,-0.9249396324118628,0.6097560975609756,1.0,1.0,1/16,3.32%,VAV3
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.5977078134606647,-0.9245535158339434,0.6875,1.0,1.0,1/7,6.42%,TGFB1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.5120350197380522,0.9244571522470809,0.5789473684210527,1.0,1.0,3/11,4.03%,HCN2;ATP1B2;KCNJ8
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.46145549552026105,-0.9242400666247401,0.6136363636363636,1.0,1.0,10/50,18.91%,SEC13;NUP153;NUP133;FYTTD1;NUP88;SRSF5;SYMPK;SMG7;ALKBH5;RANBP2
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.5634864101773895,-0.9241768245720778,0.6352941176470588,1.0,1.0,1/8,1.32%,TWIST1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.5467706065222807,-0.9240739237926855,0.6301369863013698,1.0,1.0,3/10,31.11%,RBBP7;NASP;MIS18BP1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.5506673411768532,-0.9239435472995842,0.6,1.0,1.0,2/10,15.04%,ELF1;RUNX1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.519901772365156,0.9238339955922927,0.4583333333333333,1.0,1.0,4/9,14.39%,ANO5;SLC4A11;ANO6;ANO10
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.5728400303759986,-0.9237886072238745,0.631578947368421,1.0,1.0,5/7,30.75%,SPG7;MIPEP;PMPCB;YME1L1;AFG3L2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.46588979412974496,-0.9235198042388957,0.6413043478260869,1.0,1.0,11/47,19.39%,DDX3X;EIF2AK2;GIGYF2;GGA3;CNOT8;IGF2BP2;CLU;RPL13A;IGFBP5;BTG2;RTN1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.4697640822689812,-0.9232655258290876,0.651685393258427,1.0,1.0,7/39,21.88%,HABP4;DDX3X;CDC123;CSDE1;AGO2;UHMK1;EIF2AK4
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.5265537079946676,-0.9231644300092832,0.6235294117647059,1.0,1.0,5/14,28.27%,DONSON;ZRANB3;WRN;BOD1L1;MMS22L
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.5046878494688102,0.9230943472100592,0.5384615384615384,1.0,1.0,2/5,11.07%,CDKN1A;MAPK14
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.5628345904615273,-0.9227934922282784,0.6097560975609756,1.0,1.0,1/9,8.96%,DNMT1
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.4745111759509648,-0.9224969516740404,0.6853932584269663,1.0,1.0,6/45,9.93%,NRCAM;DNER;CDH20;CDH18;CDH12;GPM6A
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.5725282574972729,-0.9223655125571361,0.6666666666666666,1.0,1.0,3/10,15.00%,VEGFA;FGFR2;ERRFI1
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.6295295922325254,-0.9222723905981346,0.6142857142857143,1.0,1.0,3/5,28.64%,GRAMD1A;RORA;PTCH1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.6048133104714282,-0.9218552842447784,0.581081081081081,1.0,1.0,1/6,16.61%,LRRK2
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.5993670346621122,-0.921795159530168,0.654320987654321,1.0,1.0,4/9,33.42%,CDKN1B;POT1;TERF1;ABL1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5351519744357351,0.9216209519029795,0.4666666666666667,1.0,1.0,2/5,12.11%,C2ORF49;TSEN2
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5351519744357351,0.9216209519029795,0.4666666666666667,1.0,1.0,2/5,12.11%,C2ORF49;TSEN2
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),-0.5808920220954825,-0.9215068033245211,0.631578947368421,1.0,1.0,1/8,5.12%,DPM1
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.5922974152674303,-0.9213498861561371,0.647887323943662,1.0,1.0,2/6,12.38%,VEGFA;TGFBR1
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.6259055579258848,-0.9212169179931561,0.625,1.0,1.0,2/5,30.37%,CLU;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.4351460668575069,-0.920864318050571,0.64,1.0,1.0,34/176,24.05%,WWC1;WWC2;CREM;ESR2;SRSF10;PLAG1;RBM4B;SUFU;CTR9;HCFC2;STAT3;ZNF138;CCAR1;HIF1A;ARNT2;ANKRD17;TGFBR1;CLOCK;TERF2IP;PPARGC1A;UBE2L3;SMC3;PUM3;YAF2;HINT1;BNC2;NONO;BTG1;METAP1;NLK;ZNF536;APBB1;EIF2A;NR2C2
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.5178129673291212,-0.9208443168999525,0.611764705882353,1.0,1.0,2/16,3.49%,FHL1;ANK3
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.4990063229395886,-0.9205147391789085,0.6333333333333333,1.0,1.0,3/27,11.66%,PIGL;PIGG;AGK
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5810783570649908,-0.9205145043891013,0.5584415584415584,1.0,1.0,5/6,40.15%,PYGB;PHKB;PGM2L1;AGL;RB1CC1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.4424965519342123,-0.9203308260796406,0.72,1.0,1.0,22/161,16.44%,PRKACA;CSF1;ZFP36L2;TWIST1;F3;VEGFA;TGFB1;OXSR1;STAT3;MT2A;RPS27A;HIF1A;PTPN2;TANK;CEBPD;IL18;GBP2;CDKN1B;RPL13A;TBK1;PRLR;DUSP1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.5858019143128834,-0.9203132994264439,0.6351351351351351,1.0,1.0,3/7,26.74%,RGCC;ADAM17;EGFR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5647686094046251,-0.9198052021450362,0.6363636363636364,1.0,1.0,1/9,0.88%,PRKACA
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.5847286746806788,-0.919795650018413,0.647887323943662,1.0,1.0,1/6,16.16%,APH1B
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.5177085006682282,-0.9196030110010046,0.5875,1.0,1.0,3/16,17.60%,DDX3X;C9ORF72;CSDE1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.5814996916887469,-0.9195705085294996,0.717948717948718,1.0,1.0,2/8,18.50%,CDK14;POLA1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.4500735097829028,-0.9192472178954865,0.6595744680851063,1.0,1.0,17/58,24.97%,ZFP36L2;TMSB4X;NFKBIA;PSMB1;PSMD14;TANK;PSMA4;PSMB2;GBP2;PSMA7;ERBIN;BIRC2;STAT1;ADAM17;MAP3K14;PID1;PSMA3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.525606487362115,-0.918877907478095,0.6162790697674418,1.0,1.0,7/17,25.43%,VEGFA;TGFB1;RGCC;ASS1;PPARA;NF2;MBP
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.4623903026901466,-0.9182627948239741,0.648936170212766,1.0,1.0,6/47,11.66%,SPTLC3;CSNK1G2;ALDH3A2;ENPP2;SPTLC1;AGK
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5196662982905927,-0.9182571178916805,0.6206896551724138,1.0,1.0,10/20,31.89%,SMCHD1;PRKDC;SPIDR;PARP1;FMN2;WDR48;SLF1;MRNIP;SPIRE1;SHLD2
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.5770217984507224,-0.9181137149500442,0.6231884057971014,1.0,1.0,3/6,31.34%,NPC1;ABCA8;LDLRAP1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.6225610757764751,-0.9180137552758659,0.6666666666666666,1.0,1.0,3/6,31.89%,TGFB1;TP53BP1;SHLD2
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.4423532781785688,-0.9178676850230078,0.6595744680851063,1.0,1.0,22/74,30.55%,SRSF10;CTCF;TGFB1;STMN1;MT2A;RAD21;HIF1A;CDKN1B;NOTCH2;FANCC;WRN;TRA2B;RAD23B;ARID4A;PURA;NASP;UCK2;CASP8AP2;SFPQ;SMC1A;PAFAH1B1;MTF2
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.31111142280034754,0.9177880668696383,0.8,1.0,1.0,17/81,10.28%,FAT1;CSRNP3;LMOD1;FAM13C;GPRC5B;NFASC;CAP2;MAGI1;ADCY6;EML1;SLIT2;CHST3;PTPN21;GPC6;AGAP1;GULP1;EDIL3
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.5175135110781233,-0.9174567243866849,0.6027397260273972,1.0,1.0,1/16,0.85%,HS3ST5
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.4947538430388684,-0.9172934078849819,0.6333333333333333,1.0,1.0,4/26,12.42%,IFITM3;DDX3X;EIF2AK2;PABPC1
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.5262345633207176,-0.9172834711025356,0.6666666666666666,1.0,1.0,7/13,38.79%,UBE2L3;ANAPC4;UBE2B;RNF4;UBE2D3;UBE2H;PRKN
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.5577923076594417,-0.9172601066557751,0.5822784810126582,1.0,1.0,1/9,4.16%,ARHGAP24
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.5636821123286094,-0.9171612419179221,0.6410256410256411,1.0,1.0,1/10,2.08%,KDM1A
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.4400849254344689,-0.9171311578072134,0.6666666666666666,1.0,1.0,16/60,17.94%,ADAMTS4;ASPA;PHYHIPL;OMG;SLC1A2;ENPP2;FGFR2;MT3;PLP1;TF;ARRDC2;KLHL2;ARSG;GFAP;NPC1;KIF13B
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.622940997140659,-0.9169965135508035,0.6231884057971014,1.0,1.0,2/5,19.79%,POLA1;WRN
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.5426872186696738,-0.9169485163956247,0.6666666666666666,1.0,1.0,3/15,20.25%,TGFB1;PRR5L;APPL2
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.5415484174059053,-0.9167888364358788,0.6867469879518072,1.0,1.0,3/13,10.61%,EFNB2;TGFB1;PTPN2
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.5663864190802113,-0.9167157593030477,0.6588235294117647,1.0,1.0,7/11,40.79%,GBE1;PYGB;PRKAG2;PHKB;PGM2L1;AGL;UGP2
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.4433000879933547,0.9166542218986324,0.55,1.0,1.0,1/9,1.54%,FMNL3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5859261800924334,-0.9165637583285902,0.620253164556962,1.0,1.0,2/7,14.55%,TPT1;CLU
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.45244368765319953,-0.9165035857263014,0.6382978723404256,1.0,1.0,9/60,11.54%,ELAVL3;CRMP1;PHYHIPL;ATL1;DCLK1;PTPRD;SNAP25;LRFN5;PLP1
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.5643099564965014,0.9164038493030313,0.6,1.0,1.0,2/6,8.36%,GUCY1B1;GUCY1A1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5970748916731016,-0.9162636426834078,0.6075949367088608,1.0,1.0,3/6,33.42%,RPL5;RPL11;ABL1
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.6027200313130587,-0.9159834245632384,0.6962025316455697,1.0,1.0,2/5,8.76%,TGFB2;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3519722938687623,0.9159004930944763,0.5,1.0,1.0,4/40,1.85%,ATP2B4;IL34;EDN3;PDGFA
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.5777640437675641,-0.9149977463613289,0.6621621621621622,1.0,1.0,4/6,38.94%,APPL2;PTN;NF1;KDM2B
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6154849987612215,-0.9149613294576793,0.6714285714285714,1.0,1.0,2/6,35.64%,DDX18;WDR12
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.4392435213961933,-0.9148704111448125,0.77,1.0,1.0,27/200,14.14%,TAF7;SCML1;ENO1;TWIST1;NRG1;KDM1A;BASP1;CRY1;HDAC2;PDCD4;CTCF;TGFB1;NIBAN2;CBFA2T2;CD38;ZFPM2;SNX6;MT3;TP63;RCOR1;JUN;ZHX3;EID1;CLOCK;SIN3A;FOXP2;CDKN1B
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.5860878918652705,-0.9147164172248449,0.6623376623376623,1.0,1.0,6/9,36.14%,CTR9;VIRMA;NCBP1;CPSF6;CCNT1;ZC3H14
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.5071357089238807,-0.9136741467533268,0.6153846153846154,1.0,1.0,3/16,13.43%,VEGFA;STAT3;IL18
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.5065857001685795,-0.9136215784941257,0.6585365853658537,1.0,1.0,8/27,22.46%,NRG1;TGFB2;TGFBR1;PPP3CA;SYTL4;PAK1;RAF1;SCARB1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.4730049768435996,-0.9130485821963557,0.6853932584269663,1.0,1.0,11/41,25.98%,TAF1B;CTCF;DNMT1;POLR1C;RBBP7;CREBZF;CGGBP1;DDX21;TAF1D;EED;SF3B1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.5136624820278725,0.9129782483607591,0.5416666666666666,1.0,1.0,1/8,1.32%,TRPC6
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.5963388838358338,-0.9128568514679996,0.6666666666666666,1.0,1.0,2/6,19.01%,RHOB;STARD13
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.47479984681373155,-0.9127305305367878,0.6777777777777778,1.0,1.0,7/42,9.46%,SLC22A6;CYP3A5;ATP5MK;SPTLC3;ALDH1L1;SLC16A7;ACOT11
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.5031549130140276,0.9126691336561499,0.4583333333333333,1.0,1.0,2/8,3.85%,INPP5F;PLA2G4C
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.5075822013644146,0.9125203450994983,0.5384615384615384,1.0,1.0,1/7,2.33%,SERGEF
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.587718176923377,-0.9124686796182601,0.6571428571428571,1.0,1.0,4/6,35.13%,PRKDC;XRCC6;HSPD1;CD47
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.6044205763630515,-0.9121860249453597,0.6527777777777778,1.0,1.0,4/7,37.36%,PRKDC;LAS1L;WDR12;EXOSC10
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.5036895640522986,-0.911912748634365,0.6162790697674418,1.0,1.0,3/16,3.16%,PRKACA;NR4A3;PDE4B
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.5998264302782624,-0.9118951747516244,0.6296296296296297,1.0,1.0,1/7,2.67%,ROBO2
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.5726791393189026,-0.9117810417880502,0.6891891891891891,1.0,1.0,5/9,31.17%,SLC47A1;SLC1A1;SLC6A20;SLC22A2;SLC6A13
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.5907316588125561,-0.9112801634148422,0.6621621621621622,1.0,1.0,3/5,36.85%,NRP2;NF1;FZD3
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.5225447139507905,-0.9111569728022219,0.6623376623376623,1.0,1.0,3/16,13.18%,CSNK1D;HDGFL3;GOLGA2
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.43499510697653104,-0.9109373820931238,0.77,1.0,1.0,41/244,18.73%,TAF7;SCML1;ENO1;TWIST1;NRG1;KDM1A;BASP1;CRY1;SELENOS;HDAC2;PDCD4;DDX3X;CTCF;TGFB1;NIBAN2;EIF2AK2;CBFA2T2;CD38;ZFPM2;GIGYF2;SNX6;MT3;TP63;RCOR1;JUN;ZHX3;EID1;CNOT8;CLOCK;SIN3A;IGF2BP2;FOXP2;CDKN1B;RPL13A;TSPYL2;WWP1;IGFBP5;TSHZ3;CREBZF;BTRC;BTG2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.42497351448595594,-0.9104461053689065,0.7070707070707071,1.0,1.0,48/185,23.26%,SOD1;TPT1;IFIT3;APIP;VEGFA;CD44;MYDGF;PTRH2;NFKBIA;HDAC2;DDX3X;ITGA5;SOD2;PRKCI;NIBAN2;RHBDD1;CD38;ARF4;SMAD6;RPS27A;SNX6;MT3;FHL2;PRKDC;NAIP;ANXA5;CFL1;WDR73;HSPA5;FMN2;PPARGC1A;NOTCH2;NAA15;PRLR;RNF213;UNC5B;DNAJA1;NR4A2;BEX3;SEMA4D;CPEB4;MAPK1;RAF1;BIRC2;SETX;AVEN;GLO1;FSTL1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.6222722723318174,-0.9100423986854473,0.6891891891891891,1.0,1.0,2/6,26.04%,COLEC12;RIOK3
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.6134515361872677,-0.9098711279853652,0.6842105263157895,1.0,1.0,4/5,35.90%,DENND4C;DENND4A;MADD;DENND1A
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.5453154796111782,-0.909524378309289,0.6216216216216216,1.0,1.0,3/10,21.84%,SGCZ;SGCD;BMP5
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.49715782060850866,-0.9094800547130663,0.6352941176470588,1.0,1.0,1/18,0.93%,SOD1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.4453045384837458,-0.9092010041481103,0.7340425531914894,1.0,1.0,11/64,21.17%,SEC13;PPP1CC;NUP133;STMN1;GOLGA2;SMC3;GPSM2;TNKS;RANBP2;MAP9;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.4369518082688225,0.9089659585938993,0.56,1.0,1.0,1/12,1.44%,EDN3
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.5117055257823779,-0.9088818708525951,0.6363636363636364,1.0,1.0,2/14,4.73%,CD44;CREB3L2
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.4531178725882566,-0.9086969779302005,0.6021505376344086,1.0,1.0,12/38,29.09%,PANK2;SREBF1;SCD;SIN3A;LSS;PRKAG2;SREBF2;PPARA;NCOR2;RORA;SP1;OPA3
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.515888592405388,-0.9085836558377304,0.654320987654321,1.0,1.0,4/17,23.62%,DNMT1;RBBP7;CREBZF;EED
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.46687001285629437,-0.9085072415609243,0.6373626373626373,1.0,1.0,12/36,26.04%,NFKBIA;PDCD4;TGFB1;USP15;ANKRD17;IL18;SASH1;CCN4;DDX60;LPL;APP;RIOK3
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.48248566594327935,-0.9083628684395466,0.6627906976744186,1.0,1.0,7/33,17.31%,PSMB1;PSMD14;RPS27A;PSMA4;PSMB2;PSMA7;ANAPC4
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.4701274814977416,-0.9080614989341805,0.6470588235294118,1.0,1.0,11/27,32.99%,SRSF10;RBM39;KHDRBS2;METTL16;AHCYL1;NCBP1;KHDRBS3;SUPT6H;CWC22;SAFB;LARP7
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.45511879716972425,-0.9080469884261304,0.6559139784946236,1.0,1.0,6/55,8.10%,ROBO2;TENM3;PRKCI;CBFA2T2;PTPRD;ROBO1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.612602784516765,-0.9077992413885343,0.65,1.0,1.0,4/5,38.79%,PPARA;ITGAV;NR1H3;PRKN
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.5602321708867731,-0.9075066394480805,0.6623376623376623,1.0,1.0,2/10,16.39%,TMCO1;CAMK2D
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.4323700582306618,-0.9072934330072265,0.6666666666666666,1.0,1.0,16/67,19.80%,NRCAM;TGFB2;DNER;SPOCK1;PTPRD;DDIT4;GPM6A;DCDC2;CCK;WNT2B;RUNX1;ASTN2;ACSL4;SMARCA1;NR4A2;ADNP2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.4308953986411623,-0.9067766808571995,0.6804123711340206,1.0,1.0,36/97,28.64%,CRY1;NXN;TSC2;SUFU;NKD1;NIBAN2;PTPRE;PTPN1;IFT122;DDIT4;PRKCB;PTPN2;LRRK2;IGFBP5;LGR4;BRAP;BTRC;NR4A2;MTMR2;NEDD4;BMP5;LRPAP1;NLK;SFRP4;PID1;DCN;WWOX;LYN;IRS1;RACK1;EGFR;CNOT1;SIAH1;DCC;PIK3CB;PTCH1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5268219165702178,-0.9067664952038117,0.65,1.0,1.0,7/16,21.53%,VEGFA;SASH1;DUSP1;MAP3K4;ULK4;MINK1;PER1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.42623273809167034,0.9067027408081998,0.6666666666666666,1.0,1.0,3/23,2.28%,ATP2B4;RYR2;ATP1B2
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.6057154925540659,-0.9065885542734338,0.676056338028169,1.0,1.0,4/6,38.54%,TP53BP1;SUPT6H;SHLD2;PAXIP1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.44783685207886076,-0.9063963603878016,0.7473684210526316,1.0,1.0,12/74,17.79%,RIPOR1;ANK3;IPO5;XPO4;TGFB1;CEMIP;ARIH2;TP63;MICALL2;PRR5L;UBE2L3;YWHAG
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.5456544540226939,-0.9063694088838496,0.6582278481012658,1.0,1.0,1/9,9.99%,RAD21
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.305920775296363,0.9053585102302054,0.6666666666666666,1.0,1.0,15/73,8.72%,SLIT3;LMOD1;PRKG1;COL14A1;FAM13C;COL5A2;GPRC5B;KCNJ8;RASL12;TNS2;MAGI1;PRRX1;EML1;SLIT2;PTPN21
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.5588350186219823,-0.9052146388292094,0.6857142857142857,1.0,1.0,2/7,11.66%,SPTLC1;AGK
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.5811170790778517,-0.9051355803115818,0.6571428571428571,1.0,1.0,2/7,26.74%,ATAD5;EGFR
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.4333325465702711,-0.9050358471997973,0.7291666666666666,1.0,1.0,18/95,21.12%,PRKACA;PPME1;CSNK1D;TUBA1A;CEP57;MELK;LATS2;CCP110;NINL;CDKN1B;CCNH;PPP2R2A;CDK14;YWHAG;BTRC;PHLDA1;SKP1;CRLF3
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.5388049968817277,-0.9050259416028146,0.6621621621621622,1.0,1.0,2/8,20.01%,GPSM2;MAP9
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.5390583207310937,0.9047526217631673,0.5652173913043478,1.0,1.0,1/5,0.59%,SLIT3
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.5390583207310937,0.9047526217631673,0.5652173913043478,1.0,1.0,1/5,0.59%,SLIT3
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.623899178639126,-0.9046895766891773,0.7402597402597403,1.0,1.0,2/5,10.61%,CSF1;PTPN2
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.6137133386228532,-0.9046400306990797,0.7352941176470589,1.0,1.0,6/7,32.49%,HIF1A;RPL5;DCUN1D4;DCUN1D2;RPL11;DCUN1D1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.6025262344269928,-0.9033736674106813,0.6901408450704225,1.0,1.0,4/5,38.79%,LRRK2;MAPK1;ABL1;PRKN
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.6025262344269928,-0.9033736674106813,0.6901408450704225,1.0,1.0,4/5,38.79%,LRRK2;MAPK1;ABL1;PRKN
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.5432435327473117,-0.9030479970332334,0.6753246753246753,1.0,1.0,7/13,30.85%,NR4A3;MT3;PPARGC1A;PID1;NDUFS4;ACADVL;LEPR
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.5907186093434735,-0.9029505040361476,0.6835443037974683,1.0,1.0,5/5,40.99%,EIF4G1;CORO2B;MACROH2A1;SLC38A2;ABCB1
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.5684634787186693,-0.9022397164711258,0.6582278481012658,1.0,1.0,2/7,18.47%,SLC35D1;PGM3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.5274421659835471,-0.9018673522875924,0.6823529411764706,1.0,1.0,2/15,3.16%,STC1;PDE4B
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.53898666702206,-0.9018165691720438,0.6973684210526315,1.0,1.0,6/10,32.72%,WDR43;LAS1L;RCL1;DDX18;HSPD1;SLC19A1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.537851887965676,-0.9015916595688724,0.6626506024096386,1.0,1.0,1/12,0.88%,PRKACA
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.5978505041795984,-0.9013052066723253,0.6716417910447762,1.0,1.0,1/5,6.36%,CST3
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.5877208179882478,-0.9006947696473315,0.65,1.0,1.0,1/6,7.32%,NUP88
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.4814565013762263,-0.9005276521292058,0.6436781609195402,1.0,1.0,3/27,8.37%,VEGFA;PTPRD;SYNDIG1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.45107281531411875,-0.8999732483287587,0.7065217391304348,1.0,1.0,19/62,31.45%,STRAP;DHX29;SRSF10;EIF2S2;PRKDC;RPS14;SRSF5;MCTS1;RPL5;EIF2S3;RPL24;SETX;SF3B1;CELF2;NCBP1;HSP90AB1;PRMT7;RPL11;RPL3
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.5883618445144481,-0.8999328629957623,0.7352941176470589,1.0,1.0,1/5,17.35%,NRP2
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.5260456353768571,-0.8995160424900489,0.6206896551724138,1.0,1.0,1/11,4.25%,NOS1AP
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.5260324480317428,-0.8994008252935871,0.5853658536585366,1.0,1.0,3/11,20.86%,GIGYF2;ROCK2;METTL16
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.4618183408618429,-0.8981738479809472,0.6444444444444445,1.0,1.0,5/33,15.48%,ANK3;RHOB;STMN1;ROCK2;MITD1
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.4578610015896535,0.8975060180337959,0.5833333333333334,1.0,1.0,2/6,7.92%,SERGEF;SNX3
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5348722128316777,-0.8972346655579918,0.675,1.0,1.0,2/8,20.64%,SEMA3B;SEMA4D
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.49743908117336644,0.8969095521834907,0.5,1.0,1.0,5/5,50.29%,SMC6;SMC5;RAD52;MSH3;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.4823913617760132,0.8968028269476014,0.5454545454545454,1.0,1.0,1/5,1.21%,TNIP1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.5131944689862624,-0.8963728128683102,0.6666666666666666,1.0,1.0,3/11,22.27%,SIN3A;EIF2AK4;STAT1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.42606372244528,-0.8959410390574245,0.78,1.0,1.0,38/185,17.39%,CSF1;SOD1;GJA1;TWIST1;HABP4;F3;TAF1B;CADM1;ANK3;VEGFA;NOS1AP;RPS4X;DDX3X;CTCF;TGFB1;OLFM1;EIF2AK2;STAT3;ROBO1;UPF3A;DNMT1;AFDN;RIMS2;HIF1A;MT3;KRAS;PRKDC;TGFBR1;PLD1;POLR1C;ROCK2;CLU;PPARGC1A;CALCOCO1;RIMS1;RAB27A;RGCC;DTNBP1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.4728806757644118,-0.8958224148314956,0.6091954022988506,1.0,1.0,11/31,29.62%,ELOB;CTR9;RTF1;CCNH;CCNK;AFF4;SUPT16H;NCBP1;GTF2H1;ELP2;SUPT6H
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.4728806757644118,-0.8958224148314956,0.6091954022988506,1.0,1.0,11/31,29.62%,ELOB;CTR9;RTF1;CCNH;CCNK;AFF4;SUPT16H;NCBP1;GTF2H1;ELP2;SUPT6H
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.5322411351439185,-0.895797449689818,0.7088607594936709,1.0,1.0,6/12,25.50%,NEDD4L;KCNQ1;AHCYL1;NEDD4;AKAP6;CHRM3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.589581013312062,-0.8956867131329704,0.68,1.0,1.0,3/6,25.82%,NLGN1;SYN3;STXBP1
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.5449274391782786,-0.8956609418481487,0.7073170731707317,1.0,1.0,2/10,21.17%,RAB27A;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.5569664830762363,-0.8953425867497271,0.7012987012987013,1.0,1.0,2/13,10.79%,NFKBIA;LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.5590237994832218,-0.895234410977637,0.6933333333333334,1.0,1.0,3/10,27.67%,PPP2R1B;WWOX;CYLD
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.5425639226295228,-0.8947957416142158,0.6883116883116883,1.0,1.0,1/10,4.79%,PDLIM1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.5425639226295228,-0.8947957416142158,0.6883116883116883,1.0,1.0,1/10,4.79%,PDLIM1
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.5826642498754144,-0.8943449481236941,0.6666666666666666,1.0,1.0,2/6,14.33%,SLC25A36;PARP1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.5521436464773655,-0.8942434917136112,0.6666666666666666,1.0,1.0,3/7,18.01%,CRMP1;DPYSL2;NT5E
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.41623283781921827,-0.8941729665109633,0.9,1.0,1.0,109/484,24.83%,TAF7;ETV5;TWIST1;ZFPM1;KLF2;NR4A3;KDM1A;LPIN1;VEGFA;MYDGF;AKIRIN1;NFKBIA;CREB3L2;GRIN1;ESR2;KANSL3;HDAC2;HMGN1;RARB;PLAG1;DDX3X;WDR43;CTCF;TGFB1;TET3;NIBAN2;STAT3;GLIS3;CD38;CDC5L;ARF4;ZFPM2;KLF15;RPS27A;RNF111;ACTR3;FGFR2;HIF1A;MT3;HSF2;HIVEP1;TP63;PAXBP1;ARNT2;PRKDC;ELF1;MED14;TGFBR1;JUN;SREBF1;IL18;PLAGL1;CLOCK;SIN3A;NCOA7;PARP1;ATF6;CHCHD2;WAC;TCF4;PPARGC1A;RUNX1;TBK1;NAA15;PPP3CA;TEAD1;SENP1;CALCOCO1;RNF10;RGCC;SMARCA1;CCN1;TNKS;CAMKK2;CEBPZ;BTRC;PRDM10;TET1;MYSM1;NR4A2;AGO2;KDM3A;YAF2;SREBF2;CCNK;FUBP3;NAMPT;CRLF3;PER1;PTOV1;BMP5;PPARA;CCNC;STAT1;SETX;NFIX;IRF1;TP53BP1;TCERG1;SUPT16H;STAT6;BCLAF3;APBB1;NR2C2;ELK3;DEAF1;PPP3CB;APP;PID1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.48286739253998917,-0.8941068493701361,0.6292134831460674,1.0,1.0,6/25,13.32%,TGFB2;TGFB1;OLFM1;HIF1A;TGFBR1;ROCK2
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.5396084282976699,-0.8938833435895744,0.6794871794871795,1.0,1.0,4/15,16.61%,SOD1;SPART;SLC25A36;LRRK2
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.4181828074521959,-0.8936071353465189,0.86,1.0,1.0,78/399,21.54%,WWC1;NELL1;PRDM6;CSF1;GJA1;HNRNPL;TWIST1;F3;PCBP3;ANK3;VEGFA;WWC2;TGFB2;NOS1AP;CREM;PTRH2;ZC3H7A;ESR2;SRSF10;PLAG1;DDX3X;CTCF;TGFB1;ZC3H7B;SUFU;OLFM1;CTR9;HCFC2;STAT3;ROBO1;ZNF138;DNMT1;CCAR1;AFDN;RIMS2;HIF1A;MT3;KRAS;ARNT2;PTBP2;TGFBR1;ROCK2;CLOCK;FAM50A;IGF2BP2;TERF2IP;CLU;PPARGC1A;NOTCH2;RUNX1;NDFIP2;CALCOCO1;RIMS1;UBE2L3;RAB27A;RGCC;DTNBP1;AFF2;TRIM5;PRDM10;CGGBP1;CLK1;AGO2;ADNP2;CCN4;HNRNPF;YAF2;RPL5;TRA2B;NDFIP1;FUBP3;METTL16;HINT1;MAPK1;BNC2;AFF4;PER1;NONO
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.3420566577175535,0.8935231201536029,0.75,1.0,1.0,5/41,7.44%,HSPA1A;VPS35;CELF1;NCK1;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.48133840733026156,-0.8933814917645533,0.7023809523809523,1.0,1.0,11/31,32.80%,DDX3X;PRKDC;POLR1C;TBK1;STAT1;IRF1;STAT6;RIOK3;XRCC6;HSPD1;POLR2F
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.49062466691738416,0.8933561191486491,0.56,1.0,1.0,1/6,7.52%,HSPB1
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.49062466691738416,0.8933561191486491,0.56,1.0,1.0,1/6,7.52%,HSPB1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.49062466691738416,0.8933561191486491,0.56,1.0,1.0,1/6,7.52%,HSPB1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.4978003059353029,-0.8928425199915367,0.6341463414634146,1.0,1.0,3/13,31.11%,RBBP7;NASP;MIS18BP1
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.45940119953173875,0.8922624651518741,0.631578947368421,1.0,1.0,1/8,4.54%,ZDHHC21
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.5621349608785459,-0.8922174616116035,0.6666666666666666,1.0,1.0,4/8,20.66%,VEGFA;SASH1;MAP3K4;MINK1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.46946435079149923,-0.8921916507260036,0.7362637362637363,1.0,1.0,12/45,25.36%,SSH1;IPO5;SLC38A9;DIAPH1;KCNQ1;RAP1B;IGFBP5;CPEB4;TSHR;LARS1;RRAGB;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.5204103578851483,-0.891431029433837,0.6794871794871795,1.0,1.0,5/10,18.39%,SYT1;ANK3;RIMS2;RIMS1;GRIK2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5181734183009233,-0.8910196321754045,0.7073170731707317,1.0,1.0,4/16,20.55%,ARIH2;MICALL2;UBE2L3;SREBF2
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.5784190388854809,-0.89088705873854,0.631578947368421,1.0,1.0,4/6,31.58%,ATP6V1G1;CPEB4;ATP6V0D1;NDUFS2
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.5717983033130987,-0.89071315293782,0.7702702702702703,1.0,1.0,1/6,16.02%,SENP1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.5005564735092509,-0.8906101416376146,0.6419753086419753,1.0,1.0,4/19,10.50%,ARHGAP24;TGFB2;STMN1;HEG1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.5236552817842878,-0.8904985707785976,0.6710526315789473,1.0,1.0,5/10,28.50%,SYMPK;CSTF3;CPSF2;SETX;NCBP1
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.6149899501610795,-0.890439387328405,0.6986301369863014,1.0,1.0,3/5,32.46%,NEDD4;UBE3A;UBR5
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.4437200188987147,-0.8903110697975067,0.7052631578947368,1.0,1.0,10/62,15.74%,TAF7;NR4A3;ESR2;RARB;CCN2;NRBP1;CCNH;PPARGC1A;NOTCH2;TEAD1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.44049284684431517,-0.8902372981700277,0.6813186813186813,1.0,1.0,9/51,13.43%,TMSB4X;SELENOS;NFKBIA;PDCD4;SNX6;LRFN5;PTPN2;LPCAT3;IL18
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.435574118111311,-0.8901921490394556,0.7684210526315789,1.0,1.0,12/72,12.56%,FAT3;GJA1;PCDH17;CRMP1;PHYHIPL;DCLK1;PTPRD;PDGFD;SYNDIG1;PLP1;ARNT2;PURG
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.4809210175438988,0.8890980526238376,0.5652173913043478,1.0,1.0,2/7,1.44%,RYR2;EDN3
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.4271660615580074,-0.8890141672969746,0.77,1.0,1.0,22/142,15.71%,EMP1;TTC8;PTPDC1;LZTFL1;NUDCD3;TRAF3IP1;GALNT11;ARF4;IFT122;SDCBP;ACTR3;ARMC9;RAP1B;PARVB;IFT52;DCDC2;IFT140;ATP6V1D;EXOC1;MAK;PMP22;WDR19
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.5965999331539382,-0.8887782601871758,0.711864406779661,1.0,1.0,2/6,19.59%,INTS8;INTS2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.5441574201972786,-0.8887113907466001,0.6987951807228916,1.0,1.0,2/11,9.82%,SDCBP;RNF111
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.5441574201972786,-0.8887113907466001,0.6987951807228916,1.0,1.0,2/11,9.82%,SDCBP;RNF111
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.41415398723666175,-0.8886648415541138,0.83,1.0,1.0,51/297,16.19%,SOD1;TPT1;MTCH2;IFIT3;APIP;VAV3;SRA1;VEGFA;CD44;MYDGF;NFKBIA;ARHGEF9;HDAC2;DDX3X;RHOB;OLFM1;PRKCI;NIBAN2;RHBDD1;MELK;CD38;ARF4;STK4;SMAD6;LATS2;CCAR1;RPS27A;SPTLC1;MT3;FHL2;TP63;ANKRD13C;PRKDC;IFT57;NAIP;ANXA5;JUN;SGK1;CFL1;WDR73;DDX42;ATF6;CLU;HSPA5;FMN2;NOTCH2;NAA15;MCF2L;PRLR;APH1B;NAE1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.5857283683921327,-0.8884572659948361,0.7605633802816901,1.0,1.0,2/6,26.36%,CFL1;CLASP2
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.5268412643438833,-0.8881613274923242,0.686046511627907,1.0,1.0,1/13,1.32%,TWIST1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.4389425945769664,-0.8880546691680928,0.6875,1.0,1.0,16/87,15.15%,SOD1;TWIST1;ZFPM1;F3;CADM1;PDE4B;TGFB1;EIF2AK2;STAT3;HIF1A;PRKDC;POLR1C;ROCK2;IL18;RUNX1;TBK1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.32942534325885353,0.887944695128615,1.0,1.0,1.0,2/39,1.21%,SPRY3;TNIP1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.5430816747374942,-0.8879187946051706,0.7435897435897436,1.0,1.0,3/10,16.61%,GRIN1;GABRE;LRRK2
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.5224415686588697,-0.8874747577736882,0.7073170731707317,1.0,1.0,5/16,16.52%,ITGA5;COL11A1;CTR9;RTF1;COL7A1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.577472511059353,-0.8870837793790961,0.7631578947368421,1.0,1.0,4/7,30.96%,VPS51;CTNNA2;PAFAH1B1;SPEF2
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.43854437604589636,-0.8870081802938296,0.75,1.0,1.0,11/75,12.25%,PCDH17;ELAVL3;CRMP1;PHYHIPL;DCLK1;NMNAT2;TSHZ1;SCN3A;SNAP25;SLC7A14;CCK
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.5934397899702701,-0.8868969991505133,0.7083333333333334,1.0,1.0,2/6,15.35%,AKIRIN1;PPP3CA
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.5729144190491435,-0.8863846643658988,0.7037037037037037,1.0,1.0,3/6,26.71%,MTMR9;MTMR2;MTMR1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.5672077314456813,-0.8863058085502014,0.75,1.0,1.0,6/10,32.10%,BACH2;NEMF;RSRC1;MALT1;NCBP1;NUP205
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.4847850934562107,-0.8861967506824842,0.6428571428571429,1.0,1.0,7/14,38.59%,SCARB1;XKR4;ITGAV;RHOBTB1;MEGF10;NR1H3;RAC1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.49611017871639407,-0.8856216237082195,0.6813186813186813,1.0,1.0,2/17,6.06%,PIP4P2;MTMR9
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.5913453697401703,-0.885570193648324,0.6973684210526315,1.0,1.0,3/5,27.98%,SMAD6;LDLRAD4;SNX25
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.5951861955947404,-0.8853513983556109,0.782608695652174,1.0,1.0,2/7,4.23%,ZFPM1;TGFB2
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.44143233436618917,-0.8852485180105941,0.7222222222222222,1.0,1.0,14/39,25.11%,CHST11;OGN;MGST1;SLC10A7;DSE;OMD;GLCE;PAPSS1;CHSY1;METTL16;CSGALNACT1;VCAN;CHST15;DCN
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.4795079788333542,-0.8851131404378616,0.6588235294117647,1.0,1.0,2/17,9.86%,AKIRIN1;ACTR3
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.4363360389824752,-0.8848767022718503,0.8064516129032258,1.0,1.0,18/77,20.53%,KLF2;NOS1AP;RPS4X;DDX3X;UPF3A;HIF1A;PTPN2;SLC25A37;PRKDC;PLD1;ATAD5;SREBF1;CLU;PPARGC1A;RGCC;ELAVL1;ASS1;RPL5
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.3389390035424334,0.8848705770067777,0.6,1.0,1.0,9/69,8.68%,HSPA1A;DNAI4;ARL6;PTGES3;BIN1;NCK1;CHMP4B;SHQ1;IMMP2L
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.595448457093484,-0.8848367671899326,0.7142857142857143,1.0,1.0,2/6,17.54%,KLF15;LGR4
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.5668952511207933,0.8847856511640935,0.64,1.0,1.0,2/5,8.87%,ERCC6;APLF
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.5359276457896099,-0.8846661144251602,0.6527777777777778,1.0,1.0,4/10,24.72%,STAT3;MALT1;LPL;APP
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.46515713834242306,-0.8845052198094554,0.6896551724137931,1.0,1.0,6/33,13.07%,VEGFA;TMSB4X;RHOJ;TGFB1;HIF1A;JCAD
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.5261795845841818,-0.8841362656951172,0.6582278481012658,1.0,1.0,1/14,2.64%,CRY1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.5585226260570314,-0.8836802804508894,0.7023809523809523,1.0,1.0,6/7,44.14%,CAMKK2;VPS13D;VDAC1;PRKN;SLC25A4;HTT
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4162581605022454,0.8836554155118892,0.6363636363636364,1.0,1.0,2/10,2.93%,ERBB4;NOTCH1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.5349046193754687,-0.883498879017486,0.6933333333333334,1.0,1.0,4/11,24.72%,STAT3;MALT1;LPL;APP
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.41237340802991634,-0.8831750539195102,0.76,1.0,1.0,17/123,16.38%,EPN1;SYT1;ANK3;TOR1AIP2;DNAJC6;NAPG;PRKCI;RPS27A;ACTR3;AP2A1;LPCAT3;SGCZ;USO1;TF;REPS1;MITD1;RIMS1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.5526143679891262,-0.8831734676764327,0.7073170731707317,1.0,1.0,1/8,6.73%,LIMA1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.47724140223453754,-0.8831125327718812,0.7582417582417582,1.0,1.0,10/35,30.10%,TRAF3IP1;PRKDC;POLR1C;TBK1;NPLOC4;POLA1;IRF1;STAT6;CYLD;XRCC6
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.4526085340649513,-0.8826526302916269,0.6666666666666666,1.0,1.0,6/27,13.07%,F3;VEGFA;MYDGF;HIF1A;TGFBR1;JCAD
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.4145556008927407,-0.8824953688298968,0.7575757575757576,1.0,1.0,30/147,15.99%,TPT1;IFIT3;APIP;VEGFA;CD44;MYDGF;NFKBIA;HDAC2;DDX3X;PRKCI;NIBAN2;RHBDD1;CD38;ARF4;SMAD6;RPS27A;MT3;FHL2;PRKDC;NAIP;ANXA5;CFL1;WDR73;GPX4;HSPA5;FMN2;NOTCH2;NAA15;PRLR;RAB7A
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.5354569531161597,-0.8824409794810087,0.7228915662650602,1.0,1.0,2/11,10.14%,ARHGAP24;CCP110
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.5341782217176599,-0.8821859226854144,0.6506024096385542,1.0,1.0,1/8,16.75%,SMG7
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.4521874448403168,0.8818674481810764,0.65,1.0,1.0,2/12,2.28%,ATP2B4;ATP1B2
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5391350713889829,-0.8815742422954976,0.726027397260274,1.0,1.0,6/12,31.39%,RPA1;PARP1;WRN;XPA;RPA3;PARG
prerank,PanglaoDB_Augmented_2021__T Cells,-0.48213163035204654,-0.8813934361847962,0.6551724137931034,1.0,1.0,2/19,4.40%,IFIT3;CREM
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.4324133865808582,-0.8813844179652509,0.711340206185567,1.0,1.0,7/81,6.27%,ARHGAP15;VAV3;ARHGAP31;ARHGAP24;RHOJ;ARHGEF9;RHOB
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.45961616942870626,-0.8812280275697818,0.7032967032967034,1.0,1.0,15/30,23.99%,PDK3;LGALS3;FADS2;SEMA3B;ALCAM;ANXA5;SCD;CLU;ERRFI1;LSS;SREBF2;CHKA;CPEB2;CD9;LPL
prerank,PanglaoDB_Augmented_2021__Basophils,0.3429870868848658,0.8812194877833014,0.4444444444444444,1.0,1.0,6/31,5.52%,INF2;NT5C3A;H2AC6;CD4;IGFBP7;SLC26A3
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.5347131913811608,-0.8811713201251823,0.6923076923076923,1.0,1.0,4/11,12.38%,SOD1;GRIN1;TGFB1;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.5511329216828572,-0.8809216320729192,0.6933333333333334,1.0,1.0,5/7,29.26%,SIN3A;TERF2IP;POT1;MIER1;TERF1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.4403851455606911,-0.8807457666486211,0.7415730337078652,1.0,1.0,14/64,19.08%,CSNK1D;CSNK1G2;DDX3X;PSMB1;TGFB1;PSMD14;FGFR2;PSMA4;PSMB2;PSMA7;LRRK2;LGR4;TNKS;UBE2B
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.5547305602628799,-0.8805273402682575,0.704225352112676,1.0,1.0,3/6,31.47%,PPP3CA;PPP3CB;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.5547305602628799,-0.8805273402682575,0.704225352112676,1.0,1.0,3/6,31.47%,PPP3CA;PPP3CB;NFAT5
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5297514686066338,0.8796412959898908,0.5625,1.0,1.0,2/5,11.69%,HMGB1;ATF7IP
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.5021558041609253,0.8796288472499978,0.6521739130434783,1.0,1.0,1/5,1.21%,TNIP1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.43446497429905656,-0.8793678813006778,0.7395833333333334,1.0,1.0,10/60,13.86%,NRG1;HOMER2;SPTBN4;DNER;SPOCK1;TRAF3IP1;ARFGEF3;DCDC2;IFT140;GNAL
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.5749298447843536,-0.8792692881335735,0.6625,1.0,1.0,2/7,21.29%,NEDD4L;MDM2
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.5893223847969823,-0.8790348522048359,0.7142857142857143,1.0,1.0,2/5,29.45%,CNOT1;STRN3
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.3188844113845458,0.8789107441757199,0.6666666666666666,1.0,1.0,4/72,1.35%,INF2;ZDHHC15;WTIP;ADGRA2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.5085482079579173,0.8787301720086893,0.7777777777777778,1.0,1.0,3/5,10.92%,DOCK8;RHOA;CXCL12
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.5516815756876383,-0.8785083832927244,0.6585365853658537,1.0,1.0,2/7,28.50%,AHCYL1;NCBP1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.6094315764952876,-0.8780660620174667,0.7162162162162162,1.0,1.0,4/5,38.79%,P4HB;FYN;LANCL1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.3079549041315057,0.8778106659945236,0.6666666666666666,1.0,1.0,7/40,7.92%,ZDHHC15;ATP1B2;SERPINI1;ARSB;CAPRIN2;PLXNB2;SNX3
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.4990715826563776,-0.8771399663379779,0.6588235294117647,1.0,1.0,3/14,15.82%,NIBAN2;TERF2IP;ZRANB3
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.3736994285738029,0.8769927989660153,0.75,1.0,1.0,2/51,0.34%,HSPA1A;RBM20
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.46321648683687255,-0.8768953748617226,0.6966292134831461,1.0,1.0,10/26,21.29%,ARID3A;PRKDC;PLAGL1;CNOT8;CDKN1B;WAC;RGCC;MDM4;BTG2;MDM2
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.4312126343653457,-0.8761936917829691,0.78125,1.0,1.0,24/75,27.31%,OXSR1;EIF2AK2;STK33;MELK;STK4;FGFR2;SIK2;MAK;CAMK2D;LRRK2;CAMKK2;STK24;MINK1;UHMK1;PAK1;EIF2AK4;TAOK3;MAPKAPK2;STK39;LYN;INSR;EGFR;FLT1;SLK
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.4650276616582105,-0.8758441883988666,0.7093023255813954,1.0,1.0,6/26,26.74%,TGFB1;ERBIN;ADAM17;REPS2;GRB2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.4658095230967332,-0.8756795435431677,0.7176470588235294,1.0,1.0,12/27,30.51%,SMCHD1;SPIDR;PARP1;FMN2;RNF168;UIMC1;SLF1;EGFR;EYA1;BRCC3;EYA2;SPIRE1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.46865902295445844,-0.8756409150524711,0.7142857142857143,1.0,1.0,3/25,10.61%,CRY1;STAT3;PTPN2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.3879326933719421,0.8755060950543576,0.5263157894736842,1.0,1.0,3/14,9.82%,CDC42;MYH9;GULP1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.4123915409560234,-0.8754172777514825,0.7551020408163265,1.0,1.0,43/128,25.90%,ZFP36L2;NRG1;SPTBN4;GRIN1;PPP1CC;PSMB1;NCAM1;TGFB1;MAP3K8;PSMD14;RPS27A;RBX1;FGFR2;MT3;SHC2;KRAS;PSMA4;PSMB2;IL18;PSMA7;LRRC7;PEBP1;LRRK2;RASGRF2;BRAP;CAMKK2;BTRC;SKP1;MINK1;MAPK1;PAK1;RAF1;FYN;TAOK3;SETX;MAPKAPK2;GRB2;PSMA3;KITLG;RASA3;MBP;IRS1;GRIN2B
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.5803224548301926,-0.8754106294828454,0.6621621621621622,1.0,1.0,4/5,40.06%,PYGB;PHKB;PGM2L1;AGL
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.5803224548301926,-0.8754106294828454,0.6621621621621622,1.0,1.0,4/5,40.06%,PYGB;PHKB;PGM2L1;AGL
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.39273211457876167,0.8753616344649204,0.6111111111111112,1.0,1.0,3/13,9.07%,CDC42;SYNPO2;SLC9A1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.5054353384489113,-0.8744735388694033,0.6707317073170732,1.0,1.0,5/13,31.37%,NFKBIA;SREBF2;ABCA8;PTCH1;ABCA5
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.4810694808767527,-0.8743434949458785,0.6746987951807228,1.0,1.0,7/15,27.65%,GRIN1;GRIA3;LRRC7;NLGN1;APP;GRIN2B;GRIA4
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.33290035566558734,0.8743302517881315,0.7,1.0,1.0,5/39,8.25%,LEMD3;NOTCH1;ITGA3;SKI;RBPMS2
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.4094696714474748,-0.8742851581829386,0.7653061224489796,1.0,1.0,28/119,19.08%,CSNK1D;CSNK1G2;IGFBP2;MCC;CSNK1A1;DDX3X;PSMB1;TGFB1;NKD1;STK4;PSMD14;LATS2;RBX1;FGFR2;BICC1;PSMA4;PSMB2;AMFR;UBAC2;PSMA7;TMEM64;CDK14;LRRK2;TLE4;LGR4;TNKS;BTRC;UBE2B
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.5743022867722161,-0.874207695195287,0.7285714285714285,1.0,1.0,1/5,9.66%,PRKCB
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.45722231605899705,-0.8741791798399696,0.6547619047619048,1.0,1.0,5/24,12.38%,ZFPM1;VEGFA;TGFB2;OLFM1;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.4118285262727643,-0.8738486778105122,0.7216494845360825,1.0,1.0,20/79,17.32%,IGFBP2;MCC;NXN;TSC2;CSNK1A1;PSMB1;NKD1;STK4;PSMD14;LATS2;RBX1;BICC1;PSMA4;PSMB2;AMFR;UBAC2;PSMA7;TMEM64;RNF213;TLE4
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.47158760775344855,-0.8736297918229744,0.7777777777777778,1.0,1.0,9/40,18.30%,IPO5;PTPN1;LATS2;HEG1;PRKAR1A;CDKN1B;PRKAR2A;DUSP1;PKIG
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.3891490654768741,0.8734941305127051,0.6190476190476191,1.0,1.0,4/10,17.09%,SMYD3;SETDB1;PRDM5;SETDB2
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.5739801943060212,-0.8734265639853435,0.7014925373134329,1.0,1.0,2/5,28.07%,CAMK2D;GSN
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.4156178388446171,-0.8731087300094316,0.7551020408163265,1.0,1.0,12/70,13.26%,GJA1;ELAVL3;NRXN3;DPP6;PHYHIPL;CDH20;SLC1A2;ALDH1L1;MT3;PLP1;GRIA3;CDC42EP4
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.554676130031913,-0.8731063214529221,0.7317073170731707,1.0,1.0,3/9,21.99%,PANK2;PRKAG2;PPARA
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.28209212751568535,0.8729279550629019,1.0,1.0,1.0,6/69,5.82%,CAV2;NTN4;TINAGL1;FKBP9;COL5A2;TNS2
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.5738594353023514,-0.8729121273419582,0.7307692307692307,1.0,1.0,4/6,37.76%,CCT4;CCT8;CCT6A;CCT3
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.42976598180745323,-0.8724613346731586,0.7578947368421053,1.0,1.0,25/71,33.89%,TWIST1;PTPN1;HIF1A;CNOT8;ATF6;PRR5L;LRRK2;TRIM5;PPARA;APP;TMEM59;DCN;IRS1;INSR;CNOT1;PIK3CB;GRSF1;RDX;ADAM9;FOXO1;RNF152;TP53INP1;SNX9;SH3D19;GTPBP1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.40345209520729675,-0.8723672034483552,0.89,1.0,1.0,44/198,21.84%,CSF1;NRG1;S1PR3;VEGFA;EFNB2;TGFB2;RPS4X;GRIN1;EAPP;HDAC2;DDX3X;TGFB1;PDGFD;CCN2;CCAR1;SDCBP;TBC1D8;FGFR2;MT3;SSR1;KRAS;ANKRD17;CDC123;TGFBR1;FRMD5;CNOT8;CDKN1B;AKR1C2;TRIM13;PPP3CA;PRLR;RNF10;RAB27A;COLEC12;MCTS1;TET1;NAP1L1;ADNP2;P4HB;NAMPT;TSHR;MDM2;PAK1;BMP5
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.5539413894242552,0.8723509531499578,0.625,1.0,1.0,1/5,0.37%,PGF
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.4999873666972976,-0.8718456520544487,0.6904761904761905,1.0,1.0,4/16,13.71%,RHOB;TANK;SPIDR;CLOCK
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.45524024396143703,-0.87152495935204,0.6842105263157895,1.0,1.0,6/28,13.32%,TGFB2;TGFB1;FGFR2;HIF1A;TGFBR1;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5643288116551554,-0.8714544236624219,0.6901408450704225,1.0,1.0,2/5,14.66%,PTPN1;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.5734676643208756,-0.8712919492088176,0.7380952380952381,1.0,1.0,3/6,38.79%,MTMR2;RDX;PRKN
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.5550336114502804,-0.8709369784933593,0.7051282051282052,1.0,1.0,6/7,42.93%,TSPYL2;TERF1;RAD17;PDS5A;WAPL;S100A11
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.3463811677156161,0.8707055013666681,0.7,1.0,1.0,4/27,7.72%,CACUL1;CDK6;CUL2;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.5812530463346941,-0.8700863287831627,0.6623376623376623,1.0,1.0,1/6,5.55%,TUT7
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.41505202549582376,-0.8691261832387933,0.7755102040816326,1.0,1.0,6/86,6.37%,ARHGAP15;SOD1;TBC1D20;VAV3;MMUT;RGS7
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.516540711601491,-0.868818764999595,0.7349397590361446,1.0,1.0,2/18,2.03%,GNPAT;AGPAT4
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.5850150064713293,-0.8685726609227278,0.6708860759493671,1.0,1.0,2/6,27.68%,PTS;MTHFD1L
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.5376814958941976,-0.8685299067760268,0.6582278481012658,1.0,1.0,4/11,27.95%,SREBF1;CAMKK2;SREBF2;VDAC1
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.40579058293959647,-0.8684367493056007,0.82,1.0,1.0,31/191,18.10%,CSNK1D;WIPI1;TTC8;PTPDC1;DHX29;DDX3X;LZTFL1;NUDCD3;GOLGA8A;TRAF3IP1;GALNT11;ARF4;GOLGA8B;IFT122;ACTR3;ARMC9;IFT52;DCDC2;IFT140;C9ORF72;ATG16L2;GOLGA2;ATP6V1D;EXOC1;MAK;WDR19;RAB7A;FARP2;CSDE1;TNKS;PATL1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.504150857937234,-0.8683707264501711,0.7160493827160493,1.0,1.0,7/14,43.10%,PABPC1;ELAVL1;YBX1;CIRBP;FMR1;NBAS;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.40350437794741234,0.8679358489195602,0.6470588235294118,1.0,1.0,3/15,4.85%,SERPINH1;SERPINI1;BIN1
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),-0.5100058882781933,-0.8678098422844707,0.7051282051282052,1.0,1.0,1/14,2.43%,CYTH1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.44609408095870645,-0.8674731045173185,0.7252747252747253,1.0,1.0,11/39,20.46%,MUCL1;GALNT15;DPM1;TET3;GALNT11;GALNT10;GALNT7;PGM3;TET1;XXYLT1;GALNTL6
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.5186497323961629,-0.8672112618635283,0.6463414634146342,1.0,1.0,4/11,19.76%,MCCC2;BCKDHB;BCAT2;DLD
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.5186497323961629,-0.8672112618635283,0.6463414634146342,1.0,1.0,4/11,19.76%,MCCC2;BCKDHB;BCAT2;DLD
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.5548315183909978,-0.8670844956044593,0.7027027027027027,1.0,1.0,2/5,30.27%,GPSM2;EPB41L2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.5548315183909978,-0.8670844956044593,0.7027027027027027,1.0,1.0,2/5,30.27%,GPSM2;EPB41L2
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5310499884746982,-0.8666556112361975,0.6973684210526315,1.0,1.0,2/6,14.53%,PTPN1;ATF6
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.44668062225941496,-0.8665626441045566,0.7395833333333334,1.0,1.0,12/47,22.88%,VEGFA;TMSB4X;RHOB;TGFB1;HIF1A;ROCK2;SASH1;NRP2;PLPP3;RIN2;SCARB1;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.4577545689436314,0.8656465319438036,0.625,1.0,1.0,2/6,2.93%,HEY2;NOTCH1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.4609793684600091,-0.8654480006117642,0.6956521739130435,1.0,1.0,9/25,35.02%,ANKRD17;ATAD5;TSPYL2;SMC3;EGFR;TERF1;ORC3;RBBP6;RAD17
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.46964798752604203,-0.865442502036246,0.7804878048780488,1.0,1.0,9/24,39.00%,ADM;NEDD4;CD9;GRB2;DNM3;LDLRAP1;AP2M1;CD81;DNM1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4948232688846793,-0.8647731176048493,0.7058823529411765,1.0,1.0,5/17,22.64%,CRY1;PIAS2;CLOCK;PER1;NCOR2
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.5093643400911161,0.8646792298924074,0.6666666666666666,1.0,1.0,1/5,1.32%,TRPC6
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.5119656147229251,-0.8645767089710166,0.6794871794871795,1.0,1.0,7/15,33.98%,OLFM2;RAB12;ARFGAP3;RAB8B;GOLPH3;CANX;SEL1L
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.5011783497996348,-0.8645665082669567,0.7111111111111111,1.0,1.0,6/19,12.38%,ZFPM1;ROBO2;TGFB2;ROBO1;ZFPM2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5545295010468729,-0.8644065936908406,0.7073170731707317,1.0,1.0,1/6,6.42%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.5305478168378958,-0.8643569068780036,0.7692307692307693,1.0,1.0,4/9,25.51%,ADM;PPM1K;PPARA;IRS1
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.4039938721914244,-0.8640518884911973,0.7474747474747475,1.0,1.0,24/160,16.92%,SLC2A3;CD55;CD44;MGST1;DDX3X;PSMB1;CST3;DIAPH1;LGALS3;PSMD14;SNAP25;FTH1;SDCBP;RAP1B;MANBA;SRP14;CRISPLD2;PLD1;ATP6V1D;RAB7A;LRRC7;PYGB;RAB27A;PDXK
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.5324843145084408,-0.8640306169403993,0.7272727272727273,1.0,1.0,2/14,6.42%,LZTFL1;TGFB1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.5206126273551526,-0.8636337866342455,0.7325581395348837,1.0,1.0,2/11,12.42%,ZFP36L2;PABPC1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.5206126273551526,-0.8636337866342455,0.7325581395348837,1.0,1.0,2/11,12.42%,ZFP36L2;PABPC1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.5394479406710704,-0.8632557092210978,0.7272727272727273,1.0,1.0,4/9,29.26%,HNRNPC;DCP2;POT1;TERF1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.40407986966805765,-0.8632031875620974,0.7474747474747475,1.0,1.0,24/159,16.92%,SLC2A3;CD55;CD44;MGST1;DDX3X;PSMB1;CST3;DIAPH1;LGALS3;PSMD14;SNAP25;FTH1;SDCBP;RAP1B;MANBA;SRP14;CRISPLD2;PLD1;ATP6V1D;RAB7A;LRRC7;PYGB;RAB27A;PDXK
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.47594091241866554,-0.8629963822106613,0.717391304347826,1.0,1.0,6/20,26.71%,PIP4P2;MTMR9;PLPP3;MTMR2;SYNJ2;MTMR1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5223307150756744,-0.862900730221637,0.7530864197530864,1.0,1.0,1/11,0.88%,PRKACA
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.5066467840193045,0.8628782269240582,0.5,1.0,1.0,2/8,4.06%,PLA2G4C;PTGES3
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.3468632475004196,0.8628073487180957,0.6363636363636364,1.0,1.0,3/28,3.33%,SCN1A;HCN2;FGF13
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.5391808763069245,-0.8624194731313685,0.6933333333333334,1.0,1.0,3/8,24.67%,DDIT4;ZFYVE27;GRB2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.5271020774486855,-0.8620458483561074,0.76,1.0,1.0,3/8,9.65%,KCNE4;NEDD4L;KCNQ1
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4406170163741122,-0.861930487480215,0.717391304347826,1.0,1.0,4/40,9.86%,NR4A3;VAV3;WIPF1;ACTR3
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.4991503296627766,0.8617000305037087,0.7083333333333334,1.0,1.0,1/6,9.75%,ULK2
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.4991503296627766,0.8617000305037087,0.7083333333333334,1.0,1.0,1/6,9.75%,ULK2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.5859071860934347,-0.8616220940147676,0.7368421052631579,1.0,1.0,5/5,41.47%,RUNX1;IRF1;CBFB;CD46;BCL6
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.5144124818193723,0.8616051741942768,0.6206896551724138,1.0,1.0,1/6,7.91%,PIP4K2B
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.5011334719525797,-0.861277822074972,0.7073170731707317,1.0,1.0,8/13,32.49%,GOLGA2;UBE2L3;BTRC;SKP1;DCUN1D4;RPS2;DCUN1D2;DCUN1D1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.5719731134724175,-0.8609458276638965,0.7,1.0,1.0,3/7,18.30%,PRKAR1A;PRKAR2A;PKIG
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.5180035445294021,-0.8603613293247916,0.6666666666666666,1.0,1.0,1/11,0.90%,CSF1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.39914296710282837,-0.860195104105306,0.97,1.0,1.0,177/774,24.83%,WWC1;TAF7;PRDM6;ENO1;ETV5;TWIST1;ZFPM1;KLF2;NR4A3;KDM1A;PURB;CRY1;LPIN1;SRA1;JDP2;VEGFA;WWC2;MYDGF;AKIRIN1;CREM;NFKBIA;CREB3L2;GRIN1;ESR2;PIAS2;KANSL3;HDAC2;RARB;PLAG1;DDX3X;PKNOX2;CTCF;TGFB1;SUFU;SOD2;HIVEP2;ARID3A;ZNF235;TET3;BACH2;CTR9;HCFC2;ZMYM5;STAT3;TSHZ1;HES4;GLIS3;CDC5L;ARF4;ZFPM2;SMAD6;NEDD4L;KLF15;KLF3;ZNF608;PRKCB;RPS27A;SDCBP;RNF111;ACTR3;RAD21;MED12L;FGFR2;SAP130;HIF1A;PRKAR1A;HSF2;FHL2;HIVEP1;TP63;PAXBP1;ARNT2;HDGFL3;PRKDC;RCOR1;CEBPD;RTF1;ELF1;MED14;TSHZ2;PURG;RPS14;JUN;SREBF1;ZKSCAN1;IL18;ZHX3;PLAGL1;EID1;CLOCK;SIN3A;ZNF595;FOXP2;NCOA7;PARP1;CCNH;ATF6;CHCHD2;ZSCAN18;TCF4;PPARGC1A;RUNX1;TBK1;PPP3CA;TEAD1;ZIC4;SP110;MAFK;SENP1;CALCOCO1;HIF3A;RNF10;CAMK2D;CHD2;CHD1;RGCC;MDM4;EZH1;SMARCA1;CBX7;ZNF790;CCN1;TSHZ3;TNKS;ZNF528;CREBZF;CEBPZ;ZNF814;ZNF83;PKNOX1;PRDM10;CGGBP1;TET1;MYSM1;NR4A2;AGO2;KDM3A;SREBF2;CCNK;SEMA4D;FUBP3;NAMPT;SMURF2;CRLF3;MDM2;PER1;ZNF483;PTOV1;BMP5;PPARA;CCNC;STAT1;SETX;NCOR2;NFIX;ZNF25;IRF1;TP53BP1;TCERG1;ZNF654;EED;YEATS2;STAT6;ZNF536;ZNF397;BCLAF3;APBB1;NR2C2;ZNF565;ZNF43;ELK3;ZBTB40;DEAF1;PPP3CB;APP;ZNF302;PID1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5105926487490497,-0.8599234477564967,0.7108433734939759,1.0,1.0,1/13,3.32%,VAV3
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.5849960510664268,-0.859730582518843,0.7272727272727273,1.0,1.0,4/5,37.81%,TCF4;SUPT6H;MCM3AP;SETD2
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.5420777860043193,-0.8596614498961318,0.6842105263157895,1.0,1.0,1/8,17.39%,DTNBP1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.4315448742367691,0.8595373661666422,0.6111111111111112,1.0,1.0,6/16,7.72%,PDGFA;ATM;DACH1;HMBOX1;SMOC2;CDKN1A
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.5325991183655662,-0.8593913259366256,0.7228915662650602,1.0,1.0,3/10,20.42%,TGFB1;FHL2;CHSY1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.35069279924197233,0.8593108452097482,0.7142857142857143,1.0,1.0,2/17,1.85%,SLIT3;PDGFA
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.5960347112911502,-0.8592561340836197,0.7341772151898734,1.0,1.0,1/5,21.88%,EIF2AK4
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.45522159672431484,-0.8591260972674852,0.7126436781609196,1.0,1.0,11/29,24.97%,PSMB1;PSMD14;PSMA4;PSMB2;PSMA7;BTRC;SKP1;BIRC2;MALT1;MAP3K14;PSMA3
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.5833091608910356,-0.8590591885329106,0.6986301369863014,1.0,1.0,2/7,23.28%,OXSR1;STK39
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.5317092265434222,-0.8590395713461317,0.7341772151898734,1.0,1.0,1/11,5.12%,DPM1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5393287994310886,-0.8589398275179594,0.7530864197530864,1.0,1.0,2/6,13.91%,TMSB4X;SIN3A
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.5475395617159241,-0.8588090754819074,0.6891891891891891,1.0,1.0,2/6,14.73%,LPCAT3;PLAAT3
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.4528442342704368,-0.8586878955128462,0.7159090909090909,1.0,1.0,7/33,21.01%,MAP3K8;RPS27A;ADORA2B;BTRC;SKP1;MINK1;MAPK1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.3529933579849219,0.8585906189085857,0.7272727272727273,1.0,1.0,2/33,0.37%,CAV2;PGF
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.4859681820057862,0.858352505765248,0.6666666666666666,1.0,1.0,1/6,0.82%,GALNT16
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.5014236492901443,-0.8582997024306969,0.6891891891891891,1.0,1.0,2/7,26.83%,SNX2;RAB6A
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.5085052566266666,-0.8579553364135849,0.8214285714285714,1.0,1.0,2/15,13.96%,TGFB1;SYMPK
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.42541197239661804,0.8579170518197959,0.55,1.0,1.0,4/11,14.69%,AFAP1L2;HIP1;ARAP1;FBXW7
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.4948758509683152,-0.8578537904036021,0.7528089887640449,1.0,1.0,6/18,13.32%,TWIST1;ROBO2;TGFB1;ROBO1;SMAD6;ROCK2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.458448619870665,-0.8574086748469796,0.6777777777777778,1.0,1.0,2/28,2.64%,CAMKMT;CRY1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.4692327886087826,-0.8573921114564813,0.7619047619047619,1.0,1.0,7/25,23.84%,CSNK1A1;WNT2B;LRRK2;PLPP3;NR4A2;DIXDC1;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.5113673217793827,-0.8573281684179104,0.6823529411764706,1.0,1.0,2/7,10.59%,NOS1AP;HIF1A
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.5150762238346568,-0.8572069833668992,0.775,1.0,1.0,5/14,30.09%,TGFB1;NEDD4;SIAH1;SNX25;UVRAG
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.5641271599121874,-0.8571688611504307,0.6933333333333334,1.0,1.0,1/5,12.67%,SLC39A11
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.4907835281029149,-0.8564797469049147,0.725,1.0,1.0,4/11,16.38%,SYT1;SNAP25;RIMS2;RIMS1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.47611366625567164,0.8563943858583581,0.5789473684210527,1.0,1.0,4/11,6.41%,ERBB4;BCL2L1;VPS35;BCL2
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.4570461555684771,-0.8563537693670599,0.7666666666666667,1.0,1.0,9/30,20.80%,RPA1;MORF4L1;PSMD14;RAD21;SPIDR;PARP1;FAN1;WRN;ZSWIM7
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.44203025270112556,0.8558894567063771,0.5416666666666666,1.0,1.0,1/7,2.45%,MFHAS1
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.53284020887284,-0.8558741964078617,0.75,1.0,1.0,1/8,7.96%,STAT3
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.48393370770038724,-0.855871712182627,0.7228915662650602,1.0,1.0,3/15,24.89%,MDM4;HINT1;FHIT
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.5071855908120646,-0.8557325360934416,0.7439024390243902,1.0,1.0,1/13,5.18%,HDAC2
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.47734611970338825,-0.8555579149313388,0.6666666666666666,1.0,1.0,4/21,17.01%,RAP1B;SNCAIP;ROCK2;GFAP
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.4516903002359603,-0.8544182923599811,0.7282608695652174,1.0,1.0,5/25,17.51%,CSF1;VEGFA;PARP1;RUNX1;FARP2
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.5307068033603521,-0.8540414692332197,0.725,1.0,1.0,3/9,20.35%,TUT7;DCP2;SSB
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.5368333622045622,-0.853831614893403,0.75,1.0,1.0,1/9,6.44%,ADM
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5365689712840273,-0.8536074289221887,0.7051282051282052,1.0,1.0,2/6,10.59%,NOS1AP;HIF1A
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.5659196235325814,-0.8534814777602074,0.7073170731707317,1.0,1.0,2/5,23.43%,NAA15;METAP1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.49880103639329304,-0.8533987794965724,0.691358024691358,1.0,1.0,3/14,14.21%,RPA1;ANKRD28;TERF2IP
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.49880103639329304,-0.8533987794965724,0.691358024691358,1.0,1.0,3/14,14.21%,RPA1;ANKRD28;TERF2IP
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.3811397610058843,0.8530651535427477,0.6842105263157895,1.0,1.0,4/23,7.44%,LEMD3;BIN1;NUP54;CHMP4B
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.4294915020624059,0.8529183349641142,0.6,1.0,1.0,1/9,3.60%,IWS1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.4990094147377847,0.8527574369408149,0.6923076923076923,1.0,1.0,2/5,15.77%,RAB22A;PICALM
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.4799534418313145,0.8525752863452257,0.5714285714285714,1.0,1.0,1/5,6.68%,PIK3CD
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.49888169237330104,-0.8522789916092947,0.7608695652173914,1.0,1.0,6/15,13.32%,TWIST1;ROBO2;TGFB1;ROBO1;SMAD6;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.4216744581021424,-0.8522258213492877,0.8163265306122449,1.0,1.0,18/86,18.25%,KDM1A;VEGFA;NFKBIA;ESR2;PRKCI;EIF2AK2;STAT3;PRKCB;RPS27A;IL18;CLOCK;TERF2IP;CLU;TRIM13;PPARGC1A;RGCC;PLPP3;TRIM5
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.5361736642313681,-0.8521133076771934,0.7662337662337663,1.0,1.0,2/12,6.42%,LZTFL1;TGFB1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.33417721449771776,0.8521094801841658,0.6666666666666666,1.0,1.0,2/19,5.44%,SNAP29;NSFL1C
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.46824381562363776,-0.8520182883309956,0.7619047619047619,1.0,1.0,7/20,30.94%,SLC2A1;SNAP25;CLOCK;KCNC2;PPP3CB;ENSA;PRKCA
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.5135103884864693,-0.8519952664928853,0.7764705882352941,1.0,1.0,5/13,14.98%,ROBO2;TGFB2;ROBO1;SMAD6;NOTCH2
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.41526199814250725,-0.8519731491954424,0.8163265306122449,1.0,1.0,33/105,26.74%,NR4A3;PDE4B;SSH1;SELENOS;IPO5;PLAA;SLC38A9;PDCD4;PDK3;CTR9;KCNQ1;RAP1B;MT3;JUN;ROCK2;IGFBP5;CAMKK2;MTR;ADNP2;KCNC2;CPEB4;MAPK1;TSHR;LARS1;SETX;LPL;PID1;RRAGB;AKAP6;LYN;IRS1;RORA;EGFR
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.3911135699517844,0.851863935377148,0.5,1.0,1.0,4/15,11.72%,ZDHHC15;CAPRIN2;ARHGAP44;PDLIM5
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.46065670772471073,0.8517620352661929,0.5416666666666666,1.0,1.0,3/8,12.87%,CHMP4B;SORT1;VCP
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.4203858608057507,-0.8513334195295269,0.782608695652174,1.0,1.0,20/68,29.50%,DPP6;SPTBN4;ANK3;ATP1B3;AFDN;ROCK2;DENND4C;ZFYVE27;TSPAN5;DPP10;GAK;RAB11A;RAB12;STXBP1;RAB8B;CLASP2;MAP7;PTCH1;EPB41L3;RDX
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.46071353846484164,0.85095193246251,0.5517241379310345,1.0,1.0,3/7,3.75%,SOX5;LTBP3;SOX6
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.580734571218865,-0.8506506876583346,0.7733333333333333,1.0,1.0,2/5,22.36%,PPARA;FYN
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.3989457169165958,-0.850540138748695,0.7755102040816326,1.0,1.0,24/161,16.92%,SLC2A3;CD55;CD44;MGST1;DDX3X;PSMB1;CST3;DIAPH1;LGALS3;PSMD14;SNAP25;FTH1;SDCBP;RAP1B;MANBA;SRP14;CRISPLD2;PLD1;ATP6V1D;RAB7A;LRRC7;PYGB;RAB27A;PDXK
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.438214309551741,0.8505156458053744,0.7222222222222222,1.0,1.0,2/13,5.26%,MCU;VPS35
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.46471891937143395,0.8500262145164872,0.5714285714285714,1.0,1.0,2/7,12.38%,ACTN4;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.46471891937143395,0.8500262145164872,0.5714285714285714,1.0,1.0,2/7,12.38%,ACTN4;CORO1C
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.4223417082995039,-0.8496424291177547,0.8,1.0,1.0,15/63,28.85%,SEC13;NUP153;NUP133;NUP88;SDCBP;HIF1A;CDKN1B;RANBP2;PRKAG2;KCTD20;APP;LYN;EGFR;NDUFS4;FN1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.48536467709570486,0.8492973855362821,0.6206896551724138,1.0,1.0,1/5,3.97%,CDC42
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.46370436899458106,-0.8492751086568591,0.7241379310344828,1.0,1.0,3/21,16.61%,NPRL3;C9ORF72;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.48452170706073916,-0.848985273038962,0.7045454545454546,1.0,1.0,5/17,18.49%,HDAC2;RHBDD1;TANK;BTRC;WDR48
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.4778248735144947,-0.8488374267249046,0.7777777777777778,1.0,1.0,7/26,32.37%,VEGFA;TF;CLU;SFRP4;INSR;LDLRAP1;SGIP1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.5178171111516591,-0.8486924854764534,0.7236842105263158,1.0,1.0,2/9,17.45%,SMCHD1;EZH1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),-0.5488188551341827,-0.8486322464646414,0.7466666666666667,1.0,1.0,3/5,21.90%,ATP11B;SCARB2;ATP8A2
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.49996346086210103,-0.8486217636275102,0.7654320987654321,1.0,1.0,2/10,10.50%,STMN1;HEG1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.43801808960000155,-0.8484229568717409,0.7586206896551724,1.0,1.0,12/40,16.35%,KLF2;ELOB;VEGFA;PSMB1;PSMD14;RPS27A;RBX1;HIF1A;PSMA4;PSMB2;PSMA7;HIF3A
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.5872159986463156,-0.8483725290923391,0.7692307692307693,1.0,1.0,1/5,7.26%,TRAF3IP1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.4973021901043022,-0.8482310790694855,0.7088607594936709,1.0,1.0,3/13,27.48%,MORF4L1;MORF4L2;PHF20L1
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.41674932013321325,-0.8479098070550121,0.7802197802197802,1.0,1.0,14/68,26.78%,SOD1;COG2;NAPG;USO1;ATP6V1H;GOLGA4;PAM;LAMP2;MAPK1;SNX2;STX12;ARFGAP3;EGFR;TOM1L1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.47513360106766,-0.8474423876945433,0.7241379310344828,1.0,1.0,5/26,15.28%,ELAVL3;PHYHIPL;SNAP25;NXPH1;SNAP91
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.5505467987604011,-0.8471207678666195,0.6962025316455697,1.0,1.0,3/7,37.07%,DNM3;FGD6;ARHGEF4
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.4997558351499347,-0.8470547590590901,0.7297297297297297,1.0,1.0,3/10,31.11%,RBBP7;NASP;MIS18BP1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.38709525927598804,0.847006956207214,0.6190476190476191,1.0,1.0,2/11,2.93%,ERBB4;NOTCH1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.49025035512537746,0.8467728103007691,0.7727272727272727,1.0,1.0,1/6,1.27%,CSPG4
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.49025035512537746,0.8467728103007691,0.7727272727272727,1.0,1.0,1/6,1.27%,CSPG4
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.5532495876053993,-0.8467682141404974,0.7638888888888888,1.0,1.0,1/6,9.66%,PRKCB
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.49178150979869995,-0.8467352231057282,0.75,1.0,1.0,8/18,34.12%,GGA3;ROCK2;CLU;RTN1;SP1;EPHA4;PRNP;RTN3
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.5071436876542085,-0.8465787498426693,0.7402597402597403,1.0,1.0,1/7,13.80%,NINL
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),-0.5685565771321585,-0.8465643517112327,0.7368421052631579,1.0,1.0,4/6,37.89%,TGFBR1;ACVR1B;SMAD2;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.5523104699865119,-0.8463582428478001,0.75,1.0,1.0,5/6,44.82%,ADAM9;SNX9;SH3D19;NRDC;TNFRSF1B
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.45956838394826394,-0.8462130362888094,0.7666666666666667,1.0,1.0,6/26,24.01%,KANSL3;MORF4L1;EP400;MORF4L2;PER1;APBB1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.4115840442307599,-0.845803322783935,0.8247422680412371,1.0,1.0,34/118,30.09%,RPA1;XRCC4;RPS27A;RAD21;PRKDC;PARP1;FAN1;FANCC;ZRANB3;POLK;ALKBH5;WDR48;POLA1;BTG2;UBE2B;RNF168;WRN;XPA;SETX;TP53BP1;APBB1;UIMC1;RAD23B;APTX;USP3;ZBTB1;EYA1;PARP4;RPA3;BRCC3;GTF2H1;SMC1A;ASCC3;UVRAG
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.4755023030210387,0.8456141571016645,0.64,1.0,1.0,1/10,1.38%,RYR2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.4015046626507818,-0.8451058234376916,0.82,1.0,1.0,23/140,16.80%,SOD1;MTCH2;VAV3;TGFB2;PTRH2;ARHGEF9;DDX3X;EPHA7;RHOB;OLFM1;MELK;STK4;LATS2;CCAR1;RPS27A;TP63;TGFBR1;JUN;ATF6;CLU;MCF2L;APH1B;RASGRF2
prerank,MSigDB_Hallmark_2020__Androgen Response,0.2914487732821587,0.8449398922716304,1.0,1.0,1.0,10/62,8.72%,TNFAIP8;INPP4B;ZBTB10;CDK6;MERTK;ELK4;IQGAP2;UBE2I;GUCY1A1;PTPN21
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.4382426709425669,-0.8448613948574724,0.7191011235955056,1.0,1.0,17/42,28.86%,SPTBN4;VEGFA;CD44;TGFB1;STK4;DDIT4;TERF2IP;TBK1;MTCP1;PAK1;RAF1;APP;RACK1;EGFR;PDE4D;NSD1;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.5147534416371624,-0.8445379138667637,0.6962025316455697,1.0,1.0,2/10,13.43%,CD55;IL18
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.4690025599261768,-0.8442265478746496,0.7865168539325843,1.0,1.0,6/22,26.44%,VEGFA;SDCBP;MTMR2;LRPAP1;SFRP4;INSR
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.41414810815038283,-0.8440940215086743,0.7692307692307693,1.0,1.0,21/62,31.50%,ROBO2;GRIN1;EPHA7;DDIT4;ARNT2;SLC6A17;SMARCA1;AFF2;RAB18;VPS51;SYNJ2;GRIN2B;NDUFS4;CTNNA2;PTCH1;UBE3A;TGFBR2;NF1;PAFAH1B1;SPEF2;ADGRL3
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.3856279241402256,0.8439553064656058,0.6666666666666666,1.0,1.0,6/21,15.29%,PDGFA;UBE2N;SMG1;UBE2V2;YLPM1;THOC1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.4883577966255634,-0.8438178483421388,0.6973684210526315,1.0,1.0,4/12,12.38%,TGFB2;PDCD4;OLFM1;TGFBR1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.5749159605003175,-0.8436474481870713,0.7916666666666666,1.0,1.0,3/6,23.29%,UBE2K;STAT1;IRF1
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.4765115457496964,-0.8436139600321799,0.7176470588235294,1.0,1.0,7/16,38.83%,MT3;TF;SLC40A1;CP;FTL;PRKN;ABCB7
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.4814735550018529,0.8435636464184333,0.5555555555555556,1.0,1.0,3/5,15.90%,DOCK11;PPP2R3C;MEF2C
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.42942193403810375,-0.8434336846839191,0.717391304347826,1.0,1.0,12/48,25.47%,IFITM3;DDX3X;ANKRD17;TRIM13;TBK1;COLEC12;TRIM5;ALPK1;FYN;MALT1;APP;LYN
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.40041887414098265,-0.8434056373137372,0.7959183673469388,1.0,1.0,8/81,11.03%,GJA1;ADAMTS9;GPR161;TENM3;PAPPA;PDE10A;FBN1;DENND2A
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5159278719816733,0.8430145394863455,0.68,1.0,1.0,2/7,9.83%,CDC42;NTF3
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),-0.43978760327100064,-0.8429078766433856,0.75,1.0,1.0,13/39,23.79%,OXSR1;GALNT11;PRKDC;TGFBR1;ROCK2;TBK1;CAMK2D;LRRK2;TNKS;GALNTL6;MAPK1;STK39;NLK
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.46593024536818833,-0.8426196482215055,0.7848101265822784,1.0,1.0,10/21,32.55%,DNAJC6;AP2A1;GPR107;SNAP91;GAK;AP2B1;PIP5K1C;AP2A2;SGIP1;CANX
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.4033024508926595,-0.8419533884256842,0.7395833333333334,1.0,1.0,10/59,12.44%,GJA1;PHYHIPL;CDH20;SLC1A2;ALDH1L1;SYNDIG1;SNAP25;MT3;PLP1;GRIA3
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.5387738213852105,-0.8411697503890034,0.7361111111111112,1.0,1.0,5/8,35.30%,ATP6V1H;ATP6V0D1;ATP6V0E1;DMXL1;DMXL2
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.39906161414200453,0.8411056582107239,0.6842105263157895,1.0,1.0,4/12,12.69%,SPRY3;SLIT2;MAPKAP1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5518029839341567,-0.8408282984681404,0.7763157894736842,1.0,1.0,3/7,33.05%,ROCK2;RANBP9;PRNP
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.4614680741307685,-0.8408196174254285,0.75,1.0,1.0,6/19,25.90%,GRIN1;DDX3X;FYN;ARL6IP5;MALT1;GRIN2B
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.5865259785469653,-0.840722586617275,0.7466666666666667,1.0,1.0,1/5,19.71%,AGO2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.5865259785469653,-0.840722586617275,0.7466666666666667,1.0,1.0,1/5,19.71%,AGO2
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.43501119503903046,0.840682933877894,0.6363636363636364,1.0,1.0,1/8,4.99%,CD4
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.5141651824402746,-0.8405211519184771,0.7804878048780488,1.0,1.0,2/10,10.61%,NFKBIA;PTPN2
prerank,MSigDB_Hallmark_2020__Complement,-0.4090139129440583,-0.8404218464544522,0.7934782608695652,1.0,1.0,14/65,14.66%,CTSL;F3;CD55;CFH;LIPA;LGALS3;ZFPM2;USP15;MT3;C1R;ANXA5;CA2;CLU;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.5491446084535405,-0.8402273814671651,0.7066666666666667,1.0,1.0,2/7,19.63%,LGALS3;PAG1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4951680768895639,-0.8401963268249937,0.7160493827160493,1.0,1.0,3/15,9.41%,ANK3;GLRX;ATP1B3
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5140664735446672,-0.8399733546686344,0.7428571428571429,1.0,1.0,5/8,39.98%,ATP5F1C;DMAC2L;ATP5F1E;ATP5ME;ATP5MC2
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.5140664735446672,-0.8399733546686344,0.7428571428571429,1.0,1.0,5/8,39.98%,ATP5F1C;DMAC2L;ATP5F1E;ATP5ME;ATP5MC2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.5291357092772078,-0.8399700427087037,0.7901234567901234,1.0,1.0,2/10,23.39%,RAB7A;EEA1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.42747844165307136,0.838965580163928,0.5909090909090909,1.0,1.0,1/7,2.45%,MFHAS1
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.38439627184236835,0.8383279803548159,0.7307692307692307,1.0,1.0,4/13,10.92%,LRCH1;DOCK8;RHOA;CXCL12
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.5889819766527737,-0.8381664585825739,0.8333333333333334,1.0,1.0,1/5,17.63%,NPC1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.5398612893612562,-0.8373169467810825,0.76,1.0,1.0,2/5,37.56%,SLF1;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.5398612893612562,-0.8373169467810825,0.76,1.0,1.0,2/5,37.56%,SLF1;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.5398612893612562,-0.8373169467810825,0.76,1.0,1.0,2/5,37.56%,SLF1;MACROH2A1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.5198974166235478,-0.8372857683388399,0.7674418604651163,1.0,1.0,5/10,14.98%,ROBO2;TGFB2;ROBO1;SMAD6;NOTCH2
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.3370029193722389,0.8367275383314912,0.8888888888888888,1.0,1.0,2/37,1.92%,NRG2;ERBB4
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.5581264680102281,-0.836720766285995,0.76,1.0,1.0,1/6,0.90%,CSF1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.44631648871442453,0.8365178119862067,0.6666666666666666,1.0,1.0,1/6,1.38%,RYR2
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.5539461408096835,-0.8365017617348705,0.7692307692307693,1.0,1.0,2/7,12.38%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.4347693805608297,-0.8363989366353279,0.7666666666666667,1.0,1.0,11/25,38.28%,CTCF;NAP1L1;SUPT16H;NASP;ARID1A;ANP32B;SUPT6H;MACROH2A1;MCM3AP;SETD2;ARID2
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.4893770500161835,-0.8363765314537335,0.7435897435897436,1.0,1.0,5/16,17.35%,CDKL1;ITGA5;NKD1;TP63;NRP2
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.5280404732141825,-0.8362741156788984,0.6875,1.0,1.0,3/6,38.79%,MAP1LC3B;AMBRA1;PRKN
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.4815672903230513,-0.8358184364354866,0.7738095238095238,1.0,1.0,7/24,18.89%,WASF3;WASF1;DIAPH1;HDGFL3;GPX4;MICALL2;UBE2K
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.4176667697974841,-0.8354913439195593,0.8172043010752689,1.0,1.0,15/54,26.16%,NXN;TSC2;NKD1;FGFR2;DCDC2;RUNX1;CDK14;LRRK2;BTRC;NLK;SFRP4;APP;GNAQ;WWOX;RACK1
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.46593868522274384,-0.835253137527189,0.7802197802197802,1.0,1.0,8/28,25.47%,PRAG1;ROBO1;NOTCH2;LPAR6;ERBIN;AKAP13;GRB2;LYN
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.5553257821819075,-0.8350367959335832,0.7230769230769231,1.0,1.0,2/5,26.89%,MALT1;RC3H2
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5218846580479324,-0.8350062924902781,0.7051282051282052,1.0,1.0,2/6,14.66%,PTPN1;HSPA5
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.5495045463010723,-0.8348036223689173,0.7297297297297297,1.0,1.0,1/6,19.71%,AGO2
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4577954227498712,-0.8347643710473678,0.75,1.0,1.0,8/24,32.75%,ESR2;CALCOCO1;KDM3A;NEDD4;ARID1A;UBE3A;UBR5;SAFB
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.4741199844658488,0.8346103122055065,0.6333333333333333,1.0,1.0,2/5,2.93%,HEY2;NOTCH1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.4480407680906043,-0.8345668868468139,0.7528089887640449,1.0,1.0,4/21,10.45%,ROBO2;PTPRD;SYNDIG1;LRFN5
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.41149955759063694,-0.8343879351431688,0.7684210526315789,1.0,1.0,4/73,6.42%,ZFP36L2;VEGFA;CD44;TGFB1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.42557309609472216,-0.8336740437702054,0.717391304347826,1.0,1.0,10/52,26.27%,HDAC2;HCFC2;HNRNPC;NUDT5;EZH1;SMARCA1;MYSM1;PAK1;ARID1A;ZBTB1
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.47372326383777325,-0.8335704824792359,0.75,1.0,1.0,6/22,12.38%,ZFPM1;ROBO2;TGFB2;ROBO1;ZFPM2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.4789689710126645,-0.8335601900259035,0.72,1.0,1.0,6/13,31.62%,CD55;MALT1;HLA-B;ZBTB1;FBXO38;HSPD1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.470694093909643,-0.8334758010726439,0.7195121951219512,1.0,1.0,2/16,11.34%,KDM1A;SGCZ
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.4484303082935564,0.8331946110984378,0.625,1.0,1.0,1/9,1.43%,LRCH1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.4112524993447251,-0.8331797818742384,0.8111111111111111,1.0,1.0,14/74,19.08%,CSNK1D;CSNK1G2;DDX3X;PSMB1;TGFB1;PSMD14;FGFR2;PSMA4;PSMB2;PSMA7;LRRK2;LGR4;TNKS;UBE2B
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.48643287220228526,-0.8329644384054021,0.7272727272727273,1.0,1.0,2/15,9.74%,MICOS10;SPG7
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.35772519814191345,0.8325748741982257,0.8571428571428571,1.0,1.0,4/38,5.38%,SH3RF3;RNF146;TRIM52;TRAF6
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.5055161636350447,-0.8324093587240753,0.7922077922077922,1.0,1.0,4/13,16.61%,TMEM165;CA2;SLC9A9;LRRK2
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.3858946031961437,0.8322875888995932,0.6363636363636364,1.0,1.0,3/14,4.79%,CSPG4;GLB1;ARSB
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.4724672672137992,-0.8322795616105689,0.7317073170731707,1.0,1.0,4/12,28.27%,ZRANB3;WRN;BOD1L1;MMS22L
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.518862912265817,-0.8321232665946767,0.7297297297297297,1.0,1.0,1/6,1.67%,ZFPM1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.4785189798082493,-0.8320988041899832,0.782051282051282,1.0,1.0,4/15,9.65%,GJA1;KCNE4;NEDD4L;KCNQ1
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.5263297585875448,-0.8320430227370242,0.7222222222222222,1.0,1.0,3/8,36.35%,PPARGC1A;ETFDH;SLC25A13
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.5285398937745863,-0.8313827144734147,0.7307692307692307,1.0,1.0,1/8,7.89%,PTPRD
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.36984241178456495,0.8311829273126581,0.5909090909090909,1.0,1.0,1/17,0.59%,SLIT3
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.41780838891380717,-0.8310011562172083,0.7528089887640449,1.0,1.0,15/42,24.61%,ELAVL3;PHYHIPL;SPOCK1;PDE10A;SNAP25;PLP1;CCK;NXPH1;SNAP91;GFAP;CADM2;KCNC2;NEGR1;ZNF536;LRRC4C
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.41704248336147637,-0.830872392450494,0.84375,1.0,1.0,17/65,24.36%,GJA1;PELI1;PRKCB;ANKRD17;TERF2IP;TRIM13;TBK1;NDFIP2;TRIM5;TMED4;ALPK1;NDFIP1;DDX21;AKAP13;BIRC2;MALT1;MAP3K14
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.40439272511696917,-0.8305078918902018,0.8172043010752689,1.0,1.0,18/64,27.05%,PDE4B;VAV3;PSMB1;CD38;PSMD14;PRKCB;PSMA4;PSMB2;PSMA7;BTRC;PAG1;SKP1;PAK1;FYN;MALT1;PSMA3;RC3H2;PDE4D
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.41916351843266975,-0.8304923379436382,0.7894736842105263,1.0,1.0,14/48,21.81%,NKD1;NEDD4L;CDKN1B;FMN2;AZIN1;RAB7A;WWP1;GFAP;MDM4;NSF;SMURF2;MDM2;HECW1;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5213603880623237,-0.8303055150038181,0.7236842105263158,1.0,1.0,1/7,17.31%,ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5213603880623237,-0.8303055150038181,0.7236842105263158,1.0,1.0,1/7,17.31%,ANAPC4
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5213603880623237,-0.8303055150038181,0.7236842105263158,1.0,1.0,1/7,17.31%,ANAPC4
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.5699223553668178,-0.8300552734662491,0.7971014492753623,1.0,1.0,1/6,10.95%,NPRL3
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.5283718696118169,-0.8300176087502515,0.7391304347826086,1.0,1.0,2/6,31.34%,NPC1;LDLRAP1
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.4700327182271633,0.8300040313383602,0.6521739130434783,1.0,1.0,1/7,3.13%,INPP5F
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.40872525917720026,-0.8292202054974509,0.8105263157894737,1.0,1.0,17/67,22.43%,WWC1;APIP;MYDGF;EPHA7;STK4;FGFR2;JCAD;ROCK2;DUSP1;PEBP1;CCN1;TRIM5;ULK4;MINK1;MAPK1;PAK1;TAOK3
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.44406464293776565,0.8290018641229702,0.631578947368421,1.0,1.0,2/11,4.54%,ZDHHC15;ZDHHC21
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.43994808487207376,-0.8288343868980359,0.75,1.0,1.0,6/31,9.58%,STC1;TPT1;TMCO1;GRIN1;SLC10A7;TMEM165
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.4720651235061534,-0.8287251027451022,0.7191011235955056,1.0,1.0,4/14,21.84%,DDX3X;LGALS3;RNF34;BMP5
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.4003938314722212,-0.8283594946147932,0.8041237113402062,1.0,1.0,19/86,21.50%,TSC2;NFKBIA;PDCD4;RHOB;MELK;STK4;DDIT4;TP63;IFT57;YARS1;PLAGL1;PARP1;NOTCH2;NAE1;PAWR;PRUNE2;MDM2;RAF1;AHCYL1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.43100919942987415,-0.8277708934694697,0.8089887640449438,1.0,1.0,7/41,13.29%,IGFBP2;TGFB2;PLAG1;FGGY;SLC16A7;ARPP21;SGK1
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.5357146774674382,-0.8276814170162718,0.7894736842105263,1.0,1.0,3/9,38.54%,PPARGC1A;GLYR1;PAXIP1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.4510878056622413,-0.8268787611141944,0.8372093023255814,1.0,1.0,8/23,25.06%,LZTFL1;NEDD4L;LATS2;ROCK2;SIN3A;DNAJA1;GPM6B;GOPC
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.5427213168169039,-0.8267668806953156,0.7567567567567568,1.0,1.0,2/7,11.23%,SEC11A;SRP14
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.5309932234253392,-0.8267323882662349,0.7162162162162162,1.0,1.0,2/8,19.46%,NIBAN2;NAP1L1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.3992231096584842,0.8264423047075454,0.7368421052631579,1.0,1.0,3/12,11.35%,MRPL1;MRPL33;MRPL3
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.5518388001612454,-0.8263917685731679,0.7681159420289855,1.0,1.0,3/5,39.50%,YME1L1;AFG1L;BNIP3L
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.5159030525202614,-0.8263160420727734,0.7948717948717948,1.0,1.0,4/10,29.02%,SOD2;LRRK2;FYN;PDE8A
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.49590382935736227,-0.8262229053472923,0.759493670886076,1.0,1.0,2/11,12.90%,DDX3X;DELE1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.35192957840270883,0.8256131908020864,0.5714285714285714,1.0,1.0,4/19,6.27%,HEY2;NOTCH1;PPARD;WNT5B
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.4364149976490769,-0.8254804803643034,0.7777777777777778,1.0,1.0,7/29,27.34%,ATL1;RNF213;ELAVL1;KCNC2;TP53BP1;ZBTB1;YME1L1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.4715187814976684,-0.8253101692166775,0.7816091954022989,1.0,1.0,9/20,30.10%,RPA1;PRKDC;TERF2IP;PARP1;WRN;POT1;RPA3;TERF1;XRCC6
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.40570855693400526,-0.8250838302200582,0.8247422680412371,1.0,1.0,14/79,17.68%,GJA1;PCDH17;VEGFA;CD44;DCLK1;GLUL;COL11A1;PTPRD;PLP1;CA2;CLU;ATG4B;IGFBP5;PLPP3
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.5435025708919428,-0.8248124936093444,0.6805555555555556,1.0,1.0,2/6,25.50%,TSHR;CHRM3
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.48205590188489866,-0.8245973545241423,0.7375,1.0,1.0,6/12,25.11%,CHST11;CHSY1;CSGALNACT1;VCAN;CHST15;DCN
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.4004944060656556,0.8244473680002311,0.8181818181818182,1.0,1.0,4/12,10.92%,LRCH1;DOCK8;RHOA;CXCL12
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.486168907646252,-0.8243730074657991,0.7105263157894737,1.0,1.0,6/11,25.11%,CHST11;CHSY1;CSGALNACT1;VCAN;CHST15;DCN
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.5114453168663217,-0.8243377700236424,0.7808219178082192,1.0,1.0,2/7,25.53%,SUPT16H;NASP
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.5568656334923776,-0.8242888855644043,0.7714285714285715,1.0,1.0,2/6,21.87%,LGALS3;JAM2
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.33125431397833466,0.8241563666017163,0.6875,1.0,1.0,1/21,0.64%,SNAP29
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.5367418385006109,-0.8239959178124285,0.7246376811594203,1.0,1.0,4/5,45.47%,PAPSS1;BPNT2;SLC35B3;PAPSS2
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.4026179163367548,-0.8233300901577997,0.8131868131868132,1.0,1.0,17/68,17.32%,IGFBP2;MCC;CSNK1A1;PSMB1;NKD1;STK4;PSMD14;LATS2;RBX1;BICC1;PSMA4;PSMB2;AMFR;UBAC2;PSMA7;TMEM64;TLE4
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.48398510388546245,-0.8229379007854581,0.7285714285714285,1.0,1.0,3/12,13.07%,VEGFA;RHOJ;JCAD
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.46247556244320276,-0.8229179055543416,0.7619047619047619,1.0,1.0,5/21,22.27%,IFITM3;EIF2AK2;TRIM13;TRIM5;STAT1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.49273297698917823,0.8226036341813114,0.6666666666666666,1.0,1.0,1/5,0.33%,ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.49273297698917823,0.8226036341813114,0.6666666666666666,1.0,1.0,1/5,0.33%,ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.4463871646915692,-0.8222272837982957,0.7209302325581395,1.0,1.0,10/27,25.90%,SYT1;RIMS2;RIMS1;DTNBP1;TSHZ3;GRIK2;NLGN1;EIF2AK4;APP;GRIN2B
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.5094228756427186,-0.8222049077463587,0.7439024390243902,1.0,1.0,3/11,20.49%,UBE2B;RNF168;SKP1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.3268368283895052,0.8218435832194633,0.8,1.0,1.0,4/29,5.74%,ZDHHC15;ARL6;ZDHHC21;SYNE3
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4907846253022221,0.8211383608225622,0.7407407407407407,1.0,1.0,1/5,4.42%,PPARD
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.41444339587890294,-0.8206931477205337,0.84375,1.0,1.0,11/71,17.68%,GJA1;CRMP1;TENM3;DCLK1;SYNDIG1;SHC2;ARNT2;TEAD1;SMARCA1;IGFBP5;PLPP3
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.5149871395365411,-0.8206583235884163,0.7529411764705882,1.0,1.0,1/13,6.13%,RPA1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.46082626023150175,-0.8202195084272651,0.7560975609756098,1.0,1.0,3/19,13.73%,HIF1A;TANK;GBP2
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.46216349913645505,-0.8202087170822634,0.7386363636363636,1.0,1.0,4/17,19.26%,PRLR;LSS;HSD17B4;PRKAG2
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.48308534795566926,-0.8199157412428258,0.7439024390243902,1.0,1.0,1/12,5.16%,KANSL3
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.43318465245088084,-0.8198130119429207,0.7764705882352941,1.0,1.0,4/28,17.34%,SDCBP;CCP110;TAPT1;GPSM2
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.5332641662125861,-0.81932682504189,0.7397260273972602,1.0,1.0,2/8,17.18%,MT3;CHD1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.467852043128178,-0.8192427124053036,0.7272727272727273,1.0,1.0,3/13,6.78%,ASPA;MMUT;GLUL
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.48293293452579833,0.818709498871299,0.6206896551724138,1.0,1.0,1/5,2.93%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.47823051327856736,-0.8187003694168453,0.7804878048780488,1.0,1.0,3/17,9.65%,NOS1AP;ATP1B3;KCNQ1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.4417052428418563,-0.818354586042528,0.8470588235294118,1.0,1.0,5/30,21.17%,DCDC1;CCP110;PKP4;MAP9;RAB11A
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.4464759773055371,-0.8183084832725204,0.7294117647058823,1.0,1.0,5/15,29.59%,PIP4P2;RAB27A;SCARB1;RACK1;ITGAV
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5031328234223711,-0.8174395337452496,0.8192771084337349,1.0,1.0,1/9,2.05%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5522267753970005,-0.8172634099960634,0.7571428571428571,1.0,1.0,2/5,8.31%,NIBAN2;PTPN1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.4891140999911686,-0.8164916996411572,0.7439024390243902,1.0,1.0,5/11,34.83%,RNF10;JAM2;PTPRZ1;PTN;EIF2AK3
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.5155615959682073,-0.8164755906792132,0.8,1.0,1.0,1/6,13.80%,NINL
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.4321917451246784,-0.8163274891691871,0.75,1.0,1.0,5/33,10.79%,SELENOS;TRAF3IP1;LRFN5;PTPN2;LPCAT3
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.3763856972936891,-0.8159125206464959,0.99,1.0,1.0,116/738,18.52%,WWC1;TAF7;SCML1;ENO1;ETV5;TWIST1;NRG1;KLF2;NR4A3;KDM1A;BASP1;PURB;CRY1;SRA1;JDP2;VEGFA;WWC2;CREM;CREB3L2;ESR2;PIAS2;HDAC2;SRSF10;PDCD4;PLAG1;PKNOX2;CTCF;TGFB1;SUFU;SOD2;HIVEP2;ARID3A;ZNF235;BACH2;NIBAN2;CTR9;HCFC2;CBFA2T2;STAT3;TSHZ1;HES4;GLIS3;CD38;CDC5L;ZNF138;ZFPM2;SMAD6;KLF15;KLF3;ZNF608;CCAR1;PRKCB;RNF111;RAD21;MED12L;SNX6;HIF1A;MT3;PRKAR1A;HSF2;HIVEP1;TP63;ARNT2;HDGFL3;RCOR1;CEBPD;ELF1;MED14;TGFBR1;TSHZ2;PURG;JUN;SREBF1;ZKSCAN1;ZHX3;PLAGL1;EID1;CLOCK;SIN3A;ZNF595;FOXP2;NCOA7;CDKN1B;TERF2IP;CCNH;ATF6;ZSCAN18;WAC;TCF4;PPARGC1A;RUNX1;NAA15;TEAD1;ZIC4;SP110;MAFK;CALCOCO1;CDK14;HIF3A;RNF10;CAMK2D;UBE2L3;WWP1;CHD2;CHD1;MDM4;SMARCA1;ZNF790;TSHZ3;ZNF528;CAMKK2;CREBZF;ZNF814;BTRC;POLA1;ZNF83
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.2812364187306575,0.8153773157978957,1.0,1.0,1.0,14/59,9.89%,MOCS1;FKBP9;PLS3;ARHGEF17;CAP2;MAGI1;ITGB5;ADCY6;CHST3;PTPN21;GALNT18;GPC6;PC;MYO1B
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.41561906337189525,-0.8153092213006001,0.8202247191011236,1.0,1.0,10/34,29.50%,FHL1;DDX3X;ANKRD17;MYO16;RGCC;APPL2;ADAM17;EGFR;EIF4G1;RDX
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5502409403905854,-0.8151791779819996,0.7714285714285715,1.0,1.0,2/5,17.29%,VEGFA;RGCC
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.4673369089516038,-0.8151200169367272,0.7721518987341772,1.0,1.0,9/15,39.98%,SPG7;ATP5F1C;DNAJC11;CHCHD3;AFG3L2;DMAC2L;ATP5F1E;ATP5ME;ATP5MC2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.48692623597723383,-0.8150199467644118,0.7333333333333333,1.0,1.0,3/12,19.71%,TUT7;MOV10L1;AGO2
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.43884866298024067,0.8144591849910197,0.631578947368421,1.0,1.0,4/8,15.51%,DGKB;PGS1;DGKG;DGKE
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4935589011330127,0.8143317480356805,0.6,1.0,1.0,5/5,50.68%,PARD3;DGKH;PRKD3;DGKD;PLPP1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.5094691626074779,-0.8142433056269927,0.7922077922077922,1.0,1.0,4/9,30.37%,IL18;NT5E;APP;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.4939610542533083,-0.8140644797766321,0.7468354430379747,1.0,1.0,4/9,28.60%,ROBO1;JCAD;DCN;PIK3CB
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.5416610916023228,-0.8138991210060167,0.8133333333333334,1.0,1.0,1/6,16.44%,DUSP1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4881388129649951,-0.813740632489889,0.7375,1.0,1.0,6/12,38.59%,NAV3;PAK1;CLIP1;AKAP9;DRG1;RAC1
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.46081206246026146,-0.813128667335098,0.7733333333333333,1.0,1.0,3/11,22.69%,PTGR1;GPX4;MAPKAPK2
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.5252860151097933,-0.813071713132356,0.7466666666666667,1.0,1.0,2/6,11.55%,DCDC2;ADORA2B
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5056861835300916,-0.8129841386650112,0.7948717948717948,1.0,1.0,3/9,14.14%,PDCD4;SOD2;CDKN1B
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.4883826220235469,-0.8129598264864537,0.7073170731707317,1.0,1.0,2/12,17.42%,SCD;ACSL4
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.474399126606945,-0.8128100818381024,0.8148148148148148,1.0,1.0,3/17,8.31%,RIPOR1;TGFB1;PTPN1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.5123501845020735,-0.8127366905296239,0.7926829268292683,1.0,1.0,6/10,32.51%,SPIDR;DNAJA1;KIAA0586;CEP120;GAPVD1;CORO2B
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.5412160293298023,-0.8126246650624064,0.7702702702702703,1.0,1.0,1/8,7.75%,JAM3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5282131093761451,-0.8121295059762621,0.7567567567567568,1.0,1.0,4/6,33.76%,EGFR;KDR;ABL1;PTK2B
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.47160789877897796,-0.8120767246979549,0.7875,1.0,1.0,1/15,4.62%,PLAA
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.5372538551012824,-0.8118608695682876,0.7974683544303798,1.0,1.0,1/6,3.64%,CD44
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.5630673615141087,-0.8109565299134014,0.863013698630137,1.0,1.0,2/5,14.76%,OGN;OMD
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.4808424793916495,-0.8109479076320192,0.7804878048780488,1.0,1.0,3/15,14.21%,RPA1;ANKRD28;TERF2IP
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.394774320197544,0.8108027887966974,0.7058823529411765,1.0,1.0,3/13,11.35%,MRPL1;MRPL33;MRPL3
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.3891141326106031,-0.8107516467047029,0.8297872340425532,1.0,1.0,12/74,10.73%,GJA1;CRMP1;WASF3;TGFB2;DCLK1;ADM;COL11A1;PTPRD;SYNDIG1;CCN2;LRFN5;SHC2
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.38066873031049364,0.810665395988665,0.6666666666666666,1.0,1.0,5/20,8.73%,LMOD1;BIN1;NCK1;EVL;CARMIL1
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.40476813825847513,-0.8104988813723141,0.8556701030927835,1.0,1.0,10/50,17.52%,ROBO2;TGFB1;STAT3;PTPN2;TGFBR1;IL18;SLC1A1;TBK1;LRRK2;IGFBP5
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.4913258041666674,-0.8104383729023584,0.8095238095238095,1.0,1.0,2/13,10.20%,TRAF3IP1;FGFR2
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.43551369612995916,-0.8103970800437902,0.8045977011494253,1.0,1.0,7/27,23.06%,STX6;WASHC2C;RAB7A;MICALL2;VPS39;VPS50;VPS51
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.3249755719359011,0.8091421280957024,0.8333333333333334,1.0,1.0,3/37,3.16%,ATP2B4;PSMF1;PSMD7
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.45642754408398606,-0.8084903704304587,0.7906976744186046,1.0,1.0,4/17,26.36%,STMN1;TMEFF2;ARHGAP28;CLASP2
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),-0.45793635109524566,-0.8077060359033532,0.7125,1.0,1.0,7/14,25.11%,CHST11;DSE;CHSY1;CSGALNACT1;VCAN;CHST15;DCN
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.4575194619963049,0.8076552246690158,0.7272727272727273,1.0,1.0,1/7,7.91%,PIP4K2B
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.4410841841037191,-0.8072655359742578,0.7831325301204819,1.0,1.0,4/18,19.94%,SOD1;HIF1A;DTNBP1;SYBU
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.4435211464667198,-0.8072188111952753,0.725,1.0,1.0,11/20,31.37%,SOAT1;LIMA1;IL18;NPC1;AKR1C1;SCARB1;LPL;RORA;RALY;LDLRAP1;ABCA5
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.4435211464667198,-0.8072188111952753,0.725,1.0,1.0,11/20,31.37%,SOAT1;LIMA1;IL18;NPC1;AKR1C1;SCARB1;LPL;RORA;RALY;LDLRAP1;ABCA5
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.46937269168157975,-0.8071413985548684,0.8024691358024691,1.0,1.0,6/19,26.04%,PTPN1;ERAP1;APPL2;BIRC2;IRF1;RIOK3
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.5456849892461619,-0.8069508783314252,0.8181818181818182,1.0,1.0,2/5,29.50%,C9ORF72;RDX
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.38476268673124603,0.8068178187529895,0.75,1.0,1.0,1/11,0.54%,AP3M1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.43256215911777773,-0.8063564803939997,0.8470588235294118,1.0,1.0,1/33,0.90%,CSF1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.4676258345740213,-0.8063264005682794,0.75,1.0,1.0,6/15,24.69%,CD44;PTPN2;PPP3CA;KIF13B;EIF2AK4;PPP3CB
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.3476791974353719,0.806154568744882,0.8095238095238095,1.0,1.0,3/18,6.68%,HDAC9;BCL2;PIK3CD
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.4816149973631485,0.8060988100622476,0.7037037037037037,1.0,1.0,2/7,11.46%,MTERF1;HMGB1
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.4066058190698056,-0.8049500910091582,0.8387096774193549,1.0,1.0,25/69,30.10%,RPA1;MORF4L1;PSMD14;XRCC4;RAD21;PRKDC;SPIDR;PARP1;FAN1;POLA1;RNF168;WRN;ZSWIM7;SETX;TP53BP1;APBB1;UIMC1;APTX;EYA1;RPA3;MMS22L;BRCC3;KDM2A;SFPQ;XRCC6
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.469079325312675,-0.80482491993585,0.8048780487804879,1.0,1.0,4/15,15.04%,CREB3L2;TGFB1;WNT2B;RUNX1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.3957512519626499,-0.8044671616789513,0.8229166666666666,1.0,1.0,21/65,26.63%,LPIN1;ATP6V1E1;ATP6V1G1;SELENOS;PRKCI;PTPN2;ATP6V1H;PRKDC;ATP6V1D;PARP1;DENND4C;NAMPT;CPEB2;EPRS1;GRB2;IRS1;RAB12;PKM;RAB8B;INSR;ATP6V0D1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.5074939679256046,-0.8043738945319003,0.7831325301204819,1.0,1.0,1/9,5.16%,KANSL3
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.5074939679256046,-0.8043738945319003,0.7831325301204819,1.0,1.0,1/9,5.16%,KANSL3
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.44233305460016775,-0.8043634640935173,0.7294117647058823,1.0,1.0,4/15,13.71%,STK33;CDC5L;DONSON;CLOCK
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.4780097368917458,0.8043329436135445,0.7058823529411765,1.0,1.0,1/5,0.59%,SLIT3
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.4089106316074079,0.8042203626345341,0.6666666666666666,1.0,1.0,2/10,8.59%,EDN3;SLIT2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.4034799251842771,0.8041779867001495,0.8,1.0,1.0,1/8,1.27%,CSPG4
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.3176977498819242,0.8040165029158913,0.9090909090909091,1.0,1.0,5/25,8.73%,ARHGEF10L;CDC42;RHOA;EVL;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.41202754335271796,0.8039875406589951,0.6071428571428571,1.0,1.0,3/6,13.01%,NOTCH1;PARP9;PPP1R12A
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.5240472676458868,-0.803893480444778,0.8048780487804879,1.0,1.0,5/7,32.51%,NDFIP2;DNAJA1;NDFIP1;TERF1;CORO2B
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.4420896265756638,-0.8034853156001295,0.7654320987654321,1.0,1.0,2/18,5.10%,KDM1A;PIAS2
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.5309084597173741,-0.8032088790083934,0.8588235294117647,1.0,1.0,1/7,6.98%,PARP6
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.4548506684996052,-0.8027783183613737,0.7674418604651163,1.0,1.0,8/19,33.05%,CLU;FMN2;AZIN1;MDM4;EGFR;ITGAV;HSP90AB1;PRNP
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.3234856447235658,0.802335219484904,0.9166666666666666,1.0,1.0,1/17,1.38%,RYR2
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.46371508047086446,-0.8019363367489937,0.8235294117647058,1.0,1.0,2/19,10.81%,WASF1;PARVB
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.47859622163776205,-0.8018813256847503,0.825,1.0,1.0,4/13,23.11%,LPIN1;LPCAT3;CHKA;SLC44A1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.5078473197312338,-0.8018135541806181,0.7777777777777778,1.0,1.0,2/8,26.44%,ETF1;INSR
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.4643299418519287,-0.801807651615935,0.7721518987341772,1.0,1.0,3/13,18.01%,BACH2;CD38;NT5E
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5065849638587374,-0.8017876220325677,0.7468354430379747,1.0,1.0,2/7,14.73%,LPCAT3;PLAAT3
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.457824787519716,-0.8016640792284089,0.7777777777777778,1.0,1.0,5/13,36.49%,HSPA5;SEC62;SRP54;HSPD1;PEX1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.4031710299909686,-0.8014586994906979,0.8617021276595744,1.0,1.0,15/47,30.94%,SLC2A1;TGFB2;TGFB1;SNAP25;CLOCK;EXOC1;SYTL4;KCNC2;APBB1;PPP3CB;MYO18A;GOLPH3;ENSA;ADAM9;PRKCA
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.38631555660235223,-0.801295622470656,0.8144329896907216,1.0,1.0,13/67,14.14%,ZFPM1;VEGFA;TSC2;TGFB2;PDLIM1;TGFB1;ZFPM2;IFT122;FBN1;HEG1;SGCZ;TGFBR1;CDKN1B
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.40688579873355096,-0.8004983554495219,0.782608695652174,1.0,1.0,13/49,19.85%,DPM1;COG7;TET3;MGAT1;TMEM165;GOLGA2;MGAT4A;GALNT10;GALNT7;NPC1;PGM3;TET1;SERP1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.47216718933088386,-0.8002235556310443,0.8072289156626506,1.0,1.0,2/12,6.68%,CST3;SPOCK1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.4097233816199516,-0.7996908065185944,0.8555555555555555,1.0,1.0,7/43,21.81%,SYT1;ADGRV1;PPP3CA;CAMK2D;NLGN1;AHCYL1;NEDD4
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.5076851184126442,-0.7996482452768308,0.75,1.0,1.0,2/7,26.36%,RACK1;CLASP2
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.4257226527037219,-0.7993162493458195,0.7802197802197802,1.0,1.0,8/28,20.80%,RPA1;MORF4L1;PSMD14;SPIDR;PARP1;FAN1;WRN;ZSWIM7
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.36713045552754014,0.798899378151256,0.7647058823529411,1.0,1.0,2/19,4.75%,NSUN3;TFB1M
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.3327018194197957,0.7986992931198712,0.9285714285714286,1.0,1.0,4/32,7.71%,EDN3;CDC42;NSFL1C;RHOA
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.4166357540723973,-0.7986460471584839,0.8617021276595744,1.0,1.0,12/56,17.49%,CSNK1D;RNF19A;ELOB;CSNK1A1;ARIH2;SDCBP;RBX1;UCHL5;CLU;WAC;LRRK2;FBXO22
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.4531644046930103,-0.7986441782243086,0.7831325301204819,1.0,1.0,4/20,13.32%,SOD1;TBC1D8;SGCZ;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.48208445328510197,-0.7984274744241886,0.8,1.0,1.0,2/9,3.60%,F3;VEGFA
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.4776224669483241,-0.7982650850890799,0.788235294117647,1.0,1.0,2/13,13.32%,KLF2;ROCK2
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.41636642889166764,-0.7980748598919164,0.7764705882352941,1.0,1.0,13/37,30.23%,RHOB;XRCC4;TANK;SPIDR;CLOCK;TRIM13;RNF168;UIMC1;GRB2;EYA1;MRNIP;BRCC3;IKBIP
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.49611914940951424,-0.7979714713922798,0.7682926829268293,1.0,1.0,4/9,22.43%,SASH1;MAP3K4;PAK1;TAOK3
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.4446227477579349,0.7978714607273817,0.6923076923076923,1.0,1.0,3/11,4.58%,ST3GAL2;GLB1;B3GNT2
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.4795163406228693,-0.7976650853364394,0.8170731707317073,1.0,1.0,9/17,30.10%,RPA1;PRKDC;TERF2IP;PARP1;WRN;POT1;RPA3;TERF1;XRCC6
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.43665903686805596,-0.797411494592061,0.788235294117647,1.0,1.0,10/27,33.42%,RHOB;JUN;CAMKK2;MAPK1;SETX;EGFR;AGAP3;MAPK9;PLEKHA1;ABL1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.49950078417971194,-0.7971179915216202,0.8170731707317073,1.0,1.0,3/8,26.74%,TGFB1;NCOR2;EGFR
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.46754893825531674,-0.7966863962104682,0.75,1.0,1.0,3/13,12.38%,BASP1;HES4;TGFBR1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.47455792920819545,-0.7962120680146048,0.7875,1.0,1.0,8/14,29.59%,ITGA5;COL11A1;DUSP1;COL7A1;COL12A1;FN1;LAMB1;ITGAV
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.530796702232105,-0.7960578387183699,0.8026315789473685,1.0,1.0,2/5,26.01%,GABARAPL1;MAP1LC3B
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.530796702232105,-0.7960578387183699,0.8026315789473685,1.0,1.0,2/5,26.01%,GABARAPL1;MAP1LC3B
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.42978352965518946,-0.7950783688630562,0.7682926829268293,1.0,1.0,5/21,23.12%,ACOT11;ACBD6;LRRK2;HINT1;AK4
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.4989118570081815,-0.794850081248893,0.8441558441558441,1.0,1.0,4/11,21.76%,TUT7;DCP2;SSB;CPSF2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.4232366150304554,-0.7948384674089924,0.8160919540229885,1.0,1.0,15/29,45.50%,CLIP4;WDR73;RAB11A;SLK;DST;TUBGCP3;CLIP1;DLG1;FIGN;DYNC1H1;TUBGCP5;CCDC88A;SLAIN2;CLIP2;HOOK2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.406358475380668,-0.7943168834340729,0.8452380952380952,1.0,1.0,3/37,15.99%,UBA5;RPS27A;RAB7A
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.47847245225998736,-0.7942315904661423,0.7790697674418605,1.0,1.0,4/10,30.68%,CPEB4;CPEB2;PKM;YBX3
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),-0.5026777833133531,-0.7941315489381693,0.7777777777777778,1.0,1.0,5/8,28.86%,PTPRD;LRFN5;GPC4;APP;EIF4G1
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),-0.5026777833133531,-0.7941315489381693,0.7777777777777778,1.0,1.0,5/8,28.86%,PTPRD;LRFN5;GPC4;APP;EIF4G1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.41610264337602015,0.793910777953371,0.7,1.0,1.0,1/9,2.93%,NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.49951083502666727,-0.7938719422840956,0.8051948051948052,1.0,1.0,3/10,27.05%,DDIT4;RACK1;PDE4D
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.3839382541025172,-0.7935692309411356,0.9479166666666666,1.0,1.0,18/90,17.68%,SMOC1;NXN;EFNB2;WBP1L;ITGA5;SMAD6;FAM114A1;FBN1;SVEP1;C1R;PROCR;CMKLR1;PMP22;APH1B;C1S;STXBP6;IGFBP5;PLPP3
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.38847913126028877,-0.7935060802208288,0.8571428571428571,1.0,1.0,8/87,12.41%,GNPAT;AGPAT4;LPIN1;MTMR9;SELENOI;LPCAT3;AGK;PLD1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.5081722887302978,-0.7934021434972632,0.7671232876712328,1.0,1.0,3/8,23.28%,NEDD4L;CAMK2D;STK39
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.44229775226929613,-0.7932459557106214,0.7441860465116279,1.0,1.0,2/16,12.92%,FHL1;MYO16
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.5171783101871917,-0.7930743238922994,0.8181818181818182,1.0,1.0,3/7,40.18%,RAB27A;KIF5C;TMEM230
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.418247983841217,0.7930373788343918,0.7037037037037037,1.0,1.0,3/8,8.59%,MCU;DAPK2;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.48809093784594815,-0.7928448817966439,0.8271604938271605,1.0,1.0,3/10,19.39%,GGA3;CLU;RTN1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.4204080244744952,-0.7927209736281564,0.8314606741573034,1.0,1.0,10/30,30.01%,TGFB2;TGFB1;MYRIP;EXOC1;ACSL4;SYTL4;APBB1;MYO18A;GOLPH3;ADAM9
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.38993946103491517,-0.7927191761899697,0.90625,1.0,1.0,21/99,21.25%,ADAMTS9;CD55;NCEH1;CFH;LIMA1;MLPH;NIBAN2;ENPP2;GPM6A;DGKI;C1R;DUSP1;C1S;SMARCA1;PLPP3;GRIK2;STARD13;EXT1;RIN2;SGCD;ITGA9
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.4685051543237123,0.7921705693504999,0.5294117647058824,1.0,1.0,2/5,6.41%,BCL2L1;BCL2
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.34115863356675863,0.7921627234813452,0.6666666666666666,1.0,1.0,5/29,8.73%,LMOD1;BIN1;NCK1;EVL;CARMIL1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.45209761235483986,-0.7920277810423461,0.8314606741573034,1.0,1.0,3/17,10.41%,PDE7B;PDE7A;RIMS2
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.5421751823975702,-0.7916095555475848,0.7761194029850746,1.0,1.0,2/5,25.95%,SNAP91;DNM3
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.49869338351154846,-0.790923193786732,0.8194444444444444,1.0,1.0,3/7,23.53%,EAPP;RNF168;TCERG1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.4136351896068352,-0.7908766962769873,0.8275862068965517,1.0,1.0,11/34,30.94%,SLC2A1;SNAP25;MYRIP;CLOCK;ACSL4;KCNC2;PPP3CB;IRS1;STXBP4;ENSA;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.3678120496041585,0.7906750035372585,0.6153846153846154,1.0,1.0,1/16,0.33%,ATP2B4
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.47162556642120224,-0.7905866048954819,0.8554216867469879,1.0,1.0,6/15,37.89%,TGFBR1;RACK1;TGFBR2;STAT5B;ACVR1B;ACVR1
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.32170954036273647,0.7902667201158498,0.8571428571428571,1.0,1.0,3/21,6.33%,TIPRL;MFHAS1;DLC1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.4645672429382766,-0.7899245722940246,0.7831325301204819,1.0,1.0,2/15,12.98%,CD55;ARRDC2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.47685210565931674,-0.789741040321748,0.8076923076923077,1.0,1.0,4/11,30.37%,NEDD4L;GPM6B;GOPC;HSP90AB1
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.48513927617273084,-0.7893861347601686,0.8125,1.0,1.0,2/9,21.88%,AGO2;EIF2AK4
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.48086660396919967,-0.7890471239617888,0.7976190476190477,1.0,1.0,1/10,3.77%,TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.4210305647520058,-0.7889781755716597,0.7840909090909091,1.0,1.0,9/40,17.49%,CSNK1D;RNF19A;ELOB;CSNK1A1;ARIH2;RBX1;CLU;LRRK2;FBXO22
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.39791638419855646,0.7888350700807137,0.5806451612903226,1.0,1.0,1/6,4.61%,VIT
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.3918840307885986,-0.7884499372751689,0.9021739130434783,1.0,1.0,18/64,26.44%,CTSL;WASF1;DNAJC6;ADM;HSPH1;AP2A1;GPR107;SNAP91;COLEC12;AP4E1;GAK;SCARB2;NEDD4;SCARB1;CD9;GRB2;DNM3;INSR
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.436247367937854,-0.7880890967532276,0.8021978021978022,1.0,1.0,5/26,6.85%,ENO1;TPT1;SELENOS;DDX3X;SOD2
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.375414313305388,-0.7879440358600298,0.9090909090909091,1.0,1.0,47/153,30.41%,CRY1;VAV3;RPA1;STK33;TANK;PRKDC;SPIDR;PARP1;SUSD6;WAC;FAN1;FMN2;FANCC;ZRANB3;POLK;WDR48;POLA1;BTG2;UBE2B;RNF168;WRN;XPA;CCNK;PAK1;TAOK3;SETX;MAPKAPK2;MAP2K6;TP53BP1;APBB1;APTX;ZBTB40;SLF1;GRB2;USP3;LYN;UBA1;BOD1L1;ZBTB1;KIN;PARP4;MRNIP;STXBP4;GTF2H1;SMC1A;UVRAG;TRIP12
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.5027408819194052,-0.7872746220681458,0.7671232876712328,1.0,1.0,3/7,9.65%,TGFB2;ADM;KCNQ1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.4047850682581047,-0.7867548212758698,0.8390804597701149,1.0,1.0,8/40,12.25%,ASPA;DPP6;MCF2L2;SLC1A2;KCNQ1;PRKCB;SLC7A14;CCK
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.46289791756404985,-0.7867225035086033,0.8295454545454546,1.0,1.0,4/17,16.39%,NR4A3;ROCK2;PARP1;CAMK2D
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.4445556406694087,0.7866812305818519,0.6666666666666666,1.0,1.0,1/5,3.33%,FGF13
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.3706632392551882,-0.786341106144653,0.8333333333333334,1.0,1.0,10/61,17.48%,RANBP10;WASF3;NECTIN2;RHOB;DIAPH1;PRKCI;DPYSL2;CFL1;RHOBTB3;FMNL2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.4350237084207017,-0.7862896869815367,0.7530864197530864,1.0,1.0,3/18,4.11%,CSF1;VEGFA;AKIRIN1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.32128163349701705,0.7861459879152768,0.8,1.0,1.0,3/22,4.39%,PDGFA;COL5A2;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.47221053965809023,-0.7860122862657678,0.782051282051282,1.0,1.0,4/11,27.05%,PDE4B;RUNX1;MALT1;PDE4D
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.4514706275993263,-0.7859637106988542,0.8409090909090909,1.0,1.0,4/19,24.69%,PPP3CA;AGO2;NLK;PPP3CB
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.44709159064737564,-0.7856493173899377,0.8148148148148148,1.0,1.0,4/19,20.21%,HADHA;HSD17B4;ACADL;ECHDC1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.4484042854236483,-0.7855705648994579,0.788235294117647,1.0,1.0,1/11,9.62%,DDIT4
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.49152357453774587,-0.7852475754818107,0.8,1.0,1.0,2/8,23.45%,CLU;LRPAP1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.4642724570798733,-0.7843917920035252,0.797752808988764,1.0,1.0,3/17,19.98%,JAM3;GGA3;FBLN5
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.47710874470153863,-0.7843520305321598,0.8205128205128205,1.0,1.0,2/9,13.32%,LGALS3;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.3254456658475518,0.7838409328700059,0.7,1.0,1.0,6/36,8.73%,LMOD1;SYNPO2;BIN1;NCK1;EVL;CARMIL1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.4230219399326087,-0.7837992170560636,0.7701149425287356,1.0,1.0,8/30,28.63%,WIPI1;ATG16L2;RAB7A;GABARAPL1;STX12;MAP1LC3B;WDR45B;ATG12
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.3893598177669256,-0.7836335736796888,0.8351648351648352,1.0,1.0,4/44,7.32%,PIAS2;NUP153;NUP133;NUP88
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.36732424127756214,-0.7829366742329715,0.92,1.0,1.0,31/151,20.86%,SRGN;ZFP36L2;VEGFA;TGFB2;PTRH2;DDX3X;TGFB1;OLFM1;EIF2AK2;ROBO1;DNMT1;GIGYF2;HIF1A;PTBP2;RBBP7;ROCK2;CNOT8;IGF2BP2;RPL13A;NOTCH2;RUNX1;DCP2;NDFIP2;RGCC;IGFBP5;LGR4;CREBZF;BTG2;AGO2;NDFIP1;METTL16
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.4608584806955407,-0.7827143388351658,0.8048780487804879,1.0,1.0,6/15,25.50%,FHL1;NEDD4L;AHCYL1;NEDD4;STK39;CHRM3
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.3836996749516755,-0.7826176234054428,0.8421052631578947,1.0,1.0,16/72,23.87%,TPT1;SRA1;TP63;IFT57;SGK1;DDX42;CLU;NAE1;LRRK2;WRN;RAF1;BIRC2;STAT1;NF2;TARDBP;MALT1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.4715635281989311,-0.7823058456181795,0.7906976744186046,1.0,1.0,7/13,38.66%,PTPN2;STAT1;PARP14;HSP90AB1;NR1H3;PIAS1;IFNGR2
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.4776414681638273,-0.7817090702019686,0.7631578947368421,1.0,1.0,3/8,23.53%,EAPP;RNF168;TCERG1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.5122499212318662,-0.7814435702114028,0.7605633802816901,1.0,1.0,2/5,22.66%,SLC25A37;SLC40A1
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.41779726610601053,-0.7814418621995001,0.7954545454545454,1.0,1.0,8/33,28.63%,WIPI1;ATG16L2;RAB7A;GABARAPL1;STX12;MAP1LC3B;WDR45B;ATG12
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.41335025937784203,-0.7812827747255855,0.8470588235294118,1.0,1.0,5/29,10.20%,MCC;TGFB2;TGFB1;ROBO1;FGFR2
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.32146538470460967,0.7810183714780677,0.8666666666666667,1.0,1.0,3/22,6.06%,EEFSEC;MRPL1;MRPL33
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.4113038296054206,-0.780789989053968,0.8444444444444444,1.0,1.0,15/39,28.80%,CRY1;TANK;NDFIP2;LRRK2;UBE2L3;WDR48;NDFIP1;DCUN1D4;BIRC2;MALT1;RCHY1;UBA2;PRICKLE1;UBE3A;DCUN1D2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.4029800673309266,-0.7807559658929227,0.7333333333333333,1.0,1.0,9/31,21.43%,VEGFA;CD44;TGFB1;STK4;TERF2IP;TBK1;MTCP1;PAK1;RAF1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.3785575456338047,0.7805645143261593,0.8333333333333334,1.0,1.0,2/9,2.93%,HEYL;NOTCH1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.47221400861710494,-0.780480209545697,0.810126582278481,1.0,1.0,1/10,9.99%,RAD21
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.4363636554127607,-0.7801284802757072,0.8235294117647058,1.0,1.0,4/18,26.36%,STMN1;TMEFF2;ARHGAP28;CLASP2
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.46450455487617626,0.7799383151582661,0.6666666666666666,1.0,1.0,1/5,5.78%,NIPAL2
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.5233701698760354,-0.7791365840117325,0.8133333333333334,1.0,1.0,2/5,33.56%,NLGN1;TMEM108
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.36760448729559947,-0.7786335234006274,0.8367346938775511,1.0,1.0,24/77,30.51%,GJA1;BASP1;VEGFA;NIBAN2;ENPP2;CCN2;CFL1;TAPT1;AGO2;NLGN1;SMURF2;BMP5;TP53BP1;NR2C2;DCN;CLASP2;INSR;B4GALT5;DDHD1;PTN;ADGRL1;KDR;HSP90AB1;SPIRE1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.45529635976845945,-0.7779208003167724,0.7926829268292683,1.0,1.0,3/13,5.74%,CRY1;RBM4B;PPP1CC
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.4035306022193531,-0.7776968354487586,0.8705882352941177,1.0,1.0,13/41,27.71%,PSMB1;FBXL13;PSMD14;RBX1;PSMA4;PSMB2;PSMA7;BTRC;SKP1;PSMA3;FBXL4;FBXL7;FBXO38
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.42493564183706345,-0.7776861426592443,0.7386363636363636,1.0,1.0,4/18,12.22%,TGFB2;TGFB1;FGFR2;MYL3
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.38134539162644054,-0.7776168603703576,0.9021739130434783,1.0,1.0,13/57,20.98%,TGFB2;RPS4X;DDX3X;UPF3A;HSPH1;SLC25A37;PRKDC;PLD1;ATAD5;RGCC;ELAVL1;RPL5;NAMPT
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.39564201345613736,-0.7772616183536827,0.7816091954022989,1.0,1.0,4/32,6.84%,PRAG1;NRG1;VEGFA;DIAPH1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.5240121499491142,-0.7768680901016171,0.8108108108108109,1.0,1.0,2/5,29.99%,ALKBH5;ASCC3
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.5240121499491142,-0.7768680901016171,0.8108108108108109,1.0,1.0,2/5,29.99%,ALKBH5;ASCC3
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.414101780194092,-0.7765716786158011,0.8021978021978022,1.0,1.0,9/41,17.49%,CSNK1D;RNF19A;ELOB;CSNK1A1;ARIH2;RBX1;CLU;LRRK2;FBXO22
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.37393195588006833,0.7757897188296883,0.68,1.0,1.0,11/11,62.67%,TENT4B;PARN;MTREX;DIS3L2;SND1;XRN1;ZCCHC8;TUT4;DIS3L;DIS3;EXOSC10
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.41787669566248453,-0.7754889346023759,0.8192771084337349,1.0,1.0,4/25,8.79%,SLC22A6;DCDC1;ALDH1L1;DNAH7
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.3872373513384333,-0.775182907843196,0.8602150537634409,1.0,1.0,4/56,3.88%,MID1;FHL1;TENM3;NXN
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.49153010003906283,-0.775180184789853,0.85,1.0,1.0,3/9,27.20%,CA2;SLC9A9;SLC4A10
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.49898618448078547,0.7748924554903242,0.7272727272727273,1.0,1.0,1/6,3.60%,IWS1
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.49898618448078547,0.7748924554903242,0.7272727272727273,1.0,1.0,1/6,3.60%,IWS1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.5397682777599604,-0.7748683238939311,0.8591549295774648,1.0,1.0,1/5,16.36%,RNF10
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.433555892236825,-0.7748108342509814,0.875,1.0,1.0,5/19,23.84%,TGFB1;LATS2;SMURF2;FSTL1;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.4537141034226774,-0.7746774158259017,0.8076923076923077,1.0,1.0,4/13,24.72%,STAT3;MALT1;LPL;APP
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.4597544963996056,-0.7739821746142083,0.7922077922077922,1.0,1.0,6/8,50.05%,PATL1;DYNC1H1;ATXN2;LSM14A;EIF4ENIF1;RC3H1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.3337011127586428,0.7738012284747995,0.8181818181818182,1.0,1.0,1/18,2.43%,TIPRL
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.3732410406694811,-0.7736101651365774,0.8947368421052632,1.0,1.0,13/70,17.52%,CNTN3;PCDH17;PHYHIPL;PDZRN4;THSD7A;PTPRD;SNAP25;SHC2;FGF14;PPARGC1A;SNAP91;ABCC9;IGFBP5
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.3597246074824695,0.7729317095331122,0.8461538461538461,1.0,1.0,3/22,5.26%,MCU;BCL2L11;VPS35
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.34107249675095686,0.7726061084512648,1.0,1.0,1.0,2/19,4.54%,ZDHHC15;ZDHHC21
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.46862301074972246,-0.7724008828819565,0.8292682926829268,1.0,1.0,3/11,19.39%,GGA3;CLU;RTN1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.41132597424736006,-0.772005549000834,0.8,1.0,1.0,5/26,15.35%,VEGFA;TGFB2;AFDN;FRMD5;PPP3CA
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.38123921284601275,-0.7718870999444847,0.8947368421052632,1.0,1.0,11/55,14.14%,ZFPM1;NXN;TSC2;TGFB2;PDLIM1;TGFB1;ZFPM2;FBN1;HEG1;TGFBR1;CDKN1B
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.4839479600477091,0.771488469103112,0.8571428571428571,1.0,1.0,1/6,1.38%,RYR2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.4813687338897373,-0.7709630760105012,0.8470588235294118,1.0,1.0,5/11,30.96%,FGFR2;TGFBR1;SFRP4;WWOX;SPEF2
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.4437068396030746,-0.7709081717538614,0.8170731707317073,1.0,1.0,3/18,22.18%,CCP110;LRRK2;NBDY
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.4366150689979055,-0.7706063295659714,0.8214285714285714,1.0,1.0,4/16,20.64%,SEMA3B;NRP2;FARP2;SEMA4D
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.41055625101367693,-0.7704832704959406,0.7674418604651163,1.0,1.0,8/23,21.29%,ARID3A;PLAGL1;CNOT8;CDKN1B;RGCC;MDM4;BTG2;MDM2
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4761938536627588,-0.7703201819351383,0.8028169014084507,1.0,1.0,3/7,23.99%,SREBF2;CD9;LPL
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.4380595899034438,-0.7702204727901584,0.8666666666666667,1.0,1.0,9/23,29.95%,STK33;DONSON;PRKDC;WAC;TAOK3;UIMC1;MRNIP;BRCC3;NEK11
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.39166930268498,-0.7701586108153483,0.8314606741573034,1.0,1.0,12/37,24.72%,ATL1;TOR1AIP2;ALDH3A2;LPCAT3;TRAM1;LRRK2;REEP5;SERP1;RAB18;GAK;TRAM2;APP
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.45445466138086854,-0.7701548796040261,0.8333333333333334,1.0,1.0,4/13,15.04%,ZFPM2;FGFR2;TGFBR1;RUNX1
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.4871205681180655,-0.7698759221255371,0.7721518987341772,1.0,1.0,2/6,23.84%,FGFR2;SFRP4
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.4618921902893801,-0.7697659468925494,0.8552631578947368,1.0,1.0,1/9,4.23%,TGFB2
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.4533202442135858,0.7694004429540793,0.6785714285714286,1.0,1.0,1/6,6.68%,PIK3CD
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.3068798412682569,0.7691460728549624,0.8888888888888888,1.0,1.0,7/32,9.49%,LMOD1;BIN1;NCK1;EVL;SLIT2;CARMIL1;PLEKHG2
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.3665168237841342,-0.7689247191196933,0.8787878787878788,1.0,1.0,10/125,8.87%,MID1;GJA1;VEGFA;ARHGAP24;PROS1;PLEKHH2;ADM;THSD4;THSD7A;CCN2
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.42899489559026704,0.7682128832902134,0.7391304347826086,1.0,1.0,2/6,4.25%,MECOM;ETV6
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.3868179445189605,-0.7680020068253534,0.8387096774193549,1.0,1.0,15/53,17.20%,SOD1;ETV5;SELENOS;DDX3X;SOD2;MT3;PYROXD1;PARP1;CHCHD2;PPARGC1A;TXNRD1;FANCC;PRR5L;LRRK2;GSR
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.4229865453450564,-0.7671775904329802,0.8571428571428571,1.0,1.0,2/18,10.03%,SPG7;PITRM1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.520530746076991,-0.766915124694571,0.8552631578947368,1.0,1.0,2/5,17.29%,TGFB1;RGCC
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.40909940501741043,-0.7664082990923492,0.7906976744186046,1.0,1.0,6/29,20.55%,ARIH2;TP63;MICALL2;UBE2L3;YWHAG;SREBF2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.4771853500604474,-0.7662787435743783,0.7625,1.0,1.0,3/9,21.84%,DDX3X;RNF34;BMP5
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.31514055202429586,0.7661943553205666,0.8125,1.0,1.0,5/21,8.39%,MYH9;ACTB;HSPB1;FLNA;MYL9
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.49341934771572604,-0.7660335191968181,0.7746478873239436,1.0,1.0,4/8,29.16%,UBR1;SESN1;LARS1;KLHL22
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.49341934771572604,-0.7660335191968181,0.7746478873239436,1.0,1.0,4/8,29.16%,UBR1;SESN1;LARS1;KLHL22
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.5091514545978544,-0.7658234756961457,0.8169014084507042,1.0,1.0,2/6,25.95%,SNAP91;DNM3
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.5253356737474545,-0.7657216318608936,0.7777777777777778,1.0,1.0,1/6,8.65%,ENPP2
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.47971783528319273,-0.7654144458730632,0.8831168831168831,1.0,1.0,4/11,22.91%,TRMT1L;NSUN6;TRMT13;WDR6
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.3786290400166974,-0.7650765693075242,0.8539325842696629,1.0,1.0,13/50,17.68%,CNTN3;PHYHIPL;RHOJ;ADM;PTPRD;ENPP2;DENND2A;TRPA1;GRIA3;FGF14;PPARGC1A;C1S;PLPP3
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.2885564851466489,0.7649150728034751,0.8181818181818182,1.0,1.0,3/30,7.71%,INPP5F;PIK3CD;RHOA
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.4288637157494692,0.7648802389610159,0.5909090909090909,1.0,1.0,1/5,2.67%,ARL3
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.3743863317229314,-0.7648003442038276,0.9081632653061225,1.0,1.0,24/89,26.29%,GJA1;PELI1;PRKCB;TANK;ANKRD17;TERF2IP;TRIM13;TBK1;NDFIP2;TRIM5;TMED4;ALPK1;NDFIP1;DDX21;PER1;AKAP13;BIRC2;OTUD7A;STAT1;MALT1;MAP3K14;RIOK3;RORA;MIER1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.3328684968218032,0.764659018056329,0.8421052631578947,1.0,1.0,5/20,8.36%,ADCY9;GUCY1B1;ADCY6;PPCDC;GUCY1A1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.3841166343452431,0.7646006812339994,0.8181818181818182,1.0,1.0,3/14,9.83%,CDC42;IQGAP2;NTF3
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.5082060101754073,-0.7645783865334302,0.918918918918919,1.0,1.0,4/8,35.78%,PPIB;FKBP5;PPIG;PPIA
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.5031523558523152,-0.7644495704454239,0.796875,1.0,1.0,2/5,39.00%,DNM3;DNM1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.5031523558523152,-0.7644495704454239,0.796875,1.0,1.0,2/5,39.00%,DNM3;DNM1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.4405154142000949,-0.7641293049014702,0.8024691358024691,1.0,1.0,1/13,7.09%,LGALS3
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.3754460572891901,0.764114259162731,0.8125,1.0,1.0,3/11,4.36%,PDGFA;CDC42;QRICH2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.3632276972212027,-0.7641089100404741,0.898989898989899,1.0,1.0,22/126,19.65%,SOD1;MTCH2;VAV3;ARHGEF9;DDX3X;RHOB;OLFM1;MELK;STK4;LATS2;CCAR1;RPS27A;JUN;ATF6;CLU;MCF2L;APH1B;LRRK2;RASGRF2;PAWR;DNAJA1;PHLDA1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.5142446289157252,-0.7640862312090766,0.8,1.0,1.0,2/5,36.09%,GSN;WASHC5
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.37076362810888897,-0.7637209448074143,0.8829787234042553,1.0,1.0,12/65,18.21%,TGFB2;PROS1;MARCHF6;SLC35D1;MCCC2;MT2A;PTGR1;CA2;AKR1C2;GSR;NPC1;PTS
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.3639267727028207,-0.763527502743274,0.826530612244898,1.0,1.0,17/62,31.47%,IFITM3;EIF2AK2;STAT3;PTPN2;TBK1;ALDH1A2;STAT1;MAPKAPK2;APP;PID1;AKAP6;PTPN9;GGT7;ADAM9;PRKCA;LDLRAP1;NFAT5
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.35740360584502684,0.7634378642306908,0.8125,1.0,1.0,3/21,6.41%,BCL2L1;BCL2L11;BCL2
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.4036858746487027,0.7627946281197601,0.7727272727272727,1.0,1.0,3/9,15.43%,MYLK;ITGB1;PTK2
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.35124424787873204,0.7623491874556323,0.7307692307692307,1.0,1.0,1/11,1.57%,USP16
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4703173274254288,-0.7623361942009653,0.7894736842105263,1.0,1.0,6/10,37.76%,CCT4;DCP2;CCT8;CCT6A;EXOSC10;CCT3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.49726111533856704,-0.7622049568292286,0.8333333333333334,1.0,1.0,3/8,17.88%,TERF2IP;PARP1;TNKS
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.5219618190284029,-0.7620913608527413,0.8309859154929577,1.0,1.0,5/5,47.86%,GOPC;PRNP;ABCB1;GRM5;TCAF1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.42668446733081156,-0.762083990119846,0.7411764705882353,1.0,1.0,2/17,12.92%,FHL1;MYO16
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.4226526505658059,-0.7619248443566092,0.8674698795180723,1.0,1.0,6/22,23.11%,LPIN1;ENPP2;LPCAT3;PLAAT3;CHKA;SLC44A1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.4681674253359636,-0.7617558543610705,0.7887323943661971,1.0,1.0,3/8,32.29%,FRMD5;CD9;FBLN1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.4940401581393755,-0.7616594719276256,0.8333333333333334,1.0,1.0,5/8,43.80%,DEAF1;KIAA1217;COL1A1;SULF2;DSCAML1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.4355114077293186,0.7615926666433138,0.6896551724137931,1.0,1.0,5/5,56.48%,VCP;IDE;IFNAR1;PNPT1;TRAP1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.38303659190679334,-0.7608618141459601,0.9021739130434783,1.0,1.0,13/61,20.39%,SSH1;PPP1CC;FRA10AC1;PTPRE;PPP2R1B;PTPRD;PTPN1;PPP2R2A;PPP3CA;DUSP1;PLPP3;BTRC;MTMR2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.4429005227682647,-0.7606455602529664,0.8620689655172413,1.0,1.0,3/16,15.96%,STMN1;HDGFL3;NAV3
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.4936671457931264,-0.7605822580597338,0.8714285714285714,1.0,1.0,3/7,9.65%,PRKACA;PDE4B;KCNQ1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.4936671457931264,-0.7605822580597338,0.8714285714285714,1.0,1.0,3/7,9.65%,PRKACA;PDE4B;KCNQ1
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.48075034585178755,-0.7603978589475939,0.8378378378378378,1.0,1.0,1/7,10.25%,HADHA
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.49617776103620037,-0.7600932948226649,0.7971014492753623,1.0,1.0,2/5,22.46%,SREBF1;SCARB1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.3728782473257376,-0.7599450064164314,0.8787878787878788,1.0,1.0,21/66,22.57%,SOD1;ETV5;SELENOS;SOD2;HIF1A;MT3;JUN;PYROXD1;PARP1;CHCHD2;PPARGC1A;TXNRD1;FANCC;PRR5L;LRRK2;GSR;CAMKK2;ADNP2;MAPK1;CPEB2;SETX
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.3740427068370993,-0.7597424284655526,0.875,1.0,1.0,17/64,22.05%,ROBO2;PDZRN4;COL11A1;JAM3;PTPRD;UNC5D;SCN3A;TBRG1;GRIA3;FGF14;FMN2;SNAP91;RAB27A;CADM2;SGCD;CPEB4;NOVA1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.3784922418869063,-0.7592715894324886,0.9130434782608695,1.0,1.0,21/70,29.50%,DPP6;SPTBN4;ANK3;ATP1B3;ROCK2;DENND4C;WDR19;ZFYVE27;TSPAN5;LIN7A;DPP10;GAK;RAB11A;RAB12;STXBP1;RAB8B;CLASP2;MAP7;PTCH1;EPB41L3;RDX
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.49398505022541905,-0.7591778031238245,0.8309859154929577,1.0,1.0,2/6,42.71%,NF1;TGFBR3
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4543968955099111,-0.758914051324392,0.8452380952380952,1.0,1.0,2/14,9.35%,TGFB1;LATS2
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.48502380110688126,-0.758716870609128,0.8205128205128205,1.0,1.0,3/7,31.03%,GNAQ;EGFR;LPAR1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.3999191128856067,-0.7584999014153071,0.8888888888888888,1.0,1.0,13/37,34.62%,CSF1;ROCK2;MINK1;NF2;GPM6B;SLK;PIK3CB;NF1;CASK;RASA1;PTK2B;PTPRA;ACTG1
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.368408663490951,-0.7584580455008854,0.9191919191919192,1.0,1.0,22/119,18.11%,SOD1;CSNK1D;SPTBN4;VEGFA;MYDGF;EPHA7;AKAP8;TGFB1;TRAF3IP1;STK4;MT3;KRAS;PRKDC;C9ORF72;ROCK2;TERF2IP;TSPYL2;PRR5L;LRRK2;PLPP3;CCN1;CAMKK2
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.3393567647564612,0.7570036080337218,1.0,1.0,1.0,4/35,3.37%,RCAN2;RYR2;CACNA1C;MCU
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.43421048778110233,-0.7568733447030862,0.8518518518518519,1.0,1.0,1/15,0.09%,STC1
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.44347770062028063,-0.7567161569203789,0.8607594936708861,1.0,1.0,4/14,8.98%,ZFPM1;TGFB2;OLFM1;SMAD6
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.42941080213436905,-0.7561354131481492,0.8452380952380952,1.0,1.0,8/21,38.59%,STMN1;NAV3;PAK1;ABL1;CLIP1;AKAP9;DRG1;RAC1
prerank,PanglaoDB_Augmented_2021__Neurons,-0.3533671428983753,-0.7554824556734401,0.8958333333333334,1.0,1.0,22/104,21.79%,ELAVL3;IFIT3;PHYHIPL;DNER;NAPG;SNAP25;ATP6V1H;SLC36A4;CCK;GRIA3;SLC6A17;DLGAP1;NXPH1;SLC1A1;UNC79;SNAP91;ACSL4;MATN2;CADM2;PRUNE2;GABBR2;VSNL1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.3967453014556482,-0.7552588720097057,0.8602150537634409,1.0,1.0,10/38,22.05%,HNRNPL;PCBP3;PTBP2;FAM50A;IGF2BP2;AFF2;CLK1;HNRNPF;TRA2B;NOVA1
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.47663919943920774,-0.7552470418764363,0.8571428571428571,1.0,1.0,3/10,27.61%,JUN;CHD1;SP1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.49381137466842157,-0.7551830743627072,0.8641975308641975,1.0,1.0,2/6,8.44%,ANK3;SCN3A
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.4289252035729389,0.7549637035736573,0.7878787878787878,1.0,1.0,1/7,1.44%,EDN3
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.45649660827771615,0.7549060237495974,0.6666666666666666,1.0,1.0,3/7,10.76%,EXT2;B3GNT2;CSGALNACT2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.46387814438136243,0.7542505955699679,0.76,1.0,1.0,1/5,2.16%,CNOT7
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.4498882857836961,-0.7541720633773547,0.7710843373493976,1.0,1.0,2/10,9.41%,NEDD4L;ATP1B3
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.505060228042904,-0.7540749284779684,0.8205128205128205,1.0,1.0,3/5,42.34%,JAM2;MIA3;SLC8B1
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.5084840192412123,-0.7539709458326138,0.8873239436619719,1.0,1.0,4/7,35.78%,PPIB;FKBP5;PPIG;PPIA
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.35798864392323765,-0.7536023980178647,0.8469387755102041,1.0,1.0,10/77,10.69%,APIP;CD44;EPHA7;TGFB1;PDGFD;PTPN1;CCN2;FGFR2;PTPN2;MT3
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.5038200877349671,-0.7534221801509763,0.855072463768116,1.0,1.0,3/6,18.59%,SZT2;ITFG2;SESN1
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.4409733762827843,0.7533469051764878,0.85,1.0,1.0,2/7,9.75%,FGF13;ULK2
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.40032769166214266,-0.7530786726988269,0.8571428571428571,1.0,1.0,9/32,21.81%,NKD1;NEDD4L;CDKN1B;RAB7A;WWP1;NSF;SMURF2;HECW1;NEDD4
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.40241776561233433,0.752934560195565,0.7142857142857143,1.0,1.0,1/5,10.55%,MAP2
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.43348018689906376,-0.752650603466706,0.7441860465116279,1.0,1.0,5/12,35.13%,CMKLR1;HLA-B;HSPD1;IL16;CD47
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.42728444528853454,-0.7523861696719147,0.8588235294117647,1.0,1.0,6/22,24.83%,PDK3;ARF4;MT3;AKR1C1;GRB2;PID1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.41914827215327766,0.7522147714369365,0.75,1.0,1.0,2/5,7.71%,CHMP4B;RHOA
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.40930839154496274,-0.7512785502847892,0.8488372093023255,1.0,1.0,7/21,15.23%,PSMB1;PSMD14;PSMA4;PSMB2;PPM1K;PSMA7;AZIN1
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.3631915089848445,-0.750833249218427,0.8953488372093024,1.0,1.0,8/56,11.54%,PCDH17;PHYHIPL;DHRS3;DCLK1;PTPRD;SYNDIG1;SHC2;PLP1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.47759596529179543,-0.7507726984452142,0.8536585365853658,1.0,1.0,3/8,30.10%,PRKDC;ZBTB1;XRCC6
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.3967022552053444,-0.7504911480104449,0.8214285714285714,1.0,1.0,8/34,17.59%,PRKCI;ALDH3A2;PEX3;SDCBP;SSR1;SRP14;TRAM1;NACA
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.4219219482068489,0.7494345226404455,0.6666666666666666,1.0,1.0,1/5,7.86%,ABCC5
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.4219219482068489,0.7494345226404455,0.6666666666666666,1.0,1.0,1/5,7.86%,ABCC5
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.42182043592262974,0.7491394148195363,0.7727272727272727,1.0,1.0,2/9,16.33%,HACD2;TECR
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.3970118122577921,-0.7488718959352135,0.8505747126436781,1.0,1.0,17/36,36.51%,MANBA;PRKDC;PARP1;UBE2L3;FBXO22;SERP1;CHRM3;PARP4;ST3GAL6;UBL5;FBXW2;CPE;ABL1;USP25;MSRA;UBE2D3;UBA3
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.4120854311946607,-0.748793046215834,0.8690476190476191,1.0,1.0,5/23,25.59%,HDAC2;HNRNPC;SMARCA1;NASP;ARID1A
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.4534577080226284,-0.7480630534642972,0.7560975609756098,1.0,1.0,2/9,9.41%,NEDD4L;ATP1B3
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.4534577080226284,-0.7480630534642972,0.7560975609756098,1.0,1.0,2/9,9.41%,NEDD4L;ATP1B3
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.4639681109388426,-0.7478849846487071,0.8271604938271605,1.0,1.0,2/10,16.07%,MTMR9;PPP6R2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.4742121714402361,-0.7475772679957522,0.875,1.0,1.0,1/9,5.91%,DDX3X
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.2825364830207126,0.7470267874846108,0.9333333333333333,1.0,1.0,8/31,12.70%,ATM;DAPK2;FBXL2;HSPB1;PIP4K2B;EP300;DEPP1;IFI16
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.45285493366491586,-0.7469895180874645,0.8414634146341463,1.0,1.0,1/11,1.16%,ZFP36L2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.39628604706338916,-0.7457893779112051,0.9047619047619048,1.0,1.0,5/30,14.92%,PSMB1;PSMD14;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.3152743575325619,0.7457086861638174,0.7894736842105263,1.0,1.0,4/20,8.13%,ADGRA2;MYH9;RHOA;PTP4A3
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.4807571414832918,-0.7456673165860517,0.8787878787878788,1.0,1.0,2/5,22.88%,GBP2;ADAM17
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.36428321691460963,-0.744638689336794,0.898989898989899,1.0,1.0,24/108,18.01%,GJA1;BASP1;IGFBP2;CADM1;VEGFA;CD44;WIPF1;RHOB;TGFB1;ITGA5;SPOCK1;COL11A1;CCN2;FBN1;COL6A3;JUN;NOTCH2;PMP22;GEM;COL7A1;MATN2;CCN1;PPIB;NT5E
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.49403379679887316,-0.7445647324605856,0.8857142857142857,1.0,1.0,1/6,27.67%,CYLD
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.49403379679887316,-0.7445647324605856,0.8857142857142857,1.0,1.0,1/6,27.67%,CYLD
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.38976443188170223,-0.7435467399849649,0.8791208791208791,1.0,1.0,9/45,17.49%,CSNK1D;RNF19A;ELOB;CSNK1A1;ARIH2;RBX1;CLU;LRRK2;FBXO22
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.4310964888825574,0.742986913693215,0.7857142857142857,1.0,1.0,2/5,9.34%,ACTN4;MITF
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.38179063470033214,-0.7429529212830166,0.9230769230769231,1.0,1.0,6/43,18.11%,SOD1;EPHA7;FGFR2;CDKN1B;TSPYL2;CAMKK2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.5159258835156604,-0.7426687532351717,0.868421052631579,1.0,1.0,3/5,44.71%,PID1;PRKN;HUWE1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.44716023095003743,-0.7426202663246376,0.8333333333333334,1.0,1.0,4/10,16.61%,UBAC2;TAPT1;HSPA5;LRRK2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.38176277079845194,-0.7422460958574405,0.8333333333333334,1.0,1.0,8/32,21.29%,ARID3A;PLAGL1;CNOT8;CDKN1B;RGCC;MDM4;BTG2;MDM2
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.36074668659271647,-0.7416330316245648,0.9247311827956989,1.0,1.0,29/93,29.50%,DPP6;SPTBN4;ANK3;ARL5A;ATP1B3;ROCK2;DENND4C;WDR19;ZFYVE27;LRRC7;NPC1;TSPAN5;TM9SF3;LIN7A;DPP10;NLGN1;GAK;TM9SF2;RAB11A;RAB12;STXBP1;SH3PXD2B;RAB8B;CLASP2;MAP7;PTCH1;PTN;EPB41L3;RDX
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.4262467757083306,-0.7413900840932566,0.7777777777777778,1.0,1.0,2/13,21.68%,C9ORF72;AKAP13
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.4474020531159817,0.7411094580573481,0.84,1.0,1.0,1/5,4.42%,PPARD
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.3873128378641211,-0.7404671055783363,0.8953488372093024,1.0,1.0,8/32,24.97%,PSMB1;PSMD14;PSMA4;PSMB2;PSMA7;LNPEP;HLA-B;PSMA3
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.36430952128064065,-0.740191466916316,0.8817204301075269,1.0,1.0,18/55,32.07%,PSMB1;PSMD14;AP2A1;PSMA4;PSMB2;PSMA7;PPP3CA;AGO2;SMURF2;NLK;SFRP4;PPP3CB;PSMA3;DAAM1;PRICKLE1;AP2B1;AP2A2;PSMD1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.4654165763230358,-0.7401156291955543,0.7974683544303798,1.0,1.0,3/9,26.10%,CD38;STAT6;RORA
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.44727607771480093,-0.7400770957518441,0.8,1.0,1.0,3/10,10.69%,SOD1;SOD2;MT3
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.44822573362795226,-0.73988438855934,0.8255813953488372,1.0,1.0,5/11,38.66%,PTPN2;STAT1;HSP90AB1;PIAS1;IFNGR2
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.487364641795106,-0.739866092184893,0.8333333333333334,1.0,1.0,2/5,22.46%,SREBF1;SCARB1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.42957892352206334,-0.7397210269374718,0.7901234567901234,1.0,1.0,3/13,26.44%,PRKCI;IRS1;INSR
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.4553712511927831,-0.7393289077601088,0.8860759493670886,1.0,1.0,3/14,24.67%,DDIT4;ZFYVE27;GRB2
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.3852501839719362,-0.7383725298759044,0.8505747126436781,1.0,1.0,9/26,32.38%,MT3;PPIB;PUM3;WARS1;LYN;NDUFS4;FN1;PARG;SPRED1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.452478623465408,0.7381735489136645,0.8076923076923077,1.0,1.0,2/5,13.18%,MAPK14;CFLAR
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.40281839502211314,-0.738050461372437,0.9,1.0,1.0,8/30,27.48%,MORF4L1;BRD1;EP400;MORF4L2;PER1;YEATS2;APBB1;PHF20L1
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.35108720067674815,-0.7376969798088208,0.9484536082474226,1.0,1.0,15/108,17.77%,GJA1;F3;ARHGEF9;COL11A1;BCKDHB;FHL2;ADORA2B;CDKN1B;NOTCH2;RUNX1;PMP22;DUSP1;IGFBP5;PLPP3;CCN1
prerank,PanglaoDB_Augmented_2021__Microglia,0.314968419996328,0.7376136118997234,0.7647058823529411,1.0,1.0,5/20,7.17%,MERTK;CD4;WDFY4;SKI;ITGB5
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.42780277621934604,0.737146845838902,0.7666666666666667,1.0,1.0,1/6,5.77%,SETD7
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.39351602934104135,-0.7370916262857817,0.8409090909090909,1.0,1.0,2/30,7.35%,WWC1;GALNT11
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.4678876448918807,-0.7366062751414854,0.8513513513513513,1.0,1.0,2/7,26.27%,IL18;ZBTB1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.3461847033826102,-0.7358385117566906,0.9183673469387755,1.0,1.0,12/85,13.29%,SRGN;CD55;EMP1;SLC2A1;RHOJ;CFH;CCN2;GPM6A;FHL2;C1R;PROCR;SGK1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.3943077345639315,-0.735660083204476,0.8695652173913043,1.0,1.0,9/28,29.26%,CCT4;HNRNPC;DCP2;MAP3K4;TNKS;MAPK1;POT1;CCT8;TERF1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.4219763610602404,-0.735413002285154,0.8571428571428571,1.0,1.0,3/14,5.74%,CRY1;RBM4B;PPP1CC
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.30191383831256624,0.735209722899755,0.9375,1.0,1.0,3/16,5.60%,CMTM8;NFASC;SKI
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),-0.45698254677561045,-0.7351450860594757,0.9090909090909091,1.0,1.0,1/6,15.66%,SLC12A6
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.4551029826899227,-0.7349434865152598,0.8108108108108109,1.0,1.0,4/8,31.39%,CSGALNACT1;EXTL2;FUT8;PARG
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.4908161659415067,-0.7348274937245065,0.9166666666666666,1.0,1.0,4/7,25.00%,SESN1;LARS1;EIF2AK4;RRAGB
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.4029819711902196,0.7347684549745145,0.6785714285714286,1.0,1.0,2/7,3.80%,PRPSAP1;HPRT1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.3624316927792572,-0.734615366927912,0.9175257731958762,1.0,1.0,14/81,11.88%,GJA1;EMP1;CD44;EFNB2;ITGA5;COL11A1;FAM114A1;FBN1;FGFR2;HIF1A;MRC2;SVEP1;C1R;COL6A3
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.40976745490419697,-0.7341337580338213,0.8095238095238095,1.0,1.0,4/17,14.55%,KLF2;NOS1AP;ROCK2;CLU
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.4850311253863205,-0.7337745690127658,0.8961038961038961,1.0,1.0,2/6,25.03%,GAK;CCDC91
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.4271703755508891,-0.7336147897355896,0.8354430379746836,1.0,1.0,3/15,12.47%,FTH1;MT3;TF
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.4349580875504501,0.7332196960079633,0.76,1.0,1.0,6/6,56.54%,TRIM37;BRCA1;CENATAC;KAT2B;CDK5RAP2;TMEM67
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.3456991111305825,0.7330540984592744,0.7619047619047619,1.0,1.0,2/10,4.99%,NOTCH1;CD4
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.38649301709608236,0.7329124480093064,0.8695652173913043,1.0,1.0,2/9,2.93%,HEYL;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.3765978695552592,0.7325913148461861,0.8235294117647058,1.0,1.0,2/16,6.92%,DOCK8;NCK1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.4102422780474054,-0.7313331629668025,0.85,1.0,1.0,4/12,20.64%,PTPRD;SYNDIG1;NLGN1;SEMA4D
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.4458031380974695,-0.7313319865307636,0.8795180722891566,1.0,1.0,4/13,26.74%,SDCBP;KCTD20;APP;EGFR
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.36123657009273474,0.7308900068590444,0.9411764705882353,1.0,1.0,4/19,6.41%,BCL2L1;BCL2L11;DAPK2;BCL2
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.4729098422658178,-0.7307546738625567,0.8611111111111112,1.0,1.0,2/7,23.88%,CSGALNACT1;EXTL2
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.4782815664475143,-0.73054303216506,0.8767123287671232,1.0,1.0,4/5,30.35%,LRRK2;DCN;RACK1;KDR
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.37051826392805703,-0.7304835266793313,0.9120879120879121,1.0,1.0,6/34,16.39%,PRKACA;TGFB2;ATP1B3;KCNQ1;ABCC9;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.46392935718494177,-0.7302220506900748,0.881578947368421,1.0,1.0,1/7,7.96%,STAT3
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.46392935718494177,-0.7302220506900748,0.881578947368421,1.0,1.0,1/7,7.96%,STAT3
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.378765268074124,-0.7300991023817902,0.8617021276595744,1.0,1.0,10/38,15.51%,VEGFA;RUBCN;DDX3X;CRACD;LGALS3;TRAF3IP1;TMEFF2;CLU;HSPA5;WASHC2C
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.469313357931475,-0.7300755304275558,0.7887323943661971,1.0,1.0,3/7,30.77%,DLD;AASS;ALDH7A1
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.469313357931475,-0.7300755304275558,0.7887323943661971,1.0,1.0,3/7,30.77%,DLD;AASS;ALDH7A1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.4033497359079269,0.7300381088136446,0.7241379310344828,1.0,1.0,1/5,7.38%,HLA-E
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.4666308496220147,-0.7297066344988048,0.8243243243243243,1.0,1.0,2/7,14.73%,LPCAT3;PLAAT3
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.4629402227415984,-0.7296998210387298,0.8552631578947368,1.0,1.0,1/5,4.61%,SECISBP2L
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.4629402227415984,-0.7296998210387298,0.8552631578947368,1.0,1.0,1/5,4.61%,SECISBP2L
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.4355712077783109,-0.7295431151531487,0.8333333333333334,1.0,1.0,3/13,15.46%,NIBAN2;HNRNPC;DCP2
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.3632059458349954,-0.7291506439442489,0.9052631578947369,1.0,1.0,8/54,21.37%,RHOB;DIAPH1;TRAF3IP1;ROCK2;IQCJ-SCHIP1;RHOBTB3;MAPK1;PAK1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.36302405493473144,-0.7288894708853064,0.8526315789473684,1.0,1.0,12/47,21.23%,HABP4;RPS4X;DDX3X;UPF3A;PRKDC;CDC123;PLD1;ELAVL1;AGO2;RPL5;UHMK1;EIF2S3
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.4390130094412992,-0.7285155310042939,0.8658536585365854,1.0,1.0,3/12,18.89%,PTPN1;PTPN2;UBE2K
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.3659906327996052,-0.7281616080782238,0.9157894736842105,1.0,1.0,8/59,14.22%,NRG1;F3;MYDGF;TGFB1;FGFR2;TGFBR1;IL18;AKR1C2
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.39302209614733513,-0.727670458909302,0.8636363636363636,1.0,1.0,3/30,13.73%,ZFP36L2;TANK;GBP2
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.44160496069195454,-0.7274993625571714,0.8292682926829268,1.0,1.0,1/9,7.58%,BORCS5
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.503541667078084,-0.7272201318158177,0.9324324324324325,1.0,1.0,3/5,21.84%,IGFBP2;IGFBP5;BMP5
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.3670290144197845,-0.7269919371139508,0.9680851063829787,1.0,1.0,9/74,14.22%,NRG1;F3;MYDGF;TSC2;TGFB1;FGFR2;TGFBR1;IL18;AKR1C2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.5078319634447568,-0.7268270980993726,0.9210526315789473,1.0,1.0,3/6,29.93%,PARP1;TNKS;PARP14
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.3669393298878941,-0.726630714499283,0.9340659340659341,1.0,1.0,11/47,21.54%,PRKACA;ZFP36L2;PCBP3;SRSF5;PPARGC1A;DCP2;CSTF3;ALKBH5;SSB;METTL16;NONO
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.39781019982348986,-0.7264815458515776,0.896551724137931,1.0,1.0,5/17,23.99%,DGKI;GK5;PLAAT3;LMF1;LPL
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.3380530944164422,-0.7258816927615855,0.99,1.0,1.0,66/266,23.84%,CSF1;NRG1;S1PR3;NR4A3;IFIT3;VEGFA;TSC2;EFNB2;TGFB2;RPS4X;EAPP;HDAC2;CTCF;TGFB1;SOD2;NIBAN2;EIF2AK2;STAT3;PDGFD;SMAD6;TBRG1;FTH1;CCAR1;SDCBP;TBC1D8;FGFR2;PTPN2;SSR1;KRAS;PRKDC;CDC123;TGFBR1;JUN;MYO16;SGK1;CNOT8;CDKN1B;AKR1C2;CLU;RUNX1;ALDH1A2;PRLR;RGCC;MDM4;COL18A1;BTG2;MCTS1;TET1;NAP1L1;NAMPT;TSHR;MDM2;PAK1;RAF1;BIRC2;BMP5;ATP8A2;STAT1;BTG1;NF2;ADAM17;WDR6;IRF1;WARS1;STAT6;SFRP4
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.32734761048655137,0.7258421392951003,0.95,1.0,1.0,3/16,7.82%,SERPINH1;SERPINI1;HDAC1
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.43913838320312826,-0.7258371814018348,0.875,1.0,1.0,2/11,16.61%,TMEM165;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.46254611405538854,0.7258024067783525,0.76,1.0,1.0,1/5,4.71%,MAPRE2
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.39387894708623933,-0.7254687544983062,0.8636363636363636,1.0,1.0,11/27,24.97%,PSMB1;PANK2;PSMD14;PSMA4;PSMB2;PSMA7;AZIN1;PRKAG2;PPARA;NCOR2;PSMA3
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.42059116957210074,-0.7248738125767616,0.85,1.0,1.0,6/12,37.14%,SREBF1;PPARA;SCARB1;SORBS1;MTOR;NR1H3
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.461376573130554,-0.7248107261900749,0.8382352941176471,1.0,1.0,3/7,42.71%,NF1;CEBPB;TGFBR3
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.39496841393426346,-0.7245266783872544,0.9120879120879121,1.0,1.0,6/28,20.25%,TWIST1;PTPN1;LPCAT3;CLU;BRAP;APPL2
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.3916737587518844,0.7240799817211658,0.7083333333333334,1.0,1.0,4/9,9.09%,CACNA1C;CAP2;GRM3;CACNA1D
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5040291510324945,-0.7237374916585269,0.84375,1.0,1.0,2/5,33.03%,IRS1;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),-0.5040291510324945,-0.7237374916585269,0.84375,1.0,1.0,2/5,33.03%,IRS1;SORBS1
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.4174270060449199,0.7236560485912963,0.7857142857142857,1.0,1.0,3/12,15.43%,MYLK;ITGB1;PTK2
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.37207576173731166,-0.7235965759398229,0.9032258064516129,1.0,1.0,12/35,30.01%,RIPOR1;TGFB2;TGFB1;EXOC1;PRR5L;SYTL4;APBB1;RACK1;MYO18A;GOLPH3;CNST;ADAM9
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.45090055304322113,-0.72345929298462,0.8734177215189873,1.0,1.0,6/9,44.82%,ADAM9;SNX9;SH3D19;TIMP2;NRDC;TNFRSF1B
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.4555171494031613,-0.7232886007706674,0.7837837837837838,1.0,1.0,1/5,11.66%,AGK
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.39329504889026845,0.7229871849859661,0.7857142857142857,1.0,1.0,5/5,60.70%,PKD2;UBQLN1;GNB5;CALM1;FMR1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.49208963198435096,-0.7227518327627667,0.9066666666666666,1.0,1.0,2/6,16.39%,NOS1AP;CAMK2D
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.4404661819102215,-0.7223483997674253,0.8461538461538461,1.0,1.0,2/7,8.84%,GMPS;DGUOK
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.37481855178102086,-0.7222884287155394,0.8555555555555555,1.0,1.0,11/38,28.07%,THSD7A;PTPN1;PARVB;MICALL2;DTNBP1;FARP2;MINK1;PAK1;GRB2;NEDD9;GSN
prerank,MSigDB_Hallmark_2020__Apical Surface,0.3211156511697414,0.7222382155371073,0.8666666666666667,1.0,1.0,2/14,7.52%,AFAP1L2;HSPB1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.4644603620546665,-0.7216814165146076,0.8441558441558441,1.0,1.0,2/5,37.22%,STAT1;COL4A1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.3905408531238159,-0.7216089557912181,0.8433734939759037,1.0,1.0,6/18,24.61%,GRIK1;NRG3;BTBD9;GRIK2;NLGN1;LRRC4C
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.4250470682131436,-0.7210727919636639,0.8658536585365854,1.0,1.0,5/13,31.90%,MYO16;IRS1;PIK3CB;NF1;PLEKHA1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.4069612065938459,0.7206957036552178,0.8333333333333334,1.0,1.0,1/6,7.44%,CHMP4B
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.36102297721393806,-0.7202570428407091,0.9213483146067416,1.0,1.0,7/55,9.23%,ELAVL3;PCBP3;ARHGEF9;NCAM1;CDH20;SLC1A2;SNAP25
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.4312197794281316,-0.7195669272779794,0.8641975308641975,1.0,1.0,6/13,23.12%,SLC22A6;SLC47A1;SLC13A3;ASS1;ENPEP;AK4
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.4033928977256809,-0.7195313002983378,0.8777777777777778,1.0,1.0,7/22,30.72%,SDCBP;UCHL5;WAC;RPL5;FHIT;HSP90AB1;RPL11
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.3975407771852101,0.7193566289253331,0.8260869565217391,1.0,1.0,2/9,2.93%,HEYL;NOTCH1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.49812835980451375,-0.7193233938745878,0.9154929577464789,1.0,1.0,2/5,23.26%,FBN1;FSTL1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.4619489216159678,-0.718970734063565,0.8961038961038961,1.0,1.0,6/9,37.76%,CCT4;CCT8;CEP120;CORO2B;CCT6A;CCT3
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.3800135815691025,-0.7189004906234916,0.9148936170212766,1.0,1.0,12/34,30.01%,TGFB2;TGFB1;EXOC1;RAB27A;RGCC;DTNBP1;SYTL4;APBB1;CLASP2;MYO18A;GOLPH3;ADAM9
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.37593813321825365,-0.7187521319480352,0.9176470588235294,1.0,1.0,3/33,7.24%,TGFB2;TGFB1;PRKCI
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.3128763948279734,0.7185518879244448,0.9230769230769231,1.0,1.0,4/25,10.59%,INF2;VPS35;RHOT1;EP300
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.3772073115213784,-0.7182064919501646,0.8571428571428571,1.0,1.0,10/26,36.37%,ANK3;SYTL4;NSF;SERP1;UGCG;EPB41L3;SNX9;A4GALT;MYOF;ARL8B
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3139250243060494,0.7181823755373193,0.8181818181818182,1.0,1.0,3/18,8.73%,CDC42;FLNA;CARMIL1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.3815321905188533,0.7175856995741177,0.7142857142857143,1.0,1.0,2/9,8.06%,CAPRIN2;DLG5
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.3553618516625838,-0.7174486176784387,0.9195402298850575,1.0,1.0,10/49,17.52%,CNTN3;PCDH17;PHYHIPL;PTPRD;SNAP25;SHC2;GRIA3;FGF14;SMARCA1;IGFBP5
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.4475804979059451,-0.717358400298308,0.8181818181818182,1.0,1.0,2/9,16.61%,GRIN1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.33084129141545615,0.7170985011276371,0.8695652173913043,1.0,1.0,2/11,5.91%,CNOT7;TOB1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.3247498120398416,0.7165397192197434,0.76,1.0,1.0,4/15,15.43%,MYLK;SMOC2;ITGB1;PTK2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.3709126742524863,-0.7164190374035732,0.8333333333333334,1.0,1.0,6/33,22.53%,TGFB1;SPOCK1;JAM3;DUSP1;SEMA4D;NF2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.3508661882027134,-0.7163940689661922,0.9285714285714286,1.0,1.0,19/66,24.97%,SRA1;PSMB1;TGFB1;PSMD14;SDCBP;PSMA4;PSMB2;ANGEL2;CDKN1B;PSMA7;ANAPC4;BTRC;BTG2;SKP1;MDM2;BTG1;HECA;APP;PSMA3
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.46341533281136965,-0.7159978704466571,0.8717948717948718,1.0,1.0,1/7,10.76%,PRKAR1A
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.3693883951963166,-0.7156714770987112,0.8674698795180723,1.0,1.0,6/24,24.72%,NFKBIA;PDCD4;IL18;CCN4;LPL;APP
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.46594674726515134,-0.715546532409108,0.8918918918918919,1.0,1.0,2/5,31.62%,RNF168;HSPD1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.4648437749036432,-0.7155301644485151,0.8421052631578947,1.0,1.0,6/10,40.54%,RPL5;RPL24;RPL11;RPL3;DHX30;RPL23A
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.4484632101831729,0.715210088910597,0.7894736842105263,1.0,1.0,6/6,55.20%,TRIM37;ALMS1;BRCA1;KAT2B;CDK5RAP2;CEP295
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.3881244304803679,-0.7152071163068469,0.8777777777777778,1.0,1.0,7/21,29.65%,PDCD4;PTPN1;DUSP1;DNAJA1;LYN;PIK3CB;NF1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3417191373387217,-0.7151613543086124,0.99,1.0,1.0,41/207,24.69%,KLF2;CREB3L2;ESR2;HDAC2;CTCF;TGFB1;NIBAN2;STAT3;CD38;RNF111;HIF1A;MT3;TP63;ARNT2;ELF1;MED14;TGFBR1;JUN;CLOCK;WAC;TCF4;PPARGC1A;RUNX1;NAA15;TEAD1;CALCOCO1;RNF10;SMARCA1;CAMKK2;BTRC;KDM3A;YAF2;FUBP3;CRLF3;PPARA;STAT1;IRF1;TP53BP1;APBB1;DEAF1;PPP3CB
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.35835162743637955,-0.7150639611627401,0.9347826086956522,1.0,1.0,10/48,15.04%,NRG1;VEGFA;TGFB2;TGFB1;LGALS3;NEDD4L;TGFBR1;SPIDR;CLU;RUNX1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.39666520838292,-0.7143345190173459,0.9318181818181818,1.0,1.0,3/18,24.89%,DDIT4;HINT1;FHIT
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.3352978872841081,-0.7140857106114576,0.98,1.0,1.0,54/222,24.01%,TP53TG5;ENO1;GJA1;FHL1;IFIT3;TSC2;TGFB2;PIP4P2;ESR2;PDCD4;DDX3X;RHOB;CTCF;TGFB1;SOD2;NIBAN2;EIF2AK2;CCN2;SMAD6;TBRG1;FTH1;PTPN2;MT3;LPCAT3;MYO16;RBBP7;CDKN1B;CLU;ALDH1A2;TSPYL2;DUSP1;RGCC;MDM4;CCN1;COL18A1;BTG2;ADNP2;CCN4;APPL2;SEMA4D;CRLF3;RAF1;BMP5;JAM2;ATP8A2;BTG1;NF2;CD9;WDR6;IRF1;LRPAP1;WARS1;SFRP4;APBB1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.34311104693319483,-0.7132951540511898,0.94,1.0,1.0,26/125,25.16%,NFKBIA;PSMB1;PSMD14;RPS27A;JOSD1;CCP110;USP15;HIF1A;PSMA4;PSMB2;TGFBR1;UCHL5;USP9Y;PSMA7;SENP1;MDM4;WDR48;MYSM1;SMURF2;MDM2;BIRC2;OTUD7A;UIMC1;RAD23B;PSMA3;USP3
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.44412866264887507,-0.7128488486033386,0.855072463768116,1.0,1.0,1/8,13.91%,SIN3A
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.3449606496376307,-0.7125915332280379,0.90625,1.0,1.0,2/64,3.72%,MID1;TENM3
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.38150085838305914,-0.7125453998068625,0.9111111111111111,1.0,1.0,10/38,24.94%,IFITM3;IFIT3;EIF2AK2;DDIT4;ABCC9;TRIM5;STAT1;IRF1;MAP3K14;IFI44L
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.43136095291423704,-0.7125330907477803,0.821917808219178,1.0,1.0,1/8,6.00%,WDR43
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.44579026126961696,-0.7125018067265743,0.8243243243243243,1.0,1.0,5/8,35.13%,LGALS3;PAG1;HSPD1;ABL1;CD47
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.46083114497443334,-0.7122445229801736,0.8875,1.0,1.0,1/8,4.23%,TGFB2
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.43862141688758294,0.711920135023548,0.782608695652174,1.0,1.0,1/6,4.71%,MAPRE2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3335306097022989,0.7112589102164807,0.8823529411764706,1.0,1.0,2/14,8.70%,VPS35;MARK1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.4458850803701859,-0.7110542042028406,0.9066666666666666,1.0,1.0,2/10,4.23%,ZFPM1;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.44176697469157306,-0.710832757819042,0.9186046511627907,1.0,1.0,4/12,22.53%,SH3BP5;PTPN2;SEMA4D;NF2
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.3970673576025073,-0.7108234545357538,0.9101123595505618,1.0,1.0,6/23,28.50%,SRSF10;SRSF5;SETX;SF3B1;CELF2;NCBP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.44395328173712767,0.7105964365877642,0.9310344827586207,1.0,1.0,2/5,15.90%,PIK3CD;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.33820534589163215,-0.7102403886170424,0.9696969696969697,1.0,1.0,31/144,21.84%,CSF1;CSNK1D;VEGFA;CD44;MYDGF;TGFB2;DDX3X;TGFB1;ITGA5;PDGFD;CEMIP;STK4;ENPP2;SDCBP;MT3;KRAS;TGFBR1;ROCK2;TERF2IP;TBK1;LRRK2;CCN1;CAMKK2;MTCP1;UBE2K;PRKAG2;SEMA4D;MAPK1;PAK1;RAF1;BMP5
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.33890222961924343,0.7102074532990833,0.8333333333333334,1.0,1.0,5/15,9.79%,DOCK8;WDFY4;RASGRP2;MITF;RCSD1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.41113490601071945,-0.7099403013368837,0.9113924050632911,1.0,1.0,2/17,12.42%,DDX3X;PABPC1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.38920468573904116,-0.7098081931170181,0.8928571428571429,1.0,1.0,8/27,21.88%,NRCAM;ZC4H2;SIN3A;TCF4;LRRK2;YWHAG;NLGN1;EIF2AK4
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.4247004672403393,-0.7097767726249078,0.8421052631578947,1.0,1.0,1/11,5.72%,NUP153
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.364404984306164,-0.7095949836627922,0.9340659340659341,1.0,1.0,9/39,25.47%,VAV3;WIPF1;ACTR3;MAPK1;PAK1;FYN;MYO10;GRB2;LYN
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.364404984306164,-0.7095949836627922,0.9340659340659341,1.0,1.0,9/39,25.47%,VAV3;WIPF1;ACTR3;MAPK1;PAK1;FYN;MYO10;GRB2;LYN
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),-0.47003451962700077,-0.7094525975439714,0.8461538461538461,1.0,1.0,1/5,19.26%,PRKAG2
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.39701272694890094,-0.7093880438159342,0.8928571428571429,1.0,1.0,7/21,21.84%,CSMD3;NEDD4L;LZTS1;SEMA4D;HECW1;NEDD4;BMP5
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.389128337022497,-0.7090564129882229,0.9036144578313253,1.0,1.0,3/27,11.27%,CCP110;FGFR2;TP63
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.41544567348420103,-0.708853390340898,0.8192771084337349,1.0,1.0,3/11,19.08%,CTR9;WAC;UBE2B
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.3454442286069094,0.708518764292335,0.8461538461538461,1.0,1.0,3/18,11.35%,MRPL1;MRPL33;MRPL3
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.4387229092535746,-0.7081671375395504,0.8888888888888888,1.0,1.0,2/9,3.60%,NRG1;VEGFA
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.3916889353356267,-0.7081271371374273,0.8928571428571429,1.0,1.0,6/22,27.33%,RPA1;RPS27A;POLK;UBE2B;ZBTB1;RPA3
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.3484197872787927,-0.70798872932701,0.9021739130434783,1.0,1.0,15/58,27.05%,PDE4B;PSMB1;PSMD14;PSMA4;PSMB2;PSMA7;BTRC;PAG1;SKP1;PAK1;FYN;MALT1;PSMA3;RC3H2;PDE4D
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.37963174041461845,-0.7072395543155603,0.9222222222222223,1.0,1.0,10/39,24.94%,IFITM3;IFIT3;EIF2AK2;DDIT4;ABCC9;TRIM5;STAT1;IRF1;MAP3K14;IFI44L
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.35396634264080457,-0.7064596022341421,0.898876404494382,1.0,1.0,9/42,15.28%,ELAVL3;PHYHIPL;GRIN1;SLC1A2;SNAP25;NXPH1;SLC1A1;UNC79;SNAP91
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.3310766143151416,-0.7064063649572334,0.9696969696969697,1.0,1.0,15/87,22.35%,TBC1D20;ARHGAP24;GARNL3;MMUT;RGS7;TBC1D8;AFDN;SIPA1L2;RALGAPA2;USP6NL;ZC3H15;PKP4;SEMA4D;LARS1;TBC1D15
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.36706187094987985,-0.7061157440661447,0.8791208791208791,1.0,1.0,11/34,30.10%,PSMD14;XRCC4;PRKDC;POLA1;RNF168;TP53BP1;UIMC1;BRCC3;KDM2A;UVRAG;XRCC6
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.3937029136726787,-0.7057470639692293,0.8987341772151899,1.0,1.0,4/23,18.10%,TUT7;CNOT8;DCP2;PATL1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.4187717361006713,0.7055122889918786,0.8076923076923077,1.0,1.0,2/6,8.64%,ATP1B2;WNK2
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.27988399290524657,0.7048205661715601,1.0,1.0,1.0,3/34,3.92%,CACUL1;CDK6;CUL2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.44529514740152787,0.7046534047964793,0.84,1.0,1.0,2/5,8.64%,ATP1B2;WNK2
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.4519466946500924,-0.7046159773117531,0.8607594936708861,1.0,1.0,2/7,21.84%,DUSP1;BMP5
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.3623540993198588,-0.704580108714168,0.8809523809523809,1.0,1.0,7/26,26.04%,NFKBIA;PDCD4;IL18;CCN4;LPL;APP;RIOK3
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.31439329631973806,0.7045506419181753,1.0,1.0,1.0,4/26,8.25%,LEMD3;NOTCH1;SKI;RBPMS2
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.41042478723838893,0.7043121844847179,0.8076923076923077,1.0,1.0,3/6,17.49%,SLC27A1;PLEKHA3;CERT1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.4481512148641669,-0.7039461898325265,0.8947368421052632,1.0,1.0,5/10,31.89%,SMCHD1;PRKDC;POT1;MRNIP;SHLD2
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.38463763174502974,-0.7038784741166495,0.9012345679012346,1.0,1.0,5/20,20.44%,RHOB;ROCK2;RHOBTB3;FMNL2;NLGN1
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.405167502376244,0.7035947885264795,0.7916666666666666,1.0,1.0,1/5,3.13%,INPP5F
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.39304666686494094,-0.7033604252154626,0.898876404494382,1.0,1.0,6/19,29.96%,GOLGA2;SMC3;MAP9;RAB11A;CLASP2;SMC1A
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.34801541996376517,-0.7032559632166866,0.9333333333333333,1.0,1.0,14/55,22.64%,PSMB1;PSMD14;PSMA4;PSMB2;SREBF1;SCD;ROCK2;SIN3A;PSMA7;AZIN1;LSS;SREBF2;PPARA;NCOR2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.39000641810109415,0.7030397325996245,0.7941176470588235,1.0,1.0,2/5,11.46%,MAPK14;HMGB1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.38975366853474114,-0.7029327930155568,0.8636363636363636,1.0,1.0,6/14,30.37%,CDKN1B;CCNH;CCNK;GTF2H1;CAMK2N1;HSP90AB1
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.38049339810761906,-0.7028512404092205,0.8928571428571429,1.0,1.0,7/24,24.67%,STK33;CDC5L;DONSON;CLOCK;MDM4;TP53BP1;GRB2
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.41421341128380396,0.702465681737894,0.8,1.0,1.0,2/7,10.42%,PPARD;CREB1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.3432381734604748,-0.7020440036594068,0.9052631578947369,1.0,1.0,20/71,28.82%,SSH1;PPP1CC;PTPRE;PPP2R1B;PTPRD;PTPN1;PTPN2;PPP2R2A;PPP3CA;DUSP1;BTRC;MTMR2;PPP2R3A;PPP3CB;PTPRM;DUSP16;EYA1;PTPN9;EYA2;PTPRZ1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.35993202689173454,-0.7015240699891478,0.9156626506024096,1.0,1.0,10/36,28.77%,SMCHD1;RGCC;RNF168;WRN;UIMC1;POT1;EGFR;EYA1;BRCC3;EYA2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.36297083512361306,0.7015092797522016,0.7272727272727273,1.0,1.0,3/10,5.30%,PPARD;CD4;WDFY4
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.4489112358797571,-0.7002038351319365,0.9142857142857143,1.0,1.0,4/9,32.71%,FMN2;IHO1;PTN;DIAPH2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.35528792191232184,-0.6997055262877686,0.9101123595505618,1.0,1.0,7/44,8.65%,VEGFA;CD44;TGFB1;ITGA5;STAT3;PTPN1;ENPP2
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.3768251009630319,0.6994085906066173,0.8125,1.0,1.0,10/10,62.38%,RB1;PHF8;AKAP8L;MCPH1;ACIN1;CSNK2A2;TENT4A;GPER1;CSNK2A1;TTN
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.46570069732743496,-0.6989535210556497,0.8933333333333333,1.0,1.0,1/6,10.55%,RAP1B
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.46121774222415196,-0.6988200121645335,0.8769230769230769,1.0,1.0,2/5,4.25%,VEGFA;NOS1AP
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.3983728135850488,-0.6986673824799717,0.8961038961038961,1.0,1.0,3/18,23.99%,SCD;GPX4;LPL
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.45890809377180036,-0.6984870912686136,0.918918918918919,1.0,1.0,2/6,37.52%,RAB11A;DLG1
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.45101035087788505,-0.6982723971169615,0.8552631578947368,1.0,1.0,2/8,16.61%,GRIN1;LRRK2
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.35594638871394824,-0.698245357112024,0.8928571428571429,1.0,1.0,6/34,14.92%,PSMB1;PSMD14;AP2A1;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.4172281410457914,-0.6981910145467459,0.9054054054054054,1.0,1.0,4/9,24.72%,OXSR1;ADAM17;STK39;APP
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.36702112634526574,-0.6979622479651418,0.8658536585365854,1.0,1.0,6/26,10.20%,BASP1;VEGFA;PGK1;HDAC2;LGALS3;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.3436844331367033,-0.6978952381249725,0.967741935483871,1.0,1.0,6/48,10.69%,CD44;TGFB1;PDGFD;CCN2;FGFR2;MT3
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.354241255082322,-0.6978461457391978,0.8941176470588236,1.0,1.0,6/36,14.92%,PSMB1;PSMD14;AP2A1;PSMA4;PSMB2;PSMA7
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.4700558970699017,-0.6975754878174917,0.8701298701298701,1.0,1.0,3/6,49.95%,ADH1B;ALDH2;ADH5
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.4700558970699017,-0.6975754878174917,0.8701298701298701,1.0,1.0,3/6,49.95%,ADH1B;ALDH2;ADH5
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.43190443409659984,-0.6971550469528806,0.8860759493670886,1.0,1.0,3/10,24.78%,MGAT4A;MAN2A1;FUT8
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.33664425582403423,-0.6970814482323453,0.9797979797979798,1.0,1.0,25/156,18.08%,COL4A6;NCKAP5;TGFB2;CLIP4;P4HA3;RHOB;CST3;COL11A1;STMN1;RPS27A;SHROOM3;PXDN;GGA3;HDGFL3;COL6A3;TGFBR1;SNCAIP;WDR73;RHOBTB3;APH1B;COL7A1;GFAP;TSPAN5;PPIB;COL18A1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.39251901288219776,0.6966592718749508,0.7692307692307693,1.0,1.0,5/5,60.78%,TPR;NUMA1;CSNK2A2;CSNK2A1;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.4127131738394667,-0.6966332469275367,0.9,1.0,1.0,7/13,38.54%,PARP1;WDR48;TP53BP1;MRNIP;SHLD2;ARID2;PAXIP1
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.448765685761245,-0.6964186777233844,0.8481012658227848,1.0,1.0,1/5,9.65%,KCNQ1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.45646290297616854,-0.6961070284361552,0.8656716417910447,1.0,1.0,2/5,24.53%,LNPEP;HLA-B
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.4256567155483827,0.6961015043092508,0.8571428571428571,1.0,1.0,1/5,5.54%,ERCC6
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.41813950208483863,-0.6958341401046001,0.8974358974358975,1.0,1.0,1/10,8.96%,DNMT1
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.41813950208483863,-0.6958341401046001,0.8974358974358975,1.0,1.0,1/10,8.96%,DNMT1
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.41813950208483863,-0.6958341401046001,0.8974358974358975,1.0,1.0,1/10,8.96%,DNMT1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.37650420348004315,0.6956664555582007,0.8695652173913043,1.0,1.0,3/11,18.73%,ZNF143;CHD8;RPTOR
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.3657140710182832,-0.6944334624968717,0.9431818181818182,1.0,1.0,10/37,28.78%,PABPC1;SRSF5;SYMPK;CSTF3;AHCYL1;CPSF2;THOC2;APP;NCBP1;GRSF1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.3855915879325848,-0.693769383826736,0.8414634146341463,1.0,1.0,11/22,39.84%,GLUL;RPL35A;RPL5;RPS24;RPL11;RPL14;RPS6;WDR12;RPS25;RPS16;RPS28
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3139287529316561,0.6927681638172515,0.8823529411764706,1.0,1.0,5/19,13.48%,ADCY9;ADCY6;FLNA;HTR1F;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.4225409832327872,-0.6925377782330224,0.85,1.0,1.0,1/9,12.17%,MED14
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.3665034956712942,-0.6925044378983151,0.9101123595505618,1.0,1.0,6/33,24.22%,TUT7;SRSF5;SYMPK;CSTF3;CPSF2;THOC2
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.3902165585852267,0.6924569585187044,0.8,1.0,1.0,1/7,1.52%,GRID1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.37240839429808326,-0.691691630311042,0.896551724137931,1.0,1.0,9/26,22.43%,VEGFA;TGFB1;PDGFD;ROBO1;SASH1;LRRK2;MAP3K4;PAK1;TAOK3
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.4393018380906403,-0.6915639621622239,0.9066666666666666,1.0,1.0,4/11,27.05%,ENTPD4;NT5E;HINT1;PDE4D
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.3842549563978948,0.6911667175597407,0.8620689655172413,1.0,1.0,1/5,4.54%,ZDHHC21
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),-0.4504926606775358,-0.690275149540454,0.9333333333333333,1.0,1.0,5/6,54.34%,NAPEPLD;HNRNPU;SIRT1;FTO;RREB1
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.4405548951627976,-0.6900899434773796,0.881578947368421,1.0,1.0,4/8,23.99%,SREBF2;PPARA;SCARB1;LPL
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.39370063704062996,-0.6900697775088853,0.9397590361445783,1.0,1.0,5/16,24.26%,CCT4;MAP3K4;TNKS;MAPK1;POT1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.38935185876275036,-0.6894250872943475,0.925,1.0,1.0,3/17,14.83%,MCTP2;MAP3K8;TCF4
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.37168468858566217,0.6890537805207604,0.9333333333333333,1.0,1.0,2/11,11.99%,DLC1;ACTN1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3934782608695653,0.6887859675341952,0.7333333333333333,1.0,1.0,8/8,60.70%,THADA;PKD2;ATP1A2;UBQLN1;YWHAE;GNB5;CALM1;FMR1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.4091261834549123,0.6886749876397663,0.7931034482758621,1.0,1.0,5/5,59.12%,RAB3GAP1;RAB3GAP2;LNPK;TMEM33;ATL3
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.33530527533713744,-0.6884545946502553,0.9696969696969697,1.0,1.0,25/121,25.16%,NFKBIA;PSMB1;PSMD14;RPS27A;JOSD1;CCP110;USP15;HIF1A;PSMA4;PSMB2;TGFBR1;UCHL5;USP9Y;PSMA7;MDM4;WDR48;MYSM1;SMURF2;MDM2;BIRC2;OTUD7A;UIMC1;RAD23B;PSMA3;USP3
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.3844242733795291,0.6878201889453657,0.8333333333333334,1.0,1.0,1/7,5.18%,SMYD3
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.3629869821850343,-0.6877350225810466,0.9230769230769231,1.0,1.0,11/37,34.85%,VEGFA;ROCK2;GPM6B;CLASP2;SLK;KDR;BCAS3;ABL1;PTPRA;ACTG1;APOD
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.4621566267035426,-0.687375451731086,0.8783783783783784,1.0,1.0,2/5,27.05%,UBE2B;PDE4D
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.36038614878965375,-0.6866992406887356,0.8863636363636364,1.0,1.0,6/32,22.36%,TPT1;MT3;SLC3A2;NDFIP2;NDFIP1;FYN
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.32127514314766703,0.686562351727664,0.8333333333333334,1.0,1.0,3/18,8.27%,TNIP1;MAPKBP1;PPM1A
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.466971435752149,-0.686200474191425,0.9324324324324325,1.0,1.0,3/5,37.56%,SUPT6H;MTF2;MACROH2A1
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.3668334236613731,0.6861581907436746,0.9,1.0,1.0,1/7,3.85%,PLA2G4C
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.4554564037744806,-0.6861460159955831,0.8987341772151899,1.0,1.0,2/6,14.55%,SOD2;CLU
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.42076672357597383,0.6858797233918452,0.8928571428571429,1.0,1.0,5/5,57.96%,SETDB1;TASOR;RESF1;TOP2B;MPHOSPH8
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.34566167774325973,0.6852405891813454,0.9333333333333333,1.0,1.0,3/12,7.23%,ADCY9;CAP2;ADCY6
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.3324637852416526,0.6849144519675366,0.8888888888888888,1.0,1.0,4/8,18.36%,SKI;SORT1;MEF2C;PLD3
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.34819960309919235,0.6848028786322545,0.85,1.0,1.0,2/15,5.52%,HCN2;SLC26A3
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.41308114534064755,-0.6847419623638731,0.875,1.0,1.0,2/12,6.42%,TGFB2;TGFB1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),0.33467120441960835,0.6831702623681134,0.7727272727272727,1.0,1.0,1/11,5.06%,MRPL1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3790827958041766,-0.6826874052329461,0.8488372093023255,1.0,1.0,6/19,26.47%,CCT4;MAP3K4;TNKS;MAPK1;POT1;CCT8
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.3772364737849101,-0.6823320177757982,0.9052631578947369,1.0,1.0,4/22,13.43%,VEGFA;STAT3;PTPN2;IL18
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.4682691787018439,-0.6822460479168545,0.8840579710144928,1.0,1.0,2/5,23.28%,NEDD4L;STK39
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.3899833923775246,0.6821617232762401,0.8518518518518519,1.0,1.0,1/6,5.58%,PACS2
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.46549878838777226,-0.6817042530295474,0.8985507246376812,1.0,1.0,3/5,23.99%,SREBF2;SCARB1;LPL
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.4232606424981643,0.68149109554398,0.9411764705882353,1.0,1.0,2/8,3.80%,PRPSAP1;HPRT1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.37823965982033086,-0.6812820950318226,0.8795180722891566,1.0,1.0,13/27,44.14%,LGALS3;TGFBR1;WWOX;CYLD;ITGAV;MADD;ACVR1;FGFR1;GPER1;SP100;BIRC6;BCL2L14;HTT
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.3481421729684352,-0.6811561424611002,0.9247311827956989,1.0,1.0,12/45,21.01%,GALNT15;GLUL;CDH20;SLC1A2;ENPP2;MT3;PLP1;GRIA3;LRRK2;GFAP;RTN1;MAPK1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.37761197667617824,-0.6809905588677773,0.9090909090909091,1.0,1.0,5/28,22.69%,CTSL;RPS27A;COLEC12;BIRC2;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.42507571118811227,-0.6809826433116948,0.8734177215189873,1.0,1.0,4/7,37.76%,CCT4;CCT8;CCT6A;CCT3
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.351835512796011,-0.680903145956437,0.9195402298850575,1.0,1.0,8/37,22.46%,SLCO1A2;PEX3;PITPNC1;PITPNA;ABCA4;CHKA;AKR1C1;SCARB1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.39751852001538246,0.6808759736990395,0.9545454545454546,1.0,1.0,1/8,2.79%,GRIN2A
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.4226393963034829,-0.680702188828423,0.8533333333333334,1.0,1.0,3/9,33.89%,LRRK2;AK4;GTPBP1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.4226393963034829,-0.680702188828423,0.8533333333333334,1.0,1.0,3/9,33.89%,LRRK2;AK4;GTPBP1
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.38765521251163226,-0.6804879358050251,0.8902439024390244,1.0,1.0,5/13,19.84%,SYT1;RIMS2;RIMS1;GRIK2;NSF
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.37670807453416133,0.6802421582809408,0.8636363636363636,1.0,1.0,8/8,62.38%,RB1;PHF8;AKAP8L;MCPH1;CSNK2A2;TENT4A;CSNK2A1;TTN
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.40141340248021057,-0.6801496286893114,0.8625,1.0,1.0,3/11,28.99%,LRRC7;NLGN1;PTN
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.37745245330934074,-0.6800921061953465,0.9047619047619048,1.0,1.0,6/20,15.23%,PSMB1;PSMD14;PSMA4;PSMB2;PSMA7;AZIN1
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.3320707553316872,-0.680061503525845,0.9696969696969697,1.0,1.0,9/118,17.08%,MID1;CSNK1D;WASF1;CEP57;ARHGAP5;CDC42EP4;NOTCH2;SMC3;ATG4B
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.4616354816639824,-0.6794970507411482,0.8846153846153846,1.0,1.0,3/6,23.45%,SDCBP;MTMR2;LRPAP1
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.33773537306389606,-0.6794084996038812,0.9690721649484536,1.0,1.0,25/80,29.59%,EMP1;ZC3H7A;FAM114A1;FBN1;TP63;FILIP1L;SYNC;PMP22;TEAD1;SASH1;NRP2;PLPP3;STARD13;BNC2;PPARA;LAMA4;FSTL1;SH3PXD2B;COL12A1;EGFR;SLK;FN1;PTN;LAMB1;ITGAV
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.36138646417192344,-0.6787033067256166,0.9418604651162791,1.0,1.0,11/28,33.76%,FGFR2;PRLR;FYN;LYN;INSR;EGFR;FLT1;EPHA4;KDR;ABL1;PTK2B
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.378477048693479,-0.678657872140264,0.9333333333333333,1.0,1.0,6/21,32.27%,SPIDR;AKR1C2;GRAMD1A;GOLPH3;PTCH1;KLF9
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.3981914639565753,0.6784405667070481,0.6923076923076923,1.0,1.0,1/5,10.96%,NCOA3
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.3391960595274523,0.6781188650898606,0.8695652173913043,1.0,1.0,2/8,13.24%,FLNA;PHACTR4
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.3976408505354648,0.6779471658225039,0.8064516129032258,1.0,1.0,5/5,60.27%,RPS19;IL6R;RPL30;OPTN;DROSHA
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.34174413091559885,-0.6779189902645216,0.967391304347826,1.0,1.0,10/66,21.37%,HDAC2;HMGN1;HCFC2;FAM50A;NUDT5;CHD1;EZH1;SMARCA1;MYSM1;PAK1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.410248160471236,-0.6778374468849468,0.8375,1.0,1.0,4/11,33.92%,KIAA0586;ARL13B;PTCH1;GLI3
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.382560498237536,0.6776273804747044,0.9,1.0,1.0,2/14,4.39%,CDC42;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.3278710459640894,-0.6775975857666644,0.979381443298969,1.0,1.0,20/59,30.37%,EPHA7;TGFB1;FGFR2;CCT4;UBE2L3;MAP3K4;TNKS;DCUN1D4;MAPK1;LMO4;POT1;INSR;EGFR;FLT1;SERINC1;RPS2;DCUN1D2;EPHA4;KDR;HSP90AB1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.41964570939299684,-0.6774609838206972,0.9058823529411765,1.0,1.0,1/7,9.43%,FTH1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.36717122985572914,-0.676155356997603,0.9012345679012346,1.0,1.0,2/20,4.37%,VEGFA;RHOJ
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.42970509852123734,-0.6757341358770583,0.881578947368421,1.0,1.0,6/7,54.58%,DLG1;BMPER;SEMA5A;LOXL2;ITGB1BP1;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.4182030779842303,-0.6755730718095608,0.9135802469135802,1.0,1.0,5/8,43.64%,ZBTB1;GLI3;CD46;BCL6;ZMIZ1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.3933521268964958,-0.6754335444851712,0.8717948717948718,1.0,1.0,2/15,13.55%,TUT7;CNOT8
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.3950245905038861,-0.6751375244432024,0.9230769230769231,1.0,1.0,6/14,36.01%,JUN;CHD1;TARDBP;SP1;NAPEPLD;CCNT1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.43302909932327155,-0.6750816791340222,0.8904109589041096,1.0,1.0,3/6,45.58%,HSPD1;PEX1;DNAJC15
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),-0.43669447043685405,-0.6750326043690099,0.8873239436619719,1.0,1.0,1/7,1.40%,NRG1
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.3335056900482594,-0.673762849757842,0.968421052631579,1.0,1.0,12/55,20.89%,CYTH1;VEGFA;EPHA7;ROCK2;IL18;FRMD5;PPP3CA;DUSP1;PKP4;SEMA4D;MINK1;P4HB
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.41033806915829885,-0.6729087955723742,0.8765432098765432,1.0,1.0,3/8,27.47%,PARP1;WDR48;MRNIP
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.25321847212416515,0.6720714336436527,1.0,1.0,1.0,6/55,7.82%,HDAC9;USP16;PHC1;UBE2N;TBL1X;HDAC1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.3285872995416087,-0.671652063862707,0.9473684210526315,1.0,1.0,12/78,15.46%,ZFP36L2;PSMB1;PSMD14;RPS27A;GIGYF2;PSMA4;PSMB2;PABPC1;ROCK2;IGF2BP2;PSMA7;DCP2
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.4544367483067013,-0.6715433698716533,0.8961038961038961,1.0,1.0,1/5,25.82%,STXBP1
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.38435268550139695,0.6714652340859867,0.7307692307692307,1.0,1.0,6/6,61.60%,ACACA;MLYCD;ACSS1;ACAT1;ACACB;DIP2A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.4361748670367134,-0.6711953949668081,0.918918918918919,1.0,1.0,3/7,21.17%,MLPH;RAB27A;RAB11A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.4361748670367134,-0.6711953949668081,0.918918918918919,1.0,1.0,3/7,21.17%,MLPH;RAB27A;RAB11A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.4361748670367134,-0.6711953949668081,0.918918918918919,1.0,1.0,3/7,21.17%,MLPH;RAB27A;RAB11A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.4361748670367134,-0.6711953949668081,0.918918918918919,1.0,1.0,3/7,21.17%,MLPH;RAB27A;RAB11A
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.4365478837129673,-0.6708450908295757,0.8985507246376812,1.0,1.0,1/5,12.70%,SPIDR
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.33283172884980616,-0.6706784835696786,0.9444444444444444,1.0,1.0,9/52,25.06%,DNAJC6;FTH1;AP2A1;EXOC1;STXBP6;DTNBP1;AP4E1;APP;GOPC
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.4466747354273543,-0.6704032693573413,0.8947368421052632,1.0,1.0,1/6,6.00%,WDR43
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.4116325741832589,-0.6703504008452862,0.9090909090909091,1.0,1.0,3/11,21.01%,MAP3K4;TNKS;MAPK1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.38172098766299356,-0.6701115582911628,0.8780487804878049,1.0,1.0,3/14,16.21%,PRKCI;AFDN;MICALL2
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.2817186588319026,0.6691708219300426,1.0,1.0,1.0,1/17,1.57%,USP16
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.4239452588998768,-0.6689830532087727,0.9166666666666666,1.0,1.0,4/9,20.16%,MT3;SPIDR;MTR;KCNC2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.3885331264157714,-0.6689188117129149,0.8607594936708861,1.0,1.0,1/12,6.27%,RHOB
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.3899340081979529,-0.6682513575257433,0.8701298701298701,1.0,1.0,4/14,29.99%,ZRANB3;WRN;POT1;ASCC3
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.41020026711155166,-0.6681434718523646,0.8918918918918919,1.0,1.0,1/8,7.38%,CTR9
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3240930084082358,0.6679471352099932,0.9047619047619048,1.0,1.0,1/13,3.88%,ATM
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.3731366459627329,0.6671967881603694,0.8260869565217391,1.0,1.0,8/8,62.73%,PALLD;NEXN;CNTN4;DSCAM;NPTN;CNTN6;DSCAML1;BSG
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.4035958998647972,-0.6670856627080916,0.8481012658227848,1.0,1.0,2/9,15.66%,ATP1B3;SLC12A6
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.3989165066246336,0.6670240753458816,0.9583333333333334,1.0,1.0,1/7,2.28%,ATP1B2
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.35156480854358474,0.6664648523962157,0.8947368421052632,1.0,1.0,3/12,10.42%,ATM;WNT5B;CREB1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.43585289528934884,-0.6642968290325312,0.9066666666666666,1.0,1.0,3/7,32.89%,PPARGC1A;POR;ETFDH
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.4344923936665632,0.6638616550521105,0.8333333333333334,1.0,1.0,6/6,56.59%,FAP;APOE;CAV1;THBS1;ST3GAL4;TFPI
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),-0.4518488038072065,-0.6634100996131983,0.8656716417910447,1.0,1.0,3/5,20.16%,MT3;MTR;KCNC2
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),-0.4518488038072065,-0.6634100996131983,0.8656716417910447,1.0,1.0,3/5,20.16%,MT3;MTR;KCNC2
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),-0.4518488038072065,-0.6634100996131983,0.8656716417910447,1.0,1.0,3/5,20.16%,MT3;MTR;KCNC2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.36542561248371197,-0.662929932008921,0.8850574712643678,1.0,1.0,6/21,26.47%,CCT4;MAP3K4;TNKS;MAPK1;POT1;CCT8
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.36643795548392305,-0.6628640208244772,0.8928571428571429,1.0,1.0,3/15,16.21%,PRKCI;AFDN;MICALL2
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.39863239781406284,-0.6615539331110247,0.8795180722891566,1.0,1.0,2/9,10.20%,FBN1;FGFR2
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.373481569927245,-0.660546082416359,0.9054054054054054,1.0,1.0,3/14,30.01%,ERAP1;ADAM17;ADAM9
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.3432271616611297,-0.660509724922177,0.9247311827956989,1.0,1.0,7/32,33.42%,STK4;AMFR;LRRK2;APP;RPL11;NMD3;ABL1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.33589060715384744,-0.6602525965669287,0.968421052631579,1.0,1.0,14/48,30.66%,CSF1;EPHA7;FGFR2;CCN1;PRKAG2;LMO4;INSR;EGFR;FLT1;MRNIP;EPHA4;XRCC6;KDR;TAB2
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.3896456139948724,-0.6600219624638775,0.9012345679012346,1.0,1.0,5/13,23.68%,IFITM3;GBP2;RPL13A;STAT1;EPRS1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.40168888669300806,0.6599079558450965,0.7777777777777778,1.0,1.0,1/5,2.28%,ATP1B2
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.4069370916889923,-0.659683552032708,0.8461538461538461,1.0,1.0,3/8,30.89%,CAMK2D;GSN;ATP1A1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.4069370916889923,-0.659683552032708,0.8461538461538461,1.0,1.0,3/8,30.89%,CAMK2D;GSN;ATP1A1
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.38243038801845985,0.6586292922324432,0.9166666666666666,1.0,1.0,2/5,12.92%,WDFY4;TRIM25
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.4464305129427494,-0.6583151609110434,0.8873239436619719,1.0,1.0,4/6,39.44%,RSRC1;NUP205;NUP98;PSIP1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.3269257494557012,-0.6577721046535799,0.9473684210526315,1.0,1.0,17/85,20.69%,VEGFA;TGFB2;PTRH2;TGFB1;OLFM1;ROBO1;DNMT1;SDCBP;HIF1A;ROCK2;NOTCH2;RUNX1;NDFIP2;TET1;AGO2;MTMR2;NDFIP1
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.30310242649919245,0.657494013604414,0.8823529411764706,1.0,1.0,4/15,11.80%,MRPL1;MRPL33;MRPL3;GSPT1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.3111953038714538,0.6569949524320541,0.85,1.0,1.0,2/13,5.91%,CNOT7;TOB1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.34352223094180556,0.6567787032012768,0.9523809523809523,1.0,1.0,1/8,2.45%,MFHAS1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.44301915296314087,-0.65583797831259,0.9090909090909091,1.0,1.0,4/5,55.60%,KMT2A;ZNF451;HDAC5;BRCA1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.3665951386782405,-0.6557818712582344,0.9647058823529412,1.0,1.0,5/19,35.72%,PABPC1;ELAVL1;YBX1;CIRBP;NSUN2
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.3658151712730217,0.6557474788188544,0.8620689655172413,1.0,1.0,2/8,7.34%,SLC44A2;SLC25A26
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3335076487545773,-0.6556274235680558,0.9473684210526315,1.0,1.0,11/55,14.90%,NFKBIA;PRKCI;EIF2AK2;STAT3;PRKCB;RPS27A;IL18;CLOCK;TERF2IP;CLU;TRIM13
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.4237479067003864,-0.6553520123268601,0.9154929577464789,1.0,1.0,2/6,26.74%,MVB12B;EGFR
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.3963084565367985,-0.65494169494168,0.8860759493670886,1.0,1.0,3/10,34.49%,PPARA;KDR;CAST
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.3508036461148357,-0.6541780946340373,0.9012345679012346,1.0,1.0,4/19,20.52%,CD44;CFL1;FMNL2;CAPZB
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.2994854518563529,0.6535344124200592,0.9047619047619048,1.0,1.0,1/10,4.42%,PPARD
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.40851931849470513,-0.6532936663820171,0.925,1.0,1.0,5/11,29.59%,SDCBP;MTMR2;LRPAP1;APP;ITGAV
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.40739598275439676,-0.653291396484213,0.9113924050632911,1.0,1.0,1/10,1.05%,TBC1D20
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.3750553799923024,-0.652507722688681,0.8876404494382022,1.0,1.0,3/15,8.98%,TWIST1;SUFU;SMAD6
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.4172504529197912,-0.6508721774138678,0.9242424242424242,1.0,1.0,1/5,0.93%,SOD1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.4112925455142094,-0.6504768976318618,0.8765432098765432,1.0,1.0,4/11,31.23%,TRA2B;TRA2A;NCBP1;CIRBP
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.4167529876334283,-0.648926752249074,0.9027777777777778,1.0,1.0,2/7,23.12%,GMPS;AK4
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.38005625450193836,-0.6486781377453468,0.9285714285714286,1.0,1.0,2/11,17.42%,MYRIP;ACSL4
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.4266053153418022,-0.6486383622906711,0.9577464788732394,1.0,1.0,2/7,21.01%,LRRK2;MAPK1
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.27413071692055185,0.6485096633906117,1.0,1.0,1.0,8/27,15.60%,CDC42;ACTN4;FLNA;CARMIL1;CORO1C;PTK2;DOCK1;ILK
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.3414285290147006,0.6472833026177593,0.95,1.0,1.0,1/9,4.19%,OSBPL6
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.35517643555423273,-0.6468887035081754,0.8705882352941177,1.0,1.0,3/14,13.71%,CDC5L;DONSON;CLOCK
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.33266035098617797,0.6463890579943384,0.9375,1.0,1.0,9/9,66.78%,HMGB1;KPNB1;EXOG;CECR2;ACIN1;DICER1;GPER1;BLCAP;KPNA1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.3093824423857542,0.6462284571468774,0.8947368421052632,1.0,1.0,1/9,2.16%,CNOT7
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.3997060510638588,-0.645427328601675,0.8947368421052632,1.0,1.0,1/8,14.21%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.36768654464745737,-0.6452947927168915,0.9382716049382716,1.0,1.0,1/13,14.21%,TERF2IP
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.38957007605152877,0.644686139223804,0.7857142857142857,1.0,1.0,5/5,61.07%,TPR;GAS6;AXL;IFNAR1;RO60
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3914139810879847,-0.6443780388128655,0.9230769230769231,1.0,1.0,4/9,30.75%,SPG7;PMPCB;YME1L1;AFG3L2
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.40409987228534544,-0.644103612036183,0.9324324324324325,1.0,1.0,1/7,20.44%,NLGN1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.3887563012340157,-0.643623398637504,0.9295774647887324,1.0,1.0,5/10,48.57%,DNM3;PRKN;DNM1;MTFR1;DNM2
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.36997360658282885,0.643552218995497,0.875,1.0,1.0,7/7,63.04%,SAR1B;SAR1A;GCC2;TM9SF4;SEC16A;TMEM30A;CD81
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.3376213969532495,0.6424110662825381,0.8518518518518519,1.0,1.0,5/7,15.23%,SLIT2;CXCL12;HMGB1;ANO6;NBL1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.3040054515665289,0.6423733514066551,0.8947368421052632,1.0,1.0,2/14,6.98%,TTL;SMOC2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.31262409909130306,-0.6420179699478126,0.9473684210526315,1.0,1.0,8/57,17.48%,SLC23A2;KAZN;SEMA3B;ALCAM;ARNT2;TEAD1;GFAP;FMNL2
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.35233781361219274,-0.6416851196025666,0.9534883720930233,1.0,1.0,4/24,13.91%,HDAC2;MORF4L1;RCOR1;SIN3A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.3421197932257035,-0.640899092720931,0.9156626506024096,1.0,1.0,8/24,33.24%,CCP110;RBBP7;YAF2;EED;TOM1L1;TERF1;APAF1;TFDP2
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.4033060107441041,-0.6401693545244181,0.8461538461538461,1.0,1.0,2/6,22.30%,TP63;BTG1
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.31531973511680206,-0.6401208912138678,0.9893617021276596,1.0,1.0,16/89,18.11%,CSNK1D;VEGFA;MYDGF;NOS1AP;DDX3X;TGFB1;STK4;MT3;KRAS;GOLGA2;ROCK2;SYMPK;TERF2IP;LRRK2;CCN1;CAMKK2
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.3603571022249197,-0.6400605324927483,0.8977272727272727,1.0,1.0,6/15,43.61%,NAP1L1;NASP;ANP32B;MACROH2A1;RBBP4;UBN1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.40061074975148914,-0.6399725340194401,0.8918918918918919,1.0,1.0,1/8,5.10%,PIAS2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.33224663940232096,-0.6397999487363758,0.9659090909090909,1.0,1.0,11/35,36.97%,INTS8;ELL2;INTS4;INTS2;CCNK;SP1;NCBP1;POLR2F;GTF2E2;CCNT1;GTF2A1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.36970672472872174,-0.6388452742368225,0.8974358974358975,1.0,1.0,5/13,31.31%,ATP6V1H;ATP6V0D1;ATP6V0E1;ATP1A1;DMAC2L
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.3884157540220236,-0.6385537468453936,0.9146341463414634,1.0,1.0,5/11,21.81%,SZT2;GGA3;RAB7A;SCARB2;NEDD4
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.33843345488045223,-0.6383807559457768,0.9431818181818182,1.0,1.0,3/23,14.66%,BASP1;PLP1;HSPA5
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.3684011441333917,0.6383708622543894,0.8,1.0,1.0,1/10,0.76%,ARHGEF10L
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.317720948268007,-0.6383257009346198,0.9787234042553191,1.0,1.0,7/64,10.79%,SPTLC3;CSNK1G2;LPIN1;MGST1;ALDH3A2;SPTLC1;LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.4160468294422776,-0.6380707069869185,0.922077922077922,1.0,1.0,2/6,23.28%,NEDD4L;STK39
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.35635350921473596,0.6373818455132803,0.8333333333333334,1.0,1.0,1/6,4.99%,CD4
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.36953037839560765,-0.6372987853724043,0.8928571428571429,1.0,1.0,5/13,30.66%,RPS27A;ALPK1;MAP2K6;CYLD;TAB2
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.32939159355836134,-0.6368961068472183,0.967391304347826,1.0,1.0,9/40,20.53%,RPS4X;DDX3X;UPF3A;PRKDC;PLD1;ROCK2;CLU;ELAVL1;RPL5
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.3334629609777533,-0.6367988342337638,0.9659090909090909,1.0,1.0,11/34,36.97%,INTS8;ELL2;INTS4;INTS2;CCNK;SP1;NCBP1;POLR2F;GTF2E2;CCNT1;GTF2A1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.32220620285922474,-0.6365652078633164,0.9560439560439561,1.0,1.0,7/51,10.19%,F3;VEGFA;THSD4;CCN2;SEMA3B;FAM114A1;SHROOM3
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.3382832308988264,-0.6364824859305206,0.9759036144578314,1.0,1.0,8/28,25.22%,TGFB2;PGK1;NIBAN2;ROCK2;RGCC;STAT1;DCN;PTPRM
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.38008890852551674,-0.6363871033368067,0.9493670886075949,1.0,1.0,1/16,4.58%,OMG
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.34885052947402806,-0.635826008112581,0.9655172413793104,1.0,1.0,4/24,13.76%,ADAMTS9;HIF1A;MANBA;MGAT4A
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.3458297525567964,-0.6357377106103459,0.927710843373494,1.0,1.0,9/31,15.60%,VEGFA;PGK1;TGFB1;LGALS3;IFT122;FGFR2;AKR1C2;ERRFI1;ALDH1A2
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),-0.4030454513199775,-0.6349197744460654,0.9142857142857143,1.0,1.0,2/7,11.91%,HDAC2;RCOR1
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.34017057265839784,0.6345339699464524,0.8695652173913043,1.0,1.0,3/9,16.25%,CELF1;PRKRA;DHX9
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3707261947133687,-0.6343392672543652,0.9156626506024096,1.0,1.0,5/13,30.66%,RPS27A;RNF34;MAP2K6;CYLD;TAB2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.3673100417436503,-0.6340738628414463,0.9146341463414634,1.0,1.0,7/14,42.20%,GNAQ;EGFR;FLT1;LPAR1;FGFR1;PLCG1;NTRK3
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.35354216008502465,-0.6340531839361521,0.9529411764705882,1.0,1.0,4/17,15.66%,GLUL;SLC47A1;SNAP25;SLC12A6
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.3511331884507916,0.6339116631970045,0.8333333333333334,1.0,1.0,6/6,64.92%,PLEKHA3;CERT1;PSAP;ABCB1;PLEKHA8;SGPP1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.37732963647800954,-0.6337253496559309,0.8860759493670886,1.0,1.0,3/10,18.10%,CNOT8;DCP2;PATL1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.4035533806080066,-0.6334581779841494,0.8375,1.0,1.0,2/5,22.30%,TP63;BTG1
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.3684037160863652,-0.6329932151862668,0.9324324324324325,1.0,1.0,4/16,20.44%,PTPRD;SYNDIG1;NAP1L1;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),0.35734244023595163,0.6328648203898244,0.7857142857142857,1.0,1.0,6/6,64.30%,ZCCHC17;NAF1;TENT2;NRDE2;FMR1;SLIRP
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.3485483620555813,0.6327838217055775,0.9615384615384616,1.0,1.0,7/7,65.18%,ASXL3;PRKAA1;CCDC3;PPP2R5A;NCOR1;GPER1;APOD
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.30263421992330714,0.632727668704446,0.875,1.0,1.0,2/8,9.10%,INPP5F;PPP2R1A
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.3691933625625952,-0.6323735860142253,0.9024390243902439,1.0,1.0,3/12,16.39%,KCNQ1;MYL3;CAMK2D
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.3794013873892752,-0.6320286476679782,0.95,1.0,1.0,3/12,21.77%,HSD17B4;NPC1;AKR1C1
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.3800610664270888,0.6318106216598192,0.90625,1.0,1.0,2/5,8.61%,LARGE1;CHST3
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.3722163903617815,0.6311492656735984,0.9130434782608695,1.0,1.0,2/7,9.07%,ATP1B2;SLC9A1
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.34146971816895755,-0.6304574667465144,0.9425287356321839,1.0,1.0,3/19,16.21%,PRKCI;AFDN;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.3699161751009003,0.6300804323565552,0.8928571428571429,1.0,1.0,6/6,63.04%,SAR1B;SAR1A;TM9SF4;SEC16A;TMEM30A;CD81
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.32187111579184813,-0.6299461466795327,0.9659090909090909,1.0,1.0,9/47,20.44%,PRKCI;SDCBP;PITRM1;SRP14;NACA;KIF13B;LAMP2;AP4E1;NLGN1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.3115951048138757,-0.6292168890493728,0.9690721649484536,1.0,1.0,19/83,20.80%,COG7;MTMR9;NAPG;STK4;TBRG1;ATP1B3;MT3;CCT4;CCNH;CLU;PPARGC1A;NAA15;MDM4;PLPP3;LAMP2;PPIB;UBE2B;RPL5;ZSWIM7
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3553602693573301,-0.6291906661457388,0.9156626506024096,1.0,1.0,4/19,20.67%,PRKCI;LRRC7;LIN7A;ERBIN
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.3457514769645793,-0.6290098281202604,0.9425287356321839,1.0,1.0,6/22,25.98%,TAF1B;POLR1C;DDX21;TAF1D;ARID1A;SF3B1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.35836693898915983,-0.6289766429707416,0.9259259259259259,1.0,1.0,3/16,21.01%,MAP3K4;TNKS;MAPK1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3661651683765809,-0.6284378632678411,0.9310344827586207,1.0,1.0,1/12,8.64%,STMN1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.3195235277775427,-0.6281126509454183,0.9680851063829787,1.0,1.0,11/59,16.39%,SEC13;NUP153;RPA1;NUP133;NUP88;HSPH1;DNAJC7;AMFR;ROCK2;CHCHD2;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.38218905420376914,-0.6273486089520843,0.9186046511627907,1.0,1.0,4/13,31.23%,TRA2B;TRA2A;NCBP1;CIRBP
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),-0.3150914123558015,-0.6268509135207198,0.9456521739130435,1.0,1.0,5/42,13.31%,ATP6V1E1;ATP6V1G1;PTPN2;ATP6V1H;ATP6V1D
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.35122281546011475,0.6268497545340322,0.8095238095238095,1.0,1.0,1/9,7.44%,CHMP4B
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.3087088840025023,-0.6259300994417031,0.9787234042553191,1.0,1.0,12/69,16.33%,ZFP36L2;PSMB1;PSMD14;RPS27A;PSMA4;PSMB2;PABPC1;CNOT8;IGF2BP2;PSMA7;DCP2;PRR5L
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.4064668043507156,-0.6255977485477685,0.948051948051948,1.0,1.0,3/9,32.38%,BMP5;LDLRAD4;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.42525928744384955,-0.6255022147556526,0.9259259259259259,1.0,1.0,2/6,23.84%,BTG1;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.33699404362845053,-0.6247906765660587,0.9468085106382979,1.0,1.0,14/41,25.47%,TGFB1;TRAF3IP1;PRKDC;C9ORF72;CDKN1B;TERF2IP;PRR5L;LRRK2;PLPP3;PPARA;WARS1;TARDBP;PID1;LYN
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.3048993111253732,-0.6246562230984926,0.9797979797979798,1.0,1.0,26/70,33.86%,GJA1;FAM114A1;SVEP1;C1R;PRLR;SASH1;C1S;IGFBP5;PLPP3;MATN2;ASS1;DCN;KIAA1217;COL12A1;EGFR;TACC2;ABCA8;PTCH1;PDE8A;KDR;FBLN1;ESRRG;CPE;LAMA2;COL3A1;SH3D19
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),-0.3247271207276805,-0.6246481932319473,0.967032967032967,1.0,1.0,7/44,11.40%,SEC13;NUP153;RPA1;NUP133;NUP88;HSPH1;DNAJC7
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.3086991447067841,-0.6246302140717892,0.967032967032967,1.0,1.0,11/56,21.65%,TBC1D20;MTMR9;MMUT;RGS7;AFDN;USP6NL;ZC3H15;PKP4;WRN;SEMA4D;LARS1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.3109231636706158,-0.6245644786784299,0.989010989010989,1.0,1.0,6/67,8.59%,CSF1;VEGFA;TGFB2;DDX3X;PTPN1;STK4
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.30430619889605337,0.6240573268217618,0.8125,1.0,1.0,2/7,9.10%,INPP5F;PPP2R1A
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.36887999112019443,-0.6229944329129891,0.9523809523809523,1.0,1.0,3/10,24.69%,MYRIP;ACSL4;PPP3CB
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.34612840804784617,-0.622514252025213,0.925,1.0,1.0,4/18,17.79%,PTPN1;TSPYL2;CAMK2D;YWHAG
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.4107698349356808,-0.620220104953256,0.9620253164556962,1.0,1.0,2/8,21.88%,HSPA5;EIF2AK4
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.3673531977364448,-0.6200529794997482,0.9736842105263158,1.0,1.0,4/11,21.81%,ANK3;ZC4H2;LRRK2;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.3655421110220902,-0.6193010646803286,0.95,1.0,1.0,2/14,18.61%,FGFR2;PKP4
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.37240406053328834,-0.618719231224854,0.918918918918919,1.0,1.0,2/12,21.17%,RAB27A;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.3820192246993155,-0.6176194824431566,0.8928571428571429,1.0,1.0,2/10,17.06%,WDR43;PWP1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.39013465435688227,-0.6174432155841535,0.9625,1.0,1.0,4/10,29.26%,PARP1;TNKS;POT1;TERF1
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.28765065087680863,0.6172831256537292,0.8823529411764706,1.0,1.0,2/11,12.38%,DLC1;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.28765065087680863,0.6172831256537292,0.8823529411764706,1.0,1.0,2/11,12.38%,DLC1;CORO1C
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.36634363937539066,-0.6172816989514642,0.9036144578313253,1.0,1.0,4/9,35.50%,CAPZB;TRIOBP;GSN;SVIL
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.36634363937539066,-0.6172816989514642,0.9036144578313253,1.0,1.0,4/9,35.50%,CAPZB;TRIOBP;GSN;SVIL
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.396110546064007,-0.6157625096559175,0.9879518072289156,1.0,1.0,5/8,33.05%,MTMR2;FYN;INSR;SUPT6H;PRNP
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.3156688119572919,-0.6150516539158838,1.0,1.0,1.0,5/41,15.93%,RHOB;C9ORF72;ROCK2;NOTCH2;RHOBTB3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.3820020359672065,-0.6149256656408372,0.9512195121951219,1.0,1.0,1/8,8.51%,CEMIP
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.2948303897304853,-0.6147428588180082,1.0,1.0,1.0,24/101,24.72%,RPS4X;RBM4B;DDX3X;EIF2AK2;UPF3A;GIGYF2;PRKDC;PLD1;CNOT8;IGF2BP2;ETF1;RPL13A;IGFBP5;CSDE1;ELAVL1;BTG2;PUM3;RPL5;EIF2AK4;NEMF;METAP1;EPRS1;EIF2A;APP
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.35848052962396354,-0.6130405316639423,0.9390243902439024,1.0,1.0,2/12,14.73%,LPCAT3;PLAAT3
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.3075086976946551,-0.612861243894708,1.0,1.0,1.0,18/73,30.27%,MPZL1;NECTIN2;LIMA1;JAM3;FBN1;SYMPK;TSPAN4;CADM2;ITGA9;VCAN;NF2;NEGR1;IRS1;EGFR;PIK3CB;NF1;ADAM9;EPB41L2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.3228904813206008,-0.6128557951038961,0.9431818181818182,1.0,1.0,4/33,10.59%,VEGFA;TMSB4X;TGFB1;HIF1A
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.3784930585003772,-0.6125049078658872,0.8947368421052632,1.0,1.0,3/9,18.10%,CNOT8;DCP2;PATL1
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.3357323538744997,-0.6124016883984955,0.9259259259259259,1.0,1.0,5/18,26.74%,CREM;MOV10L1;CCDC30;CCDC91;EGFR
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.3326086956521739,0.6116727545266818,0.9130434782608695,1.0,1.0,8/8,66.78%,HMGB1;FBH1;KPNB1;EXOG;DNASE1;CECR2;DICER1;KPNA1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.3248392090674465,-0.6102683095446425,0.9560439560439561,1.0,1.0,7/29,21.11%,CHST11;COG7;MGAT1;GOLGA2;NPC1;SERP1;CSGALNACT1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.39974869373501953,-0.6094426601309861,0.9428571428571428,1.0,1.0,2/6,39.73%,SNX9;EHD2
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.35701374750608855,-0.6084976749925877,0.9777777777777777,1.0,1.0,2/18,14.22%,ROCK2;AKR1C2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.2736266092648979,0.6083618161781168,1.0,1.0,1.0,5/20,14.42%,CDC42;NDE1;RHOT1;DYNC1I1;TRAK1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.3593768318242585,0.6080311968126982,0.90625,1.0,1.0,2/5,10.20%,OSBPL11;OSBPL8
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.3275299391934311,0.6075598624380925,0.8333333333333334,1.0,1.0,1/5,6.41%,BCL2
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.4043861993932658,-0.6070980978299937,0.9382716049382716,1.0,1.0,2/5,28.29%,JAM2;GOLPH3
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4043861993932658,-0.6070980978299937,0.9382716049382716,1.0,1.0,2/5,28.29%,JAM2;GOLPH3
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.29068913615552183,0.6069856849696182,1.0,1.0,1.0,5/36,2.93%,CSRNP3;SLC35F1;ATP1B2;OPCML;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.3096664996922025,-0.6068822125414942,0.968421052631579,1.0,1.0,9/46,21.81%,NKD1;NEDD4L;CDKN1B;RAB7A;WWP1;NSF;SMURF2;HECW1;NEDD4
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.4075221805908165,-0.6066831366721559,0.9166666666666666,1.0,1.0,1/5,26.36%,CLASP2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.4075221805908165,-0.6066831366721559,0.9166666666666666,1.0,1.0,1/5,26.36%,CLASP2
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),-0.3265096013190503,-0.6064818726193698,0.9404761904761905,1.0,1.0,6/27,21.53%,HDAC2;MORF4L1;RCOR1;SIN3A;MORF4L2;PER1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.34054245043095016,-0.6054399811654017,0.9302325581395349,1.0,1.0,2/19,7.96%,TGFB1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.34288507262337087,0.6051864344774903,1.0,1.0,1.0,1/5,8.08%,FLNA
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.41084788780449333,-0.605113035910567,0.96,1.0,1.0,2/5,34.96%,RACK1;SAMD8
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.34143664943160457,-0.6047625843611133,0.9873417721518988,1.0,1.0,8/19,35.02%,DONSON;NAE1;TAOK3;UIMC1;MRNIP;BRCC3;TAOK1;RAD17
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.3232111825029018,0.6043098694405085,0.9166666666666666,1.0,1.0,1/6,5.40%,MYH9
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.32111383243844593,0.604043454625133,1.0,1.0,1.0,3/13,10.42%,ATM;WNT5B;CREB1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.3731597344423352,-0.6039349435144188,0.9166666666666666,1.0,1.0,2/7,26.55%,DUSP1;DUSP16
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3577871502237712,-0.6033068702605432,0.9761904761904762,1.0,1.0,5/13,29.59%,NOTCH2;ERBIN;GRB2;LYN;ITGAV
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.27013788287869894,0.6012672528477879,1.0,1.0,1.0,1/15,1.92%,ERBB4
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.3318184712117536,-0.6005727892163286,0.9418604651162791,1.0,1.0,3/20,13.55%,ZC3H7A;ZC3H7B;CNOT8
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.3442046925802097,-0.6004876550736344,0.9302325581395349,1.0,1.0,4/17,23.45%,SDCBP;MT3;MTMR2;LRPAP1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3442757010168989,-0.6000399748715708,0.9397590361445783,1.0,1.0,7/18,30.72%,SDCBP;UCHL5;WAC;FHIT;PSME3IP1;HSP90AB1;RPL11
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.2986530267726267,-0.5999011374011533,0.989247311827957,1.0,1.0,15/79,16.86%,TMCO1;KCND2;KCNQ3;SCN3A;ATP1B3;TMEM165;KCNQ1;ATP6V1H;TRPA1;SLC39A11;SLC6A17;ABCC9;KCNH7;SLC9A9;NALCN
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.3325587881472539,-0.5995604057804784,0.9333333333333333,1.0,1.0,3/24,12.22%,TOR1AIP2;ATP1B3;MYL3
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.31672449722389895,-0.5989573315815496,0.9555555555555556,1.0,1.0,11/27,34.91%,SMCHD1;RNF168;UIMC1;EGFR;EYA1;BRCC3;EYA2;TRIP12;PARG;UBR5;NPAS2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.23142140148908355,0.5966119962305696,1.0,1.0,1.0,11/38,15.90%,NTN4;ITGA8;RHOA;OPHN1;ACTN1;LAMB2;ANTXR1;PARVA;YTHDF2;ILK;MEF2C
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.32625282657396054,-0.5965480996762579,0.9534883720930233,1.0,1.0,8/20,30.37%,CCT4;MAP3K4;TNKS;MAPK1;POT1;PARP4;TERF1;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.39738462685151055,-0.5961829908460459,0.9411764705882353,1.0,1.0,1/5,21.84%,BMP5
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.25035090057706144,0.5947912522470958,0.95,1.0,1.0,2/17,7.18%,PHC1;RYBP
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.25035090057706144,0.5947912522470958,0.95,1.0,1.0,2/17,7.18%,PHC1;RYBP
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.2977119700104047,-0.5938601042095202,0.9887640449438202,1.0,1.0,7/58,19.26%,WIPI1;PLAA;ATG4B;LIX1L;LAMP2;VPS39;PRKAG2
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.31634693054395957,0.5935662171010692,0.9655172413793104,1.0,1.0,1/8,2.36%,NTN4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.37086849206182076,-0.5934968892229663,0.9620253164556962,1.0,1.0,3/11,24.83%,TGFB1;TMEM59;PID1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.3907824849620991,-0.5928511470262663,0.9210526315789473,1.0,1.0,2/6,27.11%,ROCK2;GCLC
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.3907824849620991,-0.5928511470262663,0.9210526315789473,1.0,1.0,2/6,27.11%,ROCK2;GCLC
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.2979499914480312,-0.5923427077124546,0.989247311827957,1.0,1.0,5/49,11.27%,ANK3;LGALS3;PRKCI;CEMIP;TP63
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.37408161954916874,-0.5916262061859325,0.9523809523809523,1.0,1.0,1/9,2.57%,OGN
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.29466645631950006,-0.588310305232505,1.0,1.0,1.0,10/62,16.61%,WASF1;MIGA1;AGTPBP1;SPG7;PITRM1;SLC25A36;PARP1;CHCHD2;PPARGC1A;LRRK2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.346463138860153,-0.5880151116406135,0.9880952380952381,1.0,1.0,2/13,15.96%,HDGFL3;NAV3
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.4029640555452094,-0.5872758682283904,0.9838709677419355,1.0,1.0,2/5,29.62%,ZBTB1;SUPT6H
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.2888681592039801,0.5867007913717599,0.9375,1.0,1.0,16/16,71.18%,DLC1;ACTN1;LAMC1;PTPRK;WHAMM;BCR;CD151;PLEC;CTTN;PEAK1;FERMT2;ARHGEF7;PIP5K1A;SORBS1;DST;FN1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.3749853014904451,-0.585067186274678,0.9512195121951219,1.0,1.0,2/8,20.25%,FBN1;APPL2
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.308977268392161,-0.5836698899071838,0.978021978021978,1.0,1.0,15/33,35.13%,ITGA5;PLPP3;ERBIN;NEDD9;FN1;PTN;ITGAV;ADAM9;FBLN1;DST;COL3A1;ABL1;PTK2B;PTPRA;CD47
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.3234518081638988,0.5836661509639168,0.9333333333333333,1.0,1.0,5/5,67.68%,NFE2L1;SUCLA2;ABCB10;COX10;PGRMC1
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.30205103097619773,0.5832548300312778,0.9,1.0,1.0,2/10,8.59%,ITGA3;SLIT2
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.2971647894808477,0.5832465883860793,1.0,1.0,1.0,2/10,7.92%,MAP2K2;SNX3
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.29023588301073844,0.5825487981590666,0.9166666666666666,1.0,1.0,1/16,2.03%,JADE3
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.35681996710235614,-0.582205807932021,0.9512195121951219,1.0,1.0,2/11,15.96%,HDGFL3;NAV3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.3265409951925853,-0.5821843878713867,0.9659090909090909,1.0,1.0,1/27,6.42%,TGFB1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.35013263968430086,0.5813411546846532,0.9629629629629629,1.0,1.0,1/5,2.53%,CDK6
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.32492633115668595,-0.581328116889809,0.9125,1.0,1.0,3/16,23.99%,ALDH1A2;HSD17B4;LPL
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.38816016697896005,-0.5801859002572217,0.9315068493150684,1.0,1.0,4/7,43.55%,PPARA;ABCB7;GPER1;TRAP1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.35673581534645804,-0.5801733232444432,0.9512195121951219,1.0,1.0,2/9,25.59%,KDM3A;ARID1A
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.3798570658093201,-0.5796276202370855,0.9459459459459459,1.0,1.0,2/6,43.10%,PARG;HNRNPU
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.3944277953566118,0.5793162905075905,1.0,1.0,1.0,1/5,2.93%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.30768661547262066,0.5786060122166289,0.9,1.0,1.0,1/6,6.51%,KLF7
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.33250543309531216,0.5782402943848579,0.92,1.0,1.0,6/6,66.78%,HMGB1;KPNB1;EXOG;CECR2;DICER1;KPNA1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.28421716747306286,-0.5778668364475239,0.9789473684210527,1.0,1.0,4/65,8.70%,PIGL;DPM1;MTMR9;PIGG
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.35992550054322525,0.5776780077756284,0.96875,1.0,1.0,5/5,64.04%,DERA;RPE;GPI;HK1;PGM2L1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.3341611050752754,0.5772070059453294,0.8695652173913043,0.9994994683691613,1.0,5/5,66.61%,RALBP1;NRP1;APOE;ABCA1;ABL1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.27995652637482193,0.5765476567962399,1.0,0.9985732154145743,1.0,1/13,1.43%,LRCH1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.35812718517057557,-0.5764577949687779,0.9605263157894737,1.0,1.0,1/8,7.34%,NIBAN2
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.34435468349005516,-0.5754804733337086,0.935064935064935,1.0,1.0,4/11,30.23%,XRCC4;BRCC3;XRCC6;IKBIP
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.3820254646866465,-0.5751120128354895,0.9583333333333334,1.0,1.0,1/7,6.39%,NUP133
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.34650396582845144,-0.5748992904415855,0.9615384615384616,1.0,1.0,3/10,26.13%,LIMA1;PAWR;NEDD9
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.34437079098743445,-0.5743518010059064,0.9493670886075949,1.0,1.0,3/11,26.13%,LIMA1;PAWR;NEDD9
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.3237577639751551,0.5741720843419602,0.9615384615384616,0.9985333123763355,1.0,8/8,67.66%,HIP1;PICALM;CLTA;FCHO2;CLTC;PIK3C2A;EPS15;SGIP1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.302022669110175,-0.5741288324610371,0.9888888888888889,1.0,1.0,15/38,42.42%,NUP153;SRSF5;THOC2;SIDT1;NCBP1;TGFBR2;YBX1;SRSF2;KIF5C;FMR1;SRSF11;SRSF3;CHTOP;UPF3B;ATXN2
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.38623504032258077,-0.5740419592578757,0.9852941176470589,1.0,1.0,1/6,17.01%,GFAP
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.3425222891356861,0.5739556739658322,0.8,0.997217140873944,1.0,3/7,11.03%,DNAI4;DNAH11;DNAH9
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.33224654556745864,0.572850817262916,0.9545454545454546,0.9964397256920967,1.0,7/7,66.81%,PTK2;PKD1;PKD2;CTNNB1;JUP;TTN;CDH2
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.34220241833662945,-0.5720039515018951,0.9518072289156626,1.0,1.0,4/13,36.03%,PRKAG2;PPARA;SORBS1;MTOR
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.3302898986670225,-0.5684939556171501,0.975609756097561,1.0,1.0,3/13,26.95%,RAB27A;APPL2;MYO18A
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.25919259409241135,0.5675556544886279,0.9444444444444444,0.9983671466220394,1.0,2/11,9.07%,CDC42;SLC9A1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.3373631526539835,0.5668108380410964,0.9354838709677419,0.9973235677215112,1.0,1/5,6.51%,KLF7
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.3811978449670411,-0.5667075600295363,0.9493670886075949,1.0,1.0,1/6,14.66%,HSPA5
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.2638737553133675,0.565997182191666,1.0,0.9965336459386459,1.0,4/12,18.58%,PLEKHG2;CXCL12;LATS1;GBA2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.29159549209641444,-0.5653781803454033,0.9887640449438202,1.0,1.0,5/36,20.56%,DDX3X;CDKN1B;CCNH;MTCP1;CCNK
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.38341229270138816,-0.5651138448563156,0.972972972972973,1.0,1.0,2/5,30.68%,PKM;YBX3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.3503845440147048,-0.5638990587362059,0.9625,1.0,1.0,6/10,33.42%,UBE2L3;DCUN1D4;RPS2;DCUN1D2;DCUN1D1;ABL1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.3756670470773162,-0.5635878743739401,0.971830985915493,1.0,1.0,1/5,15.45%,GUK1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.34719395619121124,-0.5627110089265177,0.9764705882352941,1.0,1.0,3/10,25.82%,LRRK2;MTMR2;STXBP1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.2917625626621992,-0.5612858081914036,0.9885057471264368,1.0,1.0,10/29,42.79%,RAD21;RAB11A;KLHL22;SMC1A;EML4;TTN;CSNK2A1;PDS5A;TENT4A;CSNK2A2
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.36959971830633376,-0.561115974966594,0.9879518072289156,1.0,1.0,1/6,10.53%,DGKI
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.2823419785681005,0.560583176098459,1.0,0.9981711029427739,1.0,9/9,71.81%,MAP2;GBA2;PTEN;ARHGAP35;RAPGEF2;HSP90AA1;NTRK2;HSP90AB1;B4GALT5
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.3659873816655004,-0.5591390339379348,0.972972972972973,1.0,1.0,1/6,23.36%,SYNJ2
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.3659873816655004,-0.5591390339379348,0.972972972972973,1.0,1.0,1/6,23.36%,SYNJ2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.3659873816655004,-0.5591390339379348,0.972972972972973,1.0,1.0,1/6,23.36%,SYNJ2
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.3573835968739296,-0.5577164198646937,0.9487179487179487,1.0,1.0,1/7,14.14%,CDKN1B
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.33270344570721627,-0.5574299411246425,0.926829268292683,1.0,1.0,4/14,22.43%,PDCD4;DNAJA1;PER1;TAOK3
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.3204572986663122,-0.5545020815002272,0.975,1.0,1.0,6/17,28.15%,KCNQ1;RAP1B;IGFBP5;STAT1;AKAP6;NDUFS4
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.35850171346475285,-0.554476833950158,0.972972972972973,1.0,1.0,2/5,23.28%,SLC12A6;STK39
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.2846120062933477,0.5544369537527947,0.9583333333333334,1.0,1.0,1/7,6.68%,PIK3CD
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.35432142373701836,-0.5542169357481089,0.9753086419753086,1.0,1.0,3/10,22.46%,PITPNC1;PITPNA;SCARB1
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.32108973506569005,0.5533026645679655,0.9047619047619048,0.9995599057207925,1.0,3/5,20.44%,SLIT2;NTN1;CHN1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.36331896846436273,-0.553226121550451,0.958904109589041,1.0,1.0,1/7,13.32%,ROCK2
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.38030204221238495,-0.5532165058761681,0.9714285714285714,1.0,1.0,3/5,29.81%,ROCK2;LYN;EPHA4
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.3177451961935063,-0.5523893230867812,0.975609756097561,1.0,1.0,3/21,20.66%,RPS27A;ADORA2B;MINK1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.35429016273833963,-0.5519786836200247,0.95,1.0,1.0,3/7,43.55%,LAS1L;CCT3;TRAP1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.33788394875096783,-0.548882810176889,0.9625,1.0,1.0,3/10,42.79%,IHO1;CSNK2A1;CSNK2A2
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.32453376716996196,-0.5476633544022239,0.974025974025974,1.0,1.0,4/9,40.40%,PRKAG2;SGPP1;PLEKHA8;ABCD3
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.2909509522599254,-0.5468295092756718,0.9887640449438202,1.0,1.0,4/21,24.52%,GPM6A;NLGN1;CAPZB;MYO10
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.28778903844519954,-0.543688376051227,1.0,1.0,1.0,1/21,9.71%,RPS27A
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.282602477007457,-0.5428246769357735,1.0,1.0,1.0,4/42,16.61%,STK4;STMN1;AMFR;LRRK2
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),-0.32315356532789963,-0.5426305642752295,0.9746835443037974,1.0,1.0,3/12,24.63%,USP6NL;MAPK1;PDE4DIP
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.35267798152880125,-0.5423762123602999,0.9726027397260274,1.0,1.0,1/8,16.61%,LRRK2
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.30779685822575903,-0.5423492346882112,0.9767441860465116,1.0,1.0,5/15,28.68%,DONSON;TAOK3;UIMC1;MRNIP;BRCC3
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.2939992923593305,-0.5421195609355748,1.0,1.0,1.0,3/36,12.38%,TGFB1;SMAD6;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3459777640007755,-0.5410025937785377,0.9861111111111112,1.0,1.0,2/9,21.99%,MT3;PPARA
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.37588751350095717,-0.5402489808624084,0.9850746268656716,1.0,1.0,2/5,27.42%,HSPA5;SEC62
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.3642535474145628,-0.5399642804350747,0.9746835443037974,1.0,1.0,4/6,33.05%,MTMR2;FYN;INSR;PRNP
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.3511543707962349,-0.5393483663793378,0.9743589743589743,1.0,1.0,2/6,27.25%,NBDY;CNOT1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.31823171655409016,0.5383539013825769,1.0,1.0,1.0,2/8,11.46%,AKT3;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.29171241751198795,-0.5381328149440157,0.9885057471264368,1.0,1.0,7/27,26.47%,CCT4;MAP3K4;RGCC;TNKS;MAPK1;POT1;CCT8
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.28087530999901794,-0.5377669019451843,1.0,1.0,1.0,7/45,24.89%,PDK1;DDX3X;PRKDC;STK24;HINT1;ARL6IP5;FHIT
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.30062458308525675,-0.5375064951660258,0.9647058823529412,1.0,1.0,2/14,17.79%,TP63;YWHAG
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.2662484842180635,-0.5370499167869808,0.989010989010989,1.0,1.0,4/41,13.32%,VAV3;VEGFA;SHC2;ROCK2
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.34947186520422957,-0.534729482578253,0.9746835443037974,1.0,1.0,2/5,33.11%,FN1;COL3A1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.36725052087097854,-0.5341016563078593,0.9577464788732394,1.0,1.0,1/7,9.86%,ACTR3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),-0.27808304137303197,-0.5310567487406841,0.9883720930232558,1.0,1.0,11/25,36.26%,FGFR2;FYN;LYN;INSR;EGFR;FLT1;EPHA4;KDR;ABL1;PTK2B;ABI2
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3026310880009331,-0.529952024167981,0.9753086419753086,1.0,1.0,2/13,17.79%,TP63;YWHAG
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3026310880009331,-0.529952024167981,0.9753086419753086,1.0,1.0,2/13,17.79%,TP63;YWHAG
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.33277236243235864,-0.5294549787772217,0.9753086419753086,1.0,1.0,2/10,27.17%,ACSL4;FAR2
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.27098411725051563,-0.5293026724238992,0.9894736842105263,1.0,1.0,9/48,22.53%,STMN1;CCN2;TMEFF2;TGFBR1;ROCK2;RGCC;ARHGAP28;PAK1;NF2
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.303679552864462,0.5292043184471197,1.0,1.0,1.0,7/7,69.67%,PPP1R12A;PDGFRB;CALM1;MAGI2;ITGA1;MTOR;HSP90AB1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.32409752121907276,-0.5290196058914319,0.9875,1.0,1.0,2/10,20.49%,RNF168;SKP1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.3252601935738248,-0.5289734521380951,0.9759036144578314,1.0,1.0,3/10,43.44%,CLASP2;CASK;TFPI
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.2777260018639329,0.5281265693659793,1.0,1.0,1.0,10/10,72.27%,AKR1C3;JAG1;TXNIP;BCR;CLIC4;ANXA1;ASAH1;PIP5K1A;ADAM9;UGCG
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.35689934580258253,-0.5266469026217794,0.987012987012987,1.0,1.0,2/5,39.52%,CEP120;NUMB
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.33482052096218984,-0.526599721530307,0.975,1.0,1.0,1/8,17.42%,ACSL4
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.3493771714688757,-0.5254889419901905,0.9868421052631579,1.0,1.0,2/7,15.65%,ALDH3A2;PMP22
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.34015065062764027,-0.524949330430111,0.987012987012987,1.0,1.0,1/7,26.36%,CLASP2
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.34828622881545634,-0.5232047323164521,0.9583333333333334,1.0,1.0,1/5,25.47%,LYN
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.28991635371315366,-0.5213207305065356,0.9775280898876404,1.0,1.0,5/26,26.13%,PTPRD;PRKDC;P4HB;TRIOBP;NEDD9
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.34454276868064526,-0.5210308817145071,0.9518072289156626,1.0,1.0,2/5,35.02%,NEK11;RAD17
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.2916149068322981,0.5209898649627027,0.9629629629629629,1.0,1.0,8/8,70.87%,NSL1;LATS1;RB1;TOP2B;INO80;ZNF207;SMC1A;KLHL22
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.2717715636786739,0.5196189916102398,0.9545454545454546,1.0,1.0,1/10,4.79%,ARSB
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.3261088464505001,-0.5194289612797278,1.0,1.0,1.0,3/8,43.80%,PTCH1;ACVR1;DSCAML1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.35836736770543554,-0.519143950392361,0.9710144927536232,1.0,1.0,3/5,35.65%,LMF1;LPL;PCSK6
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.2602656109524403,0.5188894378709067,1.0,1.0,1.0,3/11,15.40%,SLC27A1;ACACA;CPT1A
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.3112378624853198,-0.5176552768958076,0.9753086419753086,1.0,1.0,4/13,30.66%,RPS27A;MAP2K6;CYLD;TAB2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.3644346268089554,-0.5156085685139344,1.0,1.0,1.0,1/5,14.22%,AKR1C2
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.2637566655575303,-0.5149065433792469,1.0,1.0,1.0,7/43,29.50%,DIAPH1;USP6NL;MAPK1;SCARB2;PDE4DIP;GOLPH3;RDX
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.33742293218405317,-0.5148240882065815,1.0,1.0,1.0,2/7,36.03%,CLASP2;MTOR
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.3135870123750223,-0.5135525577113736,0.974025974025974,1.0,1.0,5/10,42.20%,FLT1;ABL1;FGFR1;PLCG1;NTRK3
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.3125046339651663,-0.5132065784692317,0.975,1.0,1.0,5/11,36.94%,NEDD4;CTNNA2;EPHA4;ABL1;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.3085594148524398,-0.511101429706246,0.9761904761904762,1.0,1.0,4/11,28.83%,ACADL;WDTC1;BMP5;ACADVL
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.3225384896970625,-0.5108890960907017,0.9736842105263158,1.0,1.0,1/6,15.51%,WASHC2C
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.31063307584298816,-0.5106134954071987,0.9659090909090909,1.0,1.0,4/12,39.33%,CLU;PSMC6;PRKN;FMR1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.2746298916652189,-0.5104485612251655,1.0,1.0,1.0,7/28,29.96%,GOLGA2;SMC3;MAP9;RAB11A;CLASP2;KLHL22;SMC1A
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.314254656964213,0.5100743237071722,1.0,1.0,1.0,1/6,7.44%,CHMP4B
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.2819875776397516,0.5094502397471192,0.9285714285714286,1.0,1.0,8/8,71.84%,SAE1;GNL3L;EGR1;HDAC4;CTNNB1;ZMIZ1;PIAS1;UBA2
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.35395742711668265,-0.5085033799975925,1.0,1.0,1.0,1/5,17.06%,PWP1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.210388267896932,0.5060880467277892,1.0,1.0,1.0,4/14,18.58%,PLEKHG2;MAP2;LATS1;GBA2
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.3277144287510388,0.5057965424853663,0.9615384615384616,1.0,1.0,1/5,4.98%,COMT
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.2997763872805677,-0.5055173110098511,1.0,1.0,1.0,3/10,27.85%,NAE1;APP;SIAH1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.3362512469072988,-0.5050206755197028,0.9726027397260274,1.0,1.0,2/5,28.32%,EGFR;NRIP1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.32036062689116734,-0.5048363617355723,0.9875,1.0,1.0,2/8,27.20%,CA2;SLC4A10
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.34613192113808244,-0.5029994375501846,1.0,1.0,1.0,1/5,32.38%,SPRED1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.33749194737745386,-0.5027343660096442,0.9852941176470589,1.0,1.0,2/5,21.11%,EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.29392767792534863,-0.5024645678337806,1.0,1.0,1.0,6/11,46.85%,OTUD7A;MINDY2;USP25;USP8;USP37;USP34
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.3284506143083675,-0.5006530817616375,1.0,1.0,1.0,3/6,29.36%,CFL1;GSN;MICAL3
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.30001552072016135,0.4971784903194868,0.9615384615384616,1.0,1.0,5/5,70.02%,MAPK14;FLOT1;EHD2;RIPOR2;ADAM9
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.28205398163171996,-0.4952209487193063,0.9883720930232558,1.0,1.0,2/14,19.26%,HSD17B4;PRKAG2
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.2886645962732919,0.4941304275483336,1.0,1.0,1.0,8/8,71.17%,KCNB1;RPTOR;PRKAA1;RPS6KB1;PRKAA2;ULK1;MTOR;EIF4G1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.3206646209377353,-0.49289249444151323,1.0,1.0,1.0,2/6,32.85%,NRP2;PLXNA2
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.29128502673435275,-0.4916363916528318,0.9879518072289156,1.0,1.0,7/18,31.75%,RPL35A;RPL5;RPL24;LAS1L;RPL11;RPL3;RPL14
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.2733501291420123,-0.48798011247567114,1.0,1.0,1.0,6/17,37.41%,ROCK2;GPM6B;SLK;PTPRA;ACTG1;MACF1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.3037404935589011,0.4863625750122898,1.0,1.0,1.0,5/5,69.65%,PCGF3;DNMT3A;MECP2;PCGF5;PRMT7
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.2822630260250139,-0.484511798648464,1.0,1.0,1.0,2/13,16.33%,NPRL3;PRR5L
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.31903028263390154,0.4839016199844582,1.0,1.0,1.0,2/5,13.66%,ULK2;ATG5
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.27963386912579796,-0.4837843682770479,0.9775280898876404,1.0,1.0,4/18,28.07%,GGA3;BTRC;MDM2;GSN
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.3034771809996895,0.4819432808474437,0.9545454545454546,1.0,1.0,6/6,69.68%,ANGPT1;PDPK1;GAS6;NFE2L2;SEMA5A;KDR
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.24163277595055288,0.48001713403702095,0.9545454545454546,1.0,1.0,1/11,7.44%,CHMP4B
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.3116575372102814,0.4788868556976146,0.95,1.0,1.0,1/5,5.26%,VPS35
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.26302841658902837,-0.4747445508887566,1.0,1.0,1.0,7/18,36.88%,CMKLR1;TMEM64;LPL;AAMDC;ZBTB16;NAPEPLD;CEBPB
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.3125157591285224,-0.46797299722925334,0.9746835443037974,1.0,1.0,3/6,37.56%,PWP1;MTOR;MACROH2A1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.24958867936058937,-0.46769746010089797,1.0,1.0,1.0,12/35,40.07%,MYO16;EXOC1;GAB2;IRS1;PIK3CB;NF1;PLCL1;PLEKHA1;PI4KB;PI4KA;FGFR1;NGF
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.24013027585410848,-0.4664824996663926,1.0,1.0,1.0,9/30,34.91%,SMCHD1;RNF168;UIMC1;EGFR;EYA1;BRCC3;EYA2;SPRED1;NPAS2
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.2502969568167662,0.4647972628674348,1.0,1.0,1.0,3/11,10.50%,CD4;HLA-E;MAF
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.2905929835454828,0.46041907132706694,1.0,1.0,1.0,6/6,70.97%,KDM7A;PHF8;KDM4B;KDM4C;KDM2B;KDM2A
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.29094152344129953,-0.45982989292582577,0.9733333333333334,1.0,1.0,2/8,26.04%,UBE2K;RIOK3
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.2805627882439825,-0.45979532805540413,0.9868421052631579,1.0,1.0,1/10,12.22%,MYL3
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.2805627882439825,-0.45979532805540413,0.9868421052631579,1.0,1.0,1/10,12.22%,MYL3
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.2513361003024259,-0.4559243487029272,1.0,1.0,1.0,7/22,32.51%,SPOCK1;WASHC2C;MINK1;GCNT2;PIK3CB;NF1;CORO2B
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.26062834585949246,-0.4551918758950399,0.987012987012987,1.0,1.0,4/12,39.00%,DNM3;WASHC5;PRKN;DNM1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.21850414887724406,0.45321387230968196,1.0,1.0,1.0,1/11,7.44%,CHMP4B
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.23783056266213826,-0.4525477871422439,1.0,1.0,1.0,5/33,24.40%,RHOB;ROCK2;RHOBTB3;PAK1;GPM6B
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.2386666236549767,-0.4515619718302833,1.0,1.0,1.0,8/27,30.30%,PARVB;TMEFF2;MICALL2;ATRNL1;FN1;LAMB1;ITGAV;RADIL
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.2650269496084798,-0.45154084556264557,1.0,1.0,1.0,2/10,30.89%,UBE2L3;ATP1A1
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.2668011795747323,0.44467415786404296,1.0,1.0,1.0,5/5,73.34%,ANTXR1;ANTXR2;SLC22A3;ADAM10;SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.30056424610741334,-0.44217627038656393,1.0,1.0,1.0,1/6,24.26%,POT1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.2521871372992661,-0.44172797948584364,1.0,1.0,1.0,2/15,20.44%,GPM6A;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.2760194516627583,-0.4407688272642155,1.0,1.0,1.0,2/6,37.56%,SFRP4;MACROH2A1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.28168546853134974,-0.4395761117273483,1.0,1.0,1.0,2/6,25.59%,SUPT16H;ARID1A
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.28168546853134974,-0.4395761117273483,1.0,1.0,1.0,2/6,25.59%,SUPT16H;ARID1A
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.2726990532360701,0.43733443787808296,1.0,1.0,1.0,5/5,72.75%,NTF3;AGT;NTRK3;TMEM108;ZDHHC17
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.25804782403516585,-0.4343602142312958,1.0,1.0,1.0,8/16,45.19%,PARVB;GOLPH3;ABLIM1;ARHGEF4;RAC1;CCDC88A;CYFIP1;ARHGEF7
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.21604268054735065,0.43377716223952406,1.0,0.9999343914350851,1.0,4/15,14.42%,NDE1;DYNC1I1;KIF3A;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.27053264807638,-0.43360894309564196,1.0,1.0,1.0,3/7,38.54%,TP53BP1;SHLD2;PAXIP1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.24520963012705435,-0.4311211867564691,1.0,1.0,1.0,8/20,38.43%,DCDC2;MINK1;FARP1;CTNNA2;PTN;TMEM106B;BTBD3;DIP2A
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.22404779990416163,0.42939262846471743,1.0,0.9988230145916012,1.0,3/13,14.07%,MORC3;TAF8;PML
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.26781296660201187,-0.4234253566825715,1.0,1.0,1.0,2/8,31.09%,SIDT1;YBX1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.2628294970984777,-0.420560716923134,1.0,1.0,1.0,2/7,25.59%,SUPT16H;ARID1A
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.2442358127326681,-0.4145677101685042,1.0,1.0,1.0,4/14,31.34%,GPC4;FYN;GSN;LDLRAP1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.27072561508976334,-0.41295735491779406,1.0,1.0,1.0,1/7,24.26%,POT1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.26286841083089424,-0.41213621208940854,1.0,1.0,1.0,2/7,25.47%,MAPK1;LYN
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.25456613169310754,-0.41200159013201026,1.0,1.0,1.0,7/17,38.76%,NF2;CLASP2;BCAS3;CASK;RASA1;APOD;NEXMIF
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.2342067460350543,-0.4118919810155478,1.0,1.0,1.0,7/20,33.72%,SPOCK1;NF2;GCNT2;FBLN1;CORO2B;CASK;RASA1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.26664699515707857,-0.40988156960785244,1.0,1.0,1.0,1/6,21.29%,MDM2
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.23031106049805786,-0.40420198138643854,0.9885057471264368,1.0,1.0,10/17,43.42%,TGFBR1;NR4A2;CYLD;MADD;PPIA;CSNK2A1;SGMS1;TMBIM6;CSNK2A2;BCL2L14
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.20404271484636577,-0.37704033747149995,1.0,1.0,1.0,6/17,39.62%,RAB27A;EEA1;WASHC4;WASHC5;DNM1;USP8
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.21836830258383788,-0.36859685088431304,1.0,1.0,1.0,1/11,20.44%,NLGN1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.23350773096880173,-0.36849699272591707,1.0,1.0,1.0,4/11,29.68%,ADAM17;FLT1;SP1;COL4A3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.20632269376895984,-0.36210339176822287,1.0,0.999879860913263,1.0,10/26,42.79%,CLU;RPL5;RAD23B;UBE3A;RPL11;PTK2B;CSNK2A1;UFL1;NUB1;CSNK2A2
